<SEC-DOCUMENT>0000886163-23-000027.txt : 20230508
<SEC-HEADER>0000886163-23-000027.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508160729
ACCESSION NUMBER:		0000886163-23-000027
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		23897765

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:9386ca9d-b089-4ae9-b9e9-dc30d8ee3e97,g:2f56508d-7938-4ed2-96f4-a768c1bc35f3,d:ce8fdea4daf543e39470dd283be54686--><html xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:lgnd="http://www.ligand.com/20230331" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM18yLTEtMS0xLTE0MjQ3MQ_44680838-df5f-4c4d-badb-a78239159ec0">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM18zLTEtMS0xLTE0MjQ3MQ_c34f36bb-b838-4009-8799-56a30e6769d4">2023</ix:nonNumeric><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM180LTEtMS0xLTE0MjQ3MQ_d12094ba-c07b-471c-8c8a-6faabbda4458">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM181LTEtMS0xLTE0MjQ3MQ_2df1a4e7-8931-41ac-ad97-b0be427de96c">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM182LTEtMS0xLTE0MjQ3MQ_c13b027a-f2a3-4e6d-8f1a-dfcd124ce86c">December 31</ix:nonNumeric><ix:nonNumeric contextRef="ia82d4ad3cea140ef9a6f0c99ee594d64_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0wLTEtMS0xNTUyNTk_fe1a7d1c-c21f-4655-88cf-d34c7d6e9def">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="id5ecd9e788f34ffe8c0888b38e2b02ee_D20221115-20221115" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80Ni9mcmFnOjc4MTYzZWU1ZjA1YzQ3Y2RhMDgxMGI2MjY0MjBkMjgyL3RhYmxlOjNhNDE3OTQxYzg2NTRiMzdiYzQxYmJiODMyOTNlNzVlL3RhYmxlcmFuZ2U6M2E0MTc5NDFjODY1NGIzN2JjNDFiYmI4MzI5M2U3NWVfMi0xLTEtMS0xNDI0NzE_e3fd8a83-b2b6-4469-a953-8ed751e4233b">0.004839</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iab7dd9fb59ed49818e2ebb4ac883d055_D20221115-20221115" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80Ni9mcmFnOjc4MTYzZWU1ZjA1YzQ3Y2RhMDgxMGI2MjY0MjBkMjgyL3RhYmxlOjNhNDE3OTQxYzg2NTRiMzdiYzQxYmJiODMyOTNlNzVlL3RhYmxlcmFuZ2U6M2E0MTc5NDFjODY1NGIzN2JjNDFiYmI4MzI5M2U3NWVfNC0xLTEtMS0xNDI0NzE_3d225a31-e933-4383-a5de-f9be155932f6">0.0062907</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecbbb8a6bbb64a8dae52bdbe8040eb90_I20230504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie1301938b25745d0b99c779227731ddd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7f8aaddec77946839e2c7db82a635cd5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id674d396b37c4237beed113c89c2675d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b1846c1e72842cea62ab4d1e84368a3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac4e08b486c498488e4ec21236f70ac_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad8c3f3b74a145eba569dc88db6a0243_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0dbfa3c35724185bcf83cfd276f013a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeeb7f4be42949899bd810534b9af482_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34b2229f7744763b8ab956b6b6373a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bf026842b724db19523809726898537_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f445f5d04b0472a806b41285302bc93_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ecad473cf1472bad6c4b549c58808b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88f3991b11274a1d83e8d12453c31bde_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7bf770f68994031a86c11e53838362b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7216ff5406b44b1ba177f63fab7ca13_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i146393ab4a57499e86ded98459711b21_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81d3755ad9d54f8ab9d3436775b7948d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d62bd1799fc4cd490f4762c0c6517d4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e09b5d001d427fbb92bfc4d9d410d7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd2fac596ab64c99aae2ed65bc41289e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabcd11cab6e246f29bd95c8775e1803a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e33362d86644981a7f835e3abb11e2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic69a583af859424c904323cce6fc7c4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dcd4935652a40d29c4ba3d9eee90955_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e695c2f9aa945e39a8aad1f6b165a20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia82d4ad3cea140ef9a6f0c99ee594d64_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d0376708afe4578ba637e295776e58e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia95820899b06425fa25a5ff7bc95fbb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49152728d14c47108836dbcc6300eb78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic77a2c8cd6b54702aad3fc849424beda_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2195045e053d42548f70094593395273_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cec76fd474f414982654002b7611f04_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f11779e9d9b4e1f94f4e39f3ebccbe6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2f609468824c07b03425783adb6d36_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccf4e3b46ee2408aa97590c16ab24104_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i136be9af2fba4063bbe5c2f2224a8bae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dbc4a0411f74b34ab89e9e5c50f68a1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ddf6ce6c34e4acfae34f5a67089e27e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lgnd:segment</xbrli:measure></xbrli:unit><xbrli:context id="i65eeea1681704584af49987ac1e87675_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc33e31ac6cb43b7a3645f8b84193980_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcf62d0f95754c7295cc30e21972ebf8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i252ec6f092314ab183cfe571c994ac8b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i507e16f565324f84b591860daa92de64_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2214c64514eb49f2a8842771d28dce64_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i471ece02df084a638a5073e4e480760e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie460943c319f46f089b3dbac6d243d9c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i603a416169e44298a4e5e843b920577a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icab12c145b7a4a9386bead15014c2002_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d1e076699044354a517e91f65469898_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb74890b7510460d8f61f873e0236e2a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9aa759764214b4c9217f0f8b8b0bf12_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65ab7c5558dc4b2691364948dff9c3bb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e6b2467288481aa925463f0f2dfa48_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2a0b5f22124e0299cea65f936d0552_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic358d5ad2b4745ce8983d4eb13528034_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf6169f7de846d8b64a2d389e36a41a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dd089aaa47c4e3f803998025bdb0535_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a21caa530e4123b94f8358586e06f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a5ad898201d43378731028a1922d796_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59e2033d633a4c469bd9429bc3777327_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c6bf9aba4794d65841b444357010217_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9af904e6214a46b3913fbe243bd898e5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ace55ddf80493b9b3d55cb674104bb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc7dff39832419b9fade16b421649d8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02a49f05176146c7b857da134f78d9be_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1cc642360a843b4be5f97a5be47caf6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i851627360fcd4241918ea438e1eab5ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d5edfb22d8410c8c18477fedb0c132_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb5915e8af3848bab85d86525cc3ec55_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i961c8d92f57e44838827ed1e6b8d9094_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4558a7c600248d4877505fd0fe0dac4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453dc18f50a14d2f9ad41790b6e0d175_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aee0771a079448d978ce5fbb46ef39d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="icab684ceae90430cbdf56e58b13b7729_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i829bcc778f774caeb60dae78412a98b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2561a5b37f2b48c99b837d7e54c57638_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00a1d092574043ac8fa8de0d23f735b1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61c033ee7b9c41bc8ce219eaf434f0fd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ff718d557e41b8a4a3be385a2d6d0d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd14e785e014eb993155735df108dfc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c4546dd49864a548bead9153260fd3d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5f7ff0e996a4591a2178b25ce967a99_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3209d0976344348a32b6d380fe3e5f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i412c3b19a5834235af99c2beb065ad68_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83dfae755f5a424a8225bff059206ef3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbeaa2397af04381b99149bf21997427_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab4f1100a55e4741878f092afbfc948d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9609e0c75f964fe2ac7c051438151f59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9fc13b3b0ca47478c28400effc30e73_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9c521f34b14454b143d1664a18a4cf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcdb5f68fd0845c89b3679a08f903458_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032e4336c3474c48b0ccfb9dc291e4eb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if81e6ed11d5b42fc92035e63ce70dab8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e9100c0c4a443939a76ff1a531948bf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dffa8f58aaf4d11b456a8821fe00c3d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ce88b885fc645c2be76eb7ae40e211f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa4dea889b3439d9ac7398cfa1a4773_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506f1c021fc0401fb3e152136e091307_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97986f33b4b455eab691feb1d28c9f6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cbda0e4f007472c8c052957a3e4b0e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd3a95bb7954a1c8b2b9ec9fb784037_I20221026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74c3b7100ae2469aa40de930920f80f3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dfb70c51fa941509f903b3ca26a5da0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i763012af38d44192b91ccced32b2f90c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f664e124e444754902048088f15d009_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af671b89641435c982e3ec096f05e13_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie398cfae0ed945faac086dc8267aff48_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be7139166474f9ab25b9eca300d94ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i915548846dd64cd49f3ecbc68b7eb50a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17e761190bb48beb5cea13631d8dfa7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aa89bb486b842e7aff0da151ea9a775_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie872097758d948b3a91b3e4335d836d6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96faa6fa418473291f9eadf582cb120_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7841b4be52746df9806cf6af4497ed3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff7de56710d4853a5026ad4854f9d4b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40daf9abfb134159be20eab4b760217b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eb9be9f22f54a458d0741083b4fffc6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626c103c32154c218e186b029cbda1e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16f7532e1db94ae1a31213e245adfb77_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie74e651db4b74a518b5c4442d96bfb40_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieee5a6d6de4e4ff4a3795c420443d61b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e4a19aec8e14496aac9d086c4eba78d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0269fb8261c141bab51cf071a61d89b3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff86df6b5e5a4a6faf716a2960401b63_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i163330301f1d4bcbbb46e375f3c79026_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i018145fcba3c41c1883b1f339bac39e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57855c3f2b4476a90c99722257f527e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87e940ff49984106a6ac855a4ae9899a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7356828798748ceb3633210d92c6664_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81bb98cab8574fe5866d8e7a307f0b74_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61bedf7508b14e8daf449211c964cd8e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e3e4858f3084a0590a2499ed0047750_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf45dbfb87d9402794f19a8fa810d6b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i885006a6753a4da88eed97931a8a1096_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b9d43cacb34c8ea3696baaeee38eb4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right"><xbrli:measure>lgnd:contingent_value_right</xbrli:measure></xbrli:unit><xbrli:context id="ifcfb68dc76174bf49f8bd077bd649ae1_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc2d9f773bb14b7fb48e90c6374538fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15a6dc40dbc74b84b8d5b169e75d071a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i168fdc9ced384d3482e3122242ace085_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad7a5d1cc5a45b3993c229ec308f769_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b9ba0d8fd854d3c980983fb9630d586_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib161369e802141d388e0bea65e72d1d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4ea1e8485f3460f9907ff44108c41a4_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id16b6127458b4c908501afd350114da9_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i745a3728e2854def929ed3c0ccc7d673_I20221115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic58510ba16f14f209b3c357f93c9d563_I20221115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba60861c19649ff96ba66c6b831281e_D20221115-20221115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-15</xbrli:startDate><xbrli:endDate>2022-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife99d31e979b471fbacc856adb204f2e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d75f220eeb405ab2f4a34303ec71f6_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71225d3c8a82435fa5cd738c3aa181d8_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebf2d4e5f2594065932aeccee4503461_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06fe0a09def94247bbb7916c23ae3017_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfd5947b908543809e005a7628c9487d_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff179ee295ea4d7c9424bd57cab84b84_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54feecd19751474e8d9edd51ce5839ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5ecd9e788f34ffe8c0888b38e2b02ee_D20221115-20221115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-15</xbrli:startDate><xbrli:endDate>2022-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7dd9fb59ed49818e2ebb4ac883d055_D20221115-20221115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-15</xbrli:startDate><xbrli:endDate>2022-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b031e51a09841e2bba31484e4e6ba22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i233c304b9e6749139554635d622968a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if88ab5f328b647e6a0703df984333731_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488634fa2ce945148adf1d9adc77ea34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ed6d7e4223c47f4aa33849b39b77065_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia698121e1ecb4b6a8dd84ec11d176568_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lgnd:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib199687300914de5bd23ec149948555c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civil_complaint"><xbrli:measure>lgnd:civil_complaint</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="ice8fdea4daf543e39470dd283be54686_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8xNzI_7a6d2203-4183-46eb-90f4-dd911ed7922d">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6Y2FhZjY0NDExMGVkNDAwMDk2Yzg1ODQxMmZiMDM4OTIvdGFibGVyYW5nZTpjYWFmNjQ0MTEwZWQ0MDAwOTZjODU4NDEyZmIwMzg5Ml8wLTAtMS0xLTE0MjQ3MQ_c6a4143f-2703-403c-9090-39c909eeab62">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yOTY_a834f892-ca12-40aa-964a-bd27bf294737">March&#160;31, 2023</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6NjA0NGViOWNhNGM5NGVjY2E2ZjAwMTUxODQ3NDFlMTQvdGFibGVyYW5nZTo2MDQ0ZWI5Y2E0Yzk0ZWNjYTZmMDAxNTE4NDc0MWUxNF8wLTAtMS0xLTE0MjQ3MQ_245e7b41-9db6-4ba4-97a9-cb9097f42dd3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAy_c936a9ee-62c7-45c4-8761-6fd598f7c4d0">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="lgnd-20230331_g1.jpg" alt="Ligand-Logo-Registered5.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8zOTg_033a5a84-c5fc-4234-b7e7-9f1ecd8f88b3">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV8wLTAtMS0xLTE0MjQ3MQ_24bdf721-91a1-419f-b792-1f0f34204588">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV8wLTEtMS0xLTE0MjQ3MQ_5c46cc84-7812-4fb1-847c-d5d55c1a373d">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV8zLTAtMS0xLTE0MjQ3MQ_53823bac-bfea-4531-ade7-650b0b0e5127">3911 Sorrento Valley Boulevard, Suite 110</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV80LTAtMS0xLTE0MjQ3MQ_931669da-5688-425c-8658-704bcf88bf01">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV81LTAtMS0xLTE0MjQ3MQ_192ebae9-ca55-4a35-8cb3-3fd1a3f069ec">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV81LTEtMS0xLTE0MjQ3MQ_50623821-f744-4115-8fde-57b8bb87590f">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAz_c14c9f3f-6168-4a5a-802b-942736726cd4">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzA0_d4ca4737-3fd6-41be-9034-c6ce01107666">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6ZmI2MGZiMjVmNzBmNGE2YTlkMzIwMjA2MDM0NThlNTAvdGFibGVyYW5nZTpmYjYwZmIyNWY3MGY0YTZhOWQzMjAyMDYwMzQ1OGU1MF8xLTAtMS0xLTE0MjQ3MQ_561a28c0-760a-4694-b634-36197c28eeee">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6ZmI2MGZiMjVmNzBmNGE2YTlkMzIwMjA2MDM0NThlNTAvdGFibGVyYW5nZTpmYjYwZmIyNWY3MGY0YTZhOWQzMjAyMDYwMzQ1OGU1MF8xLTEtMS0xLTE0MjQ3MQ_321c6a3d-8087-466f-ba4e-b70ed1993d28">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6ZmI2MGZiMjVmNzBmNGE2YTlkMzIwMjA2MDM0NThlNTAvdGFibGVyYW5nZTpmYjYwZmIyNWY3MGY0YTZhOWQzMjAyMDYwMzQ1OGU1MF8xLTItMS0xLTE0MjQ3MQ_42439529-aea4-4642-b26e-0611644afccc">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzA1_ab376826-db37-4708-847e-854709bc84f9">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAw_85c54407-c5a3-4e55-a034-d67d0a3bfdfa">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; </span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6YjBlOWQzMmQwNjFlNDEyY2JlYzYyYjZlNWE4MDM2ZGQvdGFibGVyYW5nZTpiMGU5ZDMyZDA2MWU0MTJjYmVjNjJiNmU1YTgwMzZkZF8wLTAtMS0xLTE0MjQ3MQ_eef6b635-9668-4aed-805a-5125c32c095e">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6YjBlOWQzMmQwNjFlNDEyY2JlYzYyYjZlNWE4MDM2ZGQvdGFibGVyYW5nZTpiMGU5ZDMyZDA2MWU0MTJjYmVjNjJiNmU1YTgwMzZkZF8xLTQtMS0xLTE0MjQ3MQ_9f236061-d018-4f7c-9276-3e18f2b514de">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6YjBlOWQzMmQwNjFlNDEyY2JlYzYyYjZlNWE4MDM2ZGQvdGFibGVyYW5nZTpiMGU5ZDMyZDA2MWU0MTJjYmVjNjJiNmU1YTgwMzZkZF8yLTEtMS0xLTE0MjQ3MQ_9289300a-4869-470e-b1f2-556ae6ef93dd">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAx_e22a518c-c4a0-4bcf-8b44-cae30c68e653">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  &#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of May&#160;4, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="iecbbb8a6bbb64a8dae52bdbe8040eb90_I20230504" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMjYz_ed4bbbea-3781-4dae-a932-b96bf42d2679">17,272,547</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_64">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_64">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_76">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_76">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_79">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_79">27</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_85">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_85">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_88">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_88">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_91">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_91">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_94">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_94">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_97">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_97">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_100">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_100">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_103">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_106">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_106">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ice8fdea4daf543e39470dd283be54686_106">29</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2022, filed with the SEC on February 28, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Avista Public Acquisition Corp. II (prior to its domestication in Delaware and change of name to OmniAb, Inc.)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Medicines Agency</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of March 23, 2022, among APAC, Ligand, OmniAb and Merger Sub</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Sub</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orwell Merger Sub, Inc., a wholly owned subsidiary of APAC</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">New OmniAb</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II and after it domestication in Delaware)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb Operations, Inc. (formerly known as OmniAb, Inc. and prior to being spun off by the Company)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb Business</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Ligand's antibody discovery business (prior to being spun off by the Company)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q1 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q1 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation and Distribution Agreement, dated as of March 23, 2022, among APAC, Ligand and OmniAb</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Year-to-date</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="ice8fdea4daf543e39470dd283be54686_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="ice8fdea4daf543e39470dd283be54686_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except par value)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMy0xLTEtMS0xNDI0NzE_d872bd37-b343-44a6-8cec-116707812df4">88,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMy0zLTEtMS0xNDI0NzE_d583080b-5853-4be3-b52d-683c0f66ab6b">45,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNC0xLTEtMS0xNDI0NzE_11b9c6fb-5935-4b8f-88a4-a3ac7dcebeaa">193,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNC0zLTEtMS0xNDI0NzE_074321b5-2970-4658-a334-c02ee1b1fcf0">166,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNS0xLTEtMS0xNDI0NzE_3d370262-6760-4e31-8808-b5be714a059e">29,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNS0zLTEtMS0xNDI0NzE_be735f8d-6004-4740-ac23-eea19bfcb576">30,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNi0xLTEtMS0xNDI0NzE_836b7ebb-82be-4750-b3ec-581e789d9d53">14,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNi0zLTEtMS0xNDI0NzE_b173eee1-3e88-4754-a1ae-8b1b5b0ac390">13,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNy0xLTEtMS0xNDI0NzE_b5065a23-438f-4b31-817f-6ddcb35e541a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNy0zLTEtMS0xNDI0NzE_53f848e0-f8d8-4ac7-8469-b96957b760dc">4,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOC0xLTEtMS0xNDI0NzE_7bebf3cc-923d-459f-8887-2cb125beb1bc">2,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOC0zLTEtMS0xNDI0NzE_87b6e2b4-00cf-471d-b5d5-e1c665dc5ec0">3,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOS0xLTEtMS0xNDI0NzE_e29f8508-054b-49b6-97f4-c574d2f1daef">328,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOS0zLTEtMS0xNDI0NzE_9cdbd452-9fa4-4a20-bed1-9205449fa39c">263,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTAtMS0xLTEtMTQyNDcx_6b3ca74d-f1ec-42ff-bb50-875dce62da4b">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTAtMy0xLTEtMTQyNDcx_085325f3-6eda-448e-9422-d5f5a7b355f4">8,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTEtMS0xLTEtMTQyNDcx_35c458f6-7850-48e0-a0ac-2b93b5477b65">333,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTEtMy0xLTEtMTQyNDcx_a4d726a6-7f59-4b4f-8d2f-3eb041b07343">342,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTItMS0xLTEtMTQyNDcx_9ec3f810-1164-4e81-a17f-f2a383ce9ca3">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTItMy0xLTEtMTQyNDcx_e7a68fb5-62ff-4e2e-a750-0bf57bc4050c">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commercial license rights, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTMtMS0xLTEtMTQyNDcx_dea9d91a-f377-4b95-b7d9-7d00eb744b2e">10,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTMtMy0xLTEtMTQyNDcx_57542daf-3c93-4f18-9e5e-1e2b1b4c5466">10,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTQtMS0xLTEtMTQyNDcx_29475e8c-198d-49ed-b7e2-6ababd475ec2">11,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTQtMy0xLTEtMTQyNDcx_a83aa778-09d8-4f17-852e-b80bb34e9ab3">12,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTUtMS0xLTEtMTQyNDcx_a44cf54a-fbb8-47c5-9432-02a7c2b0f095">11,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTUtMy0xLTEtMTQyNDcx_6f0d7c99-2d4b-44d5-97b5-7cae604ffd78">10,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTYtMS0xLTEtMTQyNDcx_66daf124-4d37-4608-b473-100cfff4a476">3,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTYtMy0xLTEtMTQyNDcx_e07d33e6-0006-4e61-a5f9-e6c47a0deb23">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTctMS0xLTEtMTQyNDcx_55076947-654a-463b-99d8-e5c64ae585ad">4,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTctMy0xLTEtMTQyNDcx_163e7f30-d895-4dc1-9522-fc5b8ce231cc">4,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTgtMS0xLTEtMTQyNDcx_cdb42a93-05ae-4721-b2a2-3d943a4db75b">811,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTgtMy0xLTEtMTQyNDcx_953c1211-4e81-469c-abb0-3cdb7cc53933">762,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjEtMS0xLTEtMTQyNDcx_5cc2cbf7-4adc-4bff-9f87-fd464650528d">6,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjEtMy0xLTEtMTQyNDcx_2715f1c5-5e37-4507-9a79-a1bd7a2c2123">5,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjItMS0xLTEtMTQyNDcx_be1db39f-59e0-4e7f-9582-7e7216adb8ce">14,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjItMy0xLTEtMTQyNDcx_30d26149-a0e2-4574-ab13-a98690322331">15,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjQtMS0xLTEtMTQyNDcx_b80e8e80-713c-4e32-b90a-ac681815c200">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjQtMy0xLTEtMTQyNDcx_465bf60f-2c83-4dbf-b5ff-b0f39e59af5f">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjUtMS0xLTEtMTQyNDcx_0666daf8-164c-4649-a529-ffb0226fa7c2">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjUtMy0xLTEtMTQyNDcx_1303dd9f-7fea-47aa-80db-f82d8f7c00de">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjYtMS0xLTEtMTQyNDcx_1f36cd14-8759-4154-9db5-58b6eb5634f7">660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjYtMy0xLTEtMTQyNDcx_a8abbd4c-5777-47d9-b906-859fef07269b">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current financing lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjctMS0xLTEtMTQyNDcx_f83eedbd-9c84-40bb-bada-a6b0c70c970e">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjctMy0xLTEtMTQyNDcx_9f508e6e-2fd5-45d3-a4e2-a2553c08f6aa">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjgtMS0xLTEtMTQyNDcx_59eaac34-6b3c-48c0-845f-8742398a35ea">76,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjgtMy0xLTEtMTQyNDcx_c6fe1ee3-2a7a-4ac9-8341-2527d5dc102f">76,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjktMS0xLTEtMTQyNDcx_131ce4b0-bf02-4f58-99a0-9204481dc074">98,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjktMy0xLTEtMTQyNDcx_f2077dd9-d81b-4e02-8895-5a5ddbfa8e20">98,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzEtMS0xLTEtMTQyNDcx_ed7c24e5-03f7-4081-b802-836bc5b52ea1">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzEtMy0xLTEtMTQyNDcx_a7c775f4-b834-41dd-83f4-149a4953fb07">3,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzItMS0xLTEtMTQyNDcx_b6a28245-db98-4e7a-9d17-4b94719a9a8c">30,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzItMy0xLTEtMTQyNDcx_c8c70c1e-26ab-4b52-9b29-b2b29a7e3d5c">30,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzMtMS0xLTEtMTQyNDcx_d590a051-f644-4eda-b147-b34bf43b1652">11,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzMtMy0xLTEtMTQyNDcx_6393e1d6-fb99-457a-8bed-ad41d644fd37">10,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzUtMS0xLTEtMTQyNDcx_80f847c8-122e-46f8-bb4a-d1f607047d7b">21,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzUtMy0xLTEtMTQyNDcx_3e48fcf9-ce07-42df-bd02-2dd31264231a">21,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzYtMS0xLTEtMTQyNDcx_1f77a480-2245-4b9a-84c9-ff6a5ddf1bf6">164,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzYtMy0xLTEtMTQyNDcx_2534c543-6ce6-4a4c-95f7-48a85200093b">165,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzctMS0xLTEtMTQyNDcx_50a27a87-30b2-403f-8bed-5f9553d9475d"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzctMy0xLTEtMTQyNDcx_ede440d2-e5f4-431a-ac84-6555d537bd8c"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMjQ_b14c8aed-5745-411f-996e-36371ee8bcf2"><ix:nonFraction unitRef="usdPerShare" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMjQ_df663241-8926-4417-8ae5-7406e55aa073">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMzg_4ae9d531-b2a5-4409-8ccc-4ddff0f98a49"><ix:nonFraction unitRef="shares" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMzg_598d1377-c25d-439c-8fc6-095fcbe295b8">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_251da238-4bad-4cb0-a5d9-44c0beb256bc"><ix:nonFraction unitRef="shares" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_2652d4f3-2199-49c1-b8f7-17d5697f2a43"><ix:nonFraction unitRef="shares" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_43de8e9d-2bee-4035-be8f-b4f9186433e4"><ix:nonFraction unitRef="shares" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_d23bd223-ba1f-43e9-ae7f-1d45e7d4ef05">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMS0xLTEtMTQyNDcx_ec0162fa-5477-4523-bc71-db2b2d53e473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMy0xLTEtMTQyNDcx_f181b446-6460-41e6-aa13-a8802709730c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMjE_1527d3f9-8941-4f0c-9822-d5f385543220"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMjE_209ef87e-faff-4a01-891f-c262ed5267fa">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMzU_b809b113-34a7-4123-a8f1-7c5dceb20528"><ix:nonFraction unitRef="shares" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMzU_e223dbb3-c1a8-48ac-baa1-b0551580df4d">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNTc_01882027-9cd3-48e4-81e9-65efefb0fa21"><ix:nonFraction unitRef="shares" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNTc_894b7259-528d-4995-a4d7-59488bc2fa5e">17,134</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNjQ_11cc6b25-959e-4ff4-ba84-7bd4122a7bb3"><ix:nonFraction unitRef="shares" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNjQ_ede47baa-1f99-45b6-a66c-2e7892cf671c">16,951</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMS0xLTEtMTQyNDcx_b85818a7-09fe-42a5-a9c1-d6b567e9dbb6">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMy0xLTEtMTQyNDcx_2c3f10df-46fe-411f-ab0b-452837a0597d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDEtMS0xLTEtMTQyNDcx_c5d935bc-a3ed-48f7-a8b8-8230449e2bb0">154,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDEtMy0xLTEtMTQyNDcx_8f98053d-f790-459c-81e4-a607a7755430">147,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDItMS0xLTEtMTQyNDcx_713a94b7-8f7f-42a1-bede-22f0cef1cf71">935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDItMy0xLTEtMTQyNDcx_133502ee-a659-4ccd-8bc0-ff1bb6274787">984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDMtMS0xLTEtMTQyNDcx_f43e9903-d624-4b65-a118-30183975ca10">492,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDMtMy0xLTEtMTQyNDcx_17330034-243e-41d5-b5b8-9ff05dc23ea9">450,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDQtMS0xLTEtMTQyNDcx_6c41ff16-4b37-492c-bfd3-878b2ca51573">646,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDQtMy0xLTEtMTQyNDcx_5da636ac-1676-4662-adc3-3e7a15c8024a">597,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDUtMS0xLTEtMTQyNDcx_41018261-a35e-4515-8ca9-6b7e283ffaf3">811,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDUtMy0xLTEtMTQyNDcx_5bc53f70-63c5-405a-8c5b-ab26ca89d36a">762,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:67.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id674d396b37c4237beed113c89c2675d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNC0xLTEtMS0xNDI0NzE_cf2dec23-f574-46c6-89e6-64bcdced0932">17,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1846c1e72842cea62ab4d1e84368a3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNC0zLTEtMS0xNDI0NzE_f62fe2bb-1cea-4e7c-8bee-c7947fb39027">13,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac4e08b486c498488e4ec21236f70ac_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNS0xLTEtMS0xNDI0NzE_c2a9237d-dba1-4527-8630-baf38b803c46">10,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad8c3f3b74a145eba569dc88db6a0243_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNS0zLTEtMS0xNDI0NzE_3df7a690-fdbc-4a2b-95a3-74bafe289763">12,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0dbfa3c35724185bcf83cfd276f013a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNi0xLTEtMS0xNDI0NzE_3a2d1b5a-ae82-48fd-b4ba-9567a5b2c6d2">16,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeeb7f4be42949899bd810534b9af482_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNi0zLTEtMS0xNDI0NzE_a7c200fb-707a-4d5a-b283-ab0639d9f599">10,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNy0xLTEtMS0xNDI0NzE_58e0a30d-683c-406a-b149-30f3803f09d1">43,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNy0zLTEtMS0xNDI0NzE_f29efc4c-1461-412f-8854-97058d877f3d">36,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfOS0xLTEtMS0xNDI0NzE_e125f651-2860-4b15-a108-622a8202587b">3,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfOS0zLTEtMS0xNDI0NzE_eb0a54ec-9b3d-4ff6-9170-7fa573cd2c12">4,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTAtMS0xLTEtMTQyNDcx_e3f73a4e-a368-459e-af8f-0504c2737a88">8,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTAtMy0xLTEtMTQyNDcx_88b80cc4-90cd-413a-93ef-bcdf3e263669">8,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTEtMS0xLTEtMTQyNDcx_80ccdb3c-2491-4244-be36-1abd0f2e3376">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTEtMy0xLTEtMTQyNDcx_e12e7b4a-1ead-4574-a6ba-0012e4744ded">9,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTItMS0xLTEtMTQyNDcx_78922eab-fdaf-4a69-a1f2-7be0aaffc50a">10,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTItMy0xLTEtMTQyNDcx_249d567b-4fad-4702-a9dd-0f0630727f99">11,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTQtMS0xLTEtMTQyNDcx_c35f2252-30c6-403a-9d7c-f89fd94a314d">29,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTQtMy0xLTEtMTQyNDcx_50cd9a5a-0a9e-46a5-a8ac-9382e47c737e">34,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTUtMS0xLTEtMTQyNDcx_0dbb2fb3-ea13-4176-8f7c-ffdb86b7b39b">14,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTUtMy0xLTEtMTQyNDcx_0f1457e4-f0ba-438f-977c-dfe88b83d621">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTctMS0xLTEtMTQyNDcx_9302033b-0c13-4e3d-b00b-1bc77e42a53a">39,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTctMy0xLTEtMTQyNDcx_1ab2395a-8a86-499e-847f-5e48f463faba">12,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTgtMS0xLTEtMTQyNDcx_7c04aa10-554a-4fed-b1b5-d6fe1c8066e9">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTgtMy0xLTEtMTQyNDcx_5beaf4d9-bd42-448e-93da-9c914fa530ac">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTktMS0xLTEtMTQyNDcx_f0e215be-3cc3-48f8-b6ee-05b12bc77926">240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTktMy0xLTEtMTQyNDcx_958437bd-c9ee-4f64-be62-d57bf27540a4">789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjAtMS0xLTEtMTQyNDcx_17020cfc-3bb3-4b63-a435-f19dd9d7157b">603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjAtMy0xLTEtMTQyNDcx_fc03591a-a163-4e2f-b58d-5ae3fd711857">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjEtMS0xLTEtMTQyNDcx_b4e78f23-cd85-45a6-9648-aded3d87dfeb">41,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjEtMy0xLTEtMTQyNDcx_a5dd2280-7384-41fb-9f61-db7aa1c71b2a">11,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss)  before income taxes from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjItMS0xLTEtMTQyNDcx_cc08786a-d61c-4a79-b126-bb38c58e21f8">55,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjItMy0xLTEtMTQyNDcx_de1206ad-c87a-44d0-895a-b97eca2f4319">9,144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjMtMS0xLTEtMTQyNDcx_b9baa159-9531-4d77-bb3d-f4c21431aa1e">11,922</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjMtMy0xLTEtMTQyNDcx_5812b5cb-4125-469b-924b-6e107cb590cf">3,785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMS0xLTEtMTU1MjQy_81b54c3c-bcf3-49fb-9b8c-26db03caba59">43,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMy0xLTEtMTQ0ODIz_e50e705c-2f50-4ee6-937f-7d0ba171a6ed">12,929</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjUtMS0xLTEtMTU1MjQy_f2ff8d7f-db4d-461b-b8f5-9dbcbebb35d7">1,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjUtMy0xLTEtMTQ0ODM3_18b7a837-731a-44ce-a866-3d34b90f4414">2,456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMS0xLTEtMTQyNDcx_3e583849-a62f-45fe-8fd8-02fd19f7930c">41,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMy0xLTEtMTQyNDcx_6475f5d5-b47d-4a20-a1ae-a29a6a2dceac">15,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjYtMS0xLTEtMTQyNDcx_cb322ff0-d039-4e97-a191-1530361ae691">2.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjYtMy0xLTEtMTQyNDcx_fc0e108c-f86e-4eed-a559-7c2a16661bba">0.77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net loss from discontinued operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjctMS0xLTEtMTQyNDcx_a749544b-e7f7-45ba-8255-d60895399b5e">0.10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjctMy0xLTEtMTQyNDcx_e51fcb47-09ae-4a19-a568-e7de75ec5e67">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMS0xLTEtMTU1MjQ0_7e5f46cc-e419-4f99-9189-ebb21ee98a11">2.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMy0xLTEtMTU1MjM4_f7568210-f159-48f9-bbaf-5c4320f2e3bf">0.91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculation</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzEtMS0xLTEtMTU1MjQ4_0e307a08-01a2-402b-aae4-6e1d7ea9fd54">17,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzEtMy0xLTEtMTQ0OTA5_e08aae95-1e8b-4b20-872c-484b4754cea2">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjktMS0xLTEtMTQyNDcx_ebee0942-852a-4bed-81ac-6234877d852f">2.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjktMy0xLTEtMTQyNDcx_ac84b176-2b3f-42c1-92a2-6407927372d3">0.77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMS0xLTEtMTQyNDcx_82ef2362-ea57-43be-a845-ccce7d4a1740">0.09</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMy0xLTEtMTQyNDcx_7764e38a-0628-44be-86a3-cecccc06c41a">0.15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzUtMS0xLTEtMTU1MjQ2_23294e7c-6ccd-490e-aa9b-8ed95ba6628c">2.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzUtMy0xLTEtMTU1MjQw_74d90240-468f-4c38-97b9-fd6fc20cca44">0.91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzYtMS0xLTEtMTU1MjUw_01baa84e-aad0-4230-a858-bc2cbdb7f4b7">17,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzYtMy0xLTEtMTQ0OTU3_2fc60587-c6ab-4f06-bcee-62381cc5d97b">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"></td><td style="width:63.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.970%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfMy0xLTEtMS0xNDI0NzE_96237ef3-5420-4293-8216-881e0f138d53">41,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfMy0zLTEtMS0xNDI0NzE_585ae87e-829f-4ee4-b2be-b403c67e575c">15,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net gain (loss) on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNC0xLTEtMS0xNDI0NzE_a86e5a11-1423-4f38-87be-f94c3b10dae5">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNC0zLTEtMS0xNDI0NzE_1d5b5c9c-90bd-400b-a3f8-d9e3ad419ee3">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNS0xLTEtMS0xNDI0NzE_be0c3bc0-6b71-46c0-b8c6-b10ed273c6af">41,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNS0zLTEtMS0xNDI0NzE_bda48f12-3df9-4907-af71-82ce28d0ed4e">15,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic34b2229f7744763b8ab956b6b6373a2_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi0xLTEtMS0xNDI0NzE_538435f8-9071-433c-85e5-e94aaed86593">16,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34b2229f7744763b8ab956b6b6373a2_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi0yLTEtMS0xNDI0NzE_2cbc3580-baa5-452a-baf8-e1e1b087fb4b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf026842b724db19523809726898537_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi0zLTEtMS0xNDI0NzE_a9289047-f977-4a6c-8a77-1ad3c045b635">147,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f445f5d04b0472a806b41285302bc93_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi00LTEtMS0xNDI0NzE_bb94eba3-bb5f-41a0-a4e5-247addf573cf">984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ecad473cf1472bad6c4b549c58808b_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi01LTEtMS0xNDI0NzE_16e0c6b7-6ef3-4eed-b6c3-ce7d55342fb7">450,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi02LTEtMS0xNDI0NzE_014e0bf8-b597-4314-9fe3-8731cc0c0640">597,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88f3991b11274a1d83e8d12453c31bde_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNC0xLTEtMS0xNDI0NzE_45aee39f-e484-4a05-81f4-4816c3bbcf27">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7bf770f68994031a86c11e53838362b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNC0zLTEtMS0xNDI0NzE_1ebab201-5c1b-4d83-93d3-3f18c08fb9d6">762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNC02LTEtMS0xNDI0NzE_f1296b50-8d3b-4855-8f76-ddc2b462cc80">762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bf770f68994031a86c11e53838362b_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNS0zLTEtMS0xNDI0NzE_9a0d5a17-f90f-4f9d-8938-f4a92c200b81">5,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNS02LTEtMS0xNDI0NzE_4c8d7c2e-0f24-4bdc-b806-a0f87a6ef573">5,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7216ff5406b44b1ba177f63fab7ca13_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNi00LTEtMS0xNDI0NzE_320d337d-58d4-4174-9e8e-1e210d3fb541">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNi02LTEtMS0xNDI0NzE_5b29a7be-1b55-4176-a144-a2a510849970">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Final distribution of OmniAb</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bf770f68994031a86c11e53838362b_D20230101-20230331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNi0zLTEtMS0xNjA2MTM_34fc2ab1-fe44-49f8-8bf3-96c3504c92ae">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNy02LTEtMS0xNDI0NzE_23cbc02f-cc4d-47dd-939d-6e915be5037f">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146393ab4a57499e86ded98459711b21_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOC01LTEtMS0xNDI0NzE_0c0d8e92-81d3-426a-9ad1-b844f140ca2a">41,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOC02LTEtMS0xNDI0NzE_8534d21f-359f-4891-827f-76df2556eff5">41,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81d3755ad9d54f8ab9d3436775b7948d_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS0xLTEtMS0xNDI0NzE_baa6028a-a9a8-4665-b3b6-daa21aab678c">17,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d3755ad9d54f8ab9d3436775b7948d_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS0yLTEtMS0xNDI0NzE_1531bb28-1e4f-4828-9a6a-f76ad96fdeb9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d62bd1799fc4cd490f4762c0c6517d4_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS0zLTEtMS0xNDI0NzE_d7066ddf-8ad4-4585-966f-6ea0e6b608a5">154,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67e09b5d001d427fbb92bfc4d9d410d7_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS00LTEtMS0xNDI0NzE_b6363311-7160-47ac-a507-eef8320153d6">935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2fac596ab64c99aae2ed65bc41289e_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS01LTEtMS0xNDI0NzE_f6bbf927-2772-4d61-bf17-289ca82f7d46">492,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS02LTEtMS0xNDI0NzE_35e05e79-e2a0-43f7-84d9-b77f0d660597">646,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iabcd11cab6e246f29bd95c8775e1803a_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi0xLTEtMS0xNDI0NzE_ddb1e938-5f2e-4755-b702-5591edc8a580">16,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabcd11cab6e246f29bd95c8775e1803a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi0yLTEtMS0xNDI0NzE_db27ea36-ff94-47ee-88de-d83a561f7777">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e33362d86644981a7f835e3abb11e2a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi0zLTEtMS0xNDI0NzE_354a93da-e7d1-4bc0-b830-2f38fde89f26">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69a583af859424c904323cce6fc7c4c_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi00LTEtMS0xNDI0NzE_a1a5028b-6bc4-4978-8463-50d8f7962aef">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dcd4935652a40d29c4ba3d9eee90955_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi01LTEtMS0xNDI0NzE_21a7a876-dbba-41a4-9759-4a142d4262c4">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e695c2f9aa945e39a8aad1f6b165a20_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi02LTEtMS0xNDI0NzE_4420df55-5f24-47d9-8e25-60ebb1721f46">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0wLTEtMS0xNTUyNTk_fe1a7d1c-c21f-4655-88cf-d34c7d6e9def">ASU 2020-06 adoption, net of tax (Note 1)</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d0376708afe4578ba637e295776e58e_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0zLTEtMS0xNDU2Mjc_47f5090d-3576-4793-8c58-e407aee11c39">51,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95820899b06425fa25a5ff7bc95fbb4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy01LTEtMS0xNDU2Mzg_428a4b4c-21a7-442c-8748-0c159b8b1c22">35,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49152728d14c47108836dbcc6300eb78_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy02LTEtMS0xNTUyNTk_6bc5a6dc-f6c2-4801-ba00-d5fbfe1b157a">15,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic77a2c8cd6b54702aad3fc849424beda_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0xLTEtMS0xNDI0NzE_2cd1ce45-9ed6-464d-88c4-da792fb3e4b8">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77a2c8cd6b54702aad3fc849424beda_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0yLTEtMS0xNDI0NzE_146bce1c-8d82-4309-8592-0ac65b6a3c8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2195045e053d42548f70094593395273_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0zLTEtMS0xNDI0NzE_d4ffb068-bf37-44a5-9d08-d7a6cd5564bd">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy02LTEtMS0xNDI0NzE_85fdd347-832a-4b8b-a767-f29affcb11e5">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2195045e053d42548f70094593395273_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNC0zLTEtMS0xNDI0NzE_ec7aa40d-18a9-4705-b0d9-b345c794ab8d">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNC02LTEtMS0xNDI0NzE_e7d718ce-61eb-47e3-a5d5-f5467ab15b87">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cec76fd474f414982654002b7611f04_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNS00LTEtMS0xNDI0NzE_2c5176b3-e01d-4f85-af0a-ec8c60272c27">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNS02LTEtMS0xNDI0NzE_6f09aefa-e55b-4199-9ee0-54049bc5cfaa">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f11779e9d9b4e1f94f4e39f3ebccbe6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfOS01LTEtMS0xNDI0NzE_6440b53f-bbd2-433f-b5cf-f9f0e682dbc0">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfOS02LTEtMS0xNDI0NzE_f77d89d7-8d79-4aa8-8d65-c6aa6ecc7099">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d2f609468824c07b03425783adb6d36_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtMS0xLTEtMTQyNDcx_cc5be4b3-c911-49e2-9c62-c2f17f1d1f9b">16,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f609468824c07b03425783adb6d36_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtMi0xLTEtMTQyNDcx_f642ebbc-6dd9-4b98-9cdf-5f876ae633e2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccf4e3b46ee2408aa97590c16ab24104_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtMy0xLTEtMTQyNDcx_ffa98808-3d6e-4eb1-97b3-da210a2a27e1">325,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i136be9af2fba4063bbe5c2f2224a8bae_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtNC0xLTEtMTQyNDcx_6ff13406-4e5b-4f6d-97fa-b3fe1223e9ec">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dbc4a0411f74b34ab89e9e5c50f68a1_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtNS0xLTEtMTQyNDcx_a8f181a4-6423-4497-b0af-0e9e2ab826dc">468,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddf6ce6c34e4acfae34f5a67089e27e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtNi0xLTEtMTQyNDcx_2c1ce73b-4290-4210-a769-15ab54603afe">793,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146393ab4a57499e86ded98459711b21_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNC0xLTEtMS0xNDI0NzE_25b564ab-32a1-42a5-a89c-10f3955ba3f1">41,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f11779e9d9b4e1f94f4e39f3ebccbe6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNC0zLTEtMS0xNDI0NzE_543030ad-bd69-4057-9cd0-6f707dadc0b1">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNi0xLTEtMS0xNDI0NzE_58d54cce-71d5-4212-98e3-009128a1a2c8">670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNi0zLTEtMS0xNDI0NzE_fb073a1b-4d10-4cce-a0b8-1d22698a1933">1,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNy0xLTEtMS0xNDI0NzE_6ae9b395-5b41-47a2-9016-2b5fdd58e78d">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNy0zLTEtMS0xNDI0NzE_e23031e4-6f32-4d38-a572-ac3b7e0b7c27">13,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of premium on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOC0xLTEtMS0xNDI0NzE_1e6fb22a-35e2-4d4c-81cd-6b58642957d5">282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOC0zLTEtMS0xNDI0NzE_cdf5a91b-8dfe-473f-8433-0e557e2de9de">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOS0xLTEtMS0xNDI0NzE_92eea29b-8238-468c-9786-1dfc33762480">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOS0zLTEtMS0xNDI0NzE_4b8cb8ca-ebd8-4157-9a72-ece35058bd72">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of commercial license rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTAtMS0xLTEtMTQyNDcx_c32ba9c5-4f25-43b4-b0e5-aac495847dff">379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTAtMy0xLTEtMTQyNDcx_f4452262-46e2-43cf-8f8f-a514c43a4c7e">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTEtMS0xLTEtMTQyNDcx_16262bcb-254f-4cec-9f41-e7bb79067969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTEtMy0xLTEtMTQyNDcx_60861ebe-d26f-4e36-9348-e4f16945952f">1,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTItMS0xLTEtMTQyNDcx_81582c47-ea19-4f14-bc04-fa5483c1a439">5,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTItMy0xLTEtMTQyNDcx_6d6814cc-64f5-4f4f-8c78-35b889de5251">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTMtMS0xLTEtMTQyNDcx_1d777f2f-ab00-4228-bcf1-988eb5584979">8,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTMtMy0xLTEtMTQyNDcx_ccfea4d2-a50b-4f9b-a4c3-e0ea1deaa8ee">16,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gain) loss from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTQtMS0xLTEtMTQyNDcx_f5f88360-c545-4e7b-8b2b-95bd5ee2d400">39,533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTQtMy0xLTEtMTQyNDcx_1b032fdc-fa31-4c7b-9bfd-51a31190ae51">12,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lease amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTUtMS0xLTEtMTQyNDcx_4e1c7aaa-aec5-435a-952a-da845ce92486">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTUtMy0xLTEtMTQyNDcx_d2172d6d-7d6c-48bb-8405-44204d2ea904">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTYtMS0xLTEtMTQyNDcx_01fb63c3-94da-4ac1-a7fb-6bfd5befc057">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTYtMy0xLTEtMTQyNDcx_e94306ca-2b1e-496b-95eb-0dcaf4c9ba06">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTgtMS0xLTEtMTQyNDcx_421aa349-7891-4950-89cb-35e419ce7bc6">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTgtMy0xLTEtMTQyNDcx_b85e6709-cbba-483a-95b8-69af1b5078a7">43,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTktMS0xLTEtMTQyNDcx_ce8e5e36-9f96-4c17-b5c3-02cbea2abf3b">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTktMy0xLTEtMTQyNDcx_7834a009-a460-4076-9ae7-ab7c587bd8e3">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjAtMS0xLTEtMTQyNDcx_ba756e7a-71ea-41e1-b5bc-00521d4a0167">435</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjAtMy0xLTEtMTQyNDcx_7e9ebde5-32ec-449b-b780-53a4da505233">2,708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjEtMS0xLTEtMTQyNDcx_ab36471c-d6aa-47b8-a277-253941860743">4,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjEtMy0xLTEtMTQyNDcx_aee669f1-4c5f-4829-891c-b06b1b464624">11,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjItMS0xLTEtMTQyNDcx_8dc3dec9-498e-4c5a-a39e-f240cbc092bd">98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjItMy0xLTEtMTQyNDcx_ad255d80-1f87-4878-9b89-31ca3c4365e9">2,453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other assets and liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjQtMS0xLTEtMTQyNDcx_000e5444-576c-44c7-a14e-7a94df7b8554">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjQtMy0xLTEtMTQyNDcx_55ecc3c9-be04-4482-b6a2-562687e4f649">1,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjUtMS0xLTEtMTQyNDcx_d9f8c845-e1c4-4ad5-9171-05273038920e">33,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjUtMy0xLTEtMTQyNDcx_47823863-7a18-4cd2-8e69-0d85d1a6c6fb">52,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjgtMS0xLTEtMTQyNDcx_5f1856da-9fd8-4c11-a394-18d256c38c43">39,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjgtMy0xLTEtMTQyNDcx_c341a2b5-52a0-497b-aceb-203b5cea479e">38,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjktMS0xLTEtMTQyNDcx_7bd93a2c-3f50-43d7-96e7-32592228ebb3">44,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjktMy0xLTEtMTQyNDcx_dcefffa4-578e-4ca0-af4a-1b13501f6017">132,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzAtMS0xLTEtMTQyNDcx_45be8945-ad83-4bd1-ba65-9da5a5ae3810">8,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzAtMy0xLTEtMTQyNDcx_409aa1e1-80fb-449c-8cd0-3cc980f62a6d">24,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash paid for equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzEtMS0xLTEtMTQyNDcx_1ce75f64-c34b-4c0d-a6f9-f621988079cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzEtMy0xLTEtMTQyNDcx_5ec56da6-a059-4250-a86a-ec650cbc6e92">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzItMS0xLTEtMTQyNDcx_bd1e2635-eb41-4c3f-81e1-e30d0f37d83e">2,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzItMy0xLTEtMTQyNDcx_ef1f8e12-b79b-4b3f-94cb-131fb72999e4">4,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from commercial license rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="lgnd:ProceedsFromCommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzQtMS0xLTEtMTYwMjYw_188330bd-e94a-4b6e-8773-38403b11729b">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="lgnd:ProceedsFromCommercialLicenseRights" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzQtMy0xLTEtMTYwNDEx_d384c1fc-21e8-490a-ac5f-485fd122a3b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzUtMS0xLTEtMTQyNDcx_808ba859-e886-4f80-aa53-6e94e41e46fe">10,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzUtMy0xLTEtMTQyNDcx_f57ec007-fc30-476c-b319-3b5f35ec2c97">113,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzgtMS0xLTEtMTQyNDcx_5466acd8-7140-4ea2-97fb-a5adec0be208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzgtMy0xLTEtMTQyNDcx_5502ec62-63e9-45b7-94ed-471615bfb122">163,356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments under financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzktMS0xLTEtMTQyNDcx_8d7e214a-2372-4a61-94f4-39cf433e3de4">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzktMy0xLTEtMTQyNDcx_22d7eb81-2693-41a8-8e33-6d93f2830509">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDItMS0xLTEtMTQyNDcx_c9dedb07-c7e3-4b3f-be62-03b5735040aa">3,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDItMy0xLTEtMTQyNDcx_b7741ee3-db59-4faa-ad55-4b2acf6161b5">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDMtMS0xLTEtMTQyNDcx_de2f0905-46a3-4356-948f-16f731d0cba1">4,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDMtMy0xLTEtMTQyNDcx_e0b88ee5-3d5f-436f-a2a2-515101381a49">5,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDQtMS0xLTEtMTQyNDcx_6b7e5e0e-8332-44e8-8726-8b5dda5a4a3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDQtMy0xLTEtMTQyNDcx_478aae58-e474-4e1d-b0fd-1477174ed119">1,416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMS0xLTEtMTU1MjYz_871a5e41-7959-46ff-abf7-0e9020fb1369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMy0xLTEtMTQ1Nzgw_a1db3670-6e68-4211-bfa6-58b453a1c303">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMS0xLTEtMTQyNDcx_17c40dc4-db4c-4c2d-b5a1-7241dbc4920e">775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMy0xLTEtMTQyNDcx_f76f2c57-d860-4755-b5cc-518d9911207d">170,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDctMS0xLTEtMTQyNDcx_60617888-5c1c-4dcb-946c-46b4c33b72fe">43,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDctMy0xLTEtMTQyNDcx_1b72b3b3-b0bd-40de-bc5c-ac9290d61c8a">4,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDgtMS0xLTEtMTQyNDcx_b6af7627-7b5e-4b23-98b6-d753b22867a3">45,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e695c2f9aa945e39a8aad1f6b165a20_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDgtMy0xLTEtMTQyNDcx_ed95c95e-e686-4619-9177-cee8647d0043">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDktMS0xLTEtMTQyNDcx_c6f8cfc9-d27e-493a-8772-815d91efb53d">88,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddf6ce6c34e4acfae34f5a67089e27e_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDktMy0xLTEtMTQyNDcx_060d306e-e1b0-49eb-8b1a-ee6e7f62a986">14,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMS0xLTEtMS0xNDI0NzE_63154f6e-1910-4db7-adc7-455f6a0b6d1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMS0zLTEtMS0xNDI0NzE_9d99a8bf-adfa-45bd-bb68-7630e6cac510">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfOS0xLTEtMS0xNDI0NzE_5a0e5326-d40c-4b6e-9387-90dfcea16511">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfOS0zLTEtMS0xNDI0NzE_c36b671b-123d-4b90-8c21-b5c40bc282eb">2,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTAtMS0xLTEtMTQyNDcx_9e6102e4-2bd2-443d-af59-c7951db7070d">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTAtMy0xLTEtMTQyNDcx_f48d2cff-8e76-4d82-9a87-b068fe103137">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized gain (loss) on AFS investments, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTItMS0xLTEtMTQyNDcx_969520dd-c005-45ba-a0ce-5266c79f3f1d">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTItMy0xLTEtMTQyNDcx_09501e17-fb94-4bc7-a5f1-50f7274ba90b">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_34"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNDM_62971f86-27b9-40dd-bca0-a3243f80e823" continuedAt="i373e443864ed41688a5a71a7aa576ff3" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i373e443864ed41688a5a71a7aa576ff3" continuedAt="ib2623afe057e41f88450f2d560c3501b"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="lgnd:BusinessSpinOffAndMigrationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzI5ODUzNDkzMjIxNg_17418758-935a-4444-9be9-8b35420d62ef" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed the separation (the &#8220;Separation&#8221;) of our antibody discovery business and certain related assets and liabilities (the &#8220;OmniAb Business&#8221;) through a spin-off of OmniAb to Ligand&#8217;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#8220;Distribution&#8221;) and merger (the &#8220;Merger&#8221;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#8220;New OmniAb&#8221;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#8220;Merger Agreement&#8221;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#8220;Separation Agreement&#8221;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#8220;Transaction Agreements&#8221;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in <ix:nonFraction unitRef="segment" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY3NjY3MQ_47598ced-1cda-483a-830b-79869c4d6e2e">one</ix:nonFraction> business segment: development and licensing of biopharmaceutical assets.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjA_3855db22-6288-4bab-9e98-06d2943aa43d" continuedAt="i433c5accd224451d9fef88f80783783d" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i433c5accd224451d9fef88f80783783d">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2022 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzg0ODI5MDcyMzIxNw_0f27af25-1ffa-4795-9716-84454cb49c0e" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 205-20&#8221;). Accordingly, the accompanying condensed consolidated financial statements have been updated to present the results of all discontinued operations reported as a separate component of loss in the condensed consolidated statements of operations and comprehensive loss (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Spin-off of OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). All disclosures have been adjusted to reflect continuing operations.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2022 Annual Report. </span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzA_308708ff-f9c5-41b4-895a-20b847d72268" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzk_c850bd97-b4ea-4ec5-a778-d4da98d2a38a" continuedAt="i59d0eca0f67e43cd856ba6b0dbb14e37" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib2623afe057e41f88450f2d560c3501b" continuedAt="id4f6eef324494ea5bda89349c05f5eb5"><ix:continuation id="i59d0eca0f67e43cd856ba6b0dbb14e37" continuedAt="ifa05d6cb2bff46d2af2e7726d39a2cca"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Captisol Sales</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifa05d6cb2bff46d2af2e7726d39a2cca">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</ix:continuation> During the three months ended March&#160;31, 2023 and 2022, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTEzNzY_b0af5eec-0328-4c94-a0cc-ae76f6edd1dd">0.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTEzODQ_c011fd26-ea96-4c3e-abf0-02d2511abfdc">0.3</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzc_be9d3383-a0cd-4810-9593-6d3fb42e6507" continuedAt="i93090d746e6d45bfaa34a753127a593f" escape="true">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="id4f6eef324494ea5bda89349c05f5eb5" continuedAt="i1d464c2434a24da5b7dc3efa0691c1ba"><ix:continuation id="i93090d746e6d45bfaa34a753127a593f"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:68.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.832%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.833%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65eeea1681704584af49987ac1e87675_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNC0xLTEtMS0xNDI0NzE_ae350337-0990-4812-a254-21b49b1bdfe0">6,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc33e31ac6cb43b7a3645f8b84193980_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNC0zLTEtMS0xNDI0NzE_a18d4a17-be03-44e1-9219-c1d8ea281845">4,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf62d0f95754c7295cc30e21972ebf8_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNS0xLTEtMS0xNDI0NzE_c1920f7d-3624-4c3c-a858-87cb8cf51657">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252ec6f092314ab183cfe571c994ac8b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNS0zLTEtMS0xNDI0NzE_ec134bef-3371-4650-9e31-6d52bc398438">2,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507e16f565324f84b591860daa92de64_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNi0xLTEtMS0xNDI0NzE_b56a0410-feba-4d68-be29-31495fabf3ed">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2214c64514eb49f2a8842771d28dce64_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNi0zLTEtMS0xNDI0NzE_11022a19-0239-49fd-8db8-0ea15d50b064">2,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471ece02df084a638a5073e4e480760e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNy0xLTEtMS0xNDI0NzE_859b4f1d-b2a4-4154-80e4-1935b7533f6a">2,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie460943c319f46f089b3dbac6d243d9c_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNy0zLTEtMS0xNDI0NzE_edcde0fa-5223-40dd-b91f-9208e71a69a5">1,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i603a416169e44298a4e5e843b920577a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOC0xLTEtMS0xNDI0NzE_8c1ee6fb-6f65-4c94-98a0-81b0d3bf7d01">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab12c145b7a4a9386bead15014c2002_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOC0zLTEtMS0xNDI0NzE_bf91aca7-8c60-4361-9f8e-f3e95964d879">1,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id674d396b37c4237beed113c89c2675d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOS0xLTEtMS0xNDI0NzE_0d453d7c-fd56-4341-8113-db607bae69a8">17,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1846c1e72842cea62ab4d1e84368a3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOS0zLTEtMS0xNDI0NzE_9401f54c-4cb5-4835-bb3d-f33252502458">13,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1e076699044354a517e91f65469898_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTItMS0xLTEtMTQyNDcx_9a295de2-6052-4bd3-aa27-ed40f96bc6bb">10,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb74890b7510460d8f61f873e0236e2a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTItMy0xLTEtMTQyNDcx_c85095a8-0efe-4c18-b9ee-46e2ed4e3776">6,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9aa759764214b4c9217f0f8b8b0bf12_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTMtMS0xLTEtMTQyNDcx_5a04964e-d6f8-4739-b0df-e5b2e0481bf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65ab7c5558dc4b2691364948dff9c3bb_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTMtMy0xLTEtMTQyNDcx_1eeb3b69-eacc-4f75-91dc-6840e344e4ac">5,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac4e08b486c498488e4ec21236f70ac_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTQtMS0xLTEtMTQyNDcx_1721c70a-8188-46c2-adf4-e00686582a92">10,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad8c3f3b74a145eba569dc88db6a0243_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTQtMy0xLTEtMTQyNDcx_59e85923-f5e4-4b9c-bb0f-4732c9d03e02">12,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e6b2467288481aa925463f0f2dfa48_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTgtMS0xLTEtMTQyNDcx_16e43302-e12b-42cb-85b2-9a3213838577">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2a0b5f22124e0299cea65f936d0552_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTgtMy0xLTEtMTQyNDcx_d8870f92-3734-4f2c-8487-9468e31f8976">2,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic358d5ad2b4745ce8983d4eb13528034_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTktMS0xLTEtMTQyNDcx_dc4fe534-fdfc-48c9-b262-e378e395fccb">15,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf6169f7de846d8b64a2d389e36a41a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTktMy0xLTEtMTQyNDcx_f70f6364-9e64-4dd2-b271-4d6ba8807646">5,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd089aaa47c4e3f803998025bdb0535_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjAtMS0xLTEtMTQyNDcx_682b2a4d-2bae-4592-abdd-b3642365d4c5">789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a21caa530e4123b94f8358586e06f0_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjAtMy0xLTEtMTQyNDcx_f5d5d7dd-bcea-45e0-b1a0-83f6448b92dd">2,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0dbfa3c35724185bcf83cfd276f013a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjEtMS0xLTEtMTQyNDcx_5d4f2584-303f-4756-af27-1a488a25f736">16,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeeb7f4be42949899bd810534b9af482_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjEtMy0xLTEtMTQyNDcx_07ad9890-05a9-4440-90dc-bb9988d92eda">10,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjItMS0xLTEtMTQyNDcx_604dd9d2-4c01-48dc-8a5b-ce448c9f7698">43,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjItMy0xLTEtMTQyNDcx_354a0806-c949-4929-a47f-bdfa186b029b">36,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i1d464c2434a24da5b7dc3efa0691c1ba" continuedAt="i5b91507bbae345e1ae16d92a8152f4e8"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNTE_6e74963a-c5fa-4e59-a24f-cc4b457483aa" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2023 and December 31, 2022 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:38.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.397%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.397%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.397%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a5ad898201d43378731028a1922d796_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi0xLTEtMS0xNDI0NzE_d73b9179-ea9a-4931-ab22-eae41c6bb430">19,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a5ad898201d43378731028a1922d796_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi00LTEtMS0xNDI0NzE_4c38d809-bdd4-4c4e-a4c5-0d095de79f05">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a5ad898201d43378731028a1922d796_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi03LTEtMS0xNDI0NzE_a5f4d011-822b-40ea-8ef7-2461c1e81584">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a5ad898201d43378731028a1922d796_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi0xMC0xLTEtMTQyNDcx_0e80101f-1857-4e2d-b0f0-e848d760902e">19,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy0xLTEtMS0xNDI0NzE_525d5be2-7e0d-45cc-ba61-a9b9b29beb51">9,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy00LTEtMS0xNDI0NzE_22f68359-3751-40b0-8020-1e6af13399a0">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy03LTEtMS0xNDI0NzE_1f6ebb55-e659-4394-b12e-3871438c4e87">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy0xMC0xLTEtMTQyNDcx_eee14821-75f2-4645-b9fc-46754bcc1fc1">9,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC0xLTEtMS0xNDI0NzE_bea46e65-390d-4f25-bab5-0eb7d019d979">979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC00LTEtMS0xNDI0NzE_86e2cb7c-d2e2-4010-9a89-d4df5c58b555">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC03LTEtMS0xNDI0NzE_2bec7690-deda-49cf-a289-30fd481fb29c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC0xMC0xLTEtMTQyNDcx_d75cc13c-f099-440c-9a70-efd890768f26">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS0xLTEtMS0xNDI0NzE_1c187b06-7685-41d2-99ca-7552d046e2c7">13,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS00LTEtMS0xNDI0NzE_9ccdf5e1-0f99-444e-a8df-6127b17319ca">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS03LTEtMS0xNDI0NzE_22186f87-1e17-4195-9931-0347316adf2e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS0xMC0xLTEtMTQyNDcx_65bc41fb-a4b0-4b96-a17f-b032cda3e9aa">13,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c6bf9aba4794d65841b444357010217_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xLTEtMS0xNTY2NTE_6f6cda4a-8b89-4ba3-ab73-ffcf7086e0d4">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c6bf9aba4794d65841b444357010217_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi00LTEtMS0xNTY2NjE_c13ec882-a378-40f4-bea1-5fe6e60377c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c6bf9aba4794d65841b444357010217_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi03LTEtMS0xNTY2NzE_c778ed4d-1dcb-4e9e-ae8e-79bc2ef414b1">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c6bf9aba4794d65841b444357010217_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xMC0xLTEtMTU4MTI2_c643cb74-fcd6-4de8-9b67-2ea24761c6b2">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xLTEtMS0xNDI0NzE_b2748502-f80e-47d9-aa1a-5e752a0f4f55">5,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi00LTEtMS0xNDI0NzE_a9729e76-dd1d-4edb-b999-cf2393fb3957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi03LTEtMS0xNDI0NzE_57977e76-1f36-4164-b92f-ee91a96c53e5">4,120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xMC0xLTEtMTQyNDcx_6a097325-29a1-4ae8-887e-372c3060a81b">1,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bond fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy0xLTEtMS0xNDI0NzE_0032fe03-f561-42a7-91ef-327ad1b4a32e">82,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy00LTEtMS0xNDI0NzE_ef0c22f2-6490-4572-a28a-342dcab82a7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy03LTEtMS0xNDI0NzE_917287e6-5e27-409b-83c6-88e915260a4d">807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy0xMC0xLTEtMTQyNDcx_b9244d9d-48b2-4556-ae2a-ff67529d914d">81,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC0xLTEtMS0xNDI0NzE_8d183f78-4428-43ff-b409-90cac9b39f87">6,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC00LTEtMS0xNDI0NzE_fb40f4bf-0360-42fb-8b0f-bcf55074bebf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC03LTEtMS0xNDI0NzE_892b8590-2940-498e-ae43-232535345407">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC0xMC0xLTEtMTQyNDcx_d3e3e163-5e9e-449b-80ec-8277822775fa">6,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a49f05176146c7b857da134f78d9be_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS0xLTEtMS0xNDI0NzE_582b2091-f3f9-43b9-8d7c-86cb703bc553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a49f05176146c7b857da134f78d9be_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS00LTEtMS0xNDI0NzE_6169bdf5-d912-46a3-a92b-aa522da034c1">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a49f05176146c7b857da134f78d9be_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS03LTEtMS0xNDI0NzE_2b329c3b-bb84-453f-b59d-8090c8007369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a49f05176146c7b857da134f78d9be_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS0xMC0xLTEtMTQyNDcx_e15b1f74-799e-432b-ba6c-6ced36df5349">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtMS0xLTEtMTQyNDcx_6405ca81-23ad-4657-9b32-414692dd8a1b">139,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtNC0xLTEtMTQyNDcx_6156f8ba-5b66-4efe-9d54-cac088f16e0b">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtNy0xLTEtMTQyNDcx_78cdda33-5fcd-4238-b646-8058e572e29a">5,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtMTAtMS0xLTE0MjQ3MQ_52a5d529-45f1-48b0-aa90-fa7f6fecfc66">134,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cc642360a843b4be5f97a5be47caf6_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTEtMTAtMS0xLTE0MjQ3MQ_9da5c887-e9b5-45d6-96d0-e8395ce1219e">59,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTItMTAtMS0xLTE0MjQ3MQ_496345c8-0ad9-4be4-b2a7-8295c04c4ed7">193,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtMS0xLTEtMTQyNDcx_af532a42-7d0f-41ad-be5a-c530f5ab12b4">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtNC0xLTEtMTQyNDcx_501b2260-ebe8-48aa-9599-712b52e74974">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtNy0xLTEtMTQyNDcx_27131ed8-da66-49cc-aae2-d562be674989">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtMTAtMS0xLTE0MjQ3MQ_79221016-a4c4-4a85-b27b-3311da3ee91e">4,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtMS0xLTEtMTQyNDcx_47140f9d-6dc9-48db-a35a-6969942c0872">6,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtNC0xLTEtMTQyNDcx_4c222fe3-db2d-46f2-a1c8-fc3d0b81476e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtNy0xLTEtMTQyNDcx_0c831a73-18b0-41b5-80c0-bcdf4311e0c8">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtMTAtMS0xLTE0MjQ3MQ_1a3faeae-57ca-4dfc-9eab-5ccd94294254">6,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtMS0xLTEtMTQyNDcx_55066f45-5d79-4216-b6c6-ec4966ae3a15">7,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtNC0xLTEtMTQyNDcx_c703a6aa-f2c8-418c-83e8-19434c336543">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtNy0xLTEtMTQyNDcx_157eeb48-1d55-4d90-9d91-8476283ba66d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtMTAtMS0xLTE0MjQ3MQ_14e1a2a0-469e-4b30-852c-790091f0040a">7,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktMS0xLTEtMTQyNDcx_071ebfe1-dcdd-4509-b4ea-66d9a04122ab">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktNC0xLTEtMTQyNDcx_6ead52dc-a9c6-4135-8050-b58db3b813ba">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktNy0xLTEtMTQyNDcx_75941e5c-1457-4350-af63-a41c4c661a50">4,239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktMTAtMS0xLTE0MjQ3MQ_f751bc3d-b51b-460f-9321-f42cba481408">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bond fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtMS0xLTEtMTQyNDcx_09919565-7922-486f-b326-d4e7e3a25c01">81,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtNC0xLTEtMTQyNDcx_01d6f407-4f58-43d4-9256-a090032009c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtNy0xLTEtMTQyNDcx_a23162e1-71ab-4c7e-8d5a-e5b654583532">1050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtMTAtMS0xLTE0MjQ3MQ_77a7c3ce-e7ea-4c84-92d8-c483724b0f30">80,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtMS0xLTEtMTQyNDcx_bfc791ef-29c7-46ba-b2d2-bd0946bd2be9">2,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtNC0xLTEtMTQyNDcx_ece670d5-95c2-409d-9c54-cc5f9eb06971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtNy0xLTEtMTQyNDcx_17ae0726-ce66-4be5-8409-70ac6ac49df4">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtMTAtMS0xLTE0MjQ3MQ_3ebb1851-1832-43ee-a372-02c911892951">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItMS0xLTEtMTQyNDcx_38aad831-065b-4a4a-b464-5a939fed238c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItNC0xLTEtMTQyNDcx_6d7852e4-2fc0-4f8e-a42a-6354ca1caef9">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItNy0xLTEtMTQyNDcx_05bda6e3-e96a-45d1-be73-7afb289e4a78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItMTAtMS0xLTE0MjQ3MQ_24d90fa9-1e94-4e50-a1de-f215284c1cc4">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtMS0xLTEtMTQyNDcx_00b86931-d5aa-403c-8fc3-b831e2ae6d5f">108,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtNC0xLTEtMTQyNDcx_5905e638-439d-479a-ad82-429401ec3ae8">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtNy0xLTEtMTQyNDcx_fda1f78f-3a2d-415f-a802-09418aa1f0ab">5,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtMTAtMS0xLTE0MjQ3MQ_b2b6cf02-7996-41a4-a6e0-7c392ef1e58c">103,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aee0771a079448d978ce5fbb46ef39d_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjQtMTAtMS0xLTE0MjQ3MQ_272bd51d-0504-4504-bf2d-ed2ed4be0898">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjUtMTAtMS0xLTE0MjQ3MQ_be439638-e8a8-41f1-b63d-4c333544b57f">166,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we sold <ix:nonFraction unitRef="shares" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-5" name="lgnd:EquitySecuritiesFVNIShareSoldInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1NDg4MQ_1c4a8a0e-f88e-4651-93d1-6fa1dde85d0f">3.2</ix:nonFraction>&#160;million shares of Viking common stock and recognized realized gain of $<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1NDkwMA_143abb3e-c23c-4245-a874-d715c70c97a4">20.5</ix:nonFraction> million in total.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended  March&#160;31, 2023.</span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjY_54cf48a7-fd46-4431-8761-cfd4f7c0a67c" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMi0xLTEtMS0xNDI0NzE_d6b0142a-3a78-4232-940d-9b14ffc9fd97">123,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMi0zLTEtMS0xNDI0NzE_70e11340-7206-4893-a310-6217a302ce46">123,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMy0xLTEtMS0xNDI0NzE_650b4070-bc8c-4d84-af0a-a8931d3e1d52">10,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMy0zLTEtMS0xNDI0NzE_e1483567-32a7-4a30-8a33-7158d52dc88f">10,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfNC0xLTEtMS0xNDI0NzE_d39521ff-ec36-4146-a80a-8f79399f0dd4">134,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfNC0zLTEtMS0xNDI0NzE_e8296188-44e0-4d30-b1f1-4d75ad47acc1">134,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY3NjY1OA_f3b3d99a-d59a-4693-b3f7-1a10d7349c48">68</ix:nonFraction> investments which were in an unrealized loss position with a total of $<ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDQ0MA_2c640818-275e-4308-85b0-f5ec4f0c6f20">0.1</ix:nonFraction>&#160;million unrealized losses as of March&#160;31, 2023. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTM0NTM_6ac043cf-b562-427a-b54f-388d6f0f7961">no</ix:nonFraction> credit losses were recognized for the three months ended  March&#160;31, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5b91507bbae345e1ae16d92a8152f4e8" continuedAt="i7aedc9af9d784b9991c1636f747e904e"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzE_947b28c9-5427-475a-9144-d6b3f1c97092" continuedAt="i1bc3c6affdf843a8aa3d0a61559d7c49" escape="true">Accounts Receivable and Allowance for Credit Losses</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1bc3c6affdf843a8aa3d0a61559d7c49">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</ix:continuation> During the three months ended  March&#160;31, 2023, we considered the current and expected future economic and market conditions and concluded an increase of $<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-5" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDc0NA_a5023f51-1d51-4ca9-b9f4-3b9239735c6c">0.1</ix:nonFraction> million of allowance for credit losses as of March&#160;31, 2023.</span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNjg_76f4fa06-9e41-4fbf-abe6-95bef2913e88" continuedAt="ie854b754345c4004acc3d3088251ec50" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. </span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie854b754345c4004acc3d3088251ec50">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were <ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-5" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzg0ODI5MDcyMzIyNg_51f33be5-c114-4446-820f-f9e832a6e61b"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-5" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzg0ODI5MDcyMzIyNg_e5b11366-26c8-4764-9f6f-613ebc0562cd">no</ix:nonFraction></ix:nonFraction> write-downs recorded against inventory for the three months ended  March&#160;31, 2023 and 2022. As of March&#160;31, 2023 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="icab684ceae90430cbdf56e58b13b7729_I20230331" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDc3Mg_db9bf30d-a4a9-495b-88b9-d7231f5496bb">5.4</ix:nonFraction> million, and as of December 31, 2022 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="i829bcc778f774caeb60dae78412a98b2_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDg0Mw_3cf3c629-0369-4ebf-aeb2-befdefa383ce">5.9</ix:nonFraction> million.</ix:continuation> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExODI_25f45cc7-5b89-4bdf-906b-4f3aa29071a3" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMy0xLTEtMS0xNDI0NzE_9ec3f810-1164-4e81-a17f-f2a383ce9ca3">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMy0zLTEtMS0xNDI0NzE_0ef72439-b33e-4752-8441-26da8704fa79">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2561a5b37f2b48c99b837d7e54c57638_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNS0xLTEtMS0xNDI0NzE_72066a7c-ac76-4238-86fd-540b954789dd">55,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a1d092574043ac8fa8de0d23f735b1_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNS0zLTEtMS0xNDI0NzE_91b730cc-78cd-46de-94af-e6086d7e3792">55,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2561a5b37f2b48c99b837d7e54c57638_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNi0xLTEtMS0xNDI0NzE_693597ca-365d-462b-aa70-c40b1e1b14ca">23,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a1d092574043ac8fa8de0d23f735b1_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNi0zLTEtMS0xNDI0NzE_e2e7f8eb-534e-4037-96a5-029ed68abb0a">22,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61c033ee7b9c41bc8ce219eaf434f0fd_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNy0xLTEtMS0xNDI0NzE_d8b4f70c-4860-4e02-83d1-0a6c17d9b6a8">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ff718d557e41b8a4a3be385a2d6d0d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNy0zLTEtMS0xNDI0NzE_c3996f9e-1bc6-4119-8a3e-b04d42056156">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61c033ee7b9c41bc8ce219eaf434f0fd_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOC0xLTEtMS0xNDI0NzE_70d99a4f-46ad-421f-b73e-fdd59d802820">1,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98ff718d557e41b8a4a3be385a2d6d0d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOC0zLTEtMS0xNDI0NzE_a4539034-4747-4c53-8386-ab90ccbfe22e">1,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd14e785e014eb993155735df108dfc_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOS0xLTEtMS0xNDI0NzE_e50e79ff-d6a0-4302-9c3b-abe1ae33bf61">29,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4546dd49864a548bead9153260fd3d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOS0zLTEtMS0xNDI0NzE_14b1a874-d615-49c8-a088-b9294ec2dbc2">29,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cd14e785e014eb993155735df108dfc_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTAtMS0xLTEtMTQyNDcx_21909548-24fd-408b-a19f-524b8a7aaa62">18,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4546dd49864a548bead9153260fd3d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTAtMy0xLTEtMTQyNDcx_dad988a8-3e40-4d85-8df9-3442b03875d9">17,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5f7ff0e996a4591a2178b25ce967a99_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTEtMS0xLTEtMTQyNDcx_d008fd3e-251e-4319-b83c-4e69b017788d">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3209d0976344348a32b6d380fe3e5f6_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTEtMy0xLTEtMTQyNDcx_7c214f76-602b-4c93-bcfb-b047764da0a5">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5f7ff0e996a4591a2178b25ce967a99_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTItMS0xLTEtMTQyNDcx_47216518-41ba-425f-8a68-7ea7e70dd74b">72,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3209d0976344348a32b6d380fe3e5f6_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTItMy0xLTEtMTQyNDcx_d674969c-31ed-4181-acca-c15825a1031f">65,191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTMtMS0xLTEtMTQyNDcx_7469135d-4e62-4633-a0dc-6b8abf679493">439,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTMtMy0xLTEtMTQyNDcx_f6eb714d-12cb-476b-865c-342ad13295ae">448,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="lgnd:CommercialLicenseRightsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNTI_03a00336-91c1-4c0c-a088-6fc95dc0564f" continuedAt="i74f191d0314c4d35a4246b823b282ec2" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License Rights</span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMTk_e9e1f68d-55a3-4757-9213-618543c88d48" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi0yLTEtMS0xNDI0NzE_50346d63-7f78-4e80-af0a-639cff5c1980">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi00LTEtMS0xNDI0NzE_76a1a572-afec-43f4-812c-19716fe371c4">9,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi02LTEtMS0xNDI0NzE_48c2b816-8200-40ed-927e-f144df743c72">8,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412c3b19a5834235af99c2beb065ad68_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi04LTEtMS0xNDI0NzE_c964f41d-2ffd-4af1-a136-3abab39d1d6f">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i412c3b19a5834235af99c2beb065ad68_I20221231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi0xMC0xLTEtMTQyNDcx_dc9cb95a-187b-4b13-a527-3209bf1b75c8">9,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412c3b19a5834235af99c2beb065ad68_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi0xMi0xLTEtMTQyNDcx_401ae691-ce8f-432e-a323-4468f7fdffd0">8,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83dfae755f5a424a8225bff059206ef3_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy0yLTEtMS0xNDI0NzE_af2094f2-032b-41f6-b098-0e872fddb792">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83dfae755f5a424a8225bff059206ef3_I20230331" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy00LTEtMS0xNDI0NzE_430b1040-e1b8-424d-b76d-d99e28898084">8,745</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83dfae755f5a424a8225bff059206ef3_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy02LTEtMS0xNDI0NzE_ebd6b031-152f-490a-b6ba-43af20c79da8">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbeaa2397af04381b99149bf21997427_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy04LTEtMS0xNDI0NzE_e30273b5-4bce-475a-bbad-7c18624b4e5a">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbeaa2397af04381b99149bf21997427_I20221231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy0xMC0xLTEtMTQyNDcx_e8014336-b2a3-482b-8b2b-2311ab48f9d5">8,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbeaa2397af04381b99149bf21997427_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy0xMi0xLTEtMTQyNDcx_98349481-a24e-402d-81fb-d4c5eeb29f80">2,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC0yLTEtMS0xNDI0NzE_79d8e220-e3a5-46bb-b7f6-6a16bdd9c537">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC00LTEtMS0xNDI0NzE_d7a7af8a-e9f6-4b20-9e9d-d6fc35bd3674">17,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC02LTEtMS0xNDI0NzE_8f2d5d61-03d3-41c5-ad73-2d99cabe3acf">10,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC04LTEtMS0xNDI0NzE_a5a57c31-a47d-4a47-991d-9a4a82b3354c">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC0xMC0xLTEtMTQyNDcx_0921abe4-3519-4820-ad85-94da3a079ac4">18,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC0xMi0xLTEtMTQyNDcx_334352f5-3486-45ed-9087-89a1e8f7d939">10,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTY0OTI2NzQ2NzcyNg_1760e4ed-ae13-48fa-8c80-855dd0a1f8f9">11.4</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTY0OTI2NzQ2NzczNA_b99b2002-30bd-4829-a74b-fd25e64a4432">6.5</ix:nonFraction> million as of March&#160;31, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MTcwMg_7a7dace0-31e0-4d88-b303-6f4472cb4c90">11.6</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MTcwNg_86ad999c-4455-4494-aab2-98d11bc0e793">6.5</ix:nonFraction> million as of December&#160;31, 2022.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2022 Annual Report. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i7aedc9af9d784b9991c1636f747e904e" continuedAt="ie0862253efaa4a948a88ff9077166b4a"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i74f191d0314c4d35a4246b823b282ec2">associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended  March&#160;31, 2023, we further considered the current and expected future economic and market conditions and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2023.</ix:continuation></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNDY_cbe25ef9-b891-4c72-b98f-6fdcc047657b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMi0xLTEtMS0xNDI0NzE_26ecb1eb-96f9-42da-9bc4-764690b530e3">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMi0zLTEtMS0xNDI0NzE_3f1f8fbc-76b7-49b6-b2b0-925421c81fa0">6,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMy0xLTEtMS0xNDI0NzE_1ae17532-3515-4415-8c27-5b1e7e617406">834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMy0zLTEtMS0xNDI0NzE_7dcbb7e3-c410-4925-9128-9efbb47e7ac4">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNC0xLTEtMS0xNDI0NzE_341f4c12-8bbd-4848-9fca-50112936e0e5">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNC0zLTEtMS0xNDI0NzE_68c56264-144b-4b91-9063-07b0d4044466">3,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNS0xLTEtMS0xNDcyMzY_e10d89a3-6308-41af-bb98-a73bba77c6f7">7,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNS0zLTEtMS0xNDcxODg_02fe9800-447c-4d93-86cc-3620756a3b1f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfOS0xLTEtMS0xNDcyNDY_473acd5c-299c-43d1-9fef-033c480752c4">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfOS0zLTEtMS0xNDcxOTg_c9b5cf81-0653-415f-9e13-dbb2f83b10cc">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTEtMS0xLTEtMTQyNDcx_9a3fd616-5d4a-442a-8a9a-4a5057113914">3,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTEtMy0xLTEtMTQyNDcx_9f970f6a-e317-4b69-99e3-b3006f2b81be">4,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTItMS0xLTEtMTQyNDcx_4083cf22-a743-4373-811d-f74dbb1d44c6">14,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTItMy0xLTEtMTQyNDcx_749f71e5-7cfc-428f-98dc-b521aa4e2c01">15,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNzc_fa31b73d-9690-4493-b338-51b071a9a784" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjU_595651f8-e53c-4292-b4ef-6a15ac9c6eb3" continuedAt="if804b3a91b6349e4ae5bd4900027c745" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span></div><ix:continuation id="if804b3a91b6349e4ae5bd4900027c745"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.397%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fc13b3b0ca47478c28400effc30e73_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfMy0xLTEtMS0xNDI0NzE_a82f6bfe-c26a-4d26-ae09-07a8eac7d803">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c9c521f34b14454b143d1664a18a4cf_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfMy0zLTEtMS0xNDI0NzE_0edcde3c-a949-4c28-8819-98c7b6e0d0db">2,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcdb5f68fd0845c89b3679a08f903458_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNC0xLTEtMS0xNDI0NzE_0ed5bad1-d5b0-45d5-85f8-5a6bc0a6c494">4,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032e4336c3474c48b0ccfb9dc291e4eb_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNC0zLTEtMS0xNDI0NzE_74013650-6f37-4728-8e8a-5776f92f1b13">4,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNS0xLTEtMS0xNDI0NzE_846c3915-40c9-4df4-b47c-43a36da94e62">5,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNS0zLTEtMS0xNDI0NzE_3e75c492-a517-4943-9533-132b87db9b84">7,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div></ix:continuation><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNTc_a26ef8e8-6a4d-40d4-907e-eb1353754303" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfMy0xLTEtMS0xNDI0NzE_13976a70-2b18-4ed6-bf7a-9f0ff6ca2207">4.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfMy0zLTEtMS0xNDI0NzE_48758972-6d2f-4b2a-8828-1e48041b3962">1.6</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNC0xLTEtMS0xNDI0NzE_577af6a8-cd43-4d85-9df3-5a6438b21be1">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNC0zLTEtMS0xNDI0NzE_e18140fe-7aac-4946-8784-1bfcb6e0a890">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNS0xLTEtMS0xNDI0NzE_dd342cb6-b451-43d2-99e8-06f41b6f8617">53</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNS0zLTEtMS0xNDI0NzE_04c9a089-6312-4272-9b7c-0d277022134e">50</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNi0xLTEtMS0xNDI0NzE_e0d027d6-1268-422e-b0bd-06bf321801ce">5.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNi0zLTEtMS0xNDI0NzE_e1f73f5d-49de-4e1d-88cf-bd10db616de6">4.7</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a <ix:nonNumeric contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjk_94765757-143e-4486-a1d3-4b36b14f77da">three year</ix:nonNumeric> performance period, with a range of <ix:nonFraction unitRef="number" contextRef="if81e6ed11d5b42fc92035e63ce70dab8_D20230101-20230331" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTg4MjY_2329bed2-f26f-4100-bff0-ea321a004692">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i9e9100c0c4a443939a76ff1a531948bf_D20230101-20230331" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTg4MzI_9cb8e8cf-97dc-4112-b371-818b4bcca661">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNDc_ad13ab46-24a4-4009-a3a3-39029779381a" continuedAt="i9e65efe263784224851e7d40e33c0b23" escape="true">Net Income (Loss) Per Share</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ie0862253efaa4a948a88ff9077166b4a"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9e65efe263784224851e7d40e33c0b23" continuedAt="i4381b814bbfa4b709edc5c14981afb1f">Basic net income (loss) per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</ix:continuation></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4381b814bbfa4b709edc5c14981afb1f">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards.</ix:continuation> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares are dilutive. <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNzg_294b4c1d-1434-46cb-9b15-89bd55ab4901" continuedAt="i74e9954f479d45889e4777f5c6912797" escape="true">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i74e9954f479d45889e4777f5c6912797"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.397%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfMy0xLTEtMS0xNDI0NzE_0ff8fa5d-b696-4498-9d7b-f45cba588b74"><ix:nonFraction unitRef="shares" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfMy0xLTEtMS0xNDI0NzE_b031d185-8cb2-428f-bec2-27dac06d66f3">17,063</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfMy0zLTEtMS0xNDI0NzE_28a602f4-927e-46ec-b63d-b277b01d17a8">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9dffa8f58aaf4d11b456a8821fe00c3d_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNS0xLTEtMS0xNDI0NzE_6297041b-fa99-472b-9f21-dbf7cf7ee11f">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ce88b885fc645c2be76eb7ae40e211f_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNS0zLTEtMS0xNDI0NzE_bb17dfbb-01b4-4d47-bd1d-e78923fc0d86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fa4dea889b3439d9ac7398cfa1a4773_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNi0xLTEtMS0xNDI0NzE_d10f5963-553d-4493-ac78-d9196b0e10a4">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i506f1c021fc0401fb3e152136e091307_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNi0zLTEtMS0xNDI0NzE_c4bbfb24-391c-4058-8ca5-5fbd61772310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if97986f33b4b455eab691feb1d28c9f6_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNy0xLTEtMS0xNDI0NzE_9909d694-e6eb-4591-aa60-b3307e9ab039">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9cbda0e4f007472c8c052957a3e4b0e9_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNy0zLTEtMS0xNjAxNDI_6bccbb16-2ab7-4e55-8d16-58578255811e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOC0xLTEtMS0xNDI0NzE_7a2da2ac-359d-4b49-8655-f692fb2e4a07">17,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOC0zLTEtMS0xNDI0NzE_29528725-3f68-4193-87c5-b078e4a8c269">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOS0xLTEtMS0xNDI0NzE_9baf0d7c-53c6-4db3-9a44-5f8dd1b0548b">4,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOS0zLTEtMS0xNDI0NzE_fc8f050f-fe68-4a09-a055-dc782271a518">6,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMzk0NQ_062a39b7-521b-47c4-a3b0-2a28c3bd9abe" continuedAt="i67b048206a95475688467b8d6ffec10c" escape="true">Spin-off of OmniAb</ix:nonNumeric></span></div><ix:continuation id="i67b048206a95475688467b8d6ffec10c" continuedAt="i6374e65256264491a4559a55db423cd0"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2022, we entered into the Separation Agreement to separate our OmniAb Business and the Merger Agreement, pursuant to which APAC would combine with OmniAb, and acquire Ligand's OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#8220;Transactions&#8221;). In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following <ix:nonFraction unitRef="position" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMTA5OTUxMTYzOTM5OA_043e5a46-6fbf-4c08-aacd-53719d226a07">two</ix:nonFraction> reportable segments: (1) OmniAb Business and (2) Ligand core business. The OmniAb Business segment was focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb Business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing date of the Transactions on November 1, 2022, the historical financial results of OmniAb have been reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution. Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain specific assets and liabilities constituting the OmniAb Business. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of October 26, 2022 shares of the common stock of OmniAb representing <ix:nonFraction unitRef="number" contextRef="i4dd3a95bb7954a1c8b2b9ec9fb784037_I20221026" decimals="0" name="lgnd:DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMTA5OTUxMTYzODYyMw_f13aea37-2c34-49d1-8b58-7d264ec1f4d6">100</ix:nonFraction>% of Ligand&#8217;s interest in OmniAb. Immediately following the Distribution, Merger Sub merged with and into OmniAb, with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of New OmniAb. The entire transaction was completed on November 1, 2022, and following the Merger, New OmniAb is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#8220;OABI.&#8221; After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after November 1, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the Company determined its antibody discovery business qualified for discontinued operations accounting treatment in accordance with ASC 205-20. We recognized a $<ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMTE1NDQ4NzIxMDQyMjU_b2649479-c7ec-45d2-9793-8274186b3c02">1.7</ix:nonFraction> million tax provision adjustment related to deferred taxes during the three months ended March&#160;31, 2023 that was attributable to the discontinued operations. <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMzk0Ng_a67cebb8-37bf-4c38-9c68-a728e9fe16f7" continuedAt="i5650a334281a4cd69adf6a0819f8da10" escape="true">The following table summarizes revenue and expenses of the discontinued operations for the three months ended March&#160;31, 2022 (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i5650a334281a4cd69adf6a0819f8da10" continuedAt="if812a45c1dbd496dabeb09c2370f4c2f"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:84.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c3b7100ae2469aa40de930920f80f3_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMy0xLTEtMS0xNDg1ODM_b6825e88-73cd-4022-914d-6a337ba9fe59">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dfb70c51fa941509f903b3ca26a5da0_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfNC0xLTEtMS0xNDg1ODM_dc67856e-78b2-4569-b2da-ddb9574e05d1">8,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfNS0xLTEtMS0xNTUzMTA_a29a756f-5967-4d4f-a3dd-4ceb7426321e">9,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfNy0xLTEtMS0xNDg1ODM_e35ab43f-c962-4664-9bb9-26a5fb6c6366">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfOC0xLTEtMS0xNDg1ODM_c221f0fe-e9d9-4a42-888d-0b116486f94d">11,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfOS0xLTEtMS0xNDg1ODM_a9d02c07-306f-4243-8e3e-c0db1334966c">6,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTAtMS0xLTEtMTU1MzE2_9304da69-11ed-42b3-9c5a-a50978515f12">20,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTEtMS0xLTEtMTU1MzE2_69bca460-477a-4fca-944c-e0c15b3719e0">11,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTUtMS0xLTEtMTQ4NTgz_c36354f2-d0e2-46a8-8caa-7232dc0fc336">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTYtMS0xLTEtMTU1MzE5_5c33e8f4-f4b0-4a61-8bd8-776b9be7028b">443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTctMS0xLTEtMTU1MzIy_62faa23a-a514-4506-8fd9-aed44bad54c6">10,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTgtMS0xLTEtMTQ4NTgz_85d4c42f-08e4-43c8-bb42-c77d617bf258">8,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTktMS0xLTEtMTU1MzIy_0731b9e1-11ef-4696-98de-32a52dba7123">2,456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the three months ended March&#160;31, 2022 (in thousands):</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt"><ix:continuation id="i6374e65256264491a4559a55db423cd0"><ix:continuation id="if812a45c1dbd496dabeb09c2370f4c2f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:84.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" sign="-" name="lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfMy0xLTEtMS0xNDg4NDU_33e4ced2-c471-4e57-ad53-41039a17b39b">443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortizationDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfNC0xLTEtMS0xNDg4NDU_e489ab7f-53e9-4914-bfd9-0bf0c8027688">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfNS0xLTEtMS0xNDg4NDU_87da26cb-65eb-4d7f-bfbb-e63514a6eb2d">1,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpenditureDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfOS0xLTEtMS0xNDg4NTI_c634930c-6755-45ae-a9f9-bd678c63cc65">3,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfMTMtMS0xLTEtMTQ4ODYy_cd278a80-8324-42c7-8f41-583529921f95">1,416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfMTYtMS0xLTEtMTQ4ODcy_6c2b9666-8ab8-44da-a68e-d774ba22af64">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_40"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfNTQzOA_ebcf6033-2410-4de6-9542-32194ff923c5" continuedAt="i639da59eed8f49b78fa18c7e63d0fd76" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i639da59eed8f49b78fa18c7e63d0fd76" continuedAt="ieee6cb4efe164a8bacd41c7e42a858d7"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfNTQzNg_634b7182-bbab-4f25-abf5-ef8c06ee64b2" continuedAt="i4e8bbc4bf67f455c892a2960a793872d" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763012af38d44192b91ccced32b2f90c_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0yLTEtMS0xNDI0NzE_d0bb0925-e0a1-4b41-94e7-1d18b0f118a5">7,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f664e124e444754902048088f15d009_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy00LTEtMS0xNDI0NzE_153f11ac-0432-45b9-b09b-489aab098ef2">126,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af671b89641435c982e3ec096f05e13_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy02LTEtMS0xNDI0NzE_5a697789-91d9-4032-903c-166fa0202523">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie398cfae0ed945faac086dc8267aff48_I20230331" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy04LTEtMS0xNDI0NzE_ddb92a6d-1c02-421f-a0a2-399d55c7bb17">134,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7139166474f9ab25b9eca300d94ba_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xMC0xLTEtMTQyNDcx_0c23e762-5f6f-41e0-b1e9-4e05fd0c7bd8">3,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i915548846dd64cd49f3ecbc68b7eb50a_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xMi0xLTEtMTQyNDcx_e23df4c0-1191-4caa-81c9-72035c7a5411">99,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17e761190bb48beb5cea13631d8dfa7_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xNC0xLTEtMTQyNDcx_67c8675c-d34e-477b-bec9-1e5eae5c0c70">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa89bb486b842e7aff0da151ea9a775_I20221231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xNi0xLTEtMTQyNDcx_464d502f-6eff-4b60-84d3-76ca2979c13d">103,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cc642360a843b4be5f97a5be47caf6_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0yLTEtMS0xNDI0NzE_9da5c887-e9b5-45d6-96d0-e8395ce1219e">59,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC00LTEtMS0xNDI0NzE_c496be53-3001-460c-8c4c-c39e32390ad4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96faa6fa418473291f9eadf582cb120_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC02LTEtMS0xNDI0NzE_2a27cd25-b9d5-4cd1-9b8e-210cc8a63cf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC04LTEtMS0xNDI0NzE_d8fd738e-bcac-4756-99d9-a39e282d3257">59,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xMC0xLTEtMTQyNDcx_9068cb3b-4660-4123-8fff-abd5720af52f">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40daf9abfb134159be20eab4b760217b_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xMi0xLTEtMTQyNDcx_7b922fc3-7d81-4962-81a7-bb229959c698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xNC0xLTEtMTQyNDcx_30b8d5ae-61ce-4be6-9e95-17dd5fcf07b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626c103c32154c218e186b029cbda1e6_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xNi0xLTEtMTQyNDcx_c50a6717-ebae-4a12-bc10-6d5d5a7ab500">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f7532e1db94ae1a31213e245adfb77_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0yLTEtMS0xNDI0NzE_e4468215-3e55-4a6b-baed-48d0032f7249">67,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi00LTEtMS0xNDI0NzE_ada0539d-d54f-4408-909e-754e7210ced0">126,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96faa6fa418473291f9eadf582cb120_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi02LTEtMS0xNDI0NzE_9828a887-5bc7-4e6b-841c-a13996810ada">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi04LTEtMS0xNDI0NzE_7410249c-98f4-4d33-b8c8-de45849f1857">193,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xMC0xLTEtMTQyNDcx_9a4cecac-6f47-47ca-b20d-5bf808e6671c">67,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40daf9abfb134159be20eab4b760217b_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xMi0xLTEtMTQyNDcx_3c2ac42f-08cb-4df7-a673-88a81a315c90">99,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xNC0xLTEtMTQyNDcx_724a4bd2-b40a-46ab-b210-23b7d1dc0716">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626c103c32154c218e186b029cbda1e6_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xNi0xLTEtMTQyNDcx_f348c4af-a199-44d1-aa55-04941132d7f4">166,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74e651db4b74a518b5c4442d96bfb40_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0yLTEtMS0xNDI0NzE_7b31b11b-6345-42b4-8ca9-631b2b037840">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieee5a6d6de4e4ff4a3795c420443d61b_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS00LTEtMS0xNDI0NzE_15ba7935-7035-4e8d-85ca-44645d978147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4a19aec8e14496aac9d086c4eba78d_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS02LTEtMS0xNDI0NzE_35fa4ee4-4117-4128-abce-4e55a2891c20">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0269fb8261c141bab51cf071a61d89b3_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS04LTEtMS0xNDI0NzE_42a4d805-885a-4e5a-96cc-9a019e298940">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff86df6b5e5a4a6faf716a2960401b63_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xMC0xLTEtMTQyNDcx_336806af-67e9-4a67-bebb-ca87fa3fa29c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i163330301f1d4bcbbb46e375f3c79026_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xMi0xLTEtMTQyNDcx_39f4ba8b-5523-426d-b235-6b4f7e420787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i018145fcba3c41c1883b1f339bac39e4_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xNC0xLTEtMTQyNDcx_90f0f2ac-5462-4d3c-852f-5520fd55dfc9">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57855c3f2b4476a90c99722257f527e_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xNi0xLTEtMTQyNDcx_8a97308f-10ee-43f1-b095-5015f29b47b6">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e940ff49984106a6ac855a4ae9899a_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMi0xLTEtMTQyNDcx_d201b32d-ebbc-425c-aa24-b944cb4ebdb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7356828798748ceb3633210d92c6664_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtNC0xLTEtMTQyNDcx_f25485bd-cdd7-48e1-b809-179071ed15d6">2,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bb98cab8574fe5866d8e7a307f0b74_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtNi0xLTEtMTQyNDcx_8ec760ba-95e0-4d7a-9b48-bd570eb89fc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bedf7508b14e8daf449211c964cd8e_I20230331" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtOC0xLTEtMTQyNDcx_9a15ed00-06cb-4e4c-b56f-570e2573639b">2,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3e4858f3084a0590a2499ed0047750_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTAtMS0xLTE0MjQ3MQ_e24a9a83-10e2-4e2a-96d8-dcea07ada525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf45dbfb87d9402794f19a8fa810d6b2_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTItMS0xLTE0MjQ3MQ_5d485d47-b703-4fed-b01c-fed15110e5b8">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i885006a6753a4da88eed97931a8a1096_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTQtMS0xLTE0MjQ3MQ_92acf855-8e3a-403a-8408-8eb2aecc1d8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b9d43cacb34c8ea3696baaeee38eb4_I20221231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTYtMS0xLTE0MjQ3MQ_db50f0c5-cd48-4095-8931-1e2303e23840">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f7532e1db94ae1a31213e245adfb77_I20230331" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMi0xLTEtMTQyNDcx_5e9a4b22-e433-4cbc-a3fd-d865900cd3a1">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtNC0xLTEtMTQyNDcx_6c6e4192-cc71-449f-82a1-6f636ebcf53d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96faa6fa418473291f9eadf582cb120_I20230331" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtNi0xLTEtMTQyNDcx_dc396e6e-3eb6-4439-9bbd-252f32f7e076">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtOC0xLTEtMTQyNDcx_5d5e5f02-0ab7-43cc-9de2-bb6772791e7b">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTAtMS0xLTE0MjQ3MQ_10c563a1-684e-4b5e-823a-9379d1cc177f">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40daf9abfb134159be20eab4b760217b_I20221231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTItMS0xLTE0MjQ3MQ_f7308289-8587-4df8-be43-4531eb7d4092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTQtMS0xLTE0MjQ3MQ_1c63a271-4ad2-40e2-8f4b-6597b1e2e46d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626c103c32154c218e186b029cbda1e6_I20221231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTYtMS0xLTE0MjQ3MQ_f5a3b518-062d-44c3-b8d4-1213516c4d15">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f7532e1db94ae1a31213e245adfb77_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMi0xLTEtMTQyNDcx_64c51f87-ec45-4724-9903-32ae54cdf99c">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtNC0xLTEtMTQyNDcx_a01b6fc4-4638-49b3-b4b9-60ca829dc9d9">2,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96faa6fa418473291f9eadf582cb120_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtNi0xLTEtMTQyNDcx_7821e480-7c45-447f-a598-469a2d9d5ad8">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtOC0xLTEtMTQyNDcx_d03e90fd-8f16-4628-9968-c5a6580afa8f">2,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTAtMS0xLTE0MjQ3MQ_16edf4f7-e076-4da8-a84d-37c97bfd2ed0">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40daf9abfb134159be20eab4b760217b_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTItMS0xLTE0MjQ3MQ_cc3deee5-6999-4584-8864-9a3d67ffee3c">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTQtMS0xLTE0MjQ3MQ_ea2549da-0145-4a50-a8d9-37175deb1265">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626c103c32154c218e186b029cbda1e6_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTYtMS0xLTE0MjQ3MQ_816818f9-4c8e-4fde-8fed-1a6c723f2351">3,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i4e8bbc4bf67f455c892a2960a793872d" continuedAt="i7ad0f006a0a347f9addfc3733932ae74">2.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"><ix:continuation id="i7ad0f006a0a347f9addfc3733932ae74">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingent_value_right" contextRef="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTQ0Mg_98b1b107-af6c-4237-ab41-6093767a2b54">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingent_value_right" contextRef="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTQ2MA_a1079393-690c-46e4-84ff-7309e4e64363">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingent_value_right" contextRef="ifcfb68dc76174bf49f8bd077bd649ae1_D20100101-20100131" decimals="INF" name="lgnd:NumberOfContingentValueRightsSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTQ4MA_682f84f8-8e69-4fcf-ac87-6cd8ddf40f22">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTYxNQ_6a0ba927-bb30-4fa8-aa8c-d6e97438ea00">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="icc2d9f773bb14b7fb48e90c6374538fe_I20230331" decimals="-5" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMjQxNw_38e0c526-1b36-4484-a385-91eb6f07c1c7">375.0</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i15a6dc40dbc74b84b8d5b169e75d071a_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMjUzMg_823c1e38-2eae-4222-aa20-f462babbd4b3">10.0</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial.  During the three months ended  March&#160;31, 2023, we adjusted the balance of the Metabasis CVR liability by reducing $<ix:nonFraction unitRef="usd" contextRef="i168fdc9ced384d3482e3122242ace085_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTA5OTUxMTYzNTg4MA_20fabf36-f11b-42a8-841d-47222a43336b">0.7</ix:nonFraction> million to mark to market.</ix:continuation>  </span></div><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfNTQzNw_eac458b9-a7cc-461e-bf75-87ba75923ec1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of March&#160;31, 2023 is as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2022</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ad7a5d1cc5a45b3993c229ec308f769_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOmZlM2MwM2FjYTYzOTRmODhiYzc3MGZlNzUzZDUxZjljL3RhYmxlcmFuZ2U6ZmUzYzAzYWNhNjM5NGY4OGJjNzcwZmU3NTNkNTFmOWNfMC0xLTEtMS0xNDI0NzE_a12fb30e-041c-4572-bad8-1eabeecda3a0">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b9ba0d8fd854d3c980983fb9630d586_D20230101-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOmZlM2MwM2FjYTYzOTRmODhiYzc3MGZlNzUzZDUxZjljL3RhYmxlcmFuZ2U6ZmUzYzAzYWNhNjM5NGY4OGJjNzcwZmU3NTNkNTFmOWNfMi0xLTEtMS0xNDI0NzE_0352094e-4410-4219-a1cd-1664ebd00bc8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March&#160;31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib161369e802141d388e0bea65e72d1d3_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOmZlM2MwM2FjYTYzOTRmODhiYzc3MGZlNzUzZDUxZjljL3RhYmxlcmFuZ2U6ZmUzYzAzYWNhNjM5NGY4OGJjNzcwZmU3NTNkNTFmOWNfNC0xLTEtMS0xNDI0NzE_851eba7a-2527-45f1-8227-5b538e746ec1">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ieee6cb4efe164a8bacd41c7e42a858d7"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_1451b6c9-f270-4a83-8b2a-295548efcabf"><ix:nonFraction unitRef="usd" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_37abe0d6-403b-40d1-8c14-7cd10932454a"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_74bd868c-986c-4773-9774-7aa9927ce16b"><ix:nonFraction unitRef="usd" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_d63dedda-91c5-42fa-befb-cf1f0b8d2117">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of our goodwill, indefinite-lived assets, or long-lived assets recorded during the three months ended  March&#160;31, 2023 and March&#160;31, 2022.</span></div></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_43"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 4.  <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTE2MA_ecf48e09-4fa2-45b4-b6af-d7f6f03a6bbd" continuedAt="i60116e4d2a2b454caf160be7b1625af7" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><ix:continuation id="i60116e4d2a2b454caf160be7b1625af7" continuedAt="i03428c6520924c639365b4c4baad316a"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzNzExMw_75a53f03-e31f-47d4-b9ea-7e3e3a5551d2">0.75</ix:nonFraction>%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTc_5f97b91e-49c3-4176-a17e-cadc38d9bf55">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of 2023 Notes, bearing cash interest at a rate of&#160;<ix:nonFraction unitRef="number" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTMw_75a53f03-e31f-47d4-b9ea-7e3e3a5551d2">0.75</ix:nonFraction>%&#160;per year, payable semi-annually. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="id16b6127458b4c908501afd350114da9_D20180501-20180531" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMjg2_62e950ee-c4c7-4308-b602-2c0763186aef">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on a conversion rate as discussed below. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes were entitled to convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTEwMA_b6ecdf41-2651-4ebf-8481-92b7e3a15924">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTE1Ng_21449247-e863-4086-9fde-2874ec81b5e5">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day was greater than <ix:nonFraction unitRef="number" contextRef="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTM1MQ_712d386b-1056-47ea-9013-f1a2dcbb0381">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTQxNg_12c3cd2c-be0e-40b0-992f-789b17a61e7d">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTQ2NQ_6387060c-1178-4af1-9195-81b6880ae240">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTU3NA_008e5634-9a76-4b9c-94df-bb4cbc042062">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes (the&#8220;Indenture&#8221;). </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on or after November 15, 2022 and prior to the close of business on May 11, 2023 (the second scheduled trading day preceding May 15, 2023, which is the maturity date), holders of the 2023 Notes are entitled to covert the notes without regard to the conditions described above applicable to conversions prior to November 15, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes. No holders exercised their right to convert their 2023 Notes during the applicable period for conversion. After we completed the Separation of the OmniAb Business, on November&#160;15, 2022, the conversion rate was adjusted to 4.8390 shares of common stock per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i745a3728e2854def929ed3c0ccc7d673_I20221115" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzOTY4Nw_60e31291-b114-4da6-8a38-f10d50e127b9">206.65</ix:nonFraction> per share. The maximum conversion rate of the 2023 Notes was adjusted to 6.2907 per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ic58510ba16f14f209b3c357f93c9d563_I20221115" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzOTcxNg_a3557392-cb44-43a0-b418-29fb86dd5325">158.97</ix:nonFraction>.  The conversion rate for the 2023 Notes was adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first <ix:nonFraction unitRef="position" contextRef="i6ba60861c19649ff96ba66c6b831281e_D20221115-20221115" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzOTcyMA_7e4ea1a4-7c67-46fe-9bfa-f4f1d0a154c3">10</ix:nonFraction> consecutive trading days after, and including, the ex-dividend date of the spin-off (as determined in the Indenture). The conversion rate and maximum conversion rate are subject to further adjustment under the circumstances and pursuant to the terms set forth in the Indenture.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the current conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i745a3728e2854def929ed3c0ccc7d673_I20221115" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTA0Mg_60e31291-b114-4da6-8a38-f10d50e127b9">206.65</ix:nonFraction>. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMjc2NA_6e28aa0c-0072-4eb1-87a9-0bc6786ffe7b">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, and is being amortized to interest expense using the effective interest method over the <ix:nonNumeric contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTE1OA_293035ed-7e21-4427-98ef-322acb417793">five year</ix:nonNumeric> expected life of the 2023 Notes, and the effective interest rate as of March&#160;31, 2023 is <ix:nonFraction unitRef="number" contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTMxNg_0e4719c3-d033-4bbb-bb0c-c2666d2fde6e">0.5</ix:nonFraction>%.  During the three months ended March&#160;31, 2023 we recognized a total of $<ix:nonFraction unitRef="usd" contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTQ2Ng_de36bde6-2149-4627-a1ed-ebcf5d9b5a6f">0.2</ix:nonFraction> million in interest expense which includes $<ix:nonFraction unitRef="usd" contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTQ3NQ_b77e2a07-1faf-477d-a36b-ba4600cca662">0.1</ix:nonFraction> million in contractual interest expense and $<ix:nonFraction unitRef="usd" contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTQ4NA_89ba5e9a-6aca-452c-bcdb-c86d8d5ddb4c">0.1</ix:nonFraction> million in amortized issuance costs. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i03428c6520924c639365b4c4baad316a"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we repurchased $<ix:nonFraction unitRef="usd" contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NjI2MA_36c81f29-90e6-475f-8b20-7d0aeb4d2b35">165.8</ix:nonFraction> million in principal amount of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ife99d31e979b471fbacc856adb204f2e_I20220331" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NjI2OA_68469016-2b76-4100-a7cc-b4fd3266755a">163.7</ix:nonFraction> million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MzUwNA_5f8a1a3e-ec66-40a7-82a3-13b8c4a43f8f">0.4</ix:nonFraction> million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MzUyMg_b9e657ae-7702-4ca0-a175-1e26382d4122">1.5</ix:nonFraction> million reflected in other income (expense), net, in our consolidated statement of operations for the three months ended March&#160;31, 2022, and a $<ix:nonFraction unitRef="usd" contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MzU0Mw_2cfeb084-b8a5-46ef-8cc8-a8c90743735a">0.9</ix:nonFraction> million reduction in debt discount. There was no repurchase of 2023 Notes during the three months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNDc2NQ_ed48a504-01ed-42b6-aa07-f2a388322825">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNTAzOQ_a8c63fb4-e562-459e-abb8-c0f04ff6dfdf">206.65</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="id16b6127458b4c908501afd350114da9_D20180501-20180531" decimals="-5" name="lgnd:PaymentsForConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNTEyMg_c45a0f9e-acdb-4391-af77-3a3d166748af">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNjAyMg_b6f7ff3d-8e46-497f-ac75-37ab066e5e33">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNjA4OA_68485657-0779-4f3c-9622-9b7a42e6cad9">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="id16b6127458b4c908501afd350114da9_D20180501-20180531" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNjE0Ng_3e854418-508d-4422-9bab-2728ae9432f0">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $<ix:nonFraction unitRef="usd" contextRef="i63d75f220eeb405ab2f4a34303ec71f6_I20210131" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQzOA_ea6c34aa-c20a-4e86-b2ab-a7ba11c750a1">20.3</ix:nonFraction> million in principal of the 2023 Notes for approximately $<ix:nonFraction unitRef="usd" contextRef="i71225d3c8a82435fa5cd738c3aa181d8_D20210101-20210131" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ0NQ_0e39c480-f573-4af8-9410-2ad2bb3b4863">19.1</ix:nonFraction> million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i71225d3c8a82435fa5cd738c3aa181d8_D20210101-20210131" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ1Mg_2e069f75-f2e9-4d50-9d9b-cb6939019dfb">0.1</ix:nonFraction> million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="iebf2d4e5f2594065932aeccee4503461_I20211231" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ2Mg_6287ecad-1193-4ed6-a39b-0afb5278a1ef">152.0</ix:nonFraction> million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i06fe0a09def94247bbb7916c23ae3017_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ2OQ_6dac02f5-2e82-4432-a003-c9f191debaa2">156.0</ix:nonFraction> million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i06fe0a09def94247bbb7916c23ae3017_D20210101-20211231" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ3Ng_49a95011-037c-4763-8a88-d063953eab85">0.3</ix:nonFraction> million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="ia82d4ad3cea140ef9a6f0c99ee594d64_D20210101-20211231" decimals="-5" name="lgnd:PaymentsToUnwindWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNzgwNA_dab1843e-98a7-4dfc-9f9d-7b27fe12f3df">18.4</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNzkxMw_ed48a504-01ed-42b6-aa07-f2a388322825">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="iebf2d4e5f2594065932aeccee4503461_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNzkxOQ_a8a84b84-8c05-4a66-aeac-65038a242571">2,559,254</ix:nonFraction>. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="ibfd5947b908543809e005a7628c9487d_D20220801-20220831" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ4Mw_b47cfefd-6998-4892-ac76-2fcbad648538">227.8</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ibfd5947b908543809e005a7628c9487d_D20220801-20220831" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ5MA_55ff3733-edc5-44bf-ae80-193319edaf94">223.7</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="iff179ee295ea4d7c9424bd57cab84b84_D20220101-20220630" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ5Ng_a1fb4533-93e8-4c25-92bb-7c420409136d">0.4</ix:nonFraction>&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. </span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTE2Mg_9309692b-3134-47e5-8a98-cff1d6314c03" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:68.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMS0xLTEtMS0xNDI0NzE_07383ac9-69ab-41ca-ac5a-bfc45d6a8460">76,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMS0zLTEtMS0xNDI0NzE_680669e5-264c-46d9-9587-2f408cf6deac">76,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMi0xLTEtMS0xNDI0NzE_d5571347-6dff-4e7e-bf34-235e4ccaf155">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMi0zLTEtMS0xNDI0NzE_9656e79a-9672-4653-b8f8-036847dd296f">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMy0xLTEtMS0xNDI0NzE_9833e3fc-7c4d-4a55-a8e7-894af9c1d937">76,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMy0zLTEtMS0xNDI0NzE_b5b56c57-2614-4948-b2bd-d62ed61533bc">76,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfNi0xLTEtMS0xNDI0NzE_02931346-7b10-4ed1-93ec-1315d0ce2fd3">76,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfNi0zLTEtMS0xNDI0NzE_f524d87d-c499-4ec8-b215-1da736b2307d">74,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_49"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80OS9mcmFnOjc2MDE5MDk2MTliYzRkY2Q4NmJlZGEwMjZlOTQ1ZDNjL3RleHRyZWdpb246NzYwMTkwOTYxOWJjNGRjZDg2YmVkYTAyNmU5NDVkM2NfMTM2MA_7d271e9d-4384-4d39-a707-8ba78feb7934" continuedAt="i152d37cb27e04f17aea976c609616082" escape="true">Income Tax</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i152d37cb27e04f17aea976c609616082">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended  March&#160;31, 2023 and 2022 was <ix:nonFraction unitRef="number" contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80OS9mcmFnOjc2MDE5MDk2MTliYzRkY2Q4NmJlZGEwMjZlOTQ1ZDNjL3RleHRyZWdpb246NzYwMTkwOTYxOWJjNGRjZDg2YmVkYTAyNmU5NDVkM2NfNDM4_40a9322a-9316-4657-a5f4-67e18b980b36">21.5</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80OS9mcmFnOjc2MDE5MDk2MTliYzRkY2Q4NmJlZGEwMjZlOTQ1ZDNjL3RleHRyZWdpb246NzYwMTkwOTYxOWJjNGRjZDg2YmVkYTAyNmU5NDVkM2NfNDQ1_4fa810f4-42f3-4bbc-9de7-0c1c4ba67ea6">41.4</ix:nonFraction>)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended  March&#160;31, 2023 was due primarily due to Internal Revenue Code Section 162(m) limitation on deduction for officer compensation, non-deductible incentive stock option (ISO) related stock compensation expense, which were partially offset by foreign derived intangible income tax benefit during the period. The variance from the U.S. federal tax rate of 21% for the three months ended March&#160;31, 2022 was primarily due to the tax deductions related to foreign derived intangible income tax benefit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period.</ix:continuation></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_52"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjU4Mg_8dc7665e-2d37-48ad-8726-1bebed2a607f" continuedAt="i50c5548624c24b07abee410ad1124fd5" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="i50c5548624c24b07abee410ad1124fd5" continuedAt="i728997890de34682ab4a15f64f5d0e5a"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2022 Annual Report.</span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjU4MA_c8d6db34-a66a-4f09-9a28-08ff53bb3c00" escape="true"><ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjU4MQ_702dc7f1-8feb-430b-bf26-4d351dbc86d3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b031e51a09841e2bba31484e4e6ba22_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi0xLTEtMS0xNDI0NzE_f589b3ad-7527-4177-b82c-111a6ab70ee7">2,991,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b031e51a09841e2bba31484e4e6ba22_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi0zLTEtMS0xNDI0NzE_e8e22985-78f5-469f-a33a-0d32fd44dc39">61.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i233c304b9e6749139554635d622968a6_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi01LTEtMS0xNDI0NzE_03f90597-7fe2-4a85-9824-80dd2f075557">348,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i233c304b9e6749139554635d622968a6_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi03LTEtMS0xNDI0NzE_6fa82cae-635f-41f6-90fb-47db2ca3d7b3">75.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy0xLTEtMS0xNDI0NzE_2bc528ce-8b6f-4b75-b152-eebf3d8de24c">409,591</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy0zLTEtMS0xNDI0NzE_f0fa8d16-3fe8-4e0d-80c9-c770ab3af80e">74.55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy01LTEtMS0xNDI0NzE_97d37511-8f14-4e9d-82e6-5b9155d07b0a">194,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy03LTEtMS0xNDI0NzE_fd8e6ce1-fc55-4bdc-a9ed-e895e8a650ce">84.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC0xLTEtMS0xNDI0NzE_10ad54bb-adf8-4a69-8b06-86adf926fc7c">93,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC0zLTEtMS0xNDI0NzE_4412a2b9-de87-4dc5-8ce9-d9da45a17da3">38.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC01LTEtMS0xNDI0NzE_7991e9ee-d037-420e-91a6-f8c2aeeece63">153,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC03LTEtMS0xNDI0NzE_84f4820d-0172-41ca-94f5-92e0edc1c8c7">77.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS0xLTEtMS0xNDI0NzE_d56c8cff-69a4-436f-bc7d-4b71a0f4bbd9">69,853</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS0zLTEtMS0xNDI0NzE_1c157a67-2dd8-444d-9160-7e0508dac202">61.33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS01LTEtMS0xNDI0NzE_caf344d1-3342-450a-938b-2d4c62cd9366">12,635</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS03LTEtMS0xNDI0NzE_eaf309c8-61f4-409b-85f1-aec13364977c">59.84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if88ab5f328b647e6a0703df984333731_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi0xLTEtMS0xNDI0NzE_dd7a7bec-b755-4332-ac83-f9db4f56358c">3,237,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if88ab5f328b647e6a0703df984333731_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi0zLTEtMS0xNDI0NzE_3bc570d2-e7fa-4ccb-a607-08f28fa0dcf7">63.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i488634fa2ce945148adf1d9adc77ea34_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi01LTEtMS0xNDI0NzE_3a2fa947-958f-4640-83ec-95fd65910d27">377,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i488634fa2ce945148adf1d9adc77ea34_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi03LTEtMS0xNDI0NzE_70534698-16f2-4f91-8f3f-a23a19a728ee">79.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfNDUw_b612beb9-4d3b-4a10-a1a7-f06f8ee61d62">1.8</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfNTI5_8855a7c2-2ca3-415d-bd02-5712f953426e">61.91</ix:nonFraction>.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="i5ed6d7e4223c47f4aa33849b39b77065_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfNjc4_001c0058-3b78-462e-a495-636d6453e596">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="i5ed6d7e4223c47f4aa33849b39b77065_D20230101-20230331" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfODA1_a88400f2-e55f-4af0-ac51-4f5596bb302a">35,881</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the Market Equity Offering Program</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we filed a registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. </span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i728997890de34682ab4a15f64f5d0e5a">On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#8220;Sales Agreement&#8221;) with Stifel, Nicolaus &amp; Company, Incorporated (the &#8220;Agent&#8221;), under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="ia698121e1ecb4b6a8dd84ec11d176568_I20230331" decimals="-5" name="lgnd:SaleOfStockAuthorizedOfferingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjE0Mg_74d2d55e-931c-43d9-a110-a4d544513622">100.0</ix:nonFraction>&#160;million in &#8220;at the market&#8221; offerings through the Agent (the &#8220;ATM Offering&#8221;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="ia698121e1ecb4b6a8dd84ec11d176568_I20230331" decimals="-5" name="lgnd:SaleOfStockAuthorizedOfferingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjMxOQ_74d2d55e-931c-43d9-a110-a4d544513622">100.0</ix:nonFraction>&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.</ix:continuation> </span></div><div><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_55"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfNDc3NQ_38d99a0c-deab-40cc-8c1e-cd0bf650c6e6" continuedAt="ifb3f8400348c4c2390519941516e4a79" escape="true">Commitment and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ifb3f8400348c4c2390519941516e4a79" continuedAt="i749bdf685aaa40e29483e7681931c6c7"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civil_complaint" contextRef="ib199687300914de5bd23ec149948555c_D20230101-20230331" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfMTA5OTUxMTYzODgzOA_0822fd00-b5e3-4b43-9c83-f81c3c6edcb7">three</ix:nonFraction> civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i749bdf685aaa40e29483e7681931c6c7" continuedAt="i1d73a8ea83214f16a846668ee1be9fc3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civil_complaint" contextRef="ib199687300914de5bd23ec149948555c_D20230101-20230331" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfMTA5OTUxMTYzODg0Mg_0822fd00-b5e3-4b43-9c83-f81c3c6edcb7">3</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1d73a8ea83214f16a846668ee1be9fc3">During the first quarter of 2023, we entered into an amendment to the lease agreement for our headquarters office located in San Diego, California, which resulted in a $<ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-5" name="lgnd:LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfNTQ5NzU1ODMzNjk4_2fe98717-7a43-4bf4-89f3-9236ea51fa63"><ix:nonFraction unitRef="usd" contextRef="ie1301938b25745d0b99c779227731ddd_I20230331" decimals="-5" name="lgnd:LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfNTQ5NzU1ODMzNjk4_6c3af009-a6f0-4886-9591-1dc30480e92a">1.1</ix:nonFraction></ix:nonFraction> million increase in both operating lease assets and operating lease liabilities as of March&#160;31, 2023.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A. Risk Factors. This outlook represents our current judgment on the future direction of our business. These statements include those related to our future results of operations and financial position, Captisol-related revenues and Kyprolis and other product royalty revenues and milestones under license agreements, product development, and product regulatory filings and approvals, and the timing thereof. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market. In addition, ongoing or future arbitration, litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We use our trademarks, trade names and services marks in this report as well as trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this report appear without the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade marks and trade names.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly-owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_67"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is focused on acquiring or funding programs and technologies that life science companies use to discover and develop medicines. Our business model provides a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable and diversified manner.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model is focused on funding mid to late-stage drug development in return for economic rights and outlicensing our technology platforms to help partners discover and develop medicines. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) ultimately to generate our revenue. Our Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Our Pelican Expression Technology is a validated, cost-effective and scalable platform for recombinant protein production that is especially well-suited for complex, large-scale protein production where traditional systems are not. We have established multiple alliances, licenses and other business relationships with the world&#8217;s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter International.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sales of Captisol material, and contract revenue from license, milestone and other service payments. We selectively pursue acquisitions and drug development funding opportunities that address high unmet clinical needs to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OmniAb Separation and Spin-Off</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2022, we entered into the Merger Agreement, by and among our company, APAC (which later became New OmniAb), OmniAb and Merger Sub, pursuant to which New OmniAb combined with OmniAb, our then-antibody discovery business, in a Reverse Morris Trust transaction. Pursuant to the Separation Agreement, we transferred the OmniAb Business, including certain of our related subsidiaries, to OmniAb and, in connection therewith, distributed (the Distribution) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution on November 1, 2022, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub merged with and into OmniAb (the Merger), with OmniAb continuing as the surviving company in the Merger and as a wholly-owned subsidiary of New OmniAb. After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after October 31, 2022. As a result, OmniAb's historical financial results are reflected in our consolidated financial statements as discontinued operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Updates </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travere Therapeutics (Nasdaq: TVTX) received FDA accelerated approval for FILSPARI&#8482; (sparsentan) for the treatment of IgA nephropathy (IgAN) on February 17, 2023, with commercial availability beginning in the last week of February. A review decision on sparsentan for the treatment of IgAN in Europe by the EMA is expected in the second half of 2023. On April 1, 2023, Travere announced publication in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Lancet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the interim analysis of efficacy and safety data from the ongoing pivotal, Phase 3 PROTECT Study evaluating sparsentan in adults with IgAN. The data were simultaneously presented in a late-breaking trials session at the World Congress of Nephrology 2023. On May 1, 2023, Travere announced that the pivotal Phase 3 DUPLEX Study evaluating sparsentan in focal segmental glomerulosclerosis (FSGS) did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment compared to the active control irbesartan. Travere reported that secondary and topline exploratory endpoints trended favorably and a reduction of proteinuria was sustained through 108 weeks of treatment. Travere plans to engage with regulators to explore a potential path forward for sparsentan as a treatment for FSGS in the U.S. and Europe.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viking Therapeutics (Nasdaq: VKTX) completed enrollment in its Phase 2b clinical trial of VK2809 in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH) with topline data on the primary endpoint expected in the first half of 2023. Separately, Ligand sold 3.2 million shares of Viking stock during the quarter resulting in $43 million of net proceeds following Viking&#8217;s announcement of positive data on their VK2735 obesity program. Ligand does not have any direct economic interest in VK2735. As of March 31, 2023, Ligand owned 3.6 million shares of VKTX stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novan (Nasdaq: NOVN) submitted an NDA to the U.S. FDA seeking marketing approval for berdazimer gel, 10.3% (SB206) for the topical treatment of molluscum contagiosum. The NDA has been accepted and assigned a PDUFA target date of January 5, 2024.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Palvella Therapeutics (private) announced positive topline results from its Phase 2 study of QTORIN&#8482; rapamycin in microcystic lymphatic malformations; 100% of participants were rated by physicians as being &#8220;Much Improved&#8221; or &#8220;Very Much Improved&#8221; as measured on the Clinician Global Impression of Change following 12-weeks of dosing with QTORIN rapamycin. Results showed that QTORIN was generally well-tolerated with no drug-related severe adverse events. QTORIN rapamycin has the potential to become the first FDA-approved treatment for this serious, rare genetic skin disease and has been granted Fast Track and Orphan Drug Designation from the FDA for this indication. Palvella anticipates initiation of a pivotal Phase 3 study in the second half of 2023.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novartis AG (NYSE: NVS) announced that the FDA granted approval for a liquid form of TAFINLAR&#174; (dabrafenib) + MEKINIST&#174;  (trametinib) for the treatment of pediatric patients one year of age and older with lowgrade glioma (LGG) with a BRAF V600E mutation and who require systemic therapy. This is the first approval of an oral Captisol-enabled product.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sermonix (private) announced the initiation of a registrational Phase 3 clinical study comparing targeted lasofoxifene in combination with the CDK 4/6 inhibitor abemaciclib to fulvestrant plus abemaciclib in pre- and post-menopausal subjects with locally advanced or metastatic ER+/HER2- breast cancer with an ESR1 mutation. Additionally, Sermonix announced that lasofoxifene improved vaginal/vulvar symptoms relative to fulvestrant in a study of postmenopausal women with locally advanced or metastatic estrogen receptor-positive ER+/HER2- breast cancer with an ESR1 mutation.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anebulo Pharmaceuticals (Nasdaq: ANEB) announced completion of dosing in its randomized, double-blind, placebo-controlled, Phase 2 clinical trial evaluating ANEB-001 as a potential treatment for acute cannabinoid intoxication. The preliminary data showed ANEB-001 reduced effects of a 30 mg dose of THC, and that delayed dosing of ANEB-001 rapidly reversed pre-existing THC effects. Anebulo is targeting an End of Phase 2a meeting with FDA in the second quarter 2023.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_70"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:58.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q1 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q1 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol - Core</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol - COVID</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,463&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a)    Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $7.5 million, or 20%, to $44.0 million in Q1 2023 compared to $36.5 million in Q1 2022 primarily due to a $5.2 million increase in contract revenue which was driven by the achievement of milestone tied to FDA approval of Travere&#8217;s FILSPARI. Royalty revenue increased by $3.7 million, or 28%, to $17.2 million in Q1 2023 compared to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$13.4 million in Q1 2022 primarily due to the increase of Kyprolis sales and sales of drugs using the Pelican platform. Core Captisol sales increased by $4.4 million, or 71%, to $10.6 million in Q1 2023 primarily due to the timing of customer orders. There was no Captisol sales related to COVID-19 in Q1 2023, compared with $5.9&#160;million for the same period in 2022.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3%. Evomela has a fixed royalty rate of 20%. Teriparatide injection has a tiered royalty between 25% and 40% on sales that have been adjusted for certain deductible items as defined in the respective license agreement. The Rylaze royalty rate is in the low single digits. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2023 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2023 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022 Estimated Partner Product Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022 Royalty Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">378.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teriparatide injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">83.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">158.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">644.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">452.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a)    Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(b)    Teriparatide injection sales have been adjusted for certain deductible items as defined in the respective license agreement.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:57.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.814%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,717</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,539</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,663</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,855</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29,774</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a)    Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses decreased by $4.6 million, or 13%, to $29.8 million in Q1 2023 compared to $34.4 million in Q1 2022.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Captisol decreased by $1.0 million, or (21)%, to $3.7 million in Q1 2023 compared to $4.7 million in Q1 2022, with the decrease primarily due to the lower Captisol sales this quarter. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles remained steady in Q1 2023 compared to the same period in 2022 as there have been no change to the gross balance of intangible assets over these periods. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple R&amp;D programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Research and development expense was $6.7 million for Q1 2023, compared with $9.2 million for the same period of 2022, with the decrease primarily due to lower share-based compensation, employee-related expenses and lab supply expenses. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense was $10.9&#160;million for Q1 2023, compared to $11.9&#160;million for the same period in 2022, with the decrease primarily due to a decrease in legal expenses in connection with the OmniAb spin-off. </span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:63.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.373%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,652)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41,331</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,277)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a)    Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and other equity security investments, which contributed an unrealized gain of $19.0 million in Q1 2023 as compared to an unrealized loss of $12.6 million in Q1 2022. In addition, during Q1 2023 we sold 3.2 million shares of Viking contributing to realized gains of $20.5 million compared to no Viking shares sold in Q1 2022.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The increase over the prior year was due to the increase in interest rates, partially offset by the decrease in our short-term investment balance.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes in both Q1 2023 and Q1 2022. The decrease in interest expense was primarily due to the lower average debt outstanding balance in Q1 2023 as compared to Q1 2022.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in Q1 2023 decreased by $1.7 million as compared to Q1 2022, primarily due to no debt extinguishment gain or loss in Q1 2023 compared to a $1.5 million gain on extinguishment of debt during Q1 2022. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note 4, Convertible Senior Notes.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:62.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.807%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">55,536</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,144)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(11,922)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,785)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,137)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">43,614</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,929)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a)    Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three months ended  March&#160;31, 2023 and 2022 was 21.5% and (41.4)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended  March&#160;31, 2023 was primarily due to Internal Revenue Code Section 162(m) limitation on deduction for officer compensation, non-deductible incentive stock option (ISO) related stock compensation expense, which were partially offset by foreign derived intangible income tax benefit during the period. The variance from the U.S. federal statutory tax rate of 21% for the three months ended  March&#160;31, 2022 was primarily due to the tax deductions related to foreign derived intangible income tax benefit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss from Discontinued Operations</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss from discontinued operations for Q1 2023 and Q1 2022 was $1.7 million and $2.5 million, respectively. See additional information in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Condensed Consolidated Financial Statements &#8212;Notes to Condensed Consolidated Financial Statements&#8212;Note (2), Spin-off Of OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_73"></div><div style="margin-bottom:6pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="margin-bottom:6pt;padding-right:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, our cash, cash equivalents, and short-term investments totaled $282.7 million, which increased by $70.8&#160;million from the end of last year due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and short-term investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="margin-bottom:6pt;padding-right:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 3.6 million shares of common stock in Viking.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. During the three months ended  March&#160;31, 2023, no 2023 Notes were repurchased. As of March&#160;31, 2023,  $76.9 million in principal amount of the 2023 Notes remain outstanding. We plan to use existing cash to pay off the remaining 2023 Notes on the maturity date. Since November 15, 2022, the 2023 Notes have been convertible without regard to the conditions applicable to conversions prior to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such date and will continue to be until the close of business on May 11, 2023 (the second scheduled trading day preceding May 15, 2023, which is the maturity date). It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes. No holders exercised their right to convert their 2023 Notes during the applicable period for conversion. After we completed the Separation of the OmniAb Business, on November&#160;15, 2022, the conversion rate was adjusted to 4.8390 shares of common stock per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately&#160;$206.65 per share. The maximum conversion rate of the 2023 Notes was adjusted to 6.2907 per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately $158.97.  The conversion rate for the 2023 Notes was adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dividend date of the spin-off (as determined in the Indenture). The conversion rate and maximum conversion rate are subject to further adjustment under the circumstances and pursuant to the terms set forth in the Indenture.</span></div><div style="margin-bottom:6pt;padding-right:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we entered into the Sales Agreement with the Agent, under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100.0&#160;million in &#8220;at the market&#8221; offerings through the Agent. Sales of the shares of common stock, if any, will be made at prevailing market prices at the time of sale, or as otherwise agreed with the Agent. The Agent will receive a commission from the Company of up to 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. The shares will be issued pursuant to our shelf registration statement on Form S-3 (File No. 333-267678), including the sales agreement prospectus contained therein, which automatically became effective upon filing with the SEC on September 30, 2022.</span></div><div style="margin-bottom:6pt;padding-right:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="margin-bottom:6pt;padding-right:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $2.8 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:65.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.050%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(775)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we generated cash from operations primarily due to the increase in net income. We generated cash from investing activities primarily from sale and maturity of short-term investments including Viking shares. There was no repurchase of 2023 Notes during the three months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we repurchased $165.8 million in principal amount of the 2023 Notes for $163.7 million in cash, including accrued interest of $0.4 million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2022 Annual Report.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_76"></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material changes to our market risks in the three months ended March&#160;31, 2023, when compared to the disclosures in Item 7A of our 2022 Annual Report.</span></div><div><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_79"></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of March&#160;31, 2023 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_82"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_85"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information that updates the disclosures set forth under Part I. Item 3. Legal Proceedings in our 2022 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Condensed Consolidated Financial Statements contained in Part I. Item 1. of this report.</span></div><div><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_88"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2022 Annual Report. The risk factors described in our 2022 Annual Report are not the only risks we face. Factors we currently do not know, factors that we currently consider immaterial or factors that are not specific to us, such as general economic conditions, may also materially adversely affect our business or our consolidated operating results, financial condition or cash flows.</span></div><div style="text-indent:27pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_91"></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="ice8fdea4daf543e39470dd283be54686_94"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ice8fdea4daf543e39470dd283be54686_97"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="ice8fdea4daf543e39470dd283be54686_100"></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ice8fdea4daf543e39470dd283be54686_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Incorporated by Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Description of Exhibit</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Form</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">File Number</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Date of Filing</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Filed</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522255529/d379227dex12.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At-the-Market Equity Offering Sales Agreement, dated September 30, 2022, by and between the Company and Stifel, Nicolaus &amp; Company, Incorporated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-3ASR</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-267678</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="a102-directorcompensationa.htm">10.2#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Director Compensation and Stock Ownership Policy, as amended and restated effective April 19, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="a103-changeinctrlseverance.htm">10.3#*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Form of Change in Control Severance Agreement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_33123exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_33123exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_33123exhibit321.htm">32.1**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">101</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr></table></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">#    Indicates management contract or compensatory plan.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">*    Certain schedules and annexes have been omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or annex will be furnished as a supplement to the U.S. Securities and Exchange Commission upon request.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">** These certifications are deemed not filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="ice8fdea4daf543e39470dd283be54686_106"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Octavio Espinoza</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Octavio Espinoza</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>a102-directorcompensationa.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4728e66c79c8445f93f4496f82a55001_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DIRECTOR COMPENSATION AND STOCK OWNERSHIP POLICY </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amended and Restated Effective April 19, 2023) </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">I. DIRECTOR COMPENSATION </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-employee members of the board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) of Ligand Pharmaceuticals Incorporated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) shall be eligible to receive cash and equity compensation effective as of April 19, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restatement Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), as set forth in this Director Compensation Policy. The cash compensation and stock awards described in this Director Compensation Policy shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) who may be eligible to receive such cash compensation or stock awards, unless such Independent Director declines the receipt of such cash compensation or stock awards by written notice to the Chairman of the Board. This Director Compensation Policy shall remain in effect until it is revised or rescinded by further action of the Board. The terms and conditions of this Director Compensation Policy shall supersede any prior cash or equity compensation arrangements between the Company and its directors. </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Cash Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Annual Retainer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each Independent Director shall be eligible to receive an annual retainer of $50,000 for service on the Board. In addition, an Independent Director serving as&#58; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">chairman of the Board shall be eligible to receive an additional annual retainer of $35,000 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">chairman of the Audit Committee shall be eligible to receive an additional annual retainer of $20,000 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.19pt">members (other than the chairman) of the Audit Committee shall be eligible to receive an additional annual retainer of $10,000 for such service&#59;</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.73pt">chairman of the Human Capital Management and Compensation Committee shall be eligible to receive an additional annual retainer of $15,000 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:1.5pt">members (other than the chairman) of the Human Capital Management and Compensation Committee shall be eligible to receive an additional annual retainer of $7,500 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.73pt">chairman of the Nominating and Corporate Governance Committee shall be eligible to receive an additional annual retainer of $10,000 for such service&#59; and </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:31.96pt">members (other than the chairman) of the Nominating and Corporate Governance Committee shall be eligible to receive an additional annual retainer of $5,000 for such service. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Payment of Cash Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Annual retainer fees shall be paid after each annual meeting of the Company&#8217;s stockholders in advance for the upcoming year of service and shall be prorated for the period of the year served for Independent Directors who are elected or appointed to the Board at a time other than the date of the annual meeting of the Company&#8217;s stockholders&#59; provided, however, that an Independent Director may elect in writing prior to the date of an annual meeting to receive all or a portion of his annual retainer fee in the form of such number of fully vested shares of the Company&#8217;s common stock as is equal to (i) the amount of the annual retainer the Independent Director has elected to receive in the form of shares of the Company&#8217;s common stock, divided by (ii) the closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) on the date of the annual meeting. Committee retainer fees shall also be paid annually after each annual meeting of the Company&#8217;s stockholders in advance for the upcoming year of service and shall be prorated for any partial quarters served for Independent Directors who serve on a committee for a partial year.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Equity Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Independent Directors shall be granted the following stock awards. The stock awards described below shall be granted under and shall be subject to the terms and provisions of the Company&#8217;s 2002 Stock Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">2002 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and shall be granted subject to the execution and delivery of award agreements, including attached exhibits, in substantially the same forms previously approved by the Board. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Initial Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. A person who is initially elected or appointed to the Board on or after the Restatement Effective Date, and who was or is an Independent Director at the time of such initial election or appointment, shall be eligible to receive the following stock awards on the date of such initial election or appointment (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Initial Stock Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#58; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">that number of restricted stock units determined by dividing (A) $145,000, by (B) the average closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) for the 60-calendar day period prior to the date of grant&#59; and </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">that number of stock options having a value of $280,000, calculated on the grant date in accordance with the Black-Scholes option pricing model (utilizing the same assumptions that the Company utilizes in preparation of its financial statements). </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Subsequent Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. A person who is an Independent Director as of the date of each annual meeting of the Company&#8217;s stockholders and who is re-elected for another year of service as an Independent Director at such annual meeting automatically shall be eligible to receive the following stock awards on the date of each such annual meeting of the Company&#8217;s stockholders on or after the Restatement Effective Date (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Subsequent Stock Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#58; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">that number of restricted stock units determined by dividing (A) $85,000, by (B) the average closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) for the 60-calendar day period prior to the date of grant&#59; and </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">that number of stock options having a value of $175,000, calculated on the grant date in accordance with the Black-Scholes option pricing model (utilizing the same assumptions that the Company utilizes in preparation of its financial statements). </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An Independent Director elected for the first time to the Board at an annual meeting of stockholders shall only receive an Initial Restricted Stock grant in connection with such election, and shall not receive a Subsequent Restricted Stock grant on the date of such meeting as well. The stock awards described in this clause shall be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Subsequent Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#8221; </font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Termination of Employment of Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Members of the Board who are employees of the Company or any parent or subsidiary of the Company who subsequently terminate their employment with the Company and any parent or subsidiary of the Company and remain on the Board will not receive any Initial Stock Awards pursuant to clause 2(a) above, but to the extent that they are otherwise eligible, will be eligible to receive, after termination from employment with the Company and any parent or subsidiary of the Company, Subsequent Stock Awards as described in clause 2(b) above. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Vesting of Stock Awards Granted to Independent Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">Initial Stock Awards granted hereunder shall vest in three (3) equal annual installments on each of the first three (3) anniversaries following the date of grant, subject to the Independent Director&#8217;s continuing service on the Board through each such vesting date. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">Subsequent Stock Awards granted hereunder shall vest in full on the earlier of (A) the date of the annual meeting of the Company&#8217;s stockholders next following the grant date (it being understood that the Subsequent Stock Awards shall vest on the date of such annual meeting whether or not the Independent Director is re-elected at such meeting, so long as the Independent Director serves through such meeting) and (B) on the first anniversary of the date of grant, subject to the Independent Director&#8217;s continuing service on the Board through each such vesting date. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.19pt">Any stock awards granted hereunder shall vest in full in the event of a Change in Control or a Hostile Take-Over (each as defined in the 2002 Plan) to the extent the Independent Director is serving on the Board at the time of such transaction or in the event an Independent Director ceases to serve on the Board by reason of death or Permanent Disability as defined in the 2002 Plan. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.73pt">Any unvested stock awards will be forfeited to the Company in the event an Independent Director ceases to serve on the Board prior to the vesting of such awards.</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Effect of Termination of Board Service on Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. An Independent Director shall be able to exercise his or her stock options that were vested at the time of his or her cessation of Board service until the first to occur of (i) the third anniversary of the date of his or her cessation of Board service, or (ii) the original expiration date of the term of such stock options. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.17pt;text-decoration:underline">Term of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each stock option granted hereunder shall have a term of ten (10) years measured from the date of grant. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Exercise Price of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The exercise price per share of any stock options granted hereunder shall be equal to one hundred percent (100%) of the Fair Market Value (as defined in the 2002 Plan) of the common stock on the date of grant. </font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">II. DIRECTOR STOCK OWNERSHIP GUIDELINES </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Directors are expected to own and hold shares of the Company&#8217;s common stock with a value equal to three times the annual cash retainer for service as an Independent Director (without regard to any retainers paid for committee service or service as chairman of the Board). The stock ownership level should be achieved by each Independent Director on or before April 30, 2014 or, if later, within three years after the Independent Director&#8217;s first appointment to the Board. </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock that counts toward satisfaction of these guidelines include&#58; shares of common stock owned outright by the Independent Director and his or her immediate family members who share the same household, whether held individually or jointly&#59; restricted stock where the restrictions have lapsed&#59; shares acquired upon stock option exercise&#59; shares purchased in the open market&#59; and shares held in trust for the benefit of the Independent Director or his or her family. Restricted stock units, which represent the right to receive shares, do not count towards satisfaction of these guidelines. Shares held in trust may be included. Due to the complexities of trust accounts, requests to include shares held in trust should be submitted to the Secretary of the Company and the Chairman of the Board will make the final decision as to whether to include those shares. </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An Independent Director will be deemed to be in compliance with these guidelines if the Fair Market Value (as defined in the 2002 Plan) of the shares of the Company&#8217;s common stock held by such Independent Director on any date prior to the deadline for his or her compliance equals or exceeds the required multiple of his or her annual cash retainer. After meeting the requirements set forth in these guidelines, any subsequent decreases in the market value of the Company&#8217;s common stock shall not be considered, so long as the Independent Director continues to hold at least the same number of shares of the Company&#8217;s common stock as he or she did when the guidelines were first met or exceeded by such Independent Director. </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The guidelines may be waived for Independent Directors, at the discretion of the Board, if compliance would create hardship or prevent an Independent Director from complying with a court order, as in the case of a divorce settlement. </font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>a103-changeinctrlseverance.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i11910e3c17994c99a20c8e89367974f7_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHANGE IN CONTROL SEVERANCE AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Change in Control Severance Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of _________, by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and ________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any of the following&#58; (i)&#160;Employee&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony under the laws of the United States or any state thereof&#59; (ii) Employee&#8217;s willful and material breach of any obligation or duty under this Agreement, the PIIA (as defined below) or the Company&#8217;s written employment or other written policies that have previously been furnished to Employee, which breach is not cured within thirty (30) days after written notice thereof is received by Employee, if such breach is capable of cure&#59; (iii) Employee&#8217;s gross negligence or willful misconduct, including without limitation, fraud, dishonesty or embezzlement, in the performance of his or her duties&#59; or (iv)&#160;Employee&#8217;s continuing failure or refusal to perform his or her assigned duties or to comply with reasonable directives of the Board of Directors that are consistent with Employee&#8217;s job duties (which directives are not in conflict with applicable law), which failure is not cured within thirty (30) days after written notice thereof is received by Employee.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a change in ownership or control of the Company effected through any of the following transactions&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i) &#160;&#160;&#160;&#160;a merger, consolidation or other reorganization approved by the Company&#8217;s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Company&#8217;s outstanding voting securities immediately prior to such transaction&#59; or </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">                  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii) &#160;&#160;&#160;&#160;the sale, license, transfer or other disposition (including establishing a royalty trust) of an asset or assets in one transaction or a series of related transactions which the Board of Directors determines, in its sole discretion, represent more than fifty percent (50%) of the aggregate value of the Company&#8217;s assets&#59; or</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">                  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii) &#160;&#160;&#160;&#160;the acquisition, directly or indirectly by any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company), of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding the foregoing, no transaction, event or occurrence shall constitute a Change in Control for purposes of this Agreement, unless such transaction, event or occurrence also constitutes a &#8220;change in control event&#8221; as defined in Treasury Regulation Section 1.409A-3(i)(5).</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the occurrence of any of the following events or conditions without Employee&#8217;s written consent&#58;  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;a material diminution in Employee&#8217;s authority, duties or responsibilities&#59;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;a material diminution in Employee&#8217;s base compensation&#59; </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;a material change in the geographic location at which Employee must perform his or her duties&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;any other action or inaction that constitutes a material breach by the Company or any successor or affiliate of its obligations to Employee under this Agreement.</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee must provide written notice to the Company of the occurrence of any of the foregoing events or conditions without Employee&#8217;s written consent within ninety (90) days of the occurrence of such event.  The Company or any successor or affiliate shall have a period of thirty (30) days to cure such event or condition after receipt of written notice of such event from Employee.  Any voluntary termination of Employee&#8217;s employment for &#8220;Good Reason&#8221; following such thirty (30) day cure period must occur no later than the date that is six (6) months following the initial occurrence of one of the foregoing events or conditions without Employee&#8217;s written consent.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Employee&#8217;s inability to perform the essential functions of his or her position, with or without reasonable accommodation, for a period of at least one hundred twenty (120) consecutive days because of a physical or mental impairment.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all stock options, restricted stock and such other awards granted pursuant to the Company&#8217;s stock option and equity award plans or agreements and any shares of stock issued upon exercise thereof.  </font></div><div><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;If Employee&#8217;s employment is terminated by the Company without Cause or by Employee for Good Reason within twenty-four (24) months following a Change in Control, then subject to the requirements of this Section 2 and Employee&#8217;s continued compliance with Section 3, Employee shall be entitled to receive, in lieu of any severance benefits to which Employee may otherwise be entitled, including under any Other Arrangement (as defined below), the benefits provided below&#58;</font></div><div style="padding-right:-9pt;text-indent:72pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;The Company shall pay to Employee (A) his or her fully earned but unpaid base salary, when due, through the date of termination at the rate then in effect, (B) his or her accrued but unpaid vacation or paid time off through the date of termination, when due, plus (C) all other amounts or benefits to which Employee is entitled under any compensation, retirement or benefit plan or practice of the Company at the time of termination in accordance with the terms of such plans or practices, including, without limitation, any continuation of benefits required by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or applicable law (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;Employee shall be entitled to receive severance pay in an amount equal to the sum of&#58;</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;Employee&#8217;s monthly base salary as in effect immediately prior to the date of termination for the twelve (12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">month</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">period following the date of termination, plus</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;An amount equal to the greater of (1) Employee&#8217;s maximum target bonus for the fiscal year during which the date of termination occurs or (2) Employee&#8217;s maximum target bonus for the fiscal year during which the Change in Control occurs, </font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">payable, in the case of both clauses (A) and (B), in a lump sum within ten (10) days following the effective date of Employee&#8217;s Release, but in no event later than two and one-half (2 &#189;) months following the last day of the calendar year in which the date of Employee&#8217;s termination of employment occurs&#59;</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-15.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii) &#160;&#160;&#160;&#160;Employee shall be entitled to receive a lump sum cash payment equal to (A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">twelve (12) multiplied by (B) the monthly premium Employee would be required to pay for continuation coverage pursuant to COBRA for Employee and his or her eligible dependents who were covered under the Company&#8217;s health plans as of the date of Employee&#8217;s termination such that Employee&#8217;s premiums are the same as for active employees (calculated by reference to the premium as of the date of termination) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Employee shall be solely responsible for all matters relating to his or her continuation of coverage pursuant to COBRA, including, without limitation, his or her election of such coverage and his or her timely payment of premiums), which payment shall be paid within ten (10) days following the effective date of Employee&#8217;s Release, but in no event later than two and one-half (2 &#189;) months following the last day of the calendar year in which the date of Employee&#8217;s termination of employment occurs&#59; and</font></div><div style="margin-bottom:12pt;padding-right:-15.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;The vesting and&#47;or exercisability of any outstanding unvested portions of Employee&#8217;s Stock Awards the vesting of which is solely time-based and not subject to the satisfaction of a performance condition shall be automatically accelerated on the effective date of Employee&#8217;s Release.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In </font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-15.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">addition, Employee&#8217;s Stock Awards may be exercised by Employee (or Employee&#8217;s guardian or legal representative) until (A) the date that is nine (9) months following the date of termination, or (B) such longer period as may be specified in the applicable stock award agreement&#59; provided, however, that in no event shall any Stock Award remain exercisable beyond the original outside expiration date of such Stock Award&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, any Stock Awards that vest in whole or in part based on the attainment of performance-vesting conditions shall be governed by the terms of the applicable Stock Award agreement.  Employee&#8217;s vested Stock Awards shall be governed by the terms and conditions of the Stock Award agreements and the Company&#8217;s equity plan under which such Stock Awards were granted. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, in the event the Stock Award agreement or the equity plan pursuant to which the Stock Awards were granted provides for more favorable treatment of Employee&#8217;s Stock Awards, nothing in this Agreement is intended to limit Employee&#8217;s right to such more favorable treatment as provided in such Stock Award agreement or equity plan. </font></div><div style="padding-right:-9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Employee&#8217;s employment is terminated by the Company without Cause or by Employee for Good Reason prior to a Change in Control or more than twenty-four (24) months following a Change in Control, or at any time by the Company for Cause, by Employee without Good Reason, or as a result of Employee&#8217;s death or Permanent Disability, the Company shall not have any other or further obligations to Employee under this Agreement (including any financial obligations) except that Employee shall be entitled to receive the Accrued Obligations and any rights Employee may have to severance under the Company&#8217;s standard severance policy.  The foregoing shall be in addition to, and not in lieu of, any and all other rights and remedies which may be available to the Company under the circumstances, whether at law or in equity.</font></div><div style="padding-right:-9pt;text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As a condition to Employee&#8217;s receipt of any post-termination benefits pursuant to Section 2(a) above, Employee shall execute and not revoke a general release of all claims in favor of the Company and its affiliates (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee&#8217;s Release shall be deemed effective on the day following the expiration of any applicable revocation period.  In the event the Release does not become effective within the fifty-five (55) day period following the date of Employee&#8217;s termination of employment, Employee shall not be entitled to the aforesaid payments and benefits.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of Employee&#8217;s rights to salary, severance, benefits, bonuses and other amounts hereunder (if any) accruing after the termination of Employee&#8217;s employment shall cease upon such termination.  In addition, the severance payments provided for in Section 2(a) above are intended to be the exclusive severance benefits payable to Employee, in the event of a termination without Cause or resignation for Good Reason within 24 months following a Change in Control, and such severance payments shall be paid in lieu of any severance payments Employee may otherwise be entitled to receive under any other plan, program, policy or agreement with the Company or any of its affiliates (including, without limitation, the Company&#8217;s Amended and Restated Severance Plan) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Other Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Therefore, in the event Employee becomes entitled to receive the severance payments and benefits provided under Section 2(a) of this Agreement, he or she shall receive the amounts provided under that section of this Agreement and shall not be entitled to receive any severance payments or severance benefits pursuant to any Other Arrangements.  In the event of a termination of Employee&#8217;s employment with the Company, Employee&#8217;s sole remedy shall be to receive the payments and benefits described in this Section 2.  </font></div><div style="margin-bottom:12pt;padding-right:-2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Mitigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee shall not be required to mitigate the amount of any payment provided for in this Section 2 by seeking other employment or otherwise, nor shall the amount of any payment or benefit provided for in this Section 2 be reduced by any compensation earned by Employee as the result of employment by another employer or self-employment or by retirement benefits&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that loans, advances or other amounts owed by Employee to the Company may be offset by the Company against amounts payable to Employee under this Section 2.    </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Return of the Company&#8217;s Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Employee&#8217;s employment is terminated for any reason, the Company shall have the right, at its option, to require Employee to vacate his or her offices prior to or on the effective date of termination and to cease all activities on the Company&#8217;s behalf.  Upon the termination of his or her employment in any manner, as a condition to Employee&#8217;s receipt of any post-termination benefits described in this Agreement, Employee shall immediately surrender to the Company all lists, books and records of, or in connection with, the Company&#8217;s business, and all other property belonging to the Company, it being distinctly understood that all such lists, books and records, </font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and other documents, are the property of the Company.  Employee shall deliver to the Company a signed statement certifying compliance with this Section 2(f) prior to the receipt of any post-termination benefits described in this Agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Best Pay Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">In the event that any payment or benefit received or to be received by Employee pursuant to the terms of any plan, arrangement or agreement (including any payment or benefit received in connection with a change in ownership or control or the termination of the Employee&#8217;s employment) (all such payments and benefits being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Total Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) would be subject (in whole or part) to the excise tax (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) imposed under Section 4999 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then the Total Payments shall be reduced to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (A) the net amount of such Total Payments, as so reduced (after subtracting the amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments) is greater than or equal to (B) the net amount of such Total Payments without such reduction (after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which Employee would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments).  Except to the extent that an alternative reduction order would result in a greater economic benefit to Employee on an after-tax basis, the parties intend that the Total Payments shall be reduced in the following order&#58; (w) reduction of any cash severance payments otherwise payable to Employee that are exempt from Section 409A of the Code, (x) reduction of any other cash payments or benefits otherwise payable to Employee that are exempt from Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A of the Code, (y) reduction of any other payments or benefits otherwise payable to Employee on a pro-rata basis or such other manner that complies with Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting and payment with respect to any equity award that is exempt from Section 409A of the Code, and (z) reduction of any payments attributable to the acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A of the Code&#59; provided, in case of clauses (x), (y) and (z), that reduction of any payments or benefits attributable to the acceleration of vesting of Company equity awards shall be first applied to equity awards with later vesting dates&#59; provided, further, that, notwithstanding the foregoing, any such reduction shall be undertaken in a manner that complies with and does not result in the imposition of additional taxes on Employee under Section&#160;409A of the Code.  The foregoing reductions shall be made in a manner that results in the maximum economic benefit to Employee on an after-tax basis and, to the extent economically equivalent payments or benefits are subject to reduction, in a pro rata manner. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;All determinations regarding the application of this Section 2(g) shall be made by an independent accounting firm or consulting group with nationally recognized standing and substantial expertise and experience in performing calculations regarding the applicability of Section 280G of the Code and the Excise Tax retained by the Company prior to the date of the applicable change in ownership or control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">280G Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (A) no portion of the Total Payments shall be taken into account which (x) does not constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, or (y) constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the &#8220;base amount&#8221; (as defined in Section 280G(b)(3) of the Code) allocable to such reasonable compensation, (B) no portion of the Total Payments the receipt or enjoyment of which Employee shall have waived at such time and in such manner as not to constitute a &#8220;payment&#8221; within the meaning of Section 280G(b) of the Code shall be taken into account, and (C) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the 280G Firm in accordance with the principles of Sections 280G(d)(3) and (4) of the Code.  All determinations related to the calculations to be performed pursuant to this &#8220;Best Pay Provision&#8221; section shall be done by the 280G Firm.  The 280G Firm will be directed to submit its determination and detailed supporting calculations to both Employee and the Company within fifteen (15) days after notification from either the Company or Employee that Employee may receive payments which may be &#8220;parachute payments.&#8221;  Employee and the Company will each provide the 280G Firm access to and copies of any books, records, and documents as may be reasonably requested by the 280G Firm, and otherwise cooperate with the 280G Firm in connection with the preparation and issuance of the </font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">determinations and calculations contemplated by this Agreement.  The fees and expenses of the 280G Firm for its services in connection with the determinations and calculations contemplated by this Agreement will be borne solely by the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All compensation and benefits to Employee hereunder shall be reduced by all federal, state, local and other withholdings and similar taxes and payments required by applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Deemed Resignation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon termination of Employee&#8217;s employment for any reason, Employee shall be deemed to have resigned from all offices and directorships, if any, then held with the Company or any of its subsidiaries, including his or her position as a member of the Board, if applicable, and shall take all actions reasonably requested by the Company to effectuate the foregoing.  Employee&#8217;s resignation from all such positions shall be a condition to receive of the severance payments to Employee under Section 2(a).</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">PIIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Employee and the Company have executed the Company&#8217;s proprietary information and inventions agreement, a copy of which is attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and incorporated herein by reference (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">PIIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Company shall be entitled to cease all severance payments to Employee in the event of his or her breach of this Section 3.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything herein to the contrary, nothing in this Agreement or the PIIA shall (i) prohibit Employee from filing a charge with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other comparable federal agency, state agency or securities regulatory body (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Government Agencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; (ii) prohibit Employee from reporting possible violations of law to an appropriate Government Agency in a confidential manner without notice to the Company as authorized in any whistleblower protection provisions of any federal or state law or regulation&#59; (iii) communicating directly with any governmental, law enforcement, regulatory or self-regulatory body&#59; (iv) limit Employee&#8217;s lawful opportunity to cooperate with or participate in any administrative proceeding or investigation that may be conducted by a Government Agency&#59; (v) receive awards from a Government Agency as a result of reporting or cooperation&#59; or (vi) prohibit Employee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful. With respect to any information disclosed pursuant to this protected activity exception that may constitute confidential or proprietary information, Employee agrees to take all reasonable precautions to prevent any unauthorized use or disclosure to any parties other than the relevant agency or authority. Except as prohibited by applicable law, rule, or regulation, the payments paid to pursuant to this Agreement will be the sole monetary relief available to Employee, and Employee will not be entitled to recover, and agrees to waive, any additional personal monetary relief that may be sought from or awarded against the Company in the future without regard to who filed or brought such claim. However, this Agreement does not waive Employee&#8217;s right to receive an award for original information from any Government Agency, including but not limited to any such award pursuant to Section 21F of the Securities Exchange Act of 1934. Further, Employee&#8217;s participation in an investigation or other legal matter may include a disclosure of trade secret information provided that it must comply with the restrictions in the Defend Trade Secrets Act of 2016 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">DTSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The DTSA provides that no individual will be held criminally or civilly liable under Federal or State trade secret law for the disclosure of a trade secret that&#58; (x) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney&#59; and made solely for the purpose of reporting or investigating a suspected violation of law&#59; or (y) is made in a complaint or other document if such filing is under seal so that it is not made public. Also, an individual who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by court order.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any controversy, claim or dispute arising out of or relating to this Agreement, shall be settled solely and exclusively by binding arbitration in accordance with the arbitration provisions contained in the Mutual Agreement to Arbitrate between Employee and the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Arbitration Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), a copy of which is attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and incorporated herein by reference. This Section 4 is intended to be the exclusive method for resolving any </font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and all claims by the parties against each other for payment of damages under this Agreement or relating to Employee&#8217;s employment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that neither this Agreement nor the submission to mediation or arbitration shall limit the parties&#8217; right to seek provisional relief, including without limitation injunctive relief, in any court of competent jurisdiction pursuant to California Code of Civil Procedure &#167; 1281.8 or any similar statute of an applicable jurisdiction.  Seeking any such relief shall not be deemed to be a waiver of such party&#8217;s right to compel arbitration.  Both Employee and the Company expressly waive their right to a jury trial.  The parties agree that any claim asserted in arbitration may be made only on an individual basis, and the parties may not assert claims on a representative, class or other collective basis. Finally, Employee agrees that Employee has been provided an opportunity to seek the advice of an attorney of Employee&#8217;s choice before signing this Agreement.</font></div><div style="padding-right:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">At-Will Employment Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee&#8217;s employment with the Company is at-will and not for any specified period and may be terminated at any time, with or without Cause or advance notice, by either Employee or the Company.  Any change to the at-will employment relationship must be by specific, written agreement signed by Employee and an authorized representative of the Company.  Nothing in this Agreement is intended to or should be construed to contradict, modify or alter this at-will relationship. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The rights of the Company under this Agreement may, without the consent of Employee, be assigned by the Company, in its sole and unfettered discretion, to any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of the Company.  The Company will require any successor (whether direct or indirect, by purchase, merger or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and to agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no such assumption shall relieve the Company of its obligations hereunder. &#160;As used in this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Company as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law or otherwise. Employee shall not be entitled to assign any of Employee&#8217;s rights or obligations under this Agreement.  This Agreement shall inure to the benefit of and be enforceable by Employee&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event any provision of this Agreement is found to be unenforceable by an arbitrator or court of competent jurisdiction, such provision shall be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being intended that the parties shall receive the benefit contemplated herein to the fullest extent permitted by law.  If a deemed modification is not satisfactory in the judgment of such arbitrator or court, the unenforceable provision shall be deemed deleted, and the validity and enforceability of the remaining provisions shall not be affected thereby. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Interpretation&#59; Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The headings set forth in this Agreement are for convenience only and shall not be used in interpreting this Agreement.  This Agreement has been drafted by legal counsel representing the Company, but Employee has participated in the negotiation of its terms.  Furthermore, Employee acknowledges that Employee has had an opportunity to review and revise the Agreement and have it reviewed by legal counsel, if desired, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement.  Either party&#8217;s failure to enforce any provision of this Agreement shall not in any way be construed as a waiver of any such provision, or prevent that party thereafter from enforcing each and every other provision of this Agreement.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Governing Law and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement will be governed by and construed in accordance with the laws of the United States and the State of California applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof.  Any suit brought hereon shall be brought in the state or federal courts sitting in San Diego County, California, the Parties hereby waiving any claim or defense that such forum is not convenient or proper.  Each party hereby agrees that any such court shall have in personam jurisdiction over it and consents to service of process in any manner authorized by California law.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows with notice deemed given as indicated&#58;  (i) by personal delivery when delivered personally&#59; (ii) by overnight courier upon written verification of receipt&#59; (iii) by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission&#59; or (iv) by certified or registered mail, return receipt requested, upon verification of receipt.  Notice shall be sent to Employee at his or her most recent residence and personal email address on file with the Company and to the Company at its principal place of business, or such other address as either party may specify in writing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Sections 1 (&#8220;Definitions&#8221;), 2 (&#8220;Severance&#8221;), 3 (&#8220;Restrictive Covenants&#8221;), 4 (&#8220;Dispute Resolution&#8221;) and 6 (&#8220;General Provisions&#8221;) of this Agreement&#160;shall survive termination of Employee&#8217;s employment by the Company.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement, the Arbitration Agreement and the PIIA incorporated herein by reference together constitute the entire agreement between the parties in respect of the subject matter contained herein and therein and supersede all prior or simultaneous representations, discussions, negotiations, and agreements, whether written or oral&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that for the avoidance of doubt, all Other Arrangements (as such Other Arrangements may be amended, modified or terminated from time to time) shall remain in effect in accordance with their terms, subject to Section 2(d) hereof.  This Agreement may be amended or modified only with the written consent of Employee and an authorized representative of the Company.  No oral waiver, amendment or modification will be effective under any circumstances whatsoever.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Code Section 409A Exempt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">To the extent applicable, this Agreement shall be interpreted in accordance with Section 409A of the Code and the regulations and guidance promulgated thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from Code Section 409A and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance with such intention. To the extent that any provision in this Agreement is ambiguous as to its compliance with or exemption from Code Section 409A, the provision shall be read in such a manner that no payments payable under this Agreement shall be subject to an &#8220;additional tax&#8221; as defined in Section 409A(a)(1)(B) of the Code.  If the Company and Employee determine that any compensation or benefits payable under this Agreement may be or become subject to Code Section 409A and related Department of Treasury guidance, the Company and Employee agree to amend this Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effect), or take such other actions as the Company and Employee deem necessary or appropriate to (A) exempt the compensation and benefits payable under this Agreement from Code Section 409A and&#47;or preserve the intended tax treatment of the compensation and benefits provided with respect to this Agreement, or (B) comply with the requirements of Code Section 409A and related Department of Treasury guidance.   </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">For purposes of Section 409A of the Code, any right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments. For purposes of this Agreement, to the extent necessary to ensure that the payments hereunder comply with or are exempt from Code Section 409A, all references to Employee&#8217;s &#8220;termination of employment&#8221; shall mean his or her &#8220;separation from service&#8221; (as defined in Treasury Regulation Section 1.409A-1(h)).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Notwithstanding anything in this Agreement to the contrary, if Employee is deemed by the Company at the time of Employee&#8217;s separation from service to be a &#8220;specified employee&#8221; for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Employee is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A, such portion of Employee&#8217;s benefits shall not be provided to Employee prior to the earlier of (A)&#160;the expiration of the six-month period measured from the date of Employee&#8217;s separation from service with the Company or (B) the date of Employee&#8217;s death.  Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Employee (or Employee&#8217;s estate or beneficiaries), and any remaining payments due to Employee under this Agreement shall be paid as otherwise provided herein.</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">In the event that the amounts payable under this Agreement constitute &#8220;non-qualified deferred compensation&#8221; subject to Code Section 409A, and the timing of the delivery of Employee&#8217;s Release could cause the severance benefits described in Section 2(a) to be paid in one or another calendar year, then notwithstanding the payment timing set forth in such section, such amounts shall not be payable until the later of (A) January 1 of the second calendar year, or (B) the payment date set forth in Section 2(a). </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To the extent required by Code Section 409A, any reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance with the following&#58; (A) the amount of expenses eligible for reimbursement, or in-kind benefits provided during each calendar year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year&#59; (B) any payments in lieu of the benefits shall be paid no later than the end of Employee&#8217;s taxable year next following Employee&#8217;s taxable year in which the benefit or expense was due to be paid&#59; and (C) any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be executed in multiple counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Signature Page Follows)</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;THE PARTIES TO THIS AGREEMENT HAVE READ THE FOREGOING AGREEMENT AND FULLY UNDERSTAND EACH AND EVERY PROVISION CONTAINED HEREIN. WHEREFORE, THE PARTIES HAVE EXECUTED THIS AGREEMENT ON THE DATES SHOWN BELOW.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt"><font><br></font></div><div style="padding-left:180pt"><font><br></font></div><div style="padding-left:180pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Employee</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;________&#93;</font></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Address&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><div id="i11910e3c17994c99a20c8e89367974f7_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">GENERAL RELEASE OF CLAIMS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">The language in this Release may change based on legal developments and evolving best practices&#59; this form is provided as an example of what will be included in the final Release document.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This General Release of Claims (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is entered into as of this _____ day of ________, ____, between __________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, Employee and the Company are parties to that certain Change in Control Severance Agreement dated as of November 1, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Parties agree that Employee is entitled to certain severance benefits under the Agreement, subject to Employee&#8217;s execution of this Release&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Company and Employee now wish to fully and finally to resolve all matters between them.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of, and subject to, the severance benefits payable to Employee pursuant to the Agreement, the adequacy of which is hereby acknowledged by Employee, and which Employee acknowledges that he or she would not otherwise be entitled to receive, Employee and the Company hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">General Release of Claims by Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Employee, on behalf of himself or herself and his or her executors, heirs, administrators, representatives and assigns, hereby agrees to release and forever discharge the Company and all predecessors, successors and their respective parent corporations, affiliates, related, and&#47;or subsidiary entities, and all of their past and present investors, directors, shareholders, officers, general or limited partners, employees, attorneys, agents and representatives, and the employee benefit plans in which Employee is or has been a participant by virtue of his or her employment with or service to the Company (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), from any and all claims, debts, demands, accounts, judgments, rights, causes of action, equitable relief, damages, costs, charges, complaints, obligations, promises, agreements, controversies, suits, expenses, compensation, responsibility and liability of every kind and character whatsoever (including attorneys&#8217; fees and costs), whether in law or equity, known or unknown, asserted or unasserted, suspected or unsuspected (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which Employee has or may have had against such entities based on any events or circumstances arising or occurring on or prior to the date hereof or on or prior to the date hereof, arising directly or indirectly out of, relating to, or in any other way involving in any manner whatsoever Employee&#8217;s employment by or service to the Company or the termination thereof, including any and all claims arising under federal, state, or local laws relating to employment, including without limitation claims of wrongful discharge, breach of express or implied contract, fraud, misrepresentation, defamation, or liability in tort, and claims of any kind that may be brought in any court or administrative agency including, without limitation, claims under Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. Section 2000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; the Americans with Disabilities Act, as amended, 42&#160;U.S.C. &#167;&#160;12101 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; the Rehabilitation Act of 1973, as amended, 29&#160;U.S.C. &#167;&#160;701 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; the Civil Rights Act of 1866, and the Civil Rights Act of 1991&#59; 42 U.S.C. Section 1981, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; the Age Discrimination in Employment Act, as amended, 29 U.S.C. Section 621, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; the Equal Pay Act, as amended, 29 U.S.C. Section 206(d)&#59; regulations of the Office of Federal Contract Compliance, 41 C.F.R. Section 60, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; the Family and Medical Leave Act, as amended, 29&#160;U.S.C.&#160;&#167;&#160;2601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; the Fair Labor Standards Act of 1938, as amended, 29&#160;U.S.C. &#167;&#160;201 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; the Employee Retirement Income Security Act, as amended, 29 U.S.C. &#167;&#160;1001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#59; and the California Fair Employment and Housing Act, California Government Code Section 12940, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the generality of the foregoing, Employee does not release the following claims&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;Claims for workers&#8217; compensation insurance benefits under the terms of any worker&#8217;s compensation insurance policy or fund of the Company&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;Claims pursuant to the terms and conditions of the federal law known as COBRA&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;Claims for indemnity under the bylaws of the Company, as provided for by Delaware law or under any applicable insurance policy with respect to Employee&#8217;s liability as an employee, director or officer of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;Employee&#8217;s right to bring to the attention of the Equal Employment Opportunity Commission or the California Department of Fair Employment and Housing or any other federal, state or local government agency claims of discrimination, or from participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission or any other federal, state or local government agency&#59; provided, however, that Employee does release his or her right to secure any damages for alleged discriminatory treatment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(vi)&#160;&#160;&#160;&#160;Claims based on any right Employee may have to enforce the Company&#8217;s executory obligations under the Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(vii)&#160;&#160;&#160;&#160;Claims Employee may have to vested or earned compensation and benefits&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(viii)&#160;&#160;&#160;&#160;Employee&#8217;s right to communicate or cooperate with any governmental agency.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;EMPLOYEE ACKNOWLEDGES THAT HE OR SHE HAS BEEN ADVISED OF AND IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BEING AWARE OF SAID CODE SECTION, EMPLOYEE HEREBY EXPRESSLY WAIVES ANY RIGHTS HE OR SHE MAY HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)  &#160;&#160;&#160;&#160;Employee acknowledges that this Release was presented to him or her on the date indicated above and that Employee is entitled to have twenty-one (21) days&#8217; time in which to consider it.  Employee further acknowledges that the Company has advised him or her that he or she is waiving his or her rights under the ADEA, and that Employee may obtain advice concerning this Release from an attorney of his or her choice, and Employee has had sufficient time to consider the terms of this Release.  Employee represents and acknowledges that if Employee executes this Release before twenty-one (21) days have elapsed, Employee does so knowingly, voluntarily, and upon the advice and with the approval of Employee&#8217;s legal counsel (if any), and that Employee voluntarily waives any remaining consideration period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)  &#160;&#160;&#160;&#160;Employee understands that after executing this Release, Employee has the right to revoke it within seven (7) days after his or her execution of it.  Employee understands that this Release will not become effective and enforceable unless the seven (7) day revocation period passes and Employee does not revoke the Release in writing.  Employee understands that this Release may not be revoked after the seven (7) day revocation period has passed.  Employee also understands that any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">revocation of this Release must be made in writing and delivered to the Company at its principal place of business within the seven (7) day period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e)  &#160;&#160;&#160;&#160;Employee understands that this Release shall become effective, irrevocable, and binding upon Employee on the eighth (8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day after my execution of it, so long as Employee has not revoked it within the time period and in the manner specified in clause (d) above.  Employee further understands that Employee will not be given any severance benefits under the Agreement until the effective date of this Release.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Continuing Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Employee hereby expressly reaffirms his or her obligations under Section 3 of the Agreement and the PIIA, and agrees that such obligations shall survive the date of Employee&#8217;s termination of employment.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;By signing below, Employee confirms that Employee has surrendered to the Company all lists, books and records of, or in connection with, the Company&#8217;s business, and all other property belonging to the Company, it being distinctly understood that all such lists, books and records, and other documents, are the property of the Company.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee represents and warrants to the Company Releasees that there has been no assignment or other transfer of any interest in any Claim that Employee may have against the Company Releasees, or any of them.  Employee agrees to indemnify and hold harmless the Company Releasees from any liability, claims, demands, damages, costs, expenses and attorneys&#8217; fees incurred as a result of any such assignment or transfer from Employee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event any provision of this Release is found to be unenforceable by an arbitrator or court of competent jurisdiction, such provision shall be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being intended that the parties shall receive the benefit contemplated herein to the fullest extent permitted by law.  If a deemed modification is not satisfactory in the judgment of such arbitrator or court, the unenforceable provision shall be deemed deleted, and the validity and enforceability of the remaining provisions shall not be affected thereby. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interpretation&#59; Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The headings set forth in this Release are for convenience only and shall not be used in interpreting this Agreement.  This Release has been drafted by legal counsel representing the Company, but Employee has participated in the negotiation of its terms.  Furthermore, Employee acknowledges that Employee has had an opportunity to review and revise the Release and have it reviewed by legal counsel, if desired, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Release.  Either party&#8217;s failure to enforce any provision of this Release shall not in any way be construed as a waiver of any such provision, or prevent that party thereafter from enforcing each and every other provision of this Release.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release will be governed by and construed in accordance with the laws of the United States of America and the State of California applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof.  Any suit brought hereon shall be brought in the state or federal courts sitting in San Diego County, California, the Parties hereby waiving any claim or defense that such forum is not convenient or proper.  Each party hereby agrees that any such court shall have in personam jurisdiction over it and consents to service of process in any manner authorized by California law.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release and the Agreement constitute the entire agreement of the Parties in respect of the subject matter contained herein and therein and supersede all prior or simultaneous representations, discussions, negotiations and agreements, whether written or oral, including without limitation, any offer letter between Employee and the Company.  This Release may be amended or modified only with the written consent of Employee and an authorized representative of the Company.  No oral waiver, amendment or modification will be effective under any circumstances whatsoever.  For </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the avoidance of doubt, this Release constitutes a part of the Agreement and shall be subject to the terms thereto, including Section 4.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release may be executed in multiple counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Signature Page Follows) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><div id="i11910e3c17994c99a20c8e89367974f7_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, and intending to be legally bound, the Parties have executed the foregoing Release as of the date first written above.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Employee&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ligand Pharmaceuticals Incorporated</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Print Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Print Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibits and schedules omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and&#47;or annex will be furnished as a supplement to the U.S. Securities and Exchange Commission upon request.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT B - PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT C &#8211; MUTUAL ARBITRATION AGREEMENT</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULE TO EXHIBIT 10.3</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The preceding form of Change in Control Severance Agreement was entered into between the Company and the following persons effective as of November 1, 2022&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:0.36pt;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Name of Executive</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:0.36pt;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Title</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Matthew Korenberg</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">President and Chief Operating Officer</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tavo Espinoza</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Andrew Reardon</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Legal Officer</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Audrey Warfield-Graham</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;text-indent:0.36pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief People Officer</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>lgnd_33123exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie7314434db6e4139b02e694aaafe99b5_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Todd C. Davis, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Todd C. Davis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Todd C. Davis<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>lgnd_33123exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i67bd157329f24155bbe79182d0c35eca_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Octavio Espinoza, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Octavio Espinoza</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Octavio Espinoza<br>Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>lgnd_33123exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i46b18be816934b6982e890ea2eb1136a_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Todd C. Davis, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Todd C. Davis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Todd C. Davis<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Octavio Espinoza, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Octavio Espinoza</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Octavio Espinoza<br>Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>lgnd-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9386ca9d-b089-4ae9-b9e9-dc30d8ee3e97,g:2f56508d-7938-4ed2-96f4-a768c1bc35f3-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ligand.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAb" roleURI="http://www.ligand.com/role/SpinoffofOmniAb">
        <link:definition>0000009 - Disclosure - Spin-off of OmniAb</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>0000010 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>0000011 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>0000012 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>0000013 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://www.ligand.com/role/CommitmentandContingencies">
        <link:definition>0000014 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000015 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000016 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbTables" roleURI="http://www.ligand.com/role/SpinoffofOmniAbTables">
        <link:definition>0000017 - Disclosure - Spin-off of OmniAb (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>0000018 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>0000019 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>0000020 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>0000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>0000023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>0000025 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
        <link:definition>0000026 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>0000027 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>0000030 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbNarrativeDetails" roleURI="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails">
        <link:definition>0000031 - Disclosure - Spin-off of OmniAb - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails">
        <link:definition>0000032 - Disclosure - Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails">
        <link:definition>0000033 - Disclosure - Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>0000034 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>0000035 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000036 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>0000037 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>0000038 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxDetails" roleURI="http://www.ligand.com/role/IncomeTaxDetails">
        <link:definition>0000039 - Disclosure - Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>0000040 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>0000041 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesNarrativeDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails">
        <link:definition>0000042 - Disclosure - Commitment and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_AziyoAndCorMatrixMember" abstract="true" name="AziyoAndCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EquitySecuritiesFVNIShareSoldInPeriod" abstract="false" name="EquitySecuritiesFVNIShareSoldInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_CommercialLicenseRightsPolicyTextBlock" abstract="false" name="CommercialLicenseRightsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCOVIDMember" abstract="true" name="MaterialSalesCaptisolCOVIDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCoreMember" abstract="true" name="MaterialSalesCaptisolCoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ProceedsFromCommercialLicenseRights" abstract="false" name="ProceedsFromCommercialLicenseRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" abstract="false" name="AmountsOwedToFormerLicensorFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_TeriparatideInjectionMember" abstract="true" name="TeriparatideInjectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" abstract="false" name="FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CyDexMember" abstract="true" name="CyDexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" abstract="false" name="AmortizationOfCommercialLicenseAndOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SaleOfStockAuthorizedOfferingAmount" abstract="false" name="SaleOfStockAuthorizedOfferingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" abstract="false" name="DebtInstrumentRepurchasedAmountDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_ContingentLiabilitiesMember" abstract="true" name="ContingentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_RylazeMember" abstract="true" name="RylazeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" abstract="true" name="NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" abstract="false" name="ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" abstract="true" name="BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" abstract="true" name="NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" abstract="false" name="LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AtTheMarketEquityOfferingMember" abstract="true" name="AtTheMarketEquityOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" abstract="false" name="LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedSupplierExpensesCurrent" abstract="false" name="AccruedSupplierExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" abstract="true" name="NotesRepurchasedDuringCurrentPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" abstract="false" name="BusinessSpinOffAndMigrationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_RepaymentsOfNotesPayableInterestPortion" abstract="false" name="RepaymentsOfNotesPayableInterestPortion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>lgnd-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9386ca9d-b089-4ae9-b9e9-dc30d8ee3e97,g:2f56508d-7938-4ed2-96f4-a768c1bc35f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_57a89d55-d3b1-4e62-8b76-b4ac81766c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_63e99efc-7346-4d3b-8765-5c9c56e4c56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_57a89d55-d3b1-4e62-8b76-b4ac81766c7c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_63e99efc-7346-4d3b-8765-5c9c56e4c56d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_d7c4e65a-c6b1-4848-967d-1be49dbfc121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_57a89d55-d3b1-4e62-8b76-b4ac81766c7c" xlink:to="loc_us-gaap_ShortTermInvestments_d7c4e65a-c6b1-4848-967d-1be49dbfc121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9f457209-25fa-4ab4-9a7e-96f3fca385bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_57a89d55-d3b1-4e62-8b76-b4ac81766c7c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9f457209-25fa-4ab4-9a7e-96f3fca385bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3719cdb7-8f28-440b-9822-f59e59a0a145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_57a89d55-d3b1-4e62-8b76-b4ac81766c7c" xlink:to="loc_us-gaap_InventoryNet_3719cdb7-8f28-440b-9822-f59e59a0a145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f2f655c7-98ab-48dd-988e-5fe4b5cbb768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_57a89d55-d3b1-4e62-8b76-b4ac81766c7c" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f2f655c7-98ab-48dd-988e-5fe4b5cbb768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_3e5daffb-1706-4542-a0f2-fbe2a17dd31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_57a89d55-d3b1-4e62-8b76-b4ac81766c7c" xlink:to="loc_us-gaap_OtherAssetsCurrent_3e5daffb-1706-4542-a0f2-fbe2a17dd31f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0ce5e025-03a4-4269-9d52-ebeaccc9112d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ca6443e-a379-4bf1-a76e-05fed0db3d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0ce5e025-03a4-4269-9d52-ebeaccc9112d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ca6443e-a379-4bf1-a76e-05fed0db3d10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0d8fb51a-30f0-426d-a1a6-b58cc60d9007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0ce5e025-03a4-4269-9d52-ebeaccc9112d" xlink:to="loc_us-gaap_CommonStockValue_0d8fb51a-30f0-426d-a1a6-b58cc60d9007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_70f2f85d-bc92-49d3-9710-8f326ee443d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0ce5e025-03a4-4269-9d52-ebeaccc9112d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_70f2f85d-bc92-49d3-9710-8f326ee443d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0ea4c283-72fa-4f4c-a814-6c0c185aaee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0ce5e025-03a4-4269-9d52-ebeaccc9112d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0ea4c283-72fa-4f4c-a814-6c0c185aaee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a1dfc24c-3115-4567-9bd1-8b70702b5fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0ce5e025-03a4-4269-9d52-ebeaccc9112d" xlink:to="loc_us-gaap_PreferredStockValue_a1dfc24c-3115-4567-9bd1-8b70702b5fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f81f04e0-298f-4689-9d04-778c86ab192e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f81f04e0-298f-4689-9d04-778c86ab192e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c0ddf79a-aa69-48cd-8a56-6aa3a59fd43a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c0ddf79a-aa69-48cd-8a56-6aa3a59fd43a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_19703bcb-02fc-42d6-8501-8ccd153355b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_19703bcb-02fc-42d6-8501-8ccd153355b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_cd27ed60-425f-4651-9f43-0f07ac89c1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_cd27ed60-425f-4651-9f43-0f07ac89c1d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_0814e2b3-8642-4589-b55e-5555529b706b" xlink:href="lgnd-20230331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_0814e2b3-8642-4589-b55e-5555529b706b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_76b4579f-56d5-4fb7-b7ee-a66cfd6df92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:to="loc_us-gaap_AccountsPayableCurrent_76b4579f-56d5-4fb7-b7ee-a66cfd6df92b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_b9860582-e09c-49e4-9d67-9acd2558f0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02f18c9b-8e6a-47e6-985e-05b500ca14a7" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_b9860582-e09c-49e4-9d67-9acd2558f0fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d49b80ea-21f6-45a5-806e-dac607f72211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a09e99b5-5d74-424b-b87d-706719d293c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d49b80ea-21f6-45a5-806e-dac607f72211" xlink:to="loc_us-gaap_Liabilities_a09e99b5-5d74-424b-b87d-706719d293c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1d5dae85-f572-4b2e-ad02-e89b5d0a2b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d49b80ea-21f6-45a5-806e-dac607f72211" xlink:to="loc_us-gaap_StockholdersEquity_1d5dae85-f572-4b2e-ad02-e89b5d0a2b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a91eb817-6ef1-4556-94cd-171c2ed8f3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d49b80ea-21f6-45a5-806e-dac607f72211" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a91eb817-6ef1-4556-94cd-171c2ed8f3bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5b3b831f-b159-4e49-a3ef-160676ad6225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_Goodwill_5b3b831f-b159-4e49-a3ef-160676ad6225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e78ac10c-8ffa-496f-b7d1-e354cfdf559a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e78ac10c-8ffa-496f-b7d1-e354cfdf559a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_86d562c8-96cc-4c1d-85b4-fdeb61d4b556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_86d562c8-96cc-4c1d-85b4-fdeb61d4b556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a6ded663-74d3-428f-9835-43d3714a2fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a6ded663-74d3-428f-9835-43d3714a2fb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_91fd742c-0e27-486d-be81-bdec01289d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_91fd742c-0e27-486d-be81-bdec01289d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_902c53cb-e7b9-4e85-9dc8-29efd22372ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_902c53cb-e7b9-4e85-9dc8-29efd22372ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f936f626-70ab-4a58-98ba-bd732e0a7a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_AssetsCurrent_f936f626-70ab-4a58-98ba-bd732e0a7a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_e1e2539e-ccbc-41fe-a6c7-eece412a7430" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_lgnd_CommercialLicenseRights_e1e2539e-ccbc-41fe-a6c7-eece412a7430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_52a7f0fa-307e-47f6-8193-cfe0baa00311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b4694f1c-995b-4e7d-b18d-1ff6d917097a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_52a7f0fa-307e-47f6-8193-cfe0baa00311" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_48dc45d5-b88d-4768-9209-7abb770e2d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e4aa385-eae1-43ee-8596-9f9699657403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_48dc45d5-b88d-4768-9209-7abb770e2d6a" xlink:to="loc_us-gaap_LiabilitiesCurrent_6e4aa385-eae1-43ee-8596-9f9699657403" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_75c99f86-eaf1-4460-858f-e7818c31adff" xlink:href="lgnd-20230331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_48dc45d5-b88d-4768-9209-7abb770e2d6a" xlink:to="loc_lgnd_LiabilityForContingentValueRights_75c99f86-eaf1-4460-858f-e7818c31adff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ecccc80f-04d3-4a33-bf3e-063f38225c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_48dc45d5-b88d-4768-9209-7abb770e2d6a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ecccc80f-04d3-4a33-bf3e-063f38225c1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e435bd85-f023-4ae0-9fba-427032cb2484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_48dc45d5-b88d-4768-9209-7abb770e2d6a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e435bd85-f023-4ae0-9fba-427032cb2484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_534cbf3c-3ded-4395-919a-cf27f6c93400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_48dc45d5-b88d-4768-9209-7abb770e2d6a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_534cbf3c-3ded-4395-919a-cf27f6c93400" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_eef9defe-9b68-419a-bc0a-7f8c366a55fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_87590460-ebf0-47fc-9548-5e8454458a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_eef9defe-9b68-419a-bc0a-7f8c366a55fe" xlink:to="loc_us-gaap_OperatingIncomeLoss_87590460-ebf0-47fc-9548-5e8454458a30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_79ccfaa4-1283-44c4-a1a5-8f481a0e8598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_eef9defe-9b68-419a-bc0a-7f8c366a55fe" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_79ccfaa4-1283-44c4-a1a5-8f481a0e8598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_34a2d741-b415-47dc-b7b1-656106e73865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_e147e7f3-4d58-467e-9828-e0a4b9e4697f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_34a2d741-b415-47dc-b7b1-656106e73865" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_e147e7f3-4d58-467e-9828-e0a4b9e4697f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a3d70cb0-1023-4214-8b29-85f6d30c6761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_34a2d741-b415-47dc-b7b1-656106e73865" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a3d70cb0-1023-4214-8b29-85f6d30c6761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_67e994fe-7305-409e-8291-f59807466ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ff07977a-a208-4cd4-a80a-4c0d1a79b202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_67e994fe-7305-409e-8291-f59807466ed8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ff07977a-a208-4cd4-a80a-4c0d1a79b202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9a4906da-7a5d-44d7-abdc-4634b37c0f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_67e994fe-7305-409e-8291-f59807466ed8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9a4906da-7a5d-44d7-abdc-4634b37c0f38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5bbdea4d-51ca-41a1-85f7-5743357334d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_12e44afd-1d43-4845-8cd7-ee90a81a2706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_5bbdea4d-51ca-41a1-85f7-5743357334d4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_12e44afd-1d43-4845-8cd7-ee90a81a2706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_f90de7bf-b909-44c2-9b60-c8285efd430b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_5bbdea4d-51ca-41a1-85f7-5743357334d4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_f90de7bf-b909-44c2-9b60-c8285efd430b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c2741ce6-264a-4ec2-8882-960cdff8941e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1394d88e-70d2-495c-bab1-7ac34040e282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_c2741ce6-264a-4ec2-8882-960cdff8941e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1394d88e-70d2-495c-bab1-7ac34040e282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8e5c9810-f886-470f-8606-2e955df8a2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_c2741ce6-264a-4ec2-8882-960cdff8941e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8e5c9810-f886-470f-8606-2e955df8a2e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a6788f62-871a-4ebe-9ede-8e8575f53ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_006cd1ca-9e75-4b1d-9dbe-b8cdf9591a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a6788f62-871a-4ebe-9ede-8e8575f53ebe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_006cd1ca-9e75-4b1d-9dbe-b8cdf9591a83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_3663c6b5-486b-406e-b325-fea61f430f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a6788f62-871a-4ebe-9ede-8e8575f53ebe" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_3663c6b5-486b-406e-b325-fea61f430f49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_5c3b8243-6f58-4919-999e-5b138fd8fa2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_f9b2141b-01c7-4259-af43-53fc3190bebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_5c3b8243-6f58-4919-999e-5b138fd8fa2d" xlink:to="loc_us-gaap_CostDirectMaterial_f9b2141b-01c7-4259-af43-53fc3190bebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e7beec3b-38b1-4fcc-b6ff-2acefa646ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_5c3b8243-6f58-4919-999e-5b138fd8fa2d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e7beec3b-38b1-4fcc-b6ff-2acefa646ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bf510b13-87c3-4146-8e16-1e8ba2e2fbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_5c3b8243-6f58-4919-999e-5b138fd8fa2d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bf510b13-87c3-4146-8e16-1e8ba2e2fbb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_bb2f21e8-24c5-40b8-b959-13887ba00925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_5c3b8243-6f58-4919-999e-5b138fd8fa2d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_bb2f21e8-24c5-40b8-b959-13887ba00925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dd43b208-198b-4cef-97ed-292d386aa193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_e1a270b9-7ffc-46da-8c15-0d58212970ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_dd43b208-198b-4cef-97ed-292d386aa193" xlink:to="loc_us-gaap_GainLossOnInvestments_e1a270b9-7ffc-46da-8c15-0d58212970ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_7961772e-99f0-4baf-ad30-465284bcffe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_dd43b208-198b-4cef-97ed-292d386aa193" xlink:to="loc_us-gaap_InvestmentIncomeInterest_7961772e-99f0-4baf-ad30-465284bcffe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c3fda4d3-d1d1-40aa-9a71-d40f64598054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_dd43b208-198b-4cef-97ed-292d386aa193" xlink:to="loc_us-gaap_InterestExpense_c3fda4d3-d1d1-40aa-9a71-d40f64598054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ccc98941-0562-43d1-b778-aeaf326f9942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_dd43b208-198b-4cef-97ed-292d386aa193" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ccc98941-0562-43d1-b778-aeaf326f9942" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_43e899ab-ae5b-47d1-9ee0-47f7e0dfd9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf8baf2a-04a7-422a-a517-c2c96225e0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_43e899ab-ae5b-47d1-9ee0-47f7e0dfd9c3" xlink:to="loc_us-gaap_NetIncomeLoss_bf8baf2a-04a7-422a-a517-c2c96225e0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0650b084-f63a-430a-a048-fd647084fdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_43e899ab-ae5b-47d1-9ee0-47f7e0dfd9c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0650b084-f63a-430a-a048-fd647084fdd6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf53ed9b-0ff9-449d-b2ba-9a3f773b03bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_54fece3d-1aa3-4c72-b578-5792e4f4e110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf53ed9b-0ff9-449d-b2ba-9a3f773b03bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_54fece3d-1aa3-4c72-b578-5792e4f4e110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_937d237f-4b17-4ad3-91ff-edadddd9b9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf53ed9b-0ff9-449d-b2ba-9a3f773b03bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_937d237f-4b17-4ad3-91ff-edadddd9b9c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d31a1c5-daa4-4f0a-a08e-812d653d4e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf53ed9b-0ff9-449d-b2ba-9a3f773b03bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d31a1c5-daa4-4f0a-a08e-812d653d4e1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdd38e39-895f-4db1-8d79-e8b5c7b76531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_753e31ba-284e-4228-ae93-d272065522a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdd38e39-895f-4db1-8d79-e8b5c7b76531" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_753e31ba-284e-4228-ae93-d272065522a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_61bed3bd-d983-4a61-8049-d79d6fa5afbc" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdd38e39-895f-4db1-8d79-e8b5c7b76531" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_61bed3bd-d983-4a61-8049-d79d6fa5afbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9ba3cb7e-2b45-4224-ae42-36531aac8860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdd38e39-895f-4db1-8d79-e8b5c7b76531" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9ba3cb7e-2b45-4224-ae42-36531aac8860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c345c620-7f68-4032-b122-1e969d86eedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdd38e39-895f-4db1-8d79-e8b5c7b76531" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c345c620-7f68-4032-b122-1e969d86eedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_348c35b0-bada-4991-ac5f-8419fc9eebb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdd38e39-895f-4db1-8d79-e8b5c7b76531" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_348c35b0-bada-4991-ac5f-8419fc9eebb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e59c205f-e109-498c-92e1-01581d6ffd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdd38e39-895f-4db1-8d79-e8b5c7b76531" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e59c205f-e109-498c-92e1-01581d6ffd24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_918ae006-d64e-4618-b71d-a4db4152a112" xlink:href="lgnd-20230331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_918ae006-d64e-4618-b71d-a4db4152a112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9dab76c9-3365-4666-add8-8c49b11fd168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9dab76c9-3365-4666-add8-8c49b11fd168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_87a352ee-baa3-4bb9-829a-acc9338430fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_87a352ee-baa3-4bb9-829a-acc9338430fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f25fa910-7a03-4ba6-b849-76ee6ce88518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f25fa910-7a03-4ba6-b849-76ee6ce88518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_2908acbd-6146-41fc-b0ac-f1bbd7098ce1" xlink:href="lgnd-20230331.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_2908acbd-6146-41fc-b0ac-f1bbd7098ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0748d02d-92e5-4964-996e-99c6c439596e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0748d02d-92e5-4964-996e-99c6c439596e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_afac35a9-b93a-4e99-9aa0-4e85a8ae3b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_ShareBasedCompensation_afac35a9-b93a-4e99-9aa0-4e85a8ae3b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6c474e42-7614-4cfd-9b60-27df9ac9313d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6c474e42-7614-4cfd-9b60-27df9ac9313d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_df22ac48-c493-43c7-adbd-fe83a0d73626" xlink:href="lgnd-20230331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_df22ac48-c493-43c7-adbd-fe83a0d73626" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0e73ab95-4caf-4e4e-8776-6e3dce78540c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0e73ab95-4caf-4e4e-8776-6e3dce78540c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e14018b4-5467-47c0-8758-82e7fe9ebb98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e14018b4-5467-47c0-8758-82e7fe9ebb98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1c3c3037-e81a-4c58-9d9d-c3d7491f16e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1c3c3037-e81a-4c58-9d9d-c3d7491f16e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3c0934be-6ee7-4c37-9fbf-3fa471a9899b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3c0934be-6ee7-4c37-9fbf-3fa471a9899b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f799879-1d41-4f9c-9ad9-5d624358e2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f799879-1d41-4f9c-9ad9-5d624358e2a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_7ee876dd-f102-4063-957a-6c95f9f6cb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_7ee876dd-f102-4063-957a-6c95f9f6cb0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_bc33ac5b-300e-417b-8eb6-bfa50d836db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_bc33ac5b-300e-417b-8eb6-bfa50d836db1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_0d8de19a-3a5d-44e7-8b7c-7f9af6bbe71f" xlink:href="lgnd-20230331.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_0d8de19a-3a5d-44e7-8b7c-7f9af6bbe71f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0462aee0-bcbe-4cff-a584-4f358184da81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b2221bb-4659-4a4b-a711-64e170d45726" xlink:to="loc_us-gaap_NetIncomeLoss_0462aee0-bcbe-4cff-a584-4f358184da81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc135ea2-4def-4212-bc1c-d12dd76d0cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_4aaad118-5496-4504-9460-69455961d9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc135ea2-4def-4212-bc1c-d12dd76d0cc1" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_4aaad118-5496-4504-9460-69455961d9b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_acd96d54-2ca6-4f5f-b70b-cfad639d6488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc135ea2-4def-4212-bc1c-d12dd76d0cc1" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_acd96d54-2ca6-4f5f-b70b-cfad639d6488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_104b3bc7-398e-4f49-b3c5-4add11a4d16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc135ea2-4def-4212-bc1c-d12dd76d0cc1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_104b3bc7-398e-4f49-b3c5-4add11a4d16f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_c5d71997-30a0-48d7-bb40-d1c3a5d08e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc135ea2-4def-4212-bc1c-d12dd76d0cc1" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_c5d71997-30a0-48d7-bb40-d1c3a5d08e57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_5a40ec72-4485-4dfb-b0db-7cbcb74cb4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc135ea2-4def-4212-bc1c-d12dd76d0cc1" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_5a40ec72-4485-4dfb-b0db-7cbcb74cb4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromCommercialLicenseRights_cee2560a-fd35-4edf-8f28-5bc11b9eed11" xlink:href="lgnd-20230331.xsd#lgnd_ProceedsFromCommercialLicenseRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc135ea2-4def-4212-bc1c-d12dd76d0cc1" xlink:to="loc_lgnd_ProceedsFromCommercialLicenseRights_cee2560a-fd35-4edf-8f28-5bc11b9eed11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_2089a045-1ce2-41ef-84a4-246816023e92" xlink:href="lgnd-20230331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3bec2a98-51d4-44d6-a760-2d90e4c80964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_2089a045-1ce2-41ef-84a4-246816023e92" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3bec2a98-51d4-44d6-a760-2d90e4c80964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_06eeb6b5-710a-49f2-9a8b-0ab131ee57a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_2089a045-1ce2-41ef-84a4-246816023e92" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_06eeb6b5-710a-49f2-9a8b-0ab131ee57a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e77eafc8-7213-4749-8ae6-069f50d88394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_faa3b902-56ee-4b6a-8bda-685a53e9eac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e77eafc8-7213-4749-8ae6-069f50d88394" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_faa3b902-56ee-4b6a-8bda-685a53e9eac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_01e35aec-e3ca-459e-a75a-9d8c717dbf48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e77eafc8-7213-4749-8ae6-069f50d88394" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_01e35aec-e3ca-459e-a75a-9d8c717dbf48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c9eb9bfc-8ad3-414f-8ce1-f94519be2be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e77eafc8-7213-4749-8ae6-069f50d88394" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c9eb9bfc-8ad3-414f-8ce1-f94519be2be5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_15600d20-bde4-441f-af00-8891c284126e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_9580a482-9b9b-472b-9c10-28a244838635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_15600d20-bde4-441f-af00-8891c284126e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_9580a482-9b9b-472b-9c10-28a244838635" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_38e8656e-d522-4be3-ae25-bb135cb61a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_15600d20-bde4-441f-af00-8891c284126e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_38e8656e-d522-4be3-ae25-bb135cb61a46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_a77c7479-4581-42c9-9519-802c9a3a559a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_299045c9-89a6-42a9-a37a-5a0b970e33dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_a77c7479-4581-42c9-9519-802c9a3a559a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_299045c9-89a6-42a9-a37a-5a0b970e33dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_c7a340bd-b546-4fa4-9701-9ab107e4862c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_a77c7479-4581-42c9-9519-802c9a3a559a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_c7a340bd-b546-4fa4-9701-9ab107e4862c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_bc39e77b-5615-4210-9ef6-f70d7c95fbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a112de99-c9bb-42a4-8395-c96468e22ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_bc39e77b-5615-4210-9ef6-f70d7c95fbe9" xlink:to="loc_us-gaap_Goodwill_a112de99-c9bb-42a4-8395-c96468e22ca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_66dc4f46-cdee-467f-b1e2-bf791cf24e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_bc39e77b-5615-4210-9ef6-f70d7c95fbe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_66dc4f46-cdee-467f-b1e2-bf791cf24e7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbdd1be8-51b8-47eb-bb6c-cede5edd155a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_bc39e77b-5615-4210-9ef6-f70d7c95fbe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbdd1be8-51b8-47eb-bb6c-cede5edd155a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3679be00-b260-4c7a-91b4-1b97055ae976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_9d562acd-bd6c-4ae8-985a-a2f19353ed5f" xlink:href="lgnd-20230331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3679be00-b260-4c7a-91b4-1b97055ae976" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_9d562acd-bd6c-4ae8-985a-a2f19353ed5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab036537-9bd8-460f-bc1c-9213d1b457fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3679be00-b260-4c7a-91b4-1b97055ae976" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab036537-9bd8-460f-bc1c-9213d1b457fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4ee56643-7c47-4d09-92eb-eadd24eea6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_0c68bf39-0069-4329-b0b5-e1172afce73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4ee56643-7c47-4d09-92eb-eadd24eea6b6" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_0c68bf39-0069-4329-b0b5-e1172afce73f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_8d3d913e-835f-4716-9064-f019776f559b" xlink:href="lgnd-20230331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4ee56643-7c47-4d09-92eb-eadd24eea6b6" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_8d3d913e-835f-4716-9064-f019776f559b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_2ec27333-a27b-4f0d-966d-4b7b918f23d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4ee56643-7c47-4d09-92eb-eadd24eea6b6" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_2ec27333-a27b-4f0d-966d-4b7b918f23d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_24b07771-0d30-428f-a617-d1a08e23710e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4ee56643-7c47-4d09-92eb-eadd24eea6b6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_24b07771-0d30-428f-a617-d1a08e23710e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_24c5b769-8e50-48b6-b4d9-55193810e6aa" xlink:href="lgnd-20230331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4ee56643-7c47-4d09-92eb-eadd24eea6b6" xlink:to="loc_lgnd_LicenseeAccrualCurrent_24c5b769-8e50-48b6-b4d9-55193810e6aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_be3ff1fd-d38a-4a49-aa49-5d557d03de44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4ee56643-7c47-4d09-92eb-eadd24eea6b6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_be3ff1fd-d38a-4a49-aa49-5d557d03de44" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7689dfc9-6083-4b28-a1fa-3594dac5a2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ab14ab6-11a5-4fc6-a8b7-d9fb917290ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7689dfc9-6083-4b28-a1fa-3594dac5a2b3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ab14ab6-11a5-4fc6-a8b7-d9fb917290ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8f219a35-4434-4bc2-9c5c-bed0bc9095e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7689dfc9-6083-4b28-a1fa-3594dac5a2b3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8f219a35-4434-4bc2-9c5c-bed0bc9095e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_129ff470-c272-4478-aefa-df3148b6953a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_8fc5e862-db75-40fa-859a-a1e16c096670" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_129ff470-c272-4478-aefa-df3148b6953a" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_8fc5e862-db75-40fa-859a-a1e16c096670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_5654bb16-d8e8-4a63-8aa1-b31bee9ac67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_129ff470-c272-4478-aefa-df3148b6953a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_5654bb16-d8e8-4a63-8aa1-b31bee9ac67e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_9fc198eb-ee94-4013-8bf9-48b216876107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_129ff470-c272-4478-aefa-df3148b6953a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_9fc198eb-ee94-4013-8bf9-48b216876107" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_0ddbc9a9-cd93-4e5a-9d7d-eeeb19c54cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_679c8140-7030-4d65-a75d-ee4abf3b9588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_0ddbc9a9-cd93-4e5a-9d7d-eeeb19c54cb0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_679c8140-7030-4d65-a75d-ee4abf3b9588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_caebc064-9e18-4a52-bbd3-60559b6e5d13" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_0ddbc9a9-cd93-4e5a-9d7d-eeeb19c54cb0" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_caebc064-9e18-4a52-bbd3-60559b6e5d13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_78e29967-c3aa-422c-9e29-5069d360e0cf" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_035dabfa-46a6-41b1-980f-4f5578aa530e" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_78e29967-c3aa-422c-9e29-5069d360e0cf" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_035dabfa-46a6-41b1-980f-4f5578aa530e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_fc6d4568-a461-4305-8169-ceeff0f28d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f7d70c09-6c7a-4f19-b97c-bb19c5c31bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_fc6d4568-a461-4305-8169-ceeff0f28d70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f7d70c09-6c7a-4f19-b97c-bb19c5c31bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_58b336ed-7c69-4ab2-9c1e-594ae96d972d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_fc6d4568-a461-4305-8169-ceeff0f28d70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_58b336ed-7c69-4ab2-9c1e-594ae96d972d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c7f991e7-512f-4210-8616-28ad84e7e9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_eabddf68-b8a6-4afa-8b79-af5c21529b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c7f991e7-512f-4210-8616-28ad84e7e9f4" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_eabddf68-b8a6-4afa-8b79-af5c21529b1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_ca9eb5b7-9828-4edb-8e35-acec01b9ed60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c7f991e7-512f-4210-8616-28ad84e7e9f4" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_ca9eb5b7-9828-4edb-8e35-acec01b9ed60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_64365df8-05c7-481d-9e13-cc817625d284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9d64f420-ccdc-4f53-ae2d-d00533cb5cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_64365df8-05c7-481d-9e13-cc817625d284" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9d64f420-ccdc-4f53-ae2d-d00533cb5cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_211a69d3-c4f5-482a-b0a2-8a971287d973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_68960a60-96a4-48e9-bc77-f456e504ea95" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_211a69d3-c4f5-482a-b0a2-8a971287d973" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_68960a60-96a4-48e9-bc77-f456e504ea95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_90a7cbed-a495-4840-8387-fd1549e49fed" xlink:href="lgnd-20230331.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_211a69d3-c4f5-482a-b0a2-8a971287d973" xlink:to="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_90a7cbed-a495-4840-8387-fd1549e49fed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_f6626e23-ebd2-4278-8438-2254a2100e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2015844a-c74f-4a9d-9d92-50d4e41aa478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_f6626e23-ebd2-4278-8438-2254a2100e19" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2015844a-c74f-4a9d-9d92-50d4e41aa478" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_c0b78230-99c0-4ed6-b3dc-80bc8682364c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_f6626e23-ebd2-4278-8438-2254a2100e19" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_c0b78230-99c0-4ed6-b3dc-80bc8682364c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>lgnd-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9386ca9d-b089-4ae9-b9e9-dc30d8ee3e97,g:2f56508d-7938-4ed2-96f4-a768c1bc35f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="ia6974cd1907b4277aad3f5aa33b54040_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_06a90a0b-5502-46c1-9a43-6d8d094424dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_RevenuesAbstract_06a90a0b-5502-46c1-9a43-6d8d094424dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20bd57a4-6213-4949-b902-ecd51c7bb91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_06a90a0b-5502-46c1-9a43-6d8d094424dc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20bd57a4-6213-4949-b902-ecd51c7bb91f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_0ca380f6-3a14-4da5-b402-b524bb938faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_CostDirectMaterial_0ca380f6-3a14-4da5-b402-b524bb938faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_b4b0b34b-0881-40be-b71f-d3deb793d6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_b4b0b34b-0881-40be-b71f-d3deb793d6f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f0f42e54-e3ce-4002-8f56-84736be0cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f0f42e54-e3ce-4002-8f56-84736be0cc12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_23f2e07e-e224-48e3-a518-3632d2838937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_23f2e07e-e224-48e3-a518-3632d2838937" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_7b7d704f-b0e1-4065-a2f8-7a2c0517b048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_7b7d704f-b0e1-4065-a2f8-7a2c0517b048" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_83413b39-74f0-48e8-93df-e3d2d45135fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_OperatingIncomeLoss_83413b39-74f0-48e8-93df-e3d2d45135fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_66795a70-eafd-4969-ae86-4f9b996e9f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_GainLossOnInvestments_66795a70-eafd-4969-ae86-4f9b996e9f96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6129b534-1b98-4d2b-b234-909df18670d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6129b534-1b98-4d2b-b234-909df18670d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e46e556e-18dd-4f37-8b00-c5feebe4a40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_InterestExpense_e46e556e-18dd-4f37-8b00-c5feebe4a40e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5087c5f7-436e-4f0d-ad15-d869b3df443b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5087c5f7-436e-4f0d-ad15-d869b3df443b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_63d978e0-6225-4775-8e5c-8314f28e0f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_63d978e0-6225-4775-8e5c-8314f28e0f4f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c182baa3-8b54-4e37-8487-c6e05f851b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c182baa3-8b54-4e37-8487-c6e05f851b72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7828a14d-1dca-4fc1-ae08-9a7ccc7d99b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7828a14d-1dca-4fc1-ae08-9a7ccc7d99b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c99910bc-ea12-42ef-a118-7c87e2879cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_c99910bc-ea12-42ef-a118-7c87e2879cc9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_37b2cf1f-a9c0-42b2-98ed-a866b9a0f176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_37b2cf1f-a9c0-42b2-98ed-a866b9a0f176" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_90e8dc53-7b68-4d98-8708-9f42c3c77d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_NetIncomeLoss_90e8dc53-7b68-4d98-8708-9f42c3c77d61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_48f28c63-992e-4ddb-a40d-d22545e502ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_48f28c63-992e-4ddb-a40d-d22545e502ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_04aff559-c3d8-40d4-ac7b-0bd11a62bbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_04aff559-c3d8-40d4-ac7b-0bd11a62bbc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2679f702-4f71-410d-a903-81f88a3f1432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_EarningsPerShareBasic_2679f702-4f71-410d-a903-81f88a3f1432" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6674e275-b544-46eb-be05-3d1bf90dce99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6674e275-b544-46eb-be05-3d1bf90dce99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d07d238e-12ba-4e61-9e7b-fedbea1ee06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d07d238e-12ba-4e61-9e7b-fedbea1ee06c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3070f994-0a29-4116-b999-e812df5b18c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3070f994-0a29-4116-b999-e812df5b18c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8e4df86d-3716-4316-9183-f6b5f9b19fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8e4df86d-3716-4316-9183-f6b5f9b19fa0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52ccfb3d-0e63-41d7-994d-77e46f868198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52ccfb3d-0e63-41d7-994d-77e46f868198" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_adc131b9-3c15-4076-a1b0-2ed7b5797259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_StatementTable_adc131b9-3c15-4076-a1b0-2ed7b5797259" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a7f3af62-e300-415e-95ce-17611c75fb03" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_adc131b9-3c15-4076-a1b0-2ed7b5797259" xlink:to="loc_srt_ProductOrServiceAxis_a7f3af62-e300-415e-95ce-17611c75fb03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7f3af62-e300-415e-95ce-17611c75fb03_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a7f3af62-e300-415e-95ce-17611c75fb03" xlink:to="loc_srt_ProductsAndServicesDomain_a7f3af62-e300-415e-95ce-17611c75fb03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a7f3af62-e300-415e-95ce-17611c75fb03" xlink:to="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_738b1cba-1713-4fa1-8bc1-0f5778ec256c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:to="loc_us-gaap_RoyaltyMember_738b1cba-1713-4fa1-8bc1-0f5778ec256c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_7a660da5-d1c8-4efa-9821-e668f7e8ff26" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_7a660da5-d1c8-4efa-9821-e668f7e8ff26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_ea7460a4-5c06-4cda-808f-c419d9048b40" xlink:href="lgnd-20230331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:to="loc_lgnd_ContractRevenueMember_ea7460a4-5c06-4cda-808f-c419d9048b40" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i9dba1a8c92cc40aba0430795bb4d3807_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9281f09a-c26e-4519-bfb9-3c8a56e59bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9281f09a-c26e-4519-bfb9-3c8a56e59bdb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_996184d9-893a-4a31-9903-440d914d42b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_996184d9-893a-4a31-9903-440d914d42b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e590155-d991-4781-a6f2-21674cc3fe3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_StockholdersEquity_2e590155-d991-4781-a6f2-21674cc3fe3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d6114093-f813-4325-ae7f-4c5d11fadded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d6114093-f813-4325-ae7f-4c5d11fadded" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c7b2cb2e-82da-4aa7-9594-0c0dd4959b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c7b2cb2e-82da-4aa7-9594-0c0dd4959b3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be521c51-4959-424a-b62a-79f053fc2640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be521c51-4959-424a-b62a-79f053fc2640" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e868960-9da3-477f-9b91-9dcd2131ffbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e868960-9da3-477f-9b91-9dcd2131ffbe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8f2b91c-14e6-4aa9-b286-f8e693804236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8f2b91c-14e6-4aa9-b286-f8e693804236" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation_a1e53889-25ec-437f-b520-aac36c15eeb2" xlink:href="lgnd-20230331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation_a1e53889-25ec-437f-b520-aac36c15eeb2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ef35338d-0731-433a-8d94-a560a2ab7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_NetIncomeLoss_ef35338d-0731-433a-8d94-a560a2ab7cfa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4dd0110c-f5c2-4675-ae79-08d0320c516c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9250032a-3b75-4e39-8d63-bb12249ab079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9281f09a-c26e-4519-bfb9-3c8a56e59bdb" xlink:to="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_34e2fb71-0831-404d-8231-03227196b2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_34e2fb71-0831-404d-8231-03227196b2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34e2fb71-0831-404d-8231-03227196b2cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34e2fb71-0831-404d-8231-03227196b2cd" xlink:to="loc_us-gaap_EquityComponentDomain_34e2fb71-0831-404d-8231-03227196b2cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34e2fb71-0831-404d-8231-03227196b2cd" xlink:to="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ede8d5c1-9402-4e79-9b27-c301b63103b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_CommonStockMember_ede8d5c1-9402-4e79-9b27-c301b63103b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_98113c86-005c-4d7c-bb9c-a7fd711b602c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_98113c86-005c-4d7c-bb9c-a7fd711b602c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_76baf303-695b-4fb3-9a57-da06e0174acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_76baf303-695b-4fb3-9a57-da06e0174acc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5d69c23d-92c6-4ef9-9bca-410964ba6777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_RetainedEarningsMember_5d69c23d-92c6-4ef9-9bca-410964ba6777" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_28f90ec5-7144-46e5-ab6d-bd47201db94d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_28f90ec5-7144-46e5-ab6d-bd47201db94d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28f90ec5-7144-46e5-ab6d-bd47201db94d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_28f90ec5-7144-46e5-ab6d-bd47201db94d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_28f90ec5-7144-46e5-ab6d-bd47201db94d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b6418761-36f1-48c8-99a6-0eb8e21d46d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_28f90ec5-7144-46e5-ab6d-bd47201db94d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b6418761-36f1-48c8-99a6-0eb8e21d46d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7caf050-829e-4bbe-af1f-a4546e026543" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b6418761-36f1-48c8-99a6-0eb8e21d46d8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7caf050-829e-4bbe-af1f-a4546e026543" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i5d03f855116d45f4a77004fad409fb49_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_2379643c-d1a1-4d8f-a7af-20e4281e32d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_NumberOfOperatingSegments_2379643c-d1a1-4d8f-a7af-20e4281e32d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_541efc17-62a4-42a5-80b1-9c9abf77c084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_541efc17-62a4-42a5-80b1-9c9abf77c084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIShareSoldInPeriod_ffdb670b-cccf-4994-b066-0809f6da1654" xlink:href="lgnd-20230331.xsd#lgnd_EquitySecuritiesFVNIShareSoldInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_lgnd_EquitySecuritiesFVNIShareSoldInPeriod_ffdb670b-cccf-4994-b066-0809f6da1654" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_af7ca570-bc7f-4db9-867b-992dabb27fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_af7ca570-bc7f-4db9-867b-992dabb27fe7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d18330a4-2e17-4a3b-b361-2aba2a56d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d18330a4-2e17-4a3b-b361-2aba2a56d8cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9fca3ae3-ea53-4db0-8e11-2714ef108bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9fca3ae3-ea53-4db0-8e11-2714ef108bc6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_88a2cb71-8758-4eaf-b9ae-3c657ad1216f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_88a2cb71-8758-4eaf-b9ae-3c657ad1216f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_c21d9248-47e2-4adf-abed-bd208d9c2071" xlink:href="lgnd-20230331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_c21d9248-47e2-4adf-abed-bd208d9c2071" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_09b8a752-f973-4366-9bd3-0613ded5a001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_InventoryWriteDown_09b8a752-f973-4366-9bd3-0613ded5a001" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_577c45eb-4962-42af-ac68-3ab7bec12e20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_InventoryNet_577c45eb-4962-42af-ac68-3ab7bec12e20" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b3cdecaf-b9ae-4214-9902-af3ae95612b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b3cdecaf-b9ae-4214-9902-af3ae95612b3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_f86ebf52-a19b-4be3-ba52-0f6c53c11594" xlink:href="lgnd-20230331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_f86ebf52-a19b-4be3-ba52-0f6c53c11594" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_31853a87-b847-4193-8876-c004a12d1e76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:to="loc_srt_ProductOrServiceAxis_31853a87-b847-4193-8876-c004a12d1e76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_31853a87-b847-4193-8876-c004a12d1e76_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_31853a87-b847-4193-8876-c004a12d1e76" xlink:to="loc_srt_ProductsAndServicesDomain_31853a87-b847-4193-8876-c004a12d1e76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0189010c-8a3d-4593-b046-7aeb94358d6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_31853a87-b847-4193-8876-c004a12d1e76" xlink:to="loc_srt_ProductsAndServicesDomain_0189010c-8a3d-4593-b046-7aeb94358d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_5a8a6603-e610-4d9b-8982-a2cd7e4a7eea" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0189010c-8a3d-4593-b046-7aeb94358d6c" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_5a8a6603-e610-4d9b-8982-a2cd7e4a7eea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3883e199-3290-4efa-9a93-3af2bb81edda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:to="loc_us-gaap_AwardTypeAxis_3883e199-3290-4efa-9a93-3af2bb81edda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3883e199-3290-4efa-9a93-3af2bb81edda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3883e199-3290-4efa-9a93-3af2bb81edda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3883e199-3290-4efa-9a93-3af2bb81edda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a829c64c-1919-4564-9a60-6249c478db5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3883e199-3290-4efa-9a93-3af2bb81edda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a829c64c-1919-4564-9a60-6249c478db5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a64641f6-32ec-4efc-a47d-0e8cd54d7309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a829c64c-1919-4564-9a60-6249c478db5d" xlink:to="loc_us-gaap_RestrictedStockMember_a64641f6-32ec-4efc-a47d-0e8cd54d7309" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a727c95-9968-46b7-8029-6ee4f311f4af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:to="loc_srt_RangeAxis_9a727c95-9968-46b7-8029-6ee4f311f4af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9a727c95-9968-46b7-8029-6ee4f311f4af_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9a727c95-9968-46b7-8029-6ee4f311f4af" xlink:to="loc_srt_RangeMember_9a727c95-9968-46b7-8029-6ee4f311f4af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9a727c95-9968-46b7-8029-6ee4f311f4af" xlink:to="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7c4c409c-fd8d-493d-8bc9-a00f6cd3f880" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:to="loc_srt_MinimumMember_7c4c409c-fd8d-493d-8bc9-a00f6cd3f880" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c2de0e8-3bdc-4093-a2a1-8e5d96ac716a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:to="loc_srt_MaximumMember_0c2de0e8-3bdc-4093-a2a1-8e5d96ac716a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="iff7638ecfbab4389a37d628ca193f422_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8efe5e25-9b36-4d21-8538-1438b2f8b535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_073c5e3a-71d0-4057-a7df-002b478f017f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8efe5e25-9b36-4d21-8538-1438b2f8b535" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_073c5e3a-71d0-4057-a7df-002b478f017f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ffa1b6c0-7710-4be9-916a-dc25c53348d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8efe5e25-9b36-4d21-8538-1438b2f8b535" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ffa1b6c0-7710-4be9-916a-dc25c53348d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffa1b6c0-7710-4be9-916a-dc25c53348d9" xlink:to="loc_srt_ProductOrServiceAxis_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4" xlink:to="loc_srt_ProductsAndServicesDomain_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4" xlink:to="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:to="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_3238010c-fa5c-492d-adcc-11950815d3ed" xlink:href="lgnd-20230331.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_KyprolisMember_3238010c-fa5c-492d-adcc-11950815d3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_58827ec3-980e-4b40-b66b-a7c64f49db55" xlink:href="lgnd-20230331.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_EvomelaMember_58827ec3-980e-4b40-b66b-a7c64f49db55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_70c8ba4c-18da-4452-9461-652cb581a879" xlink:href="lgnd-20230331.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_TeriparatideInjectionMember_70c8ba4c-18da-4452-9461-652cb581a879" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_dd33f0f2-41c8-4e1c-916e-3758645f9f50" xlink:href="lgnd-20230331.xsd#lgnd_RylazeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_RylazeMember_dd33f0f2-41c8-4e1c-916e-3758645f9f50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_289dc2e3-868f-44b7-ab6b-cdd9da1cef28" xlink:href="lgnd-20230331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_RoyaltyOtherMember_289dc2e3-868f-44b7-ab6b-cdd9da1cef28" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_24970cdd-aeec-43dc-9264-13125998cfbd" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_24970cdd-aeec-43dc-9264-13125998cfbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d7d81244-7df1-4af8-b3e0-0fdbb46b4a3e" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d7d81244-7df1-4af8-b3e0-0fdbb46b4a3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:href="lgnd-20230331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:to="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_f73439c2-aa21-40fe-a124-35307b2161d0" xlink:href="lgnd-20230331.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:to="loc_lgnd_LicenseFeesMember_f73439c2-aa21-40fe-a124-35307b2161d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_b91d98a2-9f05-4913-92f2-c06ce926ddf8" xlink:href="lgnd-20230331.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:to="loc_lgnd_MilestoneMember_b91d98a2-9f05-4913-92f2-c06ce926ddf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_574b132a-fd97-4380-b24d-d5817c36fcf1" xlink:href="lgnd-20230331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_574b132a-fd97-4380-b24d-d5817c36fcf1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="i624f090307b7449cb0d6445c1aa7808c_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_16185191-19fa-490f-8a52-7ddc0af39ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_16185191-19fa-490f-8a52-7ddc0af39ff0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ed891128-2072-46be-a74b-950b1a20fbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ed891128-2072-46be-a74b-950b1a20fbba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0299f0f3-75d6-4a97-bf8e-6d5ec652965b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0299f0f3-75d6-4a97-bf8e-6d5ec652965b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_63e0e643-17bd-418b-af0a-465cd9137a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_63e0e643-17bd-418b-af0a-465cd9137a42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_5185dd92-b84d-4121-bd00-c65a9c745250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_5185dd92-b84d-4121-bd00-c65a9c745250" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_157af45c-7b59-4b95-aed5-27b632676980" xlink:href="lgnd-20230331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_157af45c-7b59-4b95-aed5-27b632676980" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6fbae8cf-6600-47f2-a39c-13e24bd4d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6fbae8cf-6600-47f2-a39c-13e24bd4d0a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_157bd50e-5869-442c-a1a8-cf04e970daa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6fbae8cf-6600-47f2-a39c-13e24bd4d0a9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_157bd50e-5869-442c-a1a8-cf04e970daa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_157bd50e-5869-442c-a1a8-cf04e970daa0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_157bd50e-5869-442c-a1a8-cf04e970daa0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_157bd50e-5869-442c-a1a8-cf04e970daa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_157bd50e-5869-442c-a1a8-cf04e970daa0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_1e386e5e-fb70-435a-94ca-2dd095dc5ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_DemandDepositsMember_1e386e5e-fb70-435a-94ca-2dd095dc5ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_4821130e-2603-4705-9f0d-42050d8ddb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_4821130e-2603-4705-9f0d-42050d8ddb9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_322e2b76-7320-4070-bf82-d5670823765f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_AgencySecuritiesMember_322e2b76-7320-4070-bf82-d5670823765f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_dfd8c43c-b37c-436f-90e9-9be5bca22d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_CommercialPaperMember_dfd8c43c-b37c-436f-90e9-9be5bca22d24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_a357d2cf-b92d-4006-8a18-bc6d47335725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_MunicipalBondsMember_a357d2cf-b92d-4006-8a18-bc6d47335725" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3c6d1f82-a708-4840-b921-2cf5003ba232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_EquitySecuritiesMember_3c6d1f82-a708-4840-b921-2cf5003ba232" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_e9abc83b-3a7d-4530-b5c8-32bd4d0f5a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_MutualFundMember_e9abc83b-3a7d-4530-b5c8-32bd4d0f5a07" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_8a83fa6a-48bb-4117-884e-59c6f3d5d88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_8a83fa6a-48bb-4117-884e-59c6f3d5d88e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_91037420-ccbd-4120-aac4-40081566e318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_WarrantMember_91037420-ccbd-4120-aac4-40081566e318" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9bb240cd-5947-40c1-b894-55ebed83e265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_CommonStockMember_9bb240cd-5947-40c1-b894-55ebed83e265" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i0805c8bcf6004683b7db76e6ca59042d_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_915cc3a9-8b2b-443f-b232-9826d72fec76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_915cc3a9-8b2b-443f-b232-9826d72fec76" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3bb433d6-e113-425a-a184-12b4e1c34401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_Goodwill_3bb433d6-e113-425a-a184-12b4e1c34401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_18c91acb-2b80-470c-b753-86c181deb062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_18c91acb-2b80-470c-b753-86c181deb062" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1601c107-1a97-4d5b-9094-79c5e59d379b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1601c107-1a97-4d5b-9094-79c5e59d379b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b7943318-7716-4267-961a-76be2b00bbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b7943318-7716-4267-961a-76be2b00bbb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3fd3280e-8114-4b77-9240-899bfadb08b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_915cc3a9-8b2b-443f-b232-9826d72fec76" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3fd3280e-8114-4b77-9240-899bfadb08b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3fd3280e-8114-4b77-9240-899bfadb08b8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_970df0b7-d2cf-4691-93ac-47b7cc0f1108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_PatentedTechnologyMember_970df0b7-d2cf-4691-93ac-47b7cc0f1108" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_22876bcb-69e3-4da2-adaf-ffac17d8ea05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_TradeNamesMember_22876bcb-69e3-4da2-adaf-ffac17d8ea05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3cc4d6b9-8bec-4a42-808d-3133e58900f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3cc4d6b9-8bec-4a42-808d-3133e58900f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_9e588f35-98cb-4ead-95d5-5a5d9fe280ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_ContractualRightsMember_9e588f35-98cb-4ead-95d5-5a5d9fe280ef" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended" id="i43626fdfd4eb4c41b01f0348a6bf889e_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1edcfe47-ab07-450b-85c3-f1145ee024d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1edcfe47-ab07-450b-85c3-f1145ee024d0" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_82a3ddf7-4ddd-4bdf-84ed-c2746d4bb3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_82a3ddf7-4ddd-4bdf-84ed-c2746d4bb3cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7ce1af20-012c-41b9-b7a5-d85c0919b201" xlink:href="lgnd-20230331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7ce1af20-012c-41b9-b7a5-d85c0919b201" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4976082f-3909-45b6-884c-3750ca0ef738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4976082f-3909-45b6-884c-3750ca0ef738" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_414ccae9-2091-482e-b5be-19945ef713e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_414ccae9-2091-482e-b5be-19945ef713e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_821e788f-50a9-40fe-8389-72c62d6e2b84" xlink:href="lgnd-20230331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_821e788f-50a9-40fe-8389-72c62d6e2b84" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1edcfe47-ab07-450b-85c3-f1145ee024d0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_141d2524-8ec9-45cb-bbbe-f9b9a133029f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_141d2524-8ec9-45cb-bbbe-f9b9a133029f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_141d2524-8ec9-45cb-bbbe-f9b9a133029f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_141d2524-8ec9-45cb-bbbe-f9b9a133029f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_141d2524-8ec9-45cb-bbbe-f9b9a133029f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7663d1db-631c-4c9b-b18c-d6c11a650256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_141d2524-8ec9-45cb-bbbe-f9b9a133029f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7663d1db-631c-4c9b-b18c-d6c11a650256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_a60d9595-a65c-47f6-9993-2128b68825d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7663d1db-631c-4c9b-b18c-d6c11a650256" xlink:to="loc_us-gaap_LicensingAgreementsMember_a60d9595-a65c-47f6-9993-2128b68825d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d85de6c5-915a-4feb-8c50-78051337d049" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:to="loc_srt_CounterpartyNameAxis_d85de6c5-915a-4feb-8c50-78051337d049" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d85de6c5-915a-4feb-8c50-78051337d049_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d85de6c5-915a-4feb-8c50-78051337d049" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d85de6c5-915a-4feb-8c50-78051337d049_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d85de6c5-915a-4feb-8c50-78051337d049" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_8115de7a-d2f4-43e3-8d8c-17853db34801" xlink:href="lgnd-20230331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_8115de7a-d2f4-43e3-8d8c-17853db34801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_61bde44c-f6df-42eb-b1cf-3273bb284e54" xlink:href="lgnd-20230331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:to="loc_lgnd_SelexisAndDianomiMember_61bde44c-f6df-42eb-b1cf-3273bb284e54" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="idf12ac3271c14571a0069ff388598e8b_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_07f9d083-fedb-4b83-96ac-3d7b4d35ab81" xlink:href="lgnd-20230331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_49e954d0-1fbf-47f0-8ca5-c9835dc4112b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_07f9d083-fedb-4b83-96ac-3d7b4d35ab81" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_49e954d0-1fbf-47f0-8ca5-c9835dc4112b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_28ee6057-3354-4293-aff2-a8caf723981f" xlink:href="lgnd-20230331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_07f9d083-fedb-4b83-96ac-3d7b4d35ab81" xlink:to="loc_lgnd_BasisOfPresentationTable_28ee6057-3354-4293-aff2-a8caf723981f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_845a6e73-647b-4556-a0d3-6509de8d8426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_28ee6057-3354-4293-aff2-a8caf723981f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_845a6e73-647b-4556-a0d3-6509de8d8426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_845a6e73-647b-4556-a0d3-6509de8d8426_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_845a6e73-647b-4556-a0d3-6509de8d8426" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_845a6e73-647b-4556-a0d3-6509de8d8426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_845a6e73-647b-4556-a0d3-6509de8d8426" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03e33f05-f807-4ac3-ad30-5c130a5c3330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03e33f05-f807-4ac3-ad30-5c130a5c3330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_00b6629a-b84d-499d-954c-f57bd1f9f1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_00b6629a-b84d-499d-954c-f57bd1f9f1b3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended" id="i582a1306052e410ab7f348877acc6f2e_BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75b5bf8f-f0d9-4b94-97f4-e00bdd7701f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75b5bf8f-f0d9-4b94-97f4-e00bdd7701f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_132b0d50-80b8-45fc-8f43-dfb3ca20b570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_132b0d50-80b8-45fc-8f43-dfb3ca20b570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f217cf67-141d-4f2b-ba58-a7aa9fa5dd82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f217cf67-141d-4f2b-ba58-a7aa9fa5dd82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5b4ee89d-782f-4d8c-9a7e-e7549fe525ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5b4ee89d-782f-4d8c-9a7e-e7549fe525ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b78e7d5b-a921-4806-af07-3159534f2001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b78e7d5b-a921-4806-af07-3159534f2001" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a2de0758-b222-41bc-acd0-f2b2ca147e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b78e7d5b-a921-4806-af07-3159534f2001" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a2de0758-b222-41bc-acd0-f2b2ca147e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a2de0758-b222-41bc-acd0-f2b2ca147e9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a2de0758-b222-41bc-acd0-f2b2ca147e9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a2de0758-b222-41bc-acd0-f2b2ca147e9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a2de0758-b222-41bc-acd0-f2b2ca147e9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ababc4c4-bd29-4116-bf04-fd5c4df7aa79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:to="loc_us-gaap_RestrictedStockMember_ababc4c4-bd29-4116-bf04-fd5c4df7aa79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f60ccedc-cdbd-4485-b59e-d656e9795bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f60ccedc-cdbd-4485-b59e-d656e9795bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_7fd308b8-b776-44e4-95c1-e9e02316259a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_7fd308b8-b776-44e4-95c1-e9e02316259a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="extended" id="i9d45b65c46674773a2f501f54d08cd0f_SpinoffofOmniAbNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a1fa0e69-9a88-4859-922c-876e066efbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a1fa0e69-9a88-4859-922c-876e066efbb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_86ebed47-5122-40ae-98a2-8e0df6398415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:to="loc_us-gaap_NumberOfReportableSegments_86ebed47-5122-40ae-98a2-8e0df6398415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_1b652392-f135-4e5d-839d-334a3ff7f01d" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_1b652392-f135-4e5d-839d-334a3ff7f01d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a9512a75-bb98-429c-80d4-7c7b454bc2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a9512a75-bb98-429c-80d4-7c7b454bc2d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3988e133-fe9d-4c70-9d72-725390a9e116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a9512a75-bb98-429c-80d4-7c7b454bc2d5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3988e133-fe9d-4c70-9d72-725390a9e116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3988e133-fe9d-4c70-9d72-725390a9e116_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3988e133-fe9d-4c70-9d72-725390a9e116" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3988e133-fe9d-4c70-9d72-725390a9e116_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_726b127c-21a1-41b8-b4d3-4c157bdb1f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3988e133-fe9d-4c70-9d72-725390a9e116" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_726b127c-21a1-41b8-b4d3-4c157bdb1f7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_c87000e3-b5ec-4ff2-a811-063cad142cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_726b127c-21a1-41b8-b4d3-4c157bdb1f7a" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_c87000e3-b5ec-4ff2-a811-063cad142cbc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="extended" id="i134d64ee36794650ba028c35bfd21562_SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_ab1491f9-726d-4188-8cf1-86a58334b80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_ab1491f9-726d-4188-8cf1-86a58334b80b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_41db1c2c-7853-4b6c-be9f-52f115ef3af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_ab1491f9-726d-4188-8cf1-86a58334b80b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_41db1c2c-7853-4b6c-be9f-52f115ef3af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_cb531641-219a-41b3-9a95-0d09ecbdb4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_cb531641-219a-41b3-9a95-0d09ecbdb4ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_62f9af6b-f83e-4fa1-8c09-93a225842cd3" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_62f9af6b-f83e-4fa1-8c09-93a225842cd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_f7443401-2ed4-4690-ae54-8b3b400c2b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_f7443401-2ed4-4690-ae54-8b3b400c2b37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_90f28cf1-8218-4386-bc95-5c7fa8a0f9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_90f28cf1-8218-4386-bc95-5c7fa8a0f9ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_414f685d-5858-46bd-9fd3-1dc2bf235424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_414f685d-5858-46bd-9fd3-1dc2bf235424" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_d3861c59-3554-4522-ba96-c0d1574f8fa5" xlink:href="lgnd-20230331.xsd#lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_d3861c59-3554-4522-ba96-c0d1574f8fa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_ded3d7a9-1cb4-4384-86fe-2226f8f30792" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_d3861c59-3554-4522-ba96-c0d1574f8fa5" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_ded3d7a9-1cb4-4384-86fe-2226f8f30792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_186acb83-823b-47c7-9d02-debe78f635e9" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_186acb83-823b-47c7-9d02-debe78f635e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_5b131319-507a-4d54-81a3-868a7870c02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_5b131319-507a-4d54-81a3-868a7870c02e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d57c5990-dd53-4384-af7b-d8ca629caeba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d57c5990-dd53-4384-af7b-d8ca629caeba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3bd8c8c6-adc9-4ab5-afcd-3ac5adea314d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3bd8c8c6-adc9-4ab5-afcd-3ac5adea314d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83acaf3e-6b03-4976-b637-3e8a4298b1db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:to="loc_srt_ProductOrServiceAxis_83acaf3e-6b03-4976-b637-3e8a4298b1db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_83acaf3e-6b03-4976-b637-3e8a4298b1db_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_83acaf3e-6b03-4976-b637-3e8a4298b1db" xlink:to="loc_srt_ProductsAndServicesDomain_83acaf3e-6b03-4976-b637-3e8a4298b1db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_83acaf3e-6b03-4976-b637-3e8a4298b1db" xlink:to="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_a8cc7d36-54ec-412b-b4c8-d3ca5b4c4ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:to="loc_us-gaap_RoyaltyMember_a8cc7d36-54ec-412b-b4c8-d3ca5b4c4ee7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_8bb7ff3d-84db-4207-9c00-be939fcba108" xlink:href="lgnd-20230331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:to="loc_lgnd_ContractRevenueMember_8bb7ff3d-84db-4207-9c00-be939fcba108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_af9dd8bc-56b1-4e19-a54f-e9e75a021089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_af9dd8bc-56b1-4e19-a54f-e9e75a021089" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_af9dd8bc-56b1-4e19-a54f-e9e75a021089_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_af9dd8bc-56b1-4e19-a54f-e9e75a021089" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_af9dd8bc-56b1-4e19-a54f-e9e75a021089_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_89008c81-bdc5-4097-91af-fa4aa1e58477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_af9dd8bc-56b1-4e19-a54f-e9e75a021089" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_89008c81-bdc5-4097-91af-fa4aa1e58477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_f8cb6d3f-4743-4367-9cef-672bcbbf8c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_89008c81-bdc5-4097-91af-fa4aa1e58477" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_f8cb6d3f-4743-4367-9cef-672bcbbf8c7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="extended" id="idef3367584554ef28252ba7b267f09f9_SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:href="lgnd-20230331.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_d3d3c327-1529-46db-9a7f-45887f866373" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_d3d3c327-1529-46db-9a7f-45887f866373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_0d7c0768-ca0f-41eb-ab4b-04b129ce4b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:to="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_0d7c0768-ca0f-41eb-ab4b-04b129ce4b31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_61c4d108-8f18-4bb0-be98-4fae00186bfc" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_61c4d108-8f18-4bb0-be98-4fae00186bfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_ceab4bc6-038b-4a6e-9f0f-fddf6f9598dd" xlink:href="lgnd-20230331.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_ceab4bc6-038b-4a6e-9f0f-fddf6f9598dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_bc2aa060-853a-4a59-a9cf-88da94d26bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_ceab4bc6-038b-4a6e-9f0f-fddf6f9598dd" xlink:to="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_bc2aa060-853a-4a59-a9cf-88da94d26bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_989c0fe4-17e2-459f-a790-2dbc00cd04b8" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_989c0fe4-17e2-459f-a790-2dbc00cd04b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_96cf589b-605c-49fc-ac33-d880758890ce" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_989c0fe4-17e2-459f-a790-2dbc00cd04b8" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_96cf589b-605c-49fc-ac33-d880758890ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_66bc2877-8797-4025-b1e5-dd825609e857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_66bc2877-8797-4025-b1e5-dd825609e857" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_b84d3858-256b-4143-ae32-40edb57dd41d" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_66bc2877-8797-4025-b1e5-dd825609e857" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_b84d3858-256b-4143-ae32-40edb57dd41d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f682bab8-e4a9-4391-9f12-0a3a6939b312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f682bab8-e4a9-4391-9f12-0a3a6939b312" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f682bab8-e4a9-4391-9f12-0a3a6939b312" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9438238b-6216-4da3-9a58-3d1bd480d48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9438238b-6216-4da3-9a58-3d1bd480d48b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_46c06b10-83f3-4b4e-85a1-1716cbfdd1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9438238b-6216-4da3-9a58-3d1bd480d48b" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_46c06b10-83f3-4b4e-85a1-1716cbfdd1dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i2401a8dc64bf418dae248f7587be1ba3_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5fd35c0b-f4d9-454d-bcbe-756eb4ca059a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5fd35c0b-f4d9-454d-bcbe-756eb4ca059a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_08d07568-a9b7-4b9f-8654-1070c1e76f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_08d07568-a9b7-4b9f-8654-1070c1e76f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_fb8612f2-8fb1-4096-b104-6b3c0f62ddb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_fb8612f2-8fb1-4096-b104-6b3c0f62ddb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_459bbe40-f625-4d41-b7c4-ac57ab67dfc5" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_459bbe40-f625-4d41-b7c4-ac57ab67dfc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_eca4df3b-a770-463c-80ac-592202f3591b" xlink:href="lgnd-20230331.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_eca4df3b-a770-463c-80ac-592202f3591b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d72cb4bd-06cf-4423-ba3c-c476f461f5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d72cb4bd-06cf-4423-ba3c-c476f461f5a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_9fd38474-ceca-4cff-a63d-91dd6e284733" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_9fd38474-ceca-4cff-a63d-91dd6e284733" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_d1a57f69-2bbc-4e8e-bc61-d2c357a11bc4" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_d1a57f69-2bbc-4e8e-bc61-d2c357a11bc4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_869329b7-eef4-4b78-b302-f6c7655b0761" xlink:href="lgnd-20230331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_869329b7-eef4-4b78-b302-f6c7655b0761" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_0a541c8a-eebf-4c75-a757-f4207db987fa" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_0a541c8a-eebf-4c75-a757-f4207db987fa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_c79919cf-0113-481e-9f72-d5cf741d73a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_Investments_c79919cf-0113-481e-9f72-d5cf741d73a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_fe5c4bb4-e57b-4c3a-aece-d9951877031c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_fe5c4bb4-e57b-4c3a-aece-d9951877031c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_433c74fb-abd3-4cc3-b231-2149460224b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_433c74fb-abd3-4cc3-b231-2149460224b1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5116b757-6029-40f3-b800-2b6e0689ecc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5116b757-6029-40f3-b800-2b6e0689ecc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5116b757-6029-40f3-b800-2b6e0689ecc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5116b757-6029-40f3-b800-2b6e0689ecc5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5116b757-6029-40f3-b800-2b6e0689ecc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7d29e08-06f7-4b5c-a9f7-08f6f96faeea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5116b757-6029-40f3-b800-2b6e0689ecc5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7d29e08-06f7-4b5c-a9f7-08f6f96faeea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e9e195ce-8360-49d1-9edd-ddaca2e87740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7d29e08-06f7-4b5c-a9f7-08f6f96faeea" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e9e195ce-8360-49d1-9edd-ddaca2e87740" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_69e4d66b-8ae8-41d7-a158-93db3ef048b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_69e4d66b-8ae8-41d7-a158-93db3ef048b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_69e4d66b-8ae8-41d7-a158-93db3ef048b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_69e4d66b-8ae8-41d7-a158-93db3ef048b1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_69e4d66b-8ae8-41d7-a158-93db3ef048b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_69e4d66b-8ae8-41d7-a158-93db3ef048b1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3bdcc841-3439-4254-88fd-b62b2de0c520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3bdcc841-3439-4254-88fd-b62b2de0c520" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b76bc9d6-4663-416b-9793-ca769199b364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b76bc9d6-4663-416b-9793-ca769199b364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_816ff0ee-ae8f-48c8-a34c-c0df9be4c818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_816ff0ee-ae8f-48c8-a34c-c0df9be4c818" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_FinancialInstrumentAxis_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_14856b64-1e3a-4959-b819-7dd442848cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_14856b64-1e3a-4959-b819-7dd442848cea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesMember_c834ec17-e7f6-45df-88c9-8720bc311749" xlink:href="lgnd-20230331.xsd#lgnd_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:to="loc_lgnd_ContingentLiabilitiesMember_c834ec17-e7f6-45df-88c9-8720bc311749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2062d0fa-f320-4456-b1c2-1358829dc76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2062d0fa-f320-4456-b1c2-1358829dc76c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2062d0fa-f320-4456-b1c2-1358829dc76c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2062d0fa-f320-4456-b1c2-1358829dc76c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2062d0fa-f320-4456-b1c2-1358829dc76c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2062d0fa-f320-4456-b1c2-1358829dc76c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CyDexMember_ee71505d-a2c4-40f4-ba8e-b49063855fa0" xlink:href="lgnd-20230331.xsd#lgnd_CyDexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:to="loc_lgnd_CyDexMember_ee71505d-a2c4-40f4-ba8e-b49063855fa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_27da52ec-1ba4-44cf-b50b-2a3febbcf697" xlink:href="lgnd-20230331.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:to="loc_lgnd_MetabasisMember_27da52ec-1ba4-44cf-b50b-2a3febbcf697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_srt_RangeAxis_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5" xlink:to="loc_srt_RangeMember_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1d8b2dc9-84e9-4d68-9912-db5d2a0ad5f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5" xlink:to="loc_srt_RangeMember_1d8b2dc9-84e9-4d68-9912-db5d2a0ad5f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6de4e83-2c82-4e19-8d5a-bb47df726a6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1d8b2dc9-84e9-4d68-9912-db5d2a0ad5f3" xlink:to="loc_srt_MaximumMember_a6de4e83-2c82-4e19-8d5a-bb47df726a6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_bc8ab290-0cbb-46ae-8c67-d340e47eacfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_bc8ab290-0cbb-46ae-8c67-d340e47eacfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_5b897338-0313-4fa6-a2fe-678cfa6ce7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_bc8ab290-0cbb-46ae-8c67-d340e47eacfc" xlink:to="loc_us-gaap_TransferredOverTimeMember_5b897338-0313-4fa6-a2fe-678cfa6ce7b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_srt_ProductOrServiceAxis_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2" xlink:to="loc_srt_ProductsAndServicesDomain_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2" xlink:to="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_dd9cf082-b5ba-47e3-b017-22b394a72fac" xlink:href="lgnd-20230331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_dd9cf082-b5ba-47e3-b017-22b394a72fac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_8e3fe225-605c-4524-bc4a-acd06a991d3e" xlink:href="lgnd-20230331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_8e3fe225-605c-4524-bc4a-acd06a991d3e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="iee10b9a28a1b4bc6bbb5971eb1793689_FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37eeff7e-0c7c-41e6-9663-a9b16c436d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37eeff7e-0c7c-41e6-9663-a9b16c436d46" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7890955c-5bfa-450c-8dbb-4572b7d506a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7890955c-5bfa-450c-8dbb-4572b7d506a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_23f29dac-50c4-4b67-acb7-e8e1a2752107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_23f29dac-50c4-4b67-acb7-e8e1a2752107" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf511b42-0359-4e5f-b9aa-689b420d5f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a5c6ba9-34dd-4665-bf45-52aa4f93f3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37eeff7e-0c7c-41e6-9663-a9b16c436d46" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a5c6ba9-34dd-4665-bf45-52aa4f93f3b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ec77072-9726-4cf6-a813-31c0f41584c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a5c6ba9-34dd-4665-bf45-52aa4f93f3b2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ec77072-9726-4cf6-a813-31c0f41584c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec77072-9726-4cf6-a813-31c0f41584c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ec77072-9726-4cf6-a813-31c0f41584c2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec77072-9726-4cf6-a813-31c0f41584c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9be0ede7-3061-4611-9ffb-f4f4f8005ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ec77072-9726-4cf6-a813-31c0f41584c2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9be0ede7-3061-4611-9ffb-f4f4f8005ea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da0db73f-e9eb-494f-9f4e-f016fa0ebec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9be0ede7-3061-4611-9ffb-f4f4f8005ea6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da0db73f-e9eb-494f-9f4e-f016fa0ebec8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="i6e0cd957878d4f84b6905a6e4a81d369_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c8ed0596-e78e-437a-85ed-81cc923b8b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c8ed0596-e78e-437a-85ed-81cc923b8b37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a41850e1-7489-40dc-abca-f15318a42a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a41850e1-7489-40dc-abca-f15318a42a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_6d375050-f79a-4265-9027-656e79f7d2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_6d375050-f79a-4265-9027-656e79f7d2bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_b794f5e2-8fa7-442d-8fb3-f64694871476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_b794f5e2-8fa7-442d-8fb3-f64694871476" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b1a1b66b-5382-421b-9bb0-3fd7c723d50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b1a1b66b-5382-421b-9bb0-3fd7c723d50b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c577895c-eb92-40dd-a5e1-d5263ed29fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c577895c-eb92-40dd-a5e1-d5263ed29fda" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_17dfde1f-5c3b-4787-a8a2-95b73816d4c8" xlink:href="lgnd-20230331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_17dfde1f-5c3b-4787-a8a2-95b73816d4c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b222e2ce-130b-4aa7-a9a4-87eabef76846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b222e2ce-130b-4aa7-a9a4-87eabef76846" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_b59d4fea-c800-4992-b941-4a8b69e9f758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_b59d4fea-c800-4992-b941-4a8b69e9f758" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_397f8127-cf49-4057-a11e-bdf6e068ca2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_397f8127-cf49-4057-a11e-bdf6e068ca2c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c1114e7d-e2e1-44b2-a08f-d220a9545059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentTerm_c1114e7d-e2e1-44b2-a08f-d220a9545059" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_6337d19e-f716-4c16-870b-f89653348c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_6337d19e-f716-4c16-870b-f89653348c31" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_96a73595-df7c-4983-a6df-136ef55f0e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_InterestExpenseDebt_96a73595-df7c-4983-a6df-136ef55f0e34" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_0883dea7-ba10-497a-ba5b-3fdacb6c4dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_0883dea7-ba10-497a-ba5b-3fdacb6c4dca" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_3ac6c649-3302-4460-8b6c-c231965fdd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_3ac6c649-3302-4460-8b6c-c231965fdd43" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_69c7cbd0-eab9-4bab-826e-ac3f582cb908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_69c7cbd0-eab9-4bab-826e-ac3f582cb908" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_26d002e1-2a8c-4e98-a97c-bdc1900321cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_26d002e1-2a8c-4e98-a97c-bdc1900321cf" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_a7b9efb7-31d1-4da0-b9fb-addcf65531df" xlink:href="lgnd-20230331.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_a7b9efb7-31d1-4da0-b9fb-addcf65531df" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2e508ed6-87a7-41a8-b253-39134615142a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2e508ed6-87a7-41a8-b253-39134615142a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_8c3aae14-27f6-4ac8-b2fb-7fd63ce13d5c" xlink:href="lgnd-20230331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_8c3aae14-27f6-4ac8-b2fb-7fd63ce13d5c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0da74889-eaf9-4a0c-b90d-cd116f0e3195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0da74889-eaf9-4a0c-b90d-cd116f0e3195" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_d1d352de-a2bd-4948-9545-1099498ad3a2" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_d1d352de-a2bd-4948-9545-1099498ad3a2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bb97d7b7-3a40-4682-b3aa-5fcc1d7db45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bb97d7b7-3a40-4682-b3aa-5fcc1d7db45b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e17ee029-e28d-462b-b8d7-0287d4963f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e17ee029-e28d-462b-b8d7-0287d4963f69" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_b20c89a5-08cd-467a-9e8e-632be9754c53" xlink:href="lgnd-20230331.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_b20c89a5-08cd-467a-9e8e-632be9754c53" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_259b0a62-bd6d-4e27-bf4c-a00a22b24c81" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_259b0a62-bd6d-4e27-bf4c-a00a22b24c81" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_39759f1b-2a3f-470d-a205-3fbd3888aee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_39759f1b-2a3f-470d-a205-3fbd3888aee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39759f1b-2a3f-470d-a205-3fbd3888aee9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_39759f1b-2a3f-470d-a205-3fbd3888aee9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39759f1b-2a3f-470d-a205-3fbd3888aee9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46f2c205-c911-4319-8150-b42f545caf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_39759f1b-2a3f-470d-a205-3fbd3888aee9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46f2c205-c911-4319-8150-b42f545caf49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_43b5b3b9-ee9f-441e-bdb6-152ffd3032c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46f2c205-c911-4319-8150-b42f545caf49" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_43b5b3b9-ee9f-441e-bdb6-152ffd3032c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_438470f0-cc12-4850-9ac2-4f5292f3e437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_DebtInstrumentAxis_438470f0-cc12-4850-9ac2-4f5292f3e437" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_438470f0-cc12-4850-9ac2-4f5292f3e437_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_438470f0-cc12-4850-9ac2-4f5292f3e437" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_438470f0-cc12-4850-9ac2-4f5292f3e437_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b72534d-65fb-4d36-9a32-be2e3e80cc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_438470f0-cc12-4850-9ac2-4f5292f3e437" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b72534d-65fb-4d36-9a32-be2e3e80cc5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_049160f9-0707-454b-b8df-79b195a52eae" xlink:href="lgnd-20230331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b72534d-65fb-4d36-9a32-be2e3e80cc5f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_049160f9-0707-454b-b8df-79b195a52eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd440e26-6037-4d32-b269-c457ab4d083b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_srt_RangeAxis_dd440e26-6037-4d32-b269-c457ab4d083b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd440e26-6037-4d32-b269-c457ab4d083b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd440e26-6037-4d32-b269-c457ab4d083b" xlink:to="loc_srt_RangeMember_dd440e26-6037-4d32-b269-c457ab4d083b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd440e26-6037-4d32-b269-c457ab4d083b" xlink:to="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_544afcb9-0e6b-42e1-a630-a01ceee22a09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:to="loc_srt_MinimumMember_544afcb9-0e6b-42e1-a630-a01ceee22a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a049c620-9787-4566-94ea-ac6b5ebe656d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:to="loc_srt_MaximumMember_a049c620-9787-4566-94ea-ac6b5ebe656d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6c7fbc62-f5ca-48a5-be98-d7dd8486c275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6c7fbc62-f5ca-48a5-be98-d7dd8486c275" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6c7fbc62-f5ca-48a5-be98-d7dd8486c275_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6c7fbc62-f5ca-48a5-be98-d7dd8486c275" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6c7fbc62-f5ca-48a5-be98-d7dd8486c275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6c7fbc62-f5ca-48a5-be98-d7dd8486c275" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_26e63832-ae25-4d7a-b96a-f1e54d01c031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_26e63832-ae25-4d7a-b96a-f1e54d01c031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9375b3a3-f3b2-49ce-9814-0179f2df1977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9375b3a3-f3b2-49ce-9814-0179f2df1977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_4c9ff54d-5737-4264-a5fe-8f874f0e6847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_4c9ff54d-5737-4264-a5fe-8f874f0e6847" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4c9ff54d-5737-4264-a5fe-8f874f0e6847_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_4c9ff54d-5737-4264-a5fe-8f874f0e6847" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4c9ff54d-5737-4264-a5fe-8f874f0e6847_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_27fd7558-343b-4859-a67e-1687ac6499bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_4c9ff54d-5737-4264-a5fe-8f874f0e6847" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_27fd7558-343b-4859-a67e-1687ac6499bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_df6adb95-f4d9-459d-bfc8-a0d1ef3acf23" xlink:href="lgnd-20230331.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_27fd7558-343b-4859-a67e-1687ac6499bb" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_df6adb95-f4d9-459d-bfc8-a0d1ef3acf23" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="i9e27bb9104e440c7b2a0f2160d9040e4_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d596e52c-8377-43ec-aff8-176b7b33e790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d596e52c-8377-43ec-aff8-176b7b33e790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_10decbea-844b-4156-aaee-5204a064379e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_10decbea-844b-4156-aaee-5204a064379e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_f21f45f4-23cd-4937-84ad-2b55958aa8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:to="loc_us-gaap_LongTermNotesPayable_f21f45f4-23cd-4937-84ad-2b55958aa8cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_2b9675d7-bf86-403a-84dd-85f1246692b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_2b9675d7-bf86-403a-84dd-85f1246692b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:to="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7826a314-2e6c-4c36-8535-474cdf5542a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7826a314-2e6c-4c36-8535-474cdf5542a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7826a314-2e6c-4c36-8535-474cdf5542a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7826a314-2e6c-4c36-8535-474cdf5542a5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7826a314-2e6c-4c36-8535-474cdf5542a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e919606f-9580-4e76-bed3-1e7aa343059d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7826a314-2e6c-4c36-8535-474cdf5542a5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e919606f-9580-4e76-bed3-1e7aa343059d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_f48eac4f-6347-4d27-99a1-1c8ca7be7afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e919606f-9580-4e76-bed3-1e7aa343059d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_f48eac4f-6347-4d27-99a1-1c8ca7be7afe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dca9335d-5ceb-4def-8593-925103c605b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:to="loc_us-gaap_DebtInstrumentAxis_dca9335d-5ceb-4def-8593-925103c605b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dca9335d-5ceb-4def-8593-925103c605b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dca9335d-5ceb-4def-8593-925103c605b3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dca9335d-5ceb-4def-8593-925103c605b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f00d1c9a-27f7-4e28-9bcf-ae59510d48af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dca9335d-5ceb-4def-8593-925103c605b3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f00d1c9a-27f7-4e28-9bcf-ae59510d48af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_9b675640-edb1-496a-9519-fce9a323ce1a" xlink:href="lgnd-20230331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f00d1c9a-27f7-4e28-9bcf-ae59510d48af" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_9b675640-edb1-496a-9519-fce9a323ce1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="i99d948ccc56d4904afa72d0cd247c308_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0a49da39-7fac-40e1-89d9-717bd6af571e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0a49da39-7fac-40e1-89d9-717bd6af571e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a15a8f35-d606-40dc-86b7-205ea6260711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a15a8f35-d606-40dc-86b7-205ea6260711" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fea54e12-7bb3-4fef-a9c9-cd487b701089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fea54e12-7bb3-4fef-a9c9-cd487b701089" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_df039cbd-99ea-4a36-aed9-7b8d2fbf48ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_df039cbd-99ea-4a36-aed9-7b8d2fbf48ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c6e5057f-734e-4a2d-9ddd-ca5d9e17fd38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a109fc07-8abf-4e0a-b7ac-5c937ff65487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a109fc07-8abf-4e0a-b7ac-5c937ff65487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d2049ed9-0fd4-48b5-bbd0-99d5d2c6e231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d2049ed9-0fd4-48b5-bbd0-99d5d2c6e231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_afc9d63e-3625-426b-bc54-a0968e8b5853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_afc9d63e-3625-426b-bc54-a0968e8b5853" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7edb819d-3e6b-49de-8ffa-5aaba8db2bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7edb819d-3e6b-49de-8ffa-5aaba8db2bdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6650e6b3-6a59-4663-8102-18730853a1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee05722f-2034-496c-96ce-308857c3d8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee05722f-2034-496c-96ce-308857c3d8e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34d3e541-a293-4e69-9450-a69b972bbf26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34d3e541-a293-4e69-9450-a69b972bbf26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_85a867e9-1390-4f05-ace2-6b95581391f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_85a867e9-1390-4f05-ace2-6b95581391f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2b1d1cb2-2546-45f0-bbd5-0eeb1e731ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2b1d1cb2-2546-45f0-bbd5-0eeb1e731ced" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d620e4a3-a3fa-4896-bd52-6adedef3520b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9aa181de-e4ff-4c6f-9362-a6f8a95b8b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9aa181de-e4ff-4c6f-9362-a6f8a95b8b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c86df621-c189-47d8-aec2-207abce07397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c86df621-c189-47d8-aec2-207abce07397" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8f7bb3b-7631-4176-af38-b6ed611c4a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8f7bb3b-7631-4176-af38-b6ed611c4a2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a5e260b9-632b-4a2d-b121-a9624d4d34ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a5e260b9-632b-4a2d-b121-a9624d4d34ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f74ef92f-311f-4093-bb65-805d01bf0027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d43e5fd7-ef94-4d89-a8e3-3266a14dc2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d43e5fd7-ef94-4d89-a8e3-3266a14dc2e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_870dda85-2a16-4bf6-bcc4-3bec270a4242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d43e5fd7-ef94-4d89-a8e3-3266a14dc2e8" xlink:to="loc_us-gaap_AwardTypeAxis_870dda85-2a16-4bf6-bcc4-3bec270a4242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_870dda85-2a16-4bf6-bcc4-3bec270a4242_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_870dda85-2a16-4bf6-bcc4-3bec270a4242" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_870dda85-2a16-4bf6-bcc4-3bec270a4242_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_870dda85-2a16-4bf6-bcc4-3bec270a4242" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_50ee7b2e-93c7-4029-8091-4fc2a829ccc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_50ee7b2e-93c7-4029-8091-4fc2a829ccc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6c0bf108-69f4-457c-aebf-e68cf381268f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:to="loc_us-gaap_RestrictedStockMember_6c0bf108-69f4-457c-aebf-e68cf381268f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i16682f05a4054674a2a32414bcafe8ab_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c8fd1c58-0683-4203-8fb2-38645a41a098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c8fd1c58-0683-4203-8fb2-38645a41a098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f936c8-7b7a-4527-9c52-779d588fd8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f936c8-7b7a-4527-9c52-779d588fd8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:href="lgnd-20230331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_11aee455-613e-456c-ae10-229f2c78cb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_11aee455-613e-456c-ae10-229f2c78cb3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_9e0829d2-2dc4-4f4a-beab-594a60e05e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_9e0829d2-2dc4-4f4a-beab-594a60e05e0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_55edea73-2401-4f99-a9ca-d56289d744dd" xlink:href="lgnd-20230331.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:to="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_55edea73-2401-4f99-a9ca-d56289d744dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_22d75d6e-1aef-436f-8b4b-2485f2aef1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:to="loc_us-gaap_PlanNameAxis_22d75d6e-1aef-436f-8b4b-2485f2aef1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_22d75d6e-1aef-436f-8b4b-2485f2aef1b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_22d75d6e-1aef-436f-8b4b-2485f2aef1b6" xlink:to="loc_us-gaap_PlanNameDomain_22d75d6e-1aef-436f-8b4b-2485f2aef1b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_88f87301-5e15-431e-98c7-c448c8d0a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_22d75d6e-1aef-436f-8b4b-2485f2aef1b6" xlink:to="loc_us-gaap_PlanNameDomain_88f87301-5e15-431e-98c7-c448c8d0a225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_a39e284a-411e-44b9-8a55-37f7325d6f3d" xlink:href="lgnd-20230331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_88f87301-5e15-431e-98c7-c448c8d0a225" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_a39e284a-411e-44b9-8a55-37f7325d6f3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_8770008e-1fd1-4ac7-89ae-7bd986aca230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_8770008e-1fd1-4ac7-89ae-7bd986aca230" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8770008e-1fd1-4ac7-89ae-7bd986aca230_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8770008e-1fd1-4ac7-89ae-7bd986aca230" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8770008e-1fd1-4ac7-89ae-7bd986aca230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6cecd8d-ddbb-48a9-8497-4156d29b61ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8770008e-1fd1-4ac7-89ae-7bd986aca230" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6cecd8d-ddbb-48a9-8497-4156d29b61ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember_635a10fa-97e3-4a72-bbdd-f14c4e87c3a2" xlink:href="lgnd-20230331.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6cecd8d-ddbb-48a9-8497-4156d29b61ad" xlink:to="loc_lgnd_AtTheMarketEquityOfferingMember_635a10fa-97e3-4a72-bbdd-f14c4e87c3a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended" id="i7ae72a65209641fc99f7ee7b1037c892_CommitmentandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_be417368-aa20-4286-8106-3b91261b6909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_be417368-aa20-4286-8106-3b91261b6909" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification_96513d12-edaf-47f9-bd05-3a94a7454bde" xlink:href="lgnd-20230331.xsd#lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:to="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification_96513d12-edaf-47f9-bd05-3a94a7454bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification_b5dd908b-f6c9-4521-846d-5ff653624a61" xlink:href="lgnd-20230331.xsd#lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:to="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification_b5dd908b-f6c9-4521-846d-5ff653624a61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_826f6810-8059-4bd6-89aa-181bf0b90133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:to="loc_us-gaap_LossContingenciesTable_826f6810-8059-4bd6-89aa-181bf0b90133" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_22ac1fc0-bf33-401a-ba0e-77ddd10a412f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_826f6810-8059-4bd6-89aa-181bf0b90133" xlink:to="loc_srt_LitigationCaseAxis_22ac1fc0-bf33-401a-ba0e-77ddd10a412f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_22ac1fc0-bf33-401a-ba0e-77ddd10a412f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_22ac1fc0-bf33-401a-ba0e-77ddd10a412f" xlink:to="loc_srt_LitigationCaseTypeDomain_22ac1fc0-bf33-401a-ba0e-77ddd10a412f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9a18a01e-302c-4086-9f7f-b64c148fbfc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_22ac1fc0-bf33-401a-ba0e-77ddd10a412f" xlink:to="loc_srt_LitigationCaseTypeDomain_9a18a01e-302c-4086-9f7f-b64c148fbfc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_1aed8cf6-f4c4-42ba-a73b-90b10ebbd3af" xlink:href="lgnd-20230331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9a18a01e-302c-4086-9f7f-b64c148fbfc9" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_1aed8cf6-f4c4-42ba-a73b-90b10ebbd3af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>lgnd-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9386ca9d-b089-4ae9-b9e9-dc30d8ee3e97,g:2f56508d-7938-4ed2-96f4-a768c1bc35f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_7623ea31-45d7-41f5-8eee-06e389b0d24b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_81f079e5-144f-48d4-a5b3-e16a150c8c44_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_cd1d66c9-1a19-46f6-8bc0-5cfee2847e00_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4d913907-65c0-4e22-a074-347b05a93681_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_0dd7a85a-a46f-44a1-9158-42f9abd64c38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_50ac9b65-bc6b-43e0-b55d-a23d4ada8a8e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_25256789-8548-4eba-a689-0e0da29af339_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_f5dd680f-d9de-4685-ae4c-2ba4e74dc9a8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_90a45c31-86d3-4416-b5d7-e34f7481b18e_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_99a92755-0be3-4482-baa9-b4259ed9cd43_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_9b107dd0-a755-44a2-86cb-0ada0793f804_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:to="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_ed062506-547c-4466-b386-9e1b0a943e53_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_5a8edc2c-618b-4555-8494-2e999e1a9341_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_e083aa9d-0ac6-45e8-a26a-f7b769cf4d4a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_daeb2b82-eb32-4f85-a850-0b14e9d63362_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0e0bdd4d-1bd1-48b5-a973-78e638757285_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_5fa7a976-bfd9-4eb6-adf7-0f710c9c8ad8_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_9e018d1a-da31-4a6c-a4d8-418ebc417f52_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_8b7a13e4-1a30-4835-9116-576c0e4b4f06_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0534025b-329a-4101-b56b-884a8e6077f0_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f053ae9d-170f-41a8-a906-b29619ad2260_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c4bf8698-61c8-4db0-aae8-317f17c6f904_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_cf8b9506-d75d-451b-b3ff-7ddbb3d967e2_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_ef1d5b5f-f863-4509-a1f1-6484bc240efc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c8a9d285-421f-4e7e-913b-e3774c6540f5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_fc7002d6-a185-4788-8a22-de9c76660a94_terseLabel_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AgencySecuritiesMember" xlink:to="lab_us-gaap_AgencySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_07c8ea1c-a44f-4b15-b399-3b5f1f165f6d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_1eaee177-c13d-465a-8eaa-0f26be3b9402_terseLabel_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease amortization expense</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_documentation_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:href="lgnd-20230331.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:to="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_60923f09-7b59-4651-863b-2327b9274499_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b9a07876-3920-4856-8324-0913f66007ad_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_7c32e3a3-9b08-4af5-97c7-2fbac8b060c8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_595d0235-f02f-4e21-9edc-ad0fe3cf5536_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_51f40e36-efc1-4690-af8b-2c5eb9ecf7e1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_58daf846-b4e1-433f-950c-69343d821cc8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_9f659f21-f628-4537-b844-9de78535f0ae_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b826e334-a230-474d-9d3f-f42ae46c0605_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_eb40d6b9-c091-4673-a2ab-706a6d4b3459_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_2e308c5d-c61b-483a-8dc7-39171cffe82a_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_14e356a6-8644-4756-be6d-f104c307d3a1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_0f3d05f2-97d3-445d-9558-f72b5651d72b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_54c86aae-4acd-44a2-af0c-b6abf542e300_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_12af8e0b-d56f-420a-a611-74345ac3720b_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_24cd15c6-c674-49eb-b605-11632cdd59b7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_db49579e-3070-4199-9ee1-72c6c613be79_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_e879bdde-854b-4819-bd59-084fe226c448_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_label_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_documentation_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:href="lgnd-20230331.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:to="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_0dac0179-2a41-4586-8526-ba9ba9bb1e0e_verboseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a8a04e0a-c016-422d-bcbd-3fdae22bf797_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6fcfecad-3838-482c-b1ce-1d1e6f63308e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) from continuing operations per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c4c007cb-d279-4fcb-9946-4614be89d083_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_242c8d6b-b99e-40d3-8856-ffa64be9ab31_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_95de344d-0347-4986-a4a8-acb4a9a62e43_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5af60f24-5400-4e8d-9981-66858d6e636f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_953843c6-2f80-4145-a2a9-c395a20f18e2_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_4ce15025-fc90-4d48-8ee9-3975f2018b1d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_ff17ee95-8aa8-497b-a245-9933c63bfe09_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_b145077d-ce86-46af-8877-0cbe50e81677_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0dc0d376-3ac6-4fae-8003-3c89cbd44a5a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4b713b20-dd54-4941-bbac-f71f255fb0de_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_fae530e9-9f10-4700-af5c-9c6e2f3c57d0_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20230331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_cf33c2a8-d7e1-40b9-8e61-fe02643d45c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_83bebfe1-09bd-498d-805d-59f18d4a69d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_6aa47d23-a198-443e-8835-3e18e6eed299_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20230331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_9eec803d-28d5-46c2-a2bc-0bb45c7d35b3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ef8c3490-371e-4ef3-a336-bbe1c48c9e96_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification_4f25e689-6f2f-4425-aac8-a5b01ce97660_terseLabel_en-US" xlink:label="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in operating lease assets</link:label>
    <link:label id="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification_label_en-US" xlink:label="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Increase (Decrease) In Operating Lease Assets Due To Modification</link:label>
    <link:label id="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification_documentation_en-US" xlink:label="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Increase (Decrease) In Operating Lease Assets Due To Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" xlink:href="lgnd-20230331.xsd#lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" xlink:to="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_df5a7816-3ffd-48c7-b196-69718648db33_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_90d36d57-2a89-4d79-bd11-9affb2db06d4_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, regulatory, &amp; commercial milestones and tiered royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20230331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_841b5043-ff25-472d-9750-2dd62cdfa546_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_372e9398-4e56-4067-aff8-3ea8a8fd343d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6476e127-8755-4942-85ae-e5106de89077_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9708dea8-c4dc-4a2b-9c78-48e5d8f23e31_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_92a67537-ea4f-4f78-b7b1-1e35ae932351_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_31efeef4-8b8f-4d04-a813-969c1fbcee7e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_2ae4adde-176b-49c7-814b-fbfbd9eaab12_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20230331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_36894669-bc73-4418-820a-d11517972a04_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3444190c-02c5-4f67-ab1b-0a481c0b3b87_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5f61f46e-1444-4cbb-8eff-bb3f38dbcb2d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_75779350-5232-4e78-9477-512e32efe2c7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c42c757-0075-4fd6-9bc6-80da62aa5f7d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eb6b65d7-add7-4e80-9e58-033678d83f08_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7933c547-2829-4671-864c-d5be662a4027_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_aea2069c-fcc2-41a5-9e82-968785813d41_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_4a6602c2-f299-4c87-8b3c-6a981ed0843b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_76aba564-270a-43a6-9195-bbd5798f8ff9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_eb37d4a8-4e71-4080-9e1c-344fbcb8faa3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_fa57eece-17a5-4e3a-b614-c60cd57357f7_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_33840014-3ab9-445e-9af2-1a8e897e2be3_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_525383d6-d3e3-4733-8a9a-761092bd9d6c_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 clinical trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20230331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e0c2ba3f-2499-45ac-a785-584def9c0c5d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_0f2cef9f-4df3-436b-8e73-d5d408e768b9_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Research and Development</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_5713d4b2-214d-4411-be85-42bae4bc9089_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_12770f7f-c2f0-4ddf-bdfd-91ddf0587081_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9a4a90be-dc77-442c-9254-a1c94c600c60_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_9bc35e00-8e29-47dc-913c-cd1476bf1b78_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_8095fbc6-6d50-412c-958e-4a1ee7c66e7d_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a9f80055-a36b-4119-a2c7-cd9893cdca5a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_b2095c93-a2a0-4cb6-ab65-d5303dd5f767_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_a0b896db-d7b2-4bae-b802-250cdb4c3a72_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_84ed73af-c834-4ec5-898d-60f8acabf681_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_0f15fd35-9991-44ce-8d57-b322f62c4bdc_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_94616448-793e-4583-aebf-7c13189a95e9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a3a669c1-4811-4605-bd2d-dd16863f7898_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_b3e3fd39-29e3-46c7-9d97-b68ec32b6bb7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_369df01b-d400-446d-a440-a33c9d0a9fba_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b08d5438-693e-4755-a781-840c693d2b63_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_eef89723-7a22-4395-b336-ca2629d12ac3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_cde1e5d8-acc2-4bfb-8065-260d68a87a65_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fbfe9d62-6372-46c8-bd86-b4c495afda42_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_dca14367-9b06-45d4-b034-9d12179375c6_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal bonds</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_30ce32e6-53d9-435e-bc4f-3a4ab8fe9860_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, excluding Viking</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba50c415-ad18-4231-ad4a-59caee33c8ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_db2f808e-c7fb-401e-ae04-ae8674535d5c_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_75693faa-2b14-4f6c-a011-a47bda3ddf92_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e7c973ff-7208-4cf5-b39c-b434684a1b87_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c044eb1d-b4d8-479a-aa19-c1df3c59f829_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_b4a54e07-0e79-4779-b811-0a12ef82077f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_61a2dad9-455b-4f9c-909a-b4d6ddd13047_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20230331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_67904801-cb9e-43a9-b093-ab4c0b3b0a43_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20230331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_d31f41cd-16fd-41fa-8aaa-da3cef3ecd55_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6bb78d08-662b-4bd5-ab47-5b8a0901dbe8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_09b8d86b-c677-490f-a3af-7a644c8486af_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net loss from discontinued operations per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0c6b6774-c707-4322-a209-febccff2011f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_d92b7d9b-3c7c-4b81-ab67-7de09d6128c2_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1d7e2ec8-d14c-4aa4-b450-eef92b5373aa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_84ee72b2-d6c4-430a-ba1b-aaa7fd4e3c26_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_fae7e396-35f7-443b-868d-e250c034b252_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_dd8d75ec-ad93-4d0a-8ab8-e1d6c783dcd5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_76ed1371-6f02-473c-94cc-7caad0fdeff6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3f283946-de0a-47ef-ba59-8fa04ac2ef0b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_b12a3ff3-5eb0-4925-82ec-76397dfcf920_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_d0407bda-7fcc-4c50-ae19-17c56aa7f51c_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3a488f5b-7c17-4f63-afc5-1d131b1c30fc_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_a8c5cf57-b7b4-4b12-be3b-8a64735a010a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_77566748-9ff0-4900-b383-87d733efb01c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_81f656f8-f354-41c8-b267-3783882ad42a_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CyDexMember_367954f3-5edb-4178-9847-650b55c2f264_terseLabel_en-US" xlink:label="lab_lgnd_CyDexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CyDex</link:label>
    <link:label id="lab_lgnd_CyDexMember_label_en-US" xlink:label="lab_lgnd_CyDexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CyDex [Member]</link:label>
    <link:label id="lab_lgnd_CyDexMember_documentation_en-US" xlink:label="lab_lgnd_CyDexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CyDex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CyDexMember" xlink:href="lgnd-20230331.xsd#lgnd_CyDexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CyDexMember" xlink:to="lab_lgnd_CyDexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_552f7149-3ecf-4240-a702-05533c90366d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d9dccb27-8993-48b9-8e95-c016afef3728_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_05230b5d-3c5e-44a2-b2fd-ebbffd7a358e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_c6430292-8ae5-4701-a401-df86a430bb6f_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20230331.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification_f102d475-ad22-4ce5-b8dc-443fa18e9781_terseLabel_en-US" xlink:label="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in operating lease liabilities</link:label>
    <link:label id="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification_label_en-US" xlink:label="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Increase (Decrease) In Operating Lease Liabilities Due To Modification</link:label>
    <link:label id="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification_documentation_en-US" xlink:label="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Increase (Decrease) In Operating Lease Liabilities Due To Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" xlink:href="lgnd-20230331.xsd#lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" xlink:to="lab_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_60555a77-4b96-4920-8ed6-56633d8d6cff_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_cb8fef9d-07af-47b5-8ae0-a08ff70f38a8_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_61e37ad0-cde4-493d-a17e-2079e9906862_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_bc3bfc30-45a0-485f-9ab9-00f53555c11e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8fd9955c-9e73-45d6-9933-89fe5a7660ae_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50df9fdb-e617-4d4b-8d51-28b8b6b7c7b0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_af410556-0755-435e-9613-608bf7b56735_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_28723307-f498-4afe-91b3-faf5ead5504e_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7f9c2cb8-b2ff-4a29-b0c8-8d52c419cb5f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7dddb20f-5c2f-426a-8b9f-a65571fb778a_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebc6c604-aeb3-4a0e-b7f1-8ac27fa4fb09_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of March&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_37db0a39-df2b-4937-a017-4b9269cce819_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_35c440b3-cda5-43f1-8e58-c4b86ef91df8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_efa59682-8473-40d8-805d-bcb2f82aae30_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_58e0c6e7-029a-4265-a39b-8fef223e61ad_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_29f77ba7-1f52-4a8c-b973-1bcd93b3b1ae_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_0e1d5b9d-3502-4ef7-b4b0-a249f69b9434_terseLabel_en-US" xlink:label="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_label_en-US" xlink:label="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense) [Abstract]</link:label>
    <link:label id="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_documentation_en-US" xlink:label="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:href="lgnd-20230331.xsd#lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_1cc0553f-1c2b-4319-962f-24d21a646b43_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_a4e17eeb-07f6-4ba1-bb5b-8c119d1e8972_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_d134a633-b234-46f5-84a8-466c00b76ea6_terseLabel_en-US" xlink:label="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensor</link:label>
    <link:label id="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Owed To Former Licensor, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Owed To Former Licensor, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:href="lgnd-20230331.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:to="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7dd84b7d-68be-4cbb-a559-0ebdb3302630_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_d663770c-970e-4e4e-a49a-008b695d498d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_10cce4c1-84a7-4367-b80d-23b8f85e6c86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period for awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_43969b2c-c3a2-4115-83ae-715e37914fd8_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_2bca3b31-ad9f-4f40-8e7f-a68b0aa9cfab_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_126c91c6-2fe1-47a3-94e9-7470e5ca096f_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_678b537b-bc6d-4200-a50a-2332f5593c4b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b4a41edf-634f-4704-879f-259f5a3a9924_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1a69636c-3c67-419d-9c73-cb43060a1f23_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e7dee7b2-ffcb-4509-8f80-720fdc0b9a70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_6aa96312-bd51-4cbb-89fe-89a24a0cf82a_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20230331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_469d201d-64e1-40bf-a696-7d9f40514234_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_bda94508-5b6a-4127-a1f4-f8a61840ee8e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5dab94d8-2957-4855-9930-296c43c3acd1_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6965c3a7-6467-4d8a-a4af-8d2f9c160dc1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_aa72893c-5cb3-4f28-bb68-ce55c525e64d_terseLabel_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide injection</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_label_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection [Member]</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_documentation_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember" xlink:href="lgnd-20230331.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TeriparatideInjectionMember" xlink:to="lab_lgnd_TeriparatideInjectionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_b0c089df-291e-4218-b8fa-27375e78e611_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20230331.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_51a0908f-fac9-445c-a6fc-01c91ba28622_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_59d79e3c-6174-4e11-b18f-a1879f022c62_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_a41bb0bb-b74c-4685-947e-1e727030825a_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20230331.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0a9e73b7-3283-4287-8a09-699e097b9378_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_1b75fbe0-256c-4464-ba23-2037414f8fc2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_2ccf5152-0ad0-46ab-a147-2fc9baa9957f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_847eedef-7fa9-47c7-aa45-9577edbc9481_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_faf30e49-559e-4d87-8125-b8be65dfb75d_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_5b38bac2-f474-49bb-b663-1be06ee237e2_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_37e6f3d8-b1ae-4b28-8889-54e77b0e0b63_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_65a95992-efe1-4555-a78b-2750435f905d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_69fa6865-ccb1-48c3-80d8-d688a7cc0bba_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20230331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_3ee5de23-f2c2-4b5e-9c42-0a04200c346d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_14011388-157e-48fa-8570-8808c3097bd1_terseLabel_en-US" xlink:label="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business</link:label>
    <link:label id="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Spin-Off And Migration [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Spin-Off And Migration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:href="lgnd-20230331.xsd#lgnd_BusinessSpinOffAndMigrationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:to="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_cfaf55fd-5a55-449c-bfae-b8784654433a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b7d5aa6a-df63-43b7-8621-bccaeb46d3d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts of Major Classes of Assets and Liabilities Related to Assets Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a6fce5c7-b4ff-4e95-84c2-490886b756b4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_26b738a5-c6b9-4a2c-9159-169c71d2582d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b149c7e3-ecb2-4b58-a26a-14e3b925f9cb_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_02962d74-95e2-4fe1-86cf-0adc11ce4749_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_79d8986d-0479-4449-83f0-40e7df9243e2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_984b70f4-6eb7-4962-b3d2-92985158ad36_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_61561fa3-e35b-4104-9a34-b2510ef70562_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_bc1d3b55-29eb-4163-96d7-1612bd7325c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_c89d125e-932a-4dac-b181-d31d91168f7e_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20230331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_179e754e-b1d9-4d02-8d8d-8996b38ac232_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_cc9d5561-af22-4569-9ea6-f72d596169b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e46a76bb-8765-4198-b406-7c431c213e95_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e94785bd-67b3-4e27-ba16-ac4979d974ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_9af287af-55e5-4f51-9679-1e6988b20aaf_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5e7ef368-7379-4efb-821e-c3a65ac79684_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_1930ef8c-14b5-4917-97da-d15c790890e2_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_57afd248-abc0-4b02-95ed-49978938f569_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1f4957cd-9513-47a9-882a-903e100f214b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_d141bbf6-b333-4ee8-b367-940ab009a9e2_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e655b63a-14d9-45f3-8f64-27bbfb489e6f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_43ef84ae-df21-40b6-9ad5-abef3c034dec_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b6dfb4ab-90dd-49c1-84f2-30b2ae0653fc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_cf8daa57-26fa-4f97-9943-b94c1cd1ef9b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6dcc441b-a0e7-415d-92bf-0470283b2a9b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_98e062d3-4d5b-4267-9fd0-3c2eed14f851_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_8aad4768-2efa-4493-85f9-07640b770bc1_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_c3d81ec8-5867-400b-8ac9-365f41bc44e0_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20230331.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a923535-ef88-470d-99c5-1a4b95b81eda_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3902cbfa-ab00-448f-9cd3-ddf0e49d6cd4_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_31b0490b-6a99-4b07-a29a-027e02d2c7bd_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_2801d587-cf5f-4268-83a6-128d12429f6f_terseLabel_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes repurchased in August 2022</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_label_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, Two [Member]</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_documentation_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:href="lgnd-20230331.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:to="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_f1e7e0fc-e43f-46ad-a9f3-9182dbe73e9c_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Financing Activities [Abstract]</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_20765c67-06b9-4801-a442-d3df0f668e6d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3895cf3f-a399-40ba-b54a-80088be60470_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ff9f14a4-896c-4249-8274-17ebcff5e3f1_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_759fef45-6c82-4024-81a3-bc595ab2a6cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_ef08e0d8-873d-423d-bdab-588ba5a83fb1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_99041942-b0b0-4922-a91c-f5eb7328c051_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cfcecf51-26e8-471b-9d83-e8a1b35f5c37_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_47226002-8251-4def-b48b-cd99afc97ce9_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f89bd193-dccf-4e0c-b56e-d318c2672886_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_87c39eed-599e-4b80-b929-83d546f5f3dc_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income from continuing operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2bb91d6c-074f-41df-9525-86fb48116a38_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_a313c540-c187-490e-a8a9-8450d06452a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_bf6a688a-15a1-4683-8abb-8cacb807fcce_terseLabel_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payout range (as a percent)</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_label_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_documentation_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:href="lgnd-20230331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:to="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_abf8770f-a0ae-42ce-898e-e8f5922da2d5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6b2db177-186a-4ea7-9cfa-862ffce01c5f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_81af8b41-a2a6-41db-a38a-af23f242e1c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_525036ac-1dd8-41b8-a724-05579eb8fbd0_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2482a9f0-82a1-4329-8daf-4acf590a92c4_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_cec1382b-2503-49b3-9810-e49822c3a922_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_8498bcd6-210e-4e33-9659-5f7ceff7e25a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_3962143d-f915-472e-b51e-8257eded145a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4c5337a4-72c6-4c09-8fc2-2070355abef9_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e5a91bfb-1326-4344-9a00-6e34c8a31aef_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_a30d300d-c2a3-4d32-80a4-0896618cbc74_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_6531bba3-7e9a-4c5e-a9df-d8e714c0c3cc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_01c35244-0d17-4c48-8f98-1968ee6a719c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_82d1b84d-b8f9-4d63-a2e2-e0ec8c5db0ce_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_24b937e2-e033-425f-bcaf-061381604c7b_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_a611afc6-2941-4975-bf44-29fcc8d5b5ca_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_bf6a5c07-2fa5-4e13-a139-1d37c8beef1d_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (in shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_17dbc3db-5e68-4266-88bb-73a632ff847b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3dbe826-3c9a-4191-9858-1c829353caf7_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6c3702ab-8ac6-4796-a4e9-46fcfa55f312_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_627dd134-6be5-4cda-94fc-ae3cfcab4535_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20230331.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_6fd0eb4e-cff6-43f7-aa5c-dbeacaff68d8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_b9c1eda8-0f0f-4dc3-b5e3-93225836d4aa_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_57a8a1f5-02ea-43be-bebd-5743ed5f841a_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20230331.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_a2e51c89-75ac-46b0-86bf-15af1214d4ac_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d68ecc4a-4aaa-4269-bb50-1931a909d0ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_fd442b67-1e54-4d8f-835f-d56f6ef705b1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_fe69fe69-e019-4624-856e-f90ed3d31d60_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_6e86a417-cec0-4a19-83d1-5176a6f1e355_terseLabel_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_label_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Operating Activities [Abstract]</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_documentation_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:href="lgnd-20230331.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:to="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f3db9117-6781-4119-8735-cfb281c06281_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 17,134 and 16,951 shares issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_242fd3ce-8e09-4c7c-b56e-ae5452708bf7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net loss from discontinued operations per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ed77e7f6-5ef8-42f2-92a0-853cf0863777_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_810e6a42-e7ed-459e-b04e-870e6c5da5c3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3ec10d44-f086-4bd7-a9bb-8bad14bf02ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_2c2f89f0-824c-4542-b569-60e4765fb892_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_8a57fc88-f914-4e41-bb77-60f43600804c_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20230331.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_2c9eb627-de82-49ae-94cc-119689fc3492_totalLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_eedc8b28-fdb6-4888-8caf-d312d497567a_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ce78f605-16ff-4f27-908b-ebd05c5b082e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f2fa778-3985-4b84-b405-a18302992ab0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ad47be1-d5de-4dd9-b876-65650237d4f3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_5b813475-7963-4f8a-a104-1f5b465c3e81_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid-in-capital from warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d7d5d23b-0bc9-4804-b380-4df19160d7af_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_e16023ff-9f5e-466a-8cf9-7da61cbffc69_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_4db57536-b7f7-4981-9197-375a039093ca_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - Core</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_5a3dc923-8bde-4a30-881e-17e6097bf1c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_21b78961-68cd-4be5-9f9e-6786fe6aeded_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_11ed672e-b762-486e-ab6b-42b45756931d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b082d111-c843-403a-8473-61ac5ba861ce_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_4f8851a9-81e7-441b-98cd-67d97edf6dd1_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_e17dd2eb-d6dc-4410-b5d5-117fc5571df4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_17b9766e-808b-4f09-aee0-7283ce197b11_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_89a27afb-f323-4fc6-a4e1-0981acad196a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_42e82a0d-6ad2-4e65-ae92-64f14d200ebb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0b2c40b9-fc3c-4b21-80a3-f03023c739df_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8fa33ec-8f6f-4e7e-b54b-dfef254266ee_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpenditureDiscontinuedOperations_019d0af8-7bb1-45b7-844b-4d87a068b50a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpenditureDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:to="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_f909f08d-9810-44a2-9aa7-c4da31cc36e8_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_3c4bde5a-adaf-4bef-a05d-6ffedf1e2376_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_f0bbc86e-8929-464b-a511-04f688570ae9_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_e156906d-7256-4648-a3fe-ec97c21d3c66_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_98e4480d-6025-4c6b-9948-2997410c258e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_761a6e67-1442-4aa9-8007-00b43d329ab1_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_e6e8f9d4-9265-4984-8af3-e61ad0bd40c8_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20230331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3b997630-6a1f-4edf-b120-09da46a1526c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6b038567-4bac-4ebc-8cf4-464a17d1cf3e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_cfe1db9d-63e6-4e09-abc0-c3073cd6064b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_62a60edb-b98d-4b37-b3d2-f0cc0eb53962_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses adjustment related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20230331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_3146b424-df5c-4df0-a1df-d2df343a949c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8a373b15-6e54-4c4f-a06d-5e5b7d19d1c5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1383a749-40a3-4148-a1d3-6171b0349525_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_cfa63a34-53c4-457f-aa99-4fb107d87c7d_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_b36e32fb-a088-4f98-907d-398b1080e811_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_bc2f4751-e819-492b-8554-353685751753_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_872561c7-7c02-4c6f-a8aa-9cf85495975c_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_0fef2e51-9d43-4d8d-9a44-aa1c071efb17_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mark-to-market adjustment of CVR liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_30fe2883-6c5e-40e1-9e17-b3d7cde9087e_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20230331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_deaaa1f1-9297-4f02-bbb1-cae860f184e4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_629d4d9a-6b66-4219-b596-9c3e7eecb60d_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b02a3ad7-59c7-4853-8fb9-f6aeb0818c8e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0759a9a2-1d3b-40e0-b0bd-a7052263329d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_050c7f9b-9297-4a23-8664-42e2c4e7b270_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20230331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_6c44aa25-d5aa-460c-a028-3d2e25996e0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_d42fb8fb-05ec-4a5d-898e-b08dfbb30c46_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b7a16a96-d17f-43b3-8f0a-ffe81745ef61_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bb8b2a2b-71d7-47e7-9882-c48551469592_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3fb63a11-1d1c-4fb5-a31a-5d419c7712ab_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_364ce399-3497-4598-b1ed-4448e9dfcea8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_583ae212-ad06-4702-a2a3-65afa4bc30c0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_e8355205-4303-4509-a2c2-e1a3e5bfbb99_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Costs and Expenses [Abstract]</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_48af2fac-e658-4b08-9046-6c714f735432_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_be9f3f3e-2f43-4cc9-9b0f-fc7351915a1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_f251bc07-d3f2-4b12-85a7-6b9f223aea30_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_55f04371-73d9-4097-ab73-4db9b0ba93f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ce35671e-87cd-4e68-97e9-5552dc35b601_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_00f7333a-7055-413c-9986-bc4411bddbad_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_35a5ad3b-6f19-43c8-9c4c-e21678731426_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e074c1bc-fabb-4b25-bc14-c77c921905ea_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_a89a46cd-ae84-4c74-abdd-a42054605730_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:href="lgnd-20230331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:to="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_dc9d64bb-53cf-41b0-9e2d-8ccea0b4e86c_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0f3862e9-d3e2-4b1c-b2a0-8b2d35d8067b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fcf03a6c-d15b-4cf4-8149-a97e7cd4e82a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_afcce6da-c521-489b-b268-8270f97a9484_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3c785725-3b8c-412d-99fd-696c059608d3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was previously deferred</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_4a1fe469-8c80-4c21-9e2b-296c4a172ff7_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_a778a200-7e9c-44b7-812e-3d822ddc9a88_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20230331.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_2de5172d-cf85-43c8-949f-3d8aae42a864_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_740f4ce8-c9fe-40eb-b334-6468c58c1058_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_8a052183-9897-4b66-8cca-dfda7c9e9e11_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1072ea06-dae2-451e-bb74-130944df49f2_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_e4de2805-f7d0-4bfd-ae48-35fdbe747369_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:href="lgnd-20230331.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3cab94fe-5705-48c6-9c0d-52795180126e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_14b3e596-09c3-4a8b-8aec-66de39641dad_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_26f1585a-3d02-4af8-8e37-ede93d592b60_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3ceb1fe2-a45a-4061-a88e-05733de19186_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7b9f9ca8-5db8-4d5e-affc-628ab3d8ccb3_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_4beb76f8-8bf7-498d-b458-b32a7cbd933d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromCommercialLicenseRights_0576c9aa-477d-485f-91c1-0cd44a19d5aa_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from commercial license rights</link:label>
    <link:label id="lab_lgnd_ProceedsFromCommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ProceedsFromCommercialLicenseRights_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromCommercialLicenseRights" xlink:href="lgnd-20230331.xsd#lgnd_ProceedsFromCommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromCommercialLicenseRights" xlink:to="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_a97731ca-2f05-499e-8742-82e5fc778021_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_b6c88833-ffa4-4af1-8319-0d84004376a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0d49aa63-2ecb-4fd3-8bb2-c30a76a2b752_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_d3ce6e4e-781c-49f4-b0b5-7b3a7d0d1ec5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7a06ad9f-767f-4a4c-a2a8-acf0281793cf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f57c69ec-99fb-4c79-9f7a-d1957cc0d0c2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5924da0f-b4f6-47d5-9c38-f80ff7bacb5d_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_3545700b-d985-4e24-ad69-a23748b32be9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_890df245-e688-433d-92a1-f80329c8ffec_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_e68dcfcc-30ae-46cc-9d01-190f0049b607_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US government securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_45653309-69a4-4a40-9d4f-eb562ae8900e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc8f0ee9-484d-4115-a030-1fae5602d7d0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_41867132-7fa5-445a-b47d-6862b2aa3892_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_041c7fd0-5f8b-4c11-a44d-9d36da5c418d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_cbab4dfe-f1b2-452a-a5a9-c3e07ee5767b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_3dae9ca2-4f81-4077-b57d-bf8841c9ecf0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_90f9933d-4fb5-47ef-ac2a-2d757c15ae24_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_6dcfa1b8-fa35-4326-91d0-68e72795159c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0b5f8224-3849-4ec2-b7a3-64a415f0b854_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dd201980-4862-4924-90e7-2963060fb26c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_e624569e-55dc-431f-8d1a-5c64ea888e6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) from continuing operations per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_ac2e80f7-dfb2-4301-aaa3-8e3eb7297491_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment included in accounts payable and accrued expenses</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_6d30ab61-84de-444a-b11f-5b8c7f1e1f03_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_13ad1c97-aa44-4faf-8e08-1e29923ae96b_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7a9c595a-a127-463d-b043-ae0ff24fe309_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6941cc25-bddc-4beb-95b3-fe7c4d3ba25b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7b864dd1-ae50-4145-8352-291d4db2c34d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RylazeMember_048aecb5-453c-45c7-a449-2fbbee9bf8e2_terseLabel_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:label id="lab_lgnd_RylazeMember_label_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze [Member]</link:label>
    <link:label id="lab_lgnd_RylazeMember_documentation_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember" xlink:href="lgnd-20230331.xsd#lgnd_RylazeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RylazeMember" xlink:to="lab_lgnd_RylazeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_060cbb0a-d1b3-411d-a79d-16b5dcdb729b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_3bcdb9a3-1cd7-4425-8bdc-18d294428357_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_dd0b320c-0f7a-4a57-996a-bc72ec4d2ed9_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20230331.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0d6c83ce-880c-45af-83fa-4d0337ab48b0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c84e0b2d-7682-4bac-9170-2155ba185d49_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7dd5396c-ad16-41a8-8a66-f096f3dfa673_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_37cedd4c-419c-4d25-8b5e-c730cfa979da_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8618fb99-a9eb-42ef-84aa-fb2907b812e8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_eec7a575-8ba6-4fb9-9209-eea1adef8a68_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_0ebb2bcb-868b-4e31-8431-b2bb9b8776a8_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operation, percentage of voting interests disposed</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c40e8f23-a6df-4596-b117-d7901eddfbd4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_5a1df8eb-3a98-4858-9d46-f3d985c26c2b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_d0fcda63-0885-4c47-aff9-550e07ff8acb_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_80ab7596-2056-4548-9c8d-2e7b11db72aa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_56d03a8a-67cc-4b98-a69b-a9aa9d30802f_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_883466b1-e819-43aa-a070-8cee074f797c_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7cd0adc-7077-4ee0-95dd-107d4a9a0ccc_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba3ad6f0-5a2c-4313-9fd8-62a318b47682_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_854c8f99-d0a3-4864-961d-5a97bb805e8e_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c882f141-0d2b-4c66-a04e-46156009213b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_041a543e-ba2d-450f-a855-2f3836947298_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_35be6797-1e00-49bf-bb63-4424df1c1325_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_89dd1fd9-0eb4-4063-9ebe-b33576f84802_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_42058f20-21f0-4953-9cf1-1b28213d93f2_terseLabel_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the Market Equity Offering</link:label>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_label_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Equity Offering [Member]</link:label>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_documentation_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Equity Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember" xlink:href="lgnd-20230331.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AtTheMarketEquityOfferingMember" xlink:to="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ef6e55da-6733-44d5-89c4-cad6cc35e847_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_af7446c2-3354-4ea8-bb73-59c354cbd6c3_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20230331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_bdfcf991-d96b-4b71-862d-cfcf725033a9_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20230331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d70dbc32-60bb-40a0-8d87-7c2a744b3ec2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_c7ee5060-59d5-43fa-bcf1-f034e92181c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_73864463-d69e-4092-bbf2-421ae8a21e6e_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:to="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ec4c7b5d-4804-4662-b231-4b60a06287f7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_829a5baf-6793-41d0-8916-bab938f00460_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_9c7818b7-8e3e-4c07-83b9-aa03eeb04829_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1800a72b-d80f-4f1d-8e5c-0bda4ae6724e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_fa90199f-fccb-4e70-9efb-8b8b84cc3c92_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_0ba1a455-1a81-4336-b0bc-ffe2aa1ae904_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d9a676b6-ff91-4163-9be2-91090a549b40_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_b1b5a51a-374d-4867-a6ec-a510036546fc_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b649d80c-c4a2-47e7-a509-fdc06f6cfd3e_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f2dbf429-a93f-4dce-a699-14a6aa58b9fb_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_e54bd1c2-4e32-4331-80f2-3f1d9d9b6da9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_5da947ae-0ccf-4d7e-8f6b-9efad167eec5_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4a28115e-504b-4ec7-b218-3ff90b38f128_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_15741922-ee9a-486d-8e98-a74fe0146adf_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20230331.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8eae2105-5426-4406-906d-a4660f9e6cbe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7ec1c3b8-0d49-4b6c-9efa-644c07e65b4d_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5036d99c-c6d4-4bbf-8796-3c73bca00bd9_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_4ce5560e-2d1f-44ac-9998-20976790f93f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_7f56b718-eb1f-4093-8ad5-bbcfe8214b7b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_84b6ae45-a8a0-41cf-857f-5514d7c2571a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_2aef6cdd-d100-4afb-b441-d21494363d25_terseLabel_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, authorized offering amount</link:label>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_label_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Authorized Offering Amount</link:label>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_documentation_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Authorized Offering Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:href="lgnd-20230331.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:to="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_6521f9d2-bf7e-41f9-b645-0bf80afe67b3_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20230331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_55a8d0c3-a26f-46dc-bb48-217356325c23_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_ab1f4b52-ba7a-455a-ba96-428057336cb5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_c0ae6590-abcd-42c6-bda8-54d60539b355_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_cb72a14e-03a2-48a6-a2fd-46690a1ea021_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_0643c98c-2884-499e-b788-873d8efca571_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_52fcb6a7-89f0-485f-888e-9c909e01a766_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-off of OmniAb</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_8ba4c731-1899-4666-9fe2-3f5df149f80c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6f01b3b9-5933-44e4-8f5a-6fa175180a85_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2e2ef84b-6987-48e0-9ccf-ec85540fdb6d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e9d6a687-f201-4617-9f8e-46565775d68b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_ddf6ad52-2c1f-4a53-96f3-e9fb8a1ec516_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_b5cfa278-3fc7-4b1b-8385-3ef7e3c3aa69_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20230331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d5585993-85e2-4d2c-86f9-da15347284c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_7bf54ee9-e4a9-4fc6-9bb6-6a6a42d7668f_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20230331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_10f6df9b-1d54-474d-8717-80beec1190ee_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on AFS investments, net of tax</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_3213aa17-cf5f-4e32-a6ab-132e7c01bd9c_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_73562431-5f7a-4e4e-b7df-1831e71c16d3_terseLabel_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_label_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Investing Activities [Abstract]</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_documentation_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" xlink:href="lgnd-20230331.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" xlink:to="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_35148cc3-e8f3-4e4a-9da7-948501ec6e9c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_674464dd-6bb6-434b-8082-fbcbf320e28f_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ebdc01db-49e5-436e-a648-7f562c95bcba_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_af7d126a-c083-4833-af26-9b35ac84c230_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_915a09f0-f409-496e-87e7-33022bae1e44_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cfa7dccc-8bec-4040-9380-d03bffd5f908_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_b9f53b50-b10a-4aae-abb3-7f5a97ede43f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_72d814ab-db66-40c1-9bea-55a88fbaf1dc_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20230331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_f84c52fa-b1fb-4e0e-8234-d21b91533f2f_terseLabel_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember" xlink:href="lgnd-20230331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoAndCorMatrixMember" xlink:to="lab_lgnd_AziyoAndCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentLiabilitiesMember_450f9e64-f576-43f2-bbf6-bd0fe47c1c4e_terseLabel_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities</link:label>
    <link:label id="lab_lgnd_ContingentLiabilitiesMember_label_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities [Member]</link:label>
    <link:label id="lab_lgnd_ContingentLiabilitiesMember_documentation_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesMember" xlink:href="lgnd-20230331.xsd#lgnd_ContingentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentLiabilitiesMember" xlink:to="lab_lgnd_ContingentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9f97d5b6-3d91-4433-919d-2724860ded6e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIShareSoldInPeriod_2c8cd3fa-6dae-4dca-b2cc-cc85fbd0b181_terseLabel_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIShareSoldInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Viking common stock (in shares)</link:label>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIShareSoldInPeriod_label_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIShareSoldInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV NI, Share Sold In Period</link:label>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIShareSoldInPeriod_documentation_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIShareSoldInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV NI, Share Sold In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIShareSoldInPeriod" xlink:href="lgnd-20230331.xsd#lgnd_EquitySecuritiesFVNIShareSoldInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EquitySecuritiesFVNIShareSoldInPeriod" xlink:to="lab_lgnd_EquitySecuritiesFVNIShareSoldInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e7222531-85a4-4c92-a9af-e44570573654_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b2ffef78-4cd5-4a58-aec4-865ff30b0b5e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3490fc02-311f-4aa6-8b35-85115a439be6_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7c80f34c-cb12-4c61-a0e7-572bc20d139b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_0c381819-b535-4721-92d4-27e20d8d65c9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_1e85f643-4ba0-4852-a805-b5ebf48a5f11_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_af336ea7-3397-4a69-894a-f82a1ddf282a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f134e498-8552-41a9-b9b3-72e8d7866c90_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd977a00-3e3d-4817-8fcd-aec1fed96ded_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06a54601-ff44-4067-8ecb-980f4b56f812_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_ed029209-1441-4966-b87d-f77671efe470_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8658c418-0961-43e3-a66b-34662202d8be_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_484c06c3-bd11-4e5f-8c83-74853e418d6f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_65e949ab-43e9-4514-9a71-3e5bce482bbc_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_66611e78-174f-4c72-aa0e-66c523b776f2_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_99612127-8a88-4bf6-b5ca-25e025b5473f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_36a79541-8454-40fe-b208-fd906ed5084f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_eed221e5-38ba-4cde-9b2b-8641f6a4368a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_e91e02ec-1963-4a6e-98be-f5c98761559e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e3412afa-2805-45d0-a6b3-2374053c14f8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_89c287a5-7cc1-448e-b74a-90da62514cec_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_168a82d1-59d0-41ff-a50b-fdede8f5a36a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_6259eb36-41d8-4b2c-a16a-875f67e1d979_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation_44045f88-3966-43e8-84b8-6eefdd8e9cd1_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final distribution of OmniAb</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid in Capital, Increase Due To Separation</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid in Capital, Increase Due To Separation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" xlink:href="lgnd-20230331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_317b12fa-2252-4e7b-b0a2-8009dbf56c2e_terseLabel_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest portion of repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_label_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_documentation_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:href="lgnd-20230331.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:to="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_502fe7c3-8dc6-4acb-ab9b-fb1623fc76c9_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - COVID</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_29ee2ddc-b2f4-4273-b406-1b36a962001d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_948724f3-457a-4409-a0b3-44887bb84848_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20230331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_0b41e0b9-54fd-4785-b707-f83ad555445c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0ea459d2-afaa-417a-aa6e-88538d0fce03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_db23aeec-ce31-4c9f-a4a0-d6a59d3e44b2_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20230331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9627701f-e815-4d23-9483-2ff71732bea5_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_47c58cfa-f9ca-43ca-b2bb-6ef7290cd836_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term investments</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20230331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_f8541024-4d3b-44e3-84a2-d094572f5a69_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_4cbd1817-57b2-46c9-b858-4118ab20c906_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1db1d431-5daa-4a55-96cf-712494bca437_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_04c057ed-f9ea-4f2c-a708-f55d8ee68e44_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>lgnd-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9386ca9d-b089-4ae9-b9e9-dc30d8ee3e97,g:2f56508d-7938-4ed2-96f4-a768c1bc35f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e1eb38d8-5731-42c2-bb3b-18845e1276c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_DocumentType_e1eb38d8-5731-42c2-bb3b-18845e1276c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d559856f-4d41-404f-91ad-284641d434d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_DocumentQuarterlyReport_d559856f-4d41-404f-91ad-284641d434d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7da5eb41-5419-49f7-b4ec-858df056e01a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_DocumentPeriodEndDate_7da5eb41-5419-49f7-b4ec-858df056e01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_1cd89afa-84d9-4f89-98aa-c4bbfd24037b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_DocumentTransitionReport_1cd89afa-84d9-4f89-98aa-c4bbfd24037b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_680f907e-bfc1-417b-af8d-e9f67625185a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityFileNumber_680f907e-bfc1-417b-af8d-e9f67625185a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_96f65236-50b3-47e2-b155-39694827d4a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityRegistrantName_96f65236-50b3-47e2-b155-39694827d4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ec4e5be8-4ee5-47d9-aace-f0c83ccee192" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ec4e5be8-4ee5-47d9-aace-f0c83ccee192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_97c50a2b-17ac-420e-a810-2fdf7405ae15" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityTaxIdentificationNumber_97c50a2b-17ac-420e-a810-2fdf7405ae15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d5df9811-b95e-4540-99e9-37c2c1ec5917" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityAddressAddressLine1_d5df9811-b95e-4540-99e9-37c2c1ec5917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_93a4e018-480d-4fd6-a45d-ac9ca5d6d1c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityAddressCityOrTown_93a4e018-480d-4fd6-a45d-ac9ca5d6d1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f9222bf1-92f9-48f4-8db6-9020dcfde2a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityAddressStateOrProvince_f9222bf1-92f9-48f4-8db6-9020dcfde2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_63fc8130-a18a-4fcb-94af-545bd9623136" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityAddressPostalZipCode_63fc8130-a18a-4fcb-94af-545bd9623136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b04ee9ff-fe3d-411b-8a52-b8a9c45ff627" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_CityAreaCode_b04ee9ff-fe3d-411b-8a52-b8a9c45ff627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a0778cd7-a9b4-47bc-abab-b92e0c26a397" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_LocalPhoneNumber_a0778cd7-a9b4-47bc-abab-b92e0c26a397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_06f4ed99-6ad1-4070-a5fe-b10b9229a30f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_Security12bTitle_06f4ed99-6ad1-4070-a5fe-b10b9229a30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fc0de8e5-4703-4609-93c2-1a3a22750bf9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_TradingSymbol_fc0de8e5-4703-4609-93c2-1a3a22750bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_44893a19-2958-4db9-81c0-2765920cdd4f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_SecurityExchangeName_44893a19-2958-4db9-81c0-2765920cdd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_743b8809-1efe-4448-b980-8304fcbdc6f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityCurrentReportingStatus_743b8809-1efe-4448-b980-8304fcbdc6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_27e21ffa-8835-4a2f-93ab-659dc8a8cdd0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityInteractiveDataCurrent_27e21ffa-8835-4a2f-93ab-659dc8a8cdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3886798d-aa4c-4822-b298-fe792e4aec35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityFilerCategory_3886798d-aa4c-4822-b298-fe792e4aec35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_966af2f4-1de8-4742-a070-bfe60e45afdc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntitySmallBusiness_966af2f4-1de8-4742-a070-bfe60e45afdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3b09af1b-09f6-4008-bc43-9796432b0ec1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityEmergingGrowthCompany_3b09af1b-09f6-4008-bc43-9796432b0ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_62fd77d2-ef17-44e2-a522-3964c046a385" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityShellCompany_62fd77d2-ef17-44e2-a522-3964c046a385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_84bd8742-d6a0-4f78-9cc6-1899d2cda8f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_84bd8742-d6a0-4f78-9cc6-1899d2cda8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_66968318-59df-4e58-8ae1-57510510b907" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_AmendmentFlag_66968318-59df-4e58-8ae1-57510510b907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_1a67005b-25d1-496d-9ceb-4870b4876da2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_DocumentFiscalYearFocus_1a67005b-25d1-496d-9ceb-4870b4876da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_07995a3c-a541-4612-ab57-347b273c1e15" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_DocumentFiscalPeriodFocus_07995a3c-a541-4612-ab57-347b273c1e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2c39c860-7ca8-47f5-8d10-f3c2163e94d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_EntityCentralIndexKey_2c39c860-7ca8-47f5-8d10-f3c2163e94d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_cd323f06-1d82-4e9a-84d6-83a33892413a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba3799c6-c4d1-4268-aeba-51033e582855" xlink:to="loc_dei_CurrentFiscalYearEndDate_cd323f06-1d82-4e9a-84d6-83a33892413a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_41ebd370-4ebf-4cd5-809a-d64c804ef7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_41ebd370-4ebf-4cd5-809a-d64c804ef7ee" xlink:to="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5d29698-2c5d-4b3a-be14-86ca94dccda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5d29698-2c5d-4b3a-be14-86ca94dccda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_821b1f7e-d104-49a8-843e-3443f7ef53ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:to="loc_us-gaap_ShortTermInvestments_821b1f7e-d104-49a8-843e-3443f7ef53ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b2396ef0-82b0-48be-8537-0fc621f135aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b2396ef0-82b0-48be-8537-0fc621f135aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_03ab2f27-baf6-4e66-8edb-2c147b7cbdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:to="loc_us-gaap_InventoryNet_03ab2f27-baf6-4e66-8edb-2c147b7cbdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_38d60746-37a3-41c4-82d7-e4ee47d03cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:to="loc_us-gaap_IncomeTaxesReceivable_38d60746-37a3-41c4-82d7-e4ee47d03cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_29bc487a-1643-47eb-b44c-3d9423d4d2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:to="loc_us-gaap_OtherAssetsCurrent_29bc487a-1643-47eb-b44c-3d9423d4d2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_50c915b3-9d1d-4409-a96a-558ae4d50d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbc2e581-a364-4bc7-a491-95e18728d482" xlink:to="loc_us-gaap_AssetsCurrent_50c915b3-9d1d-4409-a96a-558ae4d50d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_422f198b-8501-434e-a901-43de9e6ce9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_422f198b-8501-434e-a901-43de9e6ce9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_06b6c463-4906-4df8-884a-d90f6645a1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_06b6c463-4906-4df8-884a-d90f6645a1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_35c285e8-e831-4860-bbdc-dc0a3f40b2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_Goodwill_35c285e8-e831-4860-bbdc-dc0a3f40b2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_d9a9df50-6672-42a4-bc88-bb7ac2883b70" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_lgnd_CommercialLicenseRights_d9a9df50-6672-42a4-bc88-bb7ac2883b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9880822c-4dca-4cf7-9f76-1f7644d77153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9880822c-4dca-4cf7-9f76-1f7644d77153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_803db76a-4123-4d49-9980-774e8df324f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_803db76a-4123-4d49-9980-774e8df324f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_56121bd6-58b4-484c-beef-87a59a863622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_56121bd6-58b4-484c-beef-87a59a863622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5828f1bf-3a6f-48aa-9f3d-e1483fa887f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5828f1bf-3a6f-48aa-9f3d-e1483fa887f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d9c869ac-8dd8-40cc-9110-6dd16e7cb86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a45f76c5-d4b8-480c-bf07-0049baa92702" xlink:to="loc_us-gaap_Assets_d9c869ac-8dd8-40cc-9110-6dd16e7cb86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_41ebd370-4ebf-4cd5-809a-d64c804ef7ee" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_759c1645-4ba9-4bad-9e6b-2229eb7d5644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_us-gaap_AccountsPayableCurrent_759c1645-4ba9-4bad-9e6b-2229eb7d5644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3e1ee1e7-fb2a-4c3c-b3e0-0d2238daa849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3e1ee1e7-fb2a-4c3c-b3e0-0d2238daa849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_5f7b63c7-8aae-470a-9fe3-e39a579a41f1" xlink:href="lgnd-20230331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_5f7b63c7-8aae-470a-9fe3-e39a579a41f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_74110485-2080-41cf-92c6-7f228528b0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_74110485-2080-41cf-92c6-7f228528b0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d7e3eb8-c239-4f1c-a09d-9d9dc5b5e1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d7e3eb8-c239-4f1c-a09d-9d9dc5b5e1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_9ac55d71-8d4b-4f4d-84f8-0671b410f8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_9ac55d71-8d4b-4f4d-84f8-0671b410f8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_3d4351c3-7130-4a18-8bb5-319d646c7dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_3d4351c3-7130-4a18-8bb5-319d646c7dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_17bf3073-1a8c-4d26-b1f1-8a9405f28063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_77f63c6e-4176-493c-b5c1-65888eb53eb6" xlink:to="loc_us-gaap_LiabilitiesCurrent_17bf3073-1a8c-4d26-b1f1-8a9405f28063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_cde8ad56-db47-4b57-a7aa-50b9ecdc37fa" xlink:href="lgnd-20230331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_lgnd_LiabilityForContingentValueRights_cde8ad56-db47-4b57-a7aa-50b9ecdc37fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6daf7b40-74ed-481f-a9aa-e9a892422dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6daf7b40-74ed-481f-a9aa-e9a892422dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c27dc223-312a-4370-b173-fbb8b65c7ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c27dc223-312a-4370-b173-fbb8b65c7ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a4e5d4cc-d59f-4ba5-a049-7dff47052316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a4e5d4cc-d59f-4ba5-a049-7dff47052316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_18584430-c804-4c2a-b162-099bf00cbb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_Liabilities_18584430-c804-4c2a-b162-099bf00cbb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_65174165-105e-43fa-9059-1fef6f201caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_65174165-105e-43fa-9059-1fef6f201caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ca9f6e7d-e01b-4d9a-b2a8-be7097ee0df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:to="loc_us-gaap_PreferredStockValue_ca9f6e7d-e01b-4d9a-b2a8-be7097ee0df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_32095df9-ff5d-455e-8449-231affe3c48c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:to="loc_us-gaap_CommonStockValue_32095df9-ff5d-455e-8449-231affe3c48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3e134924-d29c-44bd-be48-f273e357d249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3e134924-d29c-44bd-be48-f273e357d249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a8bd29f-2104-4622-92d2-9a4af13109b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a8bd29f-2104-4622-92d2-9a4af13109b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_79335690-084e-43da-be2f-a8ecbc4bc394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_79335690-084e-43da-be2f-a8ecbc4bc394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ab1d97f8-2191-42e7-a05e-b517aaa176e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4df75781-01cd-446c-ac0b-1e38cc97dd3e" xlink:to="loc_us-gaap_StockholdersEquity_ab1d97f8-2191-42e7-a05e-b517aaa176e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_40f401ea-3685-4ce0-b5a1-2855e9a6f43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7270c981-532c-41f0-9a4e-498a1d8c3f8d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_40f401ea-3685-4ce0-b5a1-2855e9a6f43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_63143825-32f8-4f79-afb1-539e9acec94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_63143825-32f8-4f79-afb1-539e9acec94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_06a99145-8944-4595-ad73-fd679ce4c9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_06a99145-8944-4595-ad73-fd679ce4c9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_7f59d825-ed6a-48dd-b6c1-0a6e56b59b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_PreferredStockSharesIssued_7f59d825-ed6a-48dd-b6c1-0a6e56b59b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6a0179ee-14f1-4b3d-b25b-98e0b630c3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6a0179ee-14f1-4b3d-b25b-98e0b630c3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a9a4a179-434e-49fb-b1e1-9e7d5827a934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a9a4a179-434e-49fb-b1e1-9e7d5827a934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8231167b-a7a8-45ec-8d7b-50644e9dcaed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8231167b-a7a8-45ec-8d7b-50644e9dcaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_737eada8-e9f5-48e5-81a2-332e5f641204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_CommonStockSharesIssued_737eada8-e9f5-48e5-81a2-332e5f641204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_334a74ed-0e57-4dbf-85b8-0a04a7e60243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54d44b9f-e049-451d-8758-617bfbd8f629" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_334a74ed-0e57-4dbf-85b8-0a04a7e60243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_bc359fd6-394b-418f-ba06-128cc2444664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_adc131b9-3c15-4076-a1b0-2ed7b5797259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bc359fd6-394b-418f-ba06-128cc2444664" xlink:to="loc_us-gaap_StatementTable_adc131b9-3c15-4076-a1b0-2ed7b5797259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a7f3af62-e300-415e-95ce-17611c75fb03" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_adc131b9-3c15-4076-a1b0-2ed7b5797259" xlink:to="loc_srt_ProductOrServiceAxis_a7f3af62-e300-415e-95ce-17611c75fb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a7f3af62-e300-415e-95ce-17611c75fb03" xlink:to="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_738b1cba-1713-4fa1-8bc1-0f5778ec256c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:to="loc_us-gaap_RoyaltyMember_738b1cba-1713-4fa1-8bc1-0f5778ec256c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_7a660da5-d1c8-4efa-9821-e668f7e8ff26" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_7a660da5-d1c8-4efa-9821-e668f7e8ff26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_ea7460a4-5c06-4cda-808f-c419d9048b40" xlink:href="lgnd-20230331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_633e5ee7-8f79-467a-9a85-de87d9306de3" xlink:to="loc_lgnd_ContractRevenueMember_ea7460a4-5c06-4cda-808f-c419d9048b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_adc131b9-3c15-4076-a1b0-2ed7b5797259" xlink:to="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_06a90a0b-5502-46c1-9a43-6d8d094424dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_RevenuesAbstract_06a90a0b-5502-46c1-9a43-6d8d094424dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20bd57a4-6213-4949-b902-ecd51c7bb91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_06a90a0b-5502-46c1-9a43-6d8d094424dc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20bd57a4-6213-4949-b902-ecd51c7bb91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_0ca380f6-3a14-4da5-b402-b524bb938faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_CostDirectMaterial_0ca380f6-3a14-4da5-b402-b524bb938faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_b4b0b34b-0881-40be-b71f-d3deb793d6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_b4b0b34b-0881-40be-b71f-d3deb793d6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f0f42e54-e3ce-4002-8f56-84736be0cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f0f42e54-e3ce-4002-8f56-84736be0cc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_23f2e07e-e224-48e3-a518-3632d2838937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_23f2e07e-e224-48e3-a518-3632d2838937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_7b7d704f-b0e1-4065-a2f8-7a2c0517b048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_75f48775-a319-4e91-b5af-3418e61ed618" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_7b7d704f-b0e1-4065-a2f8-7a2c0517b048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_83413b39-74f0-48e8-93df-e3d2d45135fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_OperatingIncomeLoss_83413b39-74f0-48e8-93df-e3d2d45135fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_66795a70-eafd-4969-ae86-4f9b996e9f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_GainLossOnInvestments_66795a70-eafd-4969-ae86-4f9b996e9f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6129b534-1b98-4d2b-b234-909df18670d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6129b534-1b98-4d2b-b234-909df18670d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e46e556e-18dd-4f37-8b00-c5feebe4a40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_InterestExpense_e46e556e-18dd-4f37-8b00-c5feebe4a40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5087c5f7-436e-4f0d-ad15-d869b3df443b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5087c5f7-436e-4f0d-ad15-d869b3df443b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_63d978e0-6225-4775-8e5c-8314f28e0f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12972fa1-4c43-45c5-94c3-b61c4776a9a2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_63d978e0-6225-4775-8e5c-8314f28e0f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c182baa3-8b54-4e37-8487-c6e05f851b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c182baa3-8b54-4e37-8487-c6e05f851b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7828a14d-1dca-4fc1-ae08-9a7ccc7d99b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7828a14d-1dca-4fc1-ae08-9a7ccc7d99b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c99910bc-ea12-42ef-a118-7c87e2879cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_c99910bc-ea12-42ef-a118-7c87e2879cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_37b2cf1f-a9c0-42b2-98ed-a866b9a0f176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_37b2cf1f-a9c0-42b2-98ed-a866b9a0f176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_90e8dc53-7b68-4d98-8708-9f42c3c77d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_NetIncomeLoss_90e8dc53-7b68-4d98-8708-9f42c3c77d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d53c60-f7c1-4804-94d9-dff046aa41f7" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_48f28c63-992e-4ddb-a40d-d22545e502ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_48f28c63-992e-4ddb-a40d-d22545e502ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_04aff559-c3d8-40d4-ac7b-0bd11a62bbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_04aff559-c3d8-40d4-ac7b-0bd11a62bbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2679f702-4f71-410d-a903-81f88a3f1432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_EarningsPerShareBasic_2679f702-4f71-410d-a903-81f88a3f1432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6674e275-b544-46eb-be05-3d1bf90dce99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6674e275-b544-46eb-be05-3d1bf90dce99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d07d238e-12ba-4e61-9e7b-fedbea1ee06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d07d238e-12ba-4e61-9e7b-fedbea1ee06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3070f994-0a29-4116-b999-e812df5b18c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3070f994-0a29-4116-b999-e812df5b18c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8e4df86d-3716-4316-9183-f6b5f9b19fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8e4df86d-3716-4316-9183-f6b5f9b19fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52ccfb3d-0e63-41d7-994d-77e46f868198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8573f86-dd51-4189-b57c-12886a06d5ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52ccfb3d-0e63-41d7-994d-77e46f868198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fcc9a4b1-5666-420a-b6c7-a1a497242c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_090cee8d-e81d-4796-b9d0-7cace03c6625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fcc9a4b1-5666-420a-b6c7-a1a497242c49" xlink:to="loc_us-gaap_NetIncomeLoss_090cee8d-e81d-4796-b9d0-7cace03c6625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9527abec-aa21-4572-8982-814adf1d7b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fcc9a4b1-5666-420a-b6c7-a1a497242c49" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9527abec-aa21-4572-8982-814adf1d7b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c904f5e-6a1d-4ff9-9934-78066956f943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fcc9a4b1-5666-420a-b6c7-a1a497242c49" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c904f5e-6a1d-4ff9-9934-78066956f943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b0ac9988-aa38-4466-893c-e5c7c0cbee64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b0ac9988-aa38-4466-893c-e5c7c0cbee64" xlink:to="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_34e2fb71-0831-404d-8231-03227196b2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_34e2fb71-0831-404d-8231-03227196b2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34e2fb71-0831-404d-8231-03227196b2cd" xlink:to="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ede8d5c1-9402-4e79-9b27-c301b63103b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_CommonStockMember_ede8d5c1-9402-4e79-9b27-c301b63103b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_98113c86-005c-4d7c-bb9c-a7fd711b602c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_98113c86-005c-4d7c-bb9c-a7fd711b602c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_76baf303-695b-4fb3-9a57-da06e0174acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_76baf303-695b-4fb3-9a57-da06e0174acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5d69c23d-92c6-4ef9-9bca-410964ba6777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_63c385b2-5659-4304-a279-ad7babe24f72" xlink:to="loc_us-gaap_RetainedEarningsMember_5d69c23d-92c6-4ef9-9bca-410964ba6777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_28f90ec5-7144-46e5-ab6d-bd47201db94d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_28f90ec5-7144-46e5-ab6d-bd47201db94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b6418761-36f1-48c8-99a6-0eb8e21d46d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_28f90ec5-7144-46e5-ab6d-bd47201db94d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b6418761-36f1-48c8-99a6-0eb8e21d46d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7caf050-829e-4bbe-af1f-a4546e026543" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b6418761-36f1-48c8-99a6-0eb8e21d46d8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7caf050-829e-4bbe-af1f-a4546e026543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9281f09a-c26e-4519-bfb9-3c8a56e59bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34d7ad48-dd4b-40a2-bd26-581c5771e979" xlink:to="loc_us-gaap_StatementLineItems_9281f09a-c26e-4519-bfb9-3c8a56e59bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9281f09a-c26e-4519-bfb9-3c8a56e59bdb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_996184d9-893a-4a31-9903-440d914d42b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_996184d9-893a-4a31-9903-440d914d42b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e590155-d991-4781-a6f2-21674cc3fe3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_StockholdersEquity_2e590155-d991-4781-a6f2-21674cc3fe3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d6114093-f813-4325-ae7f-4c5d11fadded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_d6114093-f813-4325-ae7f-4c5d11fadded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c7b2cb2e-82da-4aa7-9594-0c0dd4959b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c7b2cb2e-82da-4aa7-9594-0c0dd4959b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be521c51-4959-424a-b62a-79f053fc2640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be521c51-4959-424a-b62a-79f053fc2640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e868960-9da3-477f-9b91-9dcd2131ffbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5e868960-9da3-477f-9b91-9dcd2131ffbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8f2b91c-14e6-4aa9-b286-f8e693804236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8f2b91c-14e6-4aa9-b286-f8e693804236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation_a1e53889-25ec-437f-b520-aac36c15eeb2" xlink:href="lgnd-20230331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation_a1e53889-25ec-437f-b520-aac36c15eeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ef35338d-0731-433a-8d94-a560a2ab7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_NetIncomeLoss_ef35338d-0731-433a-8d94-a560a2ab7cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4dd0110c-f5c2-4675-ae79-08d0320c516c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4dd0110c-f5c2-4675-ae79-08d0320c516c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9250032a-3b75-4e39-8d63-bb12249ab079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb80664-b205-4c14-a76e-c253f4689927" xlink:to="loc_us-gaap_StockholdersEquity_9250032a-3b75-4e39-8d63-bb12249ab079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5a3bb156-b42a-41d8-812d-25846b572c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5a3bb156-b42a-41d8-812d-25846b572c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_91c621a8-b7d0-4516-8691-9a3a4d23c391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5a3bb156-b42a-41d8-812d-25846b572c50" xlink:to="loc_us-gaap_NetIncomeLoss_91c621a8-b7d0-4516-8691-9a3a4d23c391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5a3bb156-b42a-41d8-812d-25846b572c50" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_be94f7d7-3572-4347-873d-8154c4adfdd3" xlink:href="lgnd-20230331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_be94f7d7-3572-4347-873d-8154c4adfdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_212a4736-2728-4e7f-980a-5f99113da676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_212a4736-2728-4e7f-980a-5f99113da676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_475d49ed-a111-4dce-8d61-750c6e6892fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_475d49ed-a111-4dce-8d61-750c6e6892fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5958be94-c185-474e-bcf7-42368b8ec11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5958be94-c185-474e-bcf7-42368b8ec11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_e5abad25-0941-470b-92eb-0912f8ccabd5" xlink:href="lgnd-20230331.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_e5abad25-0941-470b-92eb-0912f8ccabd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0d5d0a7a-3ae3-4fc1-a297-0fc91446b3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0d5d0a7a-3ae3-4fc1-a297-0fc91446b3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b96095b7-0de7-469e-bdc3-0f8c6b1314f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_ShareBasedCompensation_b96095b7-0de7-469e-bdc3-0f8c6b1314f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_7ac843ab-b0eb-48bd-8df8-73e5ec1e431d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_7ac843ab-b0eb-48bd-8df8-73e5ec1e431d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_50d4d52b-4d46-4e0b-bbde-1334bc9d0634" xlink:href="lgnd-20230331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_50d4d52b-4d46-4e0b-bbde-1334bc9d0634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_78d08f09-2efe-4472-8272-01be6fcd09f0" xlink:href="lgnd-20230331.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_78d08f09-2efe-4472-8272-01be6fcd09f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_86e69772-1afe-4a20-b46d-44e517405063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_86e69772-1afe-4a20-b46d-44e517405063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b42ae9dc-7bb7-4aff-b086-b5e9f0a67027" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_97bdbbf1-b37b-4dc4-958c-1ec2a8f0bb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_97bdbbf1-b37b-4dc4-958c-1ec2a8f0bb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9a841fa9-a3ff-4cff-ba3b-c2d350b2d921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9a841fa9-a3ff-4cff-ba3b-c2d350b2d921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_86230e74-9abe-48b0-93a4-e6908a5a6c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_86230e74-9abe-48b0-93a4-e6908a5a6c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bfbf0eba-c89f-47ba-9258-772eb543d007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bfbf0eba-c89f-47ba-9258-772eb543d007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_46cb8736-5c83-4f54-bc72-1e53633136cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_46cb8736-5c83-4f54-bc72-1e53633136cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b3ca9367-7c7b-46a7-a590-4a7171fc39e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d705be5-8903-4587-b786-461dcbf889ea" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b3ca9367-7c7b-46a7-a590-4a7171fc39e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_580d31be-4097-4c0c-b9cd-3767c27467e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5a3bb156-b42a-41d8-812d-25846b572c50" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_580d31be-4097-4c0c-b9cd-3767c27467e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_8e94340d-b411-473b-8480-6e6b8f366b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_8e94340d-b411-473b-8480-6e6b8f366b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_89211a3a-d2c3-45e0-9f00-efecd4ab43d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_89211a3a-d2c3-45e0-9f00-efecd4ab43d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_193ec514-afa4-48ed-9501-e95986a7d531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_193ec514-afa4-48ed-9501-e95986a7d531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_348a5678-d445-43e6-b924-3773c7190bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_348a5678-d445-43e6-b924-3773c7190bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c798afad-3313-49d4-b4c6-114760823fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c798afad-3313-49d4-b4c6-114760823fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromCommercialLicenseRights_ebaaebe7-a36e-4b16-b341-e10336fcab4f" xlink:href="lgnd-20230331.xsd#lgnd_ProceedsFromCommercialLicenseRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:to="loc_lgnd_ProceedsFromCommercialLicenseRights_ebaaebe7-a36e-4b16-b341-e10336fcab4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aadc9d17-fad0-4ec1-8033-584dfd644c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3634c444-cc40-4f36-8e4d-567ce26b549d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aadc9d17-fad0-4ec1-8033-584dfd644c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9c021993-402a-459e-8682-e9d1bf59b4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9c021993-402a-459e-8682-e9d1bf59b4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_cfea2273-5dfc-4995-ade3-9153a209c475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_cfea2273-5dfc-4995-ade3-9153a209c475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ef052f12-48a5-4c56-83d5-3a5101053de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ef052f12-48a5-4c56-83d5-3a5101053de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a7a2e21c-d8b5-4f00-821c-1d87a77e9cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a7a2e21c-d8b5-4f00-821c-1d87a77e9cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_0a6a250a-2664-4ba7-96bd-67dc2a8cfc84" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_0a6a250a-2664-4ba7-96bd-67dc2a8cfc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e2ca27e2-4f83-4aaa-91bb-641e17826df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e2ca27e2-4f83-4aaa-91bb-641e17826df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1712e045-e246-4d44-b4c3-bd7a854df202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a190a8a3-9e73-438c-ab67-5af988679bfa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1712e045-e246-4d44-b4c3-bd7a854df202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc4326bf-3077-4bb4-9d29-1479cbced8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc4326bf-3077-4bb4-9d29-1479cbced8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d8629610-1440-4ac1-b249-cff57395e768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d8629610-1440-4ac1-b249-cff57395e768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50b7b5b6-8d19-4ac7-8588-03f8719c9936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50b7b5b6-8d19-4ac7-8588-03f8719c9936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_0d6a5394-ba07-483d-8b50-8e73635ab69f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_0d6a5394-ba07-483d-8b50-8e73635ab69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_9f9bfaed-dce8-4067-b0d6-c5849f19ca86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0d6a5394-ba07-483d-8b50-8e73635ab69f" xlink:to="loc_us-gaap_InterestPaidNet_9f9bfaed-dce8-4067-b0d6-c5849f19ca86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37b5cafc-617d-47e3-a8a6-8e3d699f5174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60187f19-ca7c-496a-b54d-96c3b790a0ca" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37b5cafc-617d-47e3-a8a6-8e3d699f5174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b77c57e2-4f01-4f17-ae1e-9980829f616c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37b5cafc-617d-47e3-a8a6-8e3d699f5174" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b77c57e2-4f01-4f17-ae1e-9980829f616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_6e08e1a1-b7db-4df1-942c-413edf274bda" xlink:href="lgnd-20230331.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37b5cafc-617d-47e3-a8a6-8e3d699f5174" xlink:to="loc_lgnd_AccruedInventoryPurchases_6e08e1a1-b7db-4df1-942c-413edf274bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_202082ff-8caa-421b-a700-2b0c0a31a3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37b5cafc-617d-47e3-a8a6-8e3d699f5174" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_202082ff-8caa-421b-a700-2b0c0a31a3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9491ca63-892f-49fd-897c-08baa5036453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_bbf6e28d-4ca8-4207-b2f5-919cff27a998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9491ca63-892f-49fd-897c-08baa5036453" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_bbf6e28d-4ca8-4207-b2f5-919cff27a998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAb" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAb"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAb" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_17025536-71e2-44a2-b49f-e7899cb3b7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_1656304c-c371-466b-bd43-b92f0cb376a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_17025536-71e2-44a2-b49f-e7899cb3b7f3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_1656304c-c371-466b-bd43-b92f0cb376a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4f928855-8f79-4fe7-9ded-00678236fe38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_634a618d-34f7-49fb-b1c5-e73542579c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4f928855-8f79-4fe7-9ded-00678236fe38" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_634a618d-34f7-49fb-b1c5-e73542579c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20230331.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e69119b2-0860-42f8-bf6a-520726f0a1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_c5790a0f-6292-42eb-aefc-05dfdf0662d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e69119b2-0860-42f8-bf6a-520726f0a1d9" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_c5790a0f-6292-42eb-aefc-05dfdf0662d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20230331.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_79eb0596-bde4-46ae-af17-2bd61d2e1e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_99e3e854-2dd5-4ed3-9ce2-cff5ea244d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_79eb0596-bde4-46ae-af17-2bd61d2e1e60" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_99e3e854-2dd5-4ed3-9ce2-cff5ea244d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20230331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_651b96fb-5c56-4061-9268-767737b5373b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8d23f368-961e-425d-a921-a7f2a98e1e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_651b96fb-5c56-4061-9268-767737b5373b" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8d23f368-961e-425d-a921-a7f2a98e1e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f35e71f-4a9b-4eb8-8286-6be4bd02786c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_21e39cc1-4626-43e6-be13-b901a0980112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f35e71f-4a9b-4eb8-8286-6be4bd02786c" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_21e39cc1-4626-43e6-be13-b901a0980112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_25d13774-6fe9-42b3-8f9a-a253086fc0ef" xlink:href="lgnd-20230331.xsd#lgnd_BusinessSpinOffAndMigrationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_25d13774-6fe9-42b3-8f9a-a253086fc0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_fecd133d-e18e-47b5-9626-780a351819f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_fecd133d-e18e-47b5-9626-780a351819f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_c1809c33-17d9-44fd-8367-ad8aa670aeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_c1809c33-17d9-44fd-8367-ad8aa670aeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4f2da91d-d612-4b04-b95b-8c06eefaa903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_UseOfEstimates_4f2da91d-d612-4b04-b95b-8c06eefaa903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a944fa3d-c43a-454a-a8ff-e05d84ced545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a944fa3d-c43a-454a-a8ff-e05d84ced545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_7d8213bb-8fab-4347-a8ee-f4f853d20669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_7d8213bb-8fab-4347-a8ee-f4f853d20669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5ab02916-f315-4f09-8cad-f3d61edb41ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5ab02916-f315-4f09-8cad-f3d61edb41ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_e216678a-1449-4b12-93dc-c9eecb8c3a50" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_e216678a-1449-4b12-93dc-c9eecb8c3a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3ed6345b-ac75-4bf9-bc1b-265856fc6ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3ed6345b-ac75-4bf9-bc1b-265856fc6ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_18ebb60d-0578-4ed0-b28a-a98bc71c4797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd414459-3008-4ba5-9af3-a82ee262e39c" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_18ebb60d-0578-4ed0-b28a-a98bc71c4797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_08b25a04-5bad-422a-8738-2bdd05068e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_08b25a04-5bad-422a-8738-2bdd05068e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_4b0eedf8-08f7-4d42-bb1d-c5dfee263bcd" xlink:href="lgnd-20230331.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_4b0eedf8-08f7-4d42-bb1d-c5dfee263bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ad9d4f7f-7a44-4f5d-a5be-e6012e780851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ad9d4f7f-7a44-4f5d-a5be-e6012e780851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_5d859acb-140b-436d-8e57-83e204bad731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_5d859acb-140b-436d-8e57-83e204bad731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_db28f40a-ac89-422c-8068-a1f0758380e7" xlink:href="lgnd-20230331.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_db28f40a-ac89-422c-8068-a1f0758380e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_84f9d7e5-5c11-4530-8c0c-db62d3d62de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_84f9d7e5-5c11-4530-8c0c-db62d3d62de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_8e33ba7b-a490-48db-ab75-20d1687dc2c8" xlink:href="lgnd-20230331.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_8e33ba7b-a490-48db-ab75-20d1687dc2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_45e8d7a1-7aed-4ed5-8b6d-18b11f47da96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_45e8d7a1-7aed-4ed5-8b6d-18b11f47da96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_738b563e-4d3c-4d71-8cc7-31e6c392407f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56edd3ff-2cea-4e30-a4cc-9ead11cf9d6f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_738b563e-4d3c-4d71-8cc7-31e6c392407f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbTables" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e2f448ee-7018-4e8a-bcdd-86859b9836db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b9e83167-8cff-473e-a14d-fd832caa28bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e2f448ee-7018-4e8a-bcdd-86859b9836db" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b9e83167-8cff-473e-a14d-fd832caa28bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1c84bf7a-6526-472c-9ba4-824dea76e3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_80533ca0-2a29-478e-ac55-e1bb2ca1ef51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c84bf7a-6526-472c-9ba4-824dea76e3af" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_80533ca0-2a29-478e-ac55-e1bb2ca1ef51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8342f631-8144-4542-97d8-d5f8b1242fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c84bf7a-6526-472c-9ba4-824dea76e3af" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8342f631-8144-4542-97d8-d5f8b1242fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20230331.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e5f391b3-3068-419e-8804-9c62d1bbe171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_8d48356a-6899-490c-ab68-1796e740be94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e5f391b3-3068-419e-8804-9c62d1bbe171" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_8d48356a-6899-490c-ab68-1796e740be94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20230331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_23023b53-615c-463f-9860-8950697d0d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_175e97ab-67d9-4dc1-9506-c71da0cefd25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_23023b53-615c-463f-9860-8950697d0d75" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_175e97ab-67d9-4dc1-9506-c71da0cefd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_febb9b18-8049-4bc5-a4ae-299dde0d9537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_23023b53-615c-463f-9860-8950697d0d75" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_febb9b18-8049-4bc5-a4ae-299dde0d9537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5985dd14-ddd1-4718-bba1-20a9a5a184c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5985dd14-ddd1-4718-bba1-20a9a5a184c8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_31853a87-b847-4193-8876-c004a12d1e76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:to="loc_srt_ProductOrServiceAxis_31853a87-b847-4193-8876-c004a12d1e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0189010c-8a3d-4593-b046-7aeb94358d6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_31853a87-b847-4193-8876-c004a12d1e76" xlink:to="loc_srt_ProductsAndServicesDomain_0189010c-8a3d-4593-b046-7aeb94358d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_5a8a6603-e610-4d9b-8982-a2cd7e4a7eea" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0189010c-8a3d-4593-b046-7aeb94358d6c" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_5a8a6603-e610-4d9b-8982-a2cd7e4a7eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3883e199-3290-4efa-9a93-3af2bb81edda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:to="loc_us-gaap_AwardTypeAxis_3883e199-3290-4efa-9a93-3af2bb81edda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a829c64c-1919-4564-9a60-6249c478db5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3883e199-3290-4efa-9a93-3af2bb81edda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a829c64c-1919-4564-9a60-6249c478db5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a64641f6-32ec-4efc-a47d-0e8cd54d7309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a829c64c-1919-4564-9a60-6249c478db5d" xlink:to="loc_us-gaap_RestrictedStockMember_a64641f6-32ec-4efc-a47d-0e8cd54d7309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a727c95-9968-46b7-8029-6ee4f311f4af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:to="loc_srt_RangeAxis_9a727c95-9968-46b7-8029-6ee4f311f4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9a727c95-9968-46b7-8029-6ee4f311f4af" xlink:to="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7c4c409c-fd8d-493d-8bc9-a00f6cd3f880" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:to="loc_srt_MinimumMember_7c4c409c-fd8d-493d-8bc9-a00f6cd3f880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c2de0e8-3bdc-4093-a2a1-8e5d96ac716a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_18b73a2a-a550-4b20-8430-056c43833ffc" xlink:to="loc_srt_MaximumMember_0c2de0e8-3bdc-4093-a2a1-8e5d96ac716a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_289f9f12-0972-4d96-8958-267b8c4f5521" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_2379643c-d1a1-4d8f-a7af-20e4281e32d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_NumberOfOperatingSegments_2379643c-d1a1-4d8f-a7af-20e4281e32d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_541efc17-62a4-42a5-80b1-9c9abf77c084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_541efc17-62a4-42a5-80b1-9c9abf77c084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIShareSoldInPeriod_ffdb670b-cccf-4994-b066-0809f6da1654" xlink:href="lgnd-20230331.xsd#lgnd_EquitySecuritiesFVNIShareSoldInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_lgnd_EquitySecuritiesFVNIShareSoldInPeriod_ffdb670b-cccf-4994-b066-0809f6da1654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_af7ca570-bc7f-4db9-867b-992dabb27fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_af7ca570-bc7f-4db9-867b-992dabb27fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d18330a4-2e17-4a3b-b361-2aba2a56d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d18330a4-2e17-4a3b-b361-2aba2a56d8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9fca3ae3-ea53-4db0-8e11-2714ef108bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9fca3ae3-ea53-4db0-8e11-2714ef108bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_88a2cb71-8758-4eaf-b9ae-3c657ad1216f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_88a2cb71-8758-4eaf-b9ae-3c657ad1216f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_c21d9248-47e2-4adf-abed-bd208d9c2071" xlink:href="lgnd-20230331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_c21d9248-47e2-4adf-abed-bd208d9c2071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_09b8a752-f973-4366-9bd3-0613ded5a001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_InventoryWriteDown_09b8a752-f973-4366-9bd3-0613ded5a001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_577c45eb-4962-42af-ac68-3ab7bec12e20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_InventoryNet_577c45eb-4962-42af-ac68-3ab7bec12e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b3cdecaf-b9ae-4214-9902-af3ae95612b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b3cdecaf-b9ae-4214-9902-af3ae95612b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_f86ebf52-a19b-4be3-ba52-0f6c53c11594" xlink:href="lgnd-20230331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_150b8ff6-c82c-455d-a904-053f3cf28617" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_f86ebf52-a19b-4be3-ba52-0f6c53c11594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eccfac8a-9af2-490c-9a14-b37b912ae368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ffa1b6c0-7710-4be9-916a-dc25c53348d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eccfac8a-9af2-490c-9a14-b37b912ae368" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ffa1b6c0-7710-4be9-916a-dc25c53348d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffa1b6c0-7710-4be9-916a-dc25c53348d9" xlink:to="loc_srt_ProductOrServiceAxis_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f4c36b1f-338a-43e3-9b94-2cdbcff6a1b4" xlink:to="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:to="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_3238010c-fa5c-492d-adcc-11950815d3ed" xlink:href="lgnd-20230331.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_KyprolisMember_3238010c-fa5c-492d-adcc-11950815d3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_58827ec3-980e-4b40-b66b-a7c64f49db55" xlink:href="lgnd-20230331.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_EvomelaMember_58827ec3-980e-4b40-b66b-a7c64f49db55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_70c8ba4c-18da-4452-9461-652cb581a879" xlink:href="lgnd-20230331.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_TeriparatideInjectionMember_70c8ba4c-18da-4452-9461-652cb581a879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_dd33f0f2-41c8-4e1c-916e-3758645f9f50" xlink:href="lgnd-20230331.xsd#lgnd_RylazeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_RylazeMember_dd33f0f2-41c8-4e1c-916e-3758645f9f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_289dc2e3-868f-44b7-ab6b-cdd9da1cef28" xlink:href="lgnd-20230331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_24e1c60f-baf4-407d-a421-78092e829264" xlink:to="loc_lgnd_RoyaltyOtherMember_289dc2e3-868f-44b7-ab6b-cdd9da1cef28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_24970cdd-aeec-43dc-9264-13125998cfbd" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_24970cdd-aeec-43dc-9264-13125998cfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d7d81244-7df1-4af8-b3e0-0fdbb46b4a3e" xlink:href="lgnd-20230331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_af9b3c75-d456-4d9e-b551-52b8b13f1dd3" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d7d81244-7df1-4af8-b3e0-0fdbb46b4a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:href="lgnd-20230331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b68c2e56-bfbb-414c-9953-5652ce27345a" xlink:to="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_f73439c2-aa21-40fe-a124-35307b2161d0" xlink:href="lgnd-20230331.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:to="loc_lgnd_LicenseFeesMember_f73439c2-aa21-40fe-a124-35307b2161d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_b91d98a2-9f05-4913-92f2-c06ce926ddf8" xlink:href="lgnd-20230331.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:to="loc_lgnd_MilestoneMember_b91d98a2-9f05-4913-92f2-c06ce926ddf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_574b132a-fd97-4380-b24d-d5817c36fcf1" xlink:href="lgnd-20230331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_ac385073-c86f-496c-9254-6559ab50cfda" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_574b132a-fd97-4380-b24d-d5817c36fcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8efe5e25-9b36-4d21-8538-1438b2f8b535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffa1b6c0-7710-4be9-916a-dc25c53348d9" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8efe5e25-9b36-4d21-8538-1438b2f8b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_073c5e3a-71d0-4057-a7df-002b478f017f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8efe5e25-9b36-4d21-8538-1438b2f8b535" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_073c5e3a-71d0-4057-a7df-002b478f017f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1525cdb1-cedb-4179-bcff-2761a4ef0619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6fbae8cf-6600-47f2-a39c-13e24bd4d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1525cdb1-cedb-4179-bcff-2761a4ef0619" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6fbae8cf-6600-47f2-a39c-13e24bd4d0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_157bd50e-5869-442c-a1a8-cf04e970daa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6fbae8cf-6600-47f2-a39c-13e24bd4d0a9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_157bd50e-5869-442c-a1a8-cf04e970daa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_157bd50e-5869-442c-a1a8-cf04e970daa0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_1e386e5e-fb70-435a-94ca-2dd095dc5ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_DemandDepositsMember_1e386e5e-fb70-435a-94ca-2dd095dc5ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_4821130e-2603-4705-9f0d-42050d8ddb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_4821130e-2603-4705-9f0d-42050d8ddb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_322e2b76-7320-4070-bf82-d5670823765f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_AgencySecuritiesMember_322e2b76-7320-4070-bf82-d5670823765f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_dfd8c43c-b37c-436f-90e9-9be5bca22d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_CommercialPaperMember_dfd8c43c-b37c-436f-90e9-9be5bca22d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_a357d2cf-b92d-4006-8a18-bc6d47335725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_MunicipalBondsMember_a357d2cf-b92d-4006-8a18-bc6d47335725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3c6d1f82-a708-4840-b921-2cf5003ba232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_EquitySecuritiesMember_3c6d1f82-a708-4840-b921-2cf5003ba232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_e9abc83b-3a7d-4530-b5c8-32bd4d0f5a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_MutualFundMember_e9abc83b-3a7d-4530-b5c8-32bd4d0f5a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_8a83fa6a-48bb-4117-884e-59c6f3d5d88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_8a83fa6a-48bb-4117-884e-59c6f3d5d88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_91037420-ccbd-4120-aac4-40081566e318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_WarrantMember_91037420-ccbd-4120-aac4-40081566e318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9bb240cd-5947-40c1-b894-55ebed83e265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20a9ff03-09d8-42b3-9279-b5ee02416974" xlink:to="loc_us-gaap_CommonStockMember_9bb240cd-5947-40c1-b894-55ebed83e265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6fbae8cf-6600-47f2-a39c-13e24bd4d0a9" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_16185191-19fa-490f-8a52-7ddc0af39ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_16185191-19fa-490f-8a52-7ddc0af39ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ed891128-2072-46be-a74b-950b1a20fbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ed891128-2072-46be-a74b-950b1a20fbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0299f0f3-75d6-4a97-bf8e-6d5ec652965b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0299f0f3-75d6-4a97-bf8e-6d5ec652965b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_63e0e643-17bd-418b-af0a-465cd9137a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_63e0e643-17bd-418b-af0a-465cd9137a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_5185dd92-b84d-4121-bd00-c65a9c745250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_5185dd92-b84d-4121-bd00-c65a9c745250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_157af45c-7b59-4b95-aed5-27b632676980" xlink:href="lgnd-20230331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_40a43502-49f8-42f7-afdc-664b313b14b4" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_157af45c-7b59-4b95-aed5-27b632676980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd9e082e-9547-4f14-92d4-12ba5a9d5b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_f08713e0-b1dc-4c33-8a2f-9375ee33e2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd9e082e-9547-4f14-92d4-12ba5a9d5b6b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_f08713e0-b1dc-4c33-8a2f-9375ee33e2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_a8c4fc00-485a-40df-a3c6-e401fca2b56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_f08713e0-b1dc-4c33-8a2f-9375ee33e2f5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_a8c4fc00-485a-40df-a3c6-e401fca2b56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_4324208e-2748-4191-b9df-bdf1025b7a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_f08713e0-b1dc-4c33-8a2f-9375ee33e2f5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_4324208e-2748-4191-b9df-bdf1025b7a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_af4f71ca-3937-4d19-92ee-73552d48cfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_f08713e0-b1dc-4c33-8a2f-9375ee33e2f5" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_af4f71ca-3937-4d19-92ee-73552d48cfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8b2971ce-9f38-4fee-aa09-ca0a69279f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd9e082e-9547-4f14-92d4-12ba5a9d5b6b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8b2971ce-9f38-4fee-aa09-ca0a69279f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_29a5c6f8-c68d-4b08-a814-cd015b599234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8b2971ce-9f38-4fee-aa09-ca0a69279f22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_29a5c6f8-c68d-4b08-a814-cd015b599234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_a85f93b2-388e-4fb7-a21f-fa2016d9d60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8b2971ce-9f38-4fee-aa09-ca0a69279f22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_a85f93b2-388e-4fb7-a21f-fa2016d9d60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b6256a81-002b-4921-bb38-9f80ef739396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8b2971ce-9f38-4fee-aa09-ca0a69279f22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b6256a81-002b-4921-bb38-9f80ef739396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9fdb2ffc-9261-4155-8c03-53f8540e442f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3fd3280e-8114-4b77-9240-899bfadb08b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9fdb2ffc-9261-4155-8c03-53f8540e442f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3fd3280e-8114-4b77-9240-899bfadb08b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3fd3280e-8114-4b77-9240-899bfadb08b8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6b162ca9-6a96-4fbd-b4c7-cd2bbeee44bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_970df0b7-d2cf-4691-93ac-47b7cc0f1108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_PatentedTechnologyMember_970df0b7-d2cf-4691-93ac-47b7cc0f1108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_22876bcb-69e3-4da2-adaf-ffac17d8ea05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_TradeNamesMember_22876bcb-69e3-4da2-adaf-ffac17d8ea05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3cc4d6b9-8bec-4a42-808d-3133e58900f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3cc4d6b9-8bec-4a42-808d-3133e58900f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_9e588f35-98cb-4ead-95d5-5a5d9fe280ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bfcca0e-2103-471d-9745-23d5acc64b0c" xlink:to="loc_us-gaap_ContractualRightsMember_9e588f35-98cb-4ead-95d5-5a5d9fe280ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_915cc3a9-8b2b-443f-b232-9826d72fec76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3fd3280e-8114-4b77-9240-899bfadb08b8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_915cc3a9-8b2b-443f-b232-9826d72fec76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_915cc3a9-8b2b-443f-b232-9826d72fec76" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3bb433d6-e113-425a-a184-12b4e1c34401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_Goodwill_3bb433d6-e113-425a-a184-12b4e1c34401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_18c91acb-2b80-470c-b753-86c181deb062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_18c91acb-2b80-470c-b753-86c181deb062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1601c107-1a97-4d5b-9094-79c5e59d379b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1601c107-1a97-4d5b-9094-79c5e59d379b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b7943318-7716-4267-961a-76be2b00bbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7f279b66-c132-4e1e-bd84-578c312f11ee" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b7943318-7716-4267-961a-76be2b00bbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d425176-ca9e-4283-bcc4-955da47a1304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d425176-ca9e-4283-bcc4-955da47a1304" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_141d2524-8ec9-45cb-bbbe-f9b9a133029f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_141d2524-8ec9-45cb-bbbe-f9b9a133029f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7663d1db-631c-4c9b-b18c-d6c11a650256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_141d2524-8ec9-45cb-bbbe-f9b9a133029f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7663d1db-631c-4c9b-b18c-d6c11a650256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_a60d9595-a65c-47f6-9993-2128b68825d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7663d1db-631c-4c9b-b18c-d6c11a650256" xlink:to="loc_us-gaap_LicensingAgreementsMember_a60d9595-a65c-47f6-9993-2128b68825d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d85de6c5-915a-4feb-8c50-78051337d049" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:to="loc_srt_CounterpartyNameAxis_d85de6c5-915a-4feb-8c50-78051337d049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d85de6c5-915a-4feb-8c50-78051337d049" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_8115de7a-d2f4-43e3-8d8c-17853db34801" xlink:href="lgnd-20230331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_8115de7a-d2f4-43e3-8d8c-17853db34801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_61bde44c-f6df-42eb-b1cf-3273bb284e54" xlink:href="lgnd-20230331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf6d0c55-6fe2-41ba-8c6b-852aff09f458" xlink:to="loc_lgnd_SelexisAndDianomiMember_61bde44c-f6df-42eb-b1cf-3273bb284e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1edcfe47-ab07-450b-85c3-f1145ee024d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1c00f826-e964-41f1-a96b-2c1e4c3d5e87" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1edcfe47-ab07-450b-85c3-f1145ee024d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:href="lgnd-20230331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1edcfe47-ab07-450b-85c3-f1145ee024d0" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_82a3ddf7-4ddd-4bdf-84ed-c2746d4bb3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_82a3ddf7-4ddd-4bdf-84ed-c2746d4bb3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7ce1af20-012c-41b9-b7a5-d85c0919b201" xlink:href="lgnd-20230331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7ce1af20-012c-41b9-b7a5-d85c0919b201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4976082f-3909-45b6-884c-3750ca0ef738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4976082f-3909-45b6-884c-3750ca0ef738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_414ccae9-2091-482e-b5be-19945ef713e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_414ccae9-2091-482e-b5be-19945ef713e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_821e788f-50a9-40fe-8389-72c62d6e2b84" xlink:href="lgnd-20230331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_39e9154b-f886-4b83-bdad-2cca97293fe9" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_821e788f-50a9-40fe-8389-72c62d6e2b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6db95a0c-b335-4ef5-bac6-e319cbd2a94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6db95a0c-b335-4ef5-bac6-e319cbd2a94a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_11d33ae1-dd8a-459f-968c-39c79f22b5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_11d33ae1-dd8a-459f-968c-39c79f22b5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_419c693a-02d0-4221-b38c-18c72e483abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_419c693a-02d0-4221-b38c-18c72e483abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_c9b3f249-6522-4896-a372-092b00936ab8" xlink:href="lgnd-20230331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:to="loc_lgnd_LicenseeAccrualCurrent_c9b3f249-6522-4896-a372-092b00936ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_9b838585-1b60-41c9-9405-36543630c0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_9b838585-1b60-41c9-9405-36543630c0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_d2735c2b-7a55-4461-a4cf-dfc53f73488c" xlink:href="lgnd-20230331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_d2735c2b-7a55-4461-a4cf-dfc53f73488c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4c3c8cd3-f54a-4af4-b425-404975708141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4c3c8cd3-f54a-4af4-b425-404975708141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9459d996-2f09-4467-b3a3-3fe5c6916c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0b5cffbb-4a90-4f49-897e-652243634545" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9459d996-2f09-4467-b3a3-3fe5c6916c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d90b4029-e920-47a6-bf7c-06b54bf6aaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_28ee6057-3354-4293-aff2-a8caf723981f" xlink:href="lgnd-20230331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d90b4029-e920-47a6-bf7c-06b54bf6aaa4" xlink:to="loc_lgnd_BasisOfPresentationTable_28ee6057-3354-4293-aff2-a8caf723981f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_845a6e73-647b-4556-a0d3-6509de8d8426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_28ee6057-3354-4293-aff2-a8caf723981f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_845a6e73-647b-4556-a0d3-6509de8d8426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_845a6e73-647b-4556-a0d3-6509de8d8426" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03e33f05-f807-4ac3-ad30-5c130a5c3330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03e33f05-f807-4ac3-ad30-5c130a5c3330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_00b6629a-b84d-499d-954c-f57bd1f9f1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_31493345-413a-4652-b823-c5ed1f4f3c60" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_00b6629a-b84d-499d-954c-f57bd1f9f1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_07f9d083-fedb-4b83-96ac-3d7b4d35ab81" xlink:href="lgnd-20230331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_28ee6057-3354-4293-aff2-a8caf723981f" xlink:to="loc_lgnd_BasisOfPresentationLineItems_07f9d083-fedb-4b83-96ac-3d7b4d35ab81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_49e954d0-1fbf-47f0-8ca5-c9835dc4112b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_07f9d083-fedb-4b83-96ac-3d7b4d35ab81" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_49e954d0-1fbf-47f0-8ca5-c9835dc4112b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f697666-270f-4102-866a-99a88207a24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_feda32c8-637c-483f-bb81-1a50dcd09b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f697666-270f-4102-866a-99a88207a24d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_feda32c8-637c-483f-bb81-1a50dcd09b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_20b39061-4505-4926-9f81-44c9a39dddae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f697666-270f-4102-866a-99a88207a24d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_20b39061-4505-4926-9f81-44c9a39dddae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1659978d-9ff0-463d-b787-6aa78e504afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f697666-270f-4102-866a-99a88207a24d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1659978d-9ff0-463d-b787-6aa78e504afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7aa4b674-ac33-464d-bcff-f96a0dbc4e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f697666-270f-4102-866a-99a88207a24d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7aa4b674-ac33-464d-bcff-f96a0dbc4e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_500e8c9a-aa09-4d94-8f23-829ecec6e544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b78e7d5b-a921-4806-af07-3159534f2001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_500e8c9a-aa09-4d94-8f23-829ecec6e544" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b78e7d5b-a921-4806-af07-3159534f2001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a2de0758-b222-41bc-acd0-f2b2ca147e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b78e7d5b-a921-4806-af07-3159534f2001" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a2de0758-b222-41bc-acd0-f2b2ca147e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a2de0758-b222-41bc-acd0-f2b2ca147e9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ababc4c4-bd29-4116-bf04-fd5c4df7aa79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:to="loc_us-gaap_RestrictedStockMember_ababc4c4-bd29-4116-bf04-fd5c4df7aa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f60ccedc-cdbd-4485-b59e-d656e9795bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f60ccedc-cdbd-4485-b59e-d656e9795bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_7fd308b8-b776-44e4-95c1-e9e02316259a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421aee35-7c56-46a0-a626-45f674264797" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_7fd308b8-b776-44e4-95c1-e9e02316259a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b78e7d5b-a921-4806-af07-3159534f2001" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75b5bf8f-f0d9-4b94-97f4-e00bdd7701f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75b5bf8f-f0d9-4b94-97f4-e00bdd7701f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a11c4ad2-e7a4-4975-a154-07169094f86b" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_132b0d50-80b8-45fc-8f43-dfb3ca20b570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_132b0d50-80b8-45fc-8f43-dfb3ca20b570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f217cf67-141d-4f2b-ba58-a7aa9fa5dd82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f217cf67-141d-4f2b-ba58-a7aa9fa5dd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5b4ee89d-782f-4d8c-9a7e-e7549fe525ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_4e1b1e56-f24d-426f-bae8-bc0b176d3d68" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5b4ee89d-782f-4d8c-9a7e-e7549fe525ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_09cff5e3-006b-4a39-adfa-f4f96725eb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a9512a75-bb98-429c-80d4-7c7b454bc2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_09cff5e3-006b-4a39-adfa-f4f96725eb31" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a9512a75-bb98-429c-80d4-7c7b454bc2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3988e133-fe9d-4c70-9d72-725390a9e116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a9512a75-bb98-429c-80d4-7c7b454bc2d5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3988e133-fe9d-4c70-9d72-725390a9e116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_726b127c-21a1-41b8-b4d3-4c157bdb1f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3988e133-fe9d-4c70-9d72-725390a9e116" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_726b127c-21a1-41b8-b4d3-4c157bdb1f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_c87000e3-b5ec-4ff2-a811-063cad142cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_726b127c-21a1-41b8-b4d3-4c157bdb1f7a" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_c87000e3-b5ec-4ff2-a811-063cad142cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a9512a75-bb98-429c-80d4-7c7b454bc2d5" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a1fa0e69-9a88-4859-922c-876e066efbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a1fa0e69-9a88-4859-922c-876e066efbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_86ebed47-5122-40ae-98a2-8e0df6398415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:to="loc_us-gaap_NumberOfReportableSegments_86ebed47-5122-40ae-98a2-8e0df6398415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_1b652392-f135-4e5d-839d-334a3ff7f01d" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_615e064c-be3b-4b65-8840-edab9be55c42" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_1b652392-f135-4e5d-839d-334a3ff7f01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_64767f3f-3e31-47a4-a877-6901dfb17088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_64767f3f-3e31-47a4-a877-6901dfb17088" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83acaf3e-6b03-4976-b637-3e8a4298b1db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:to="loc_srt_ProductOrServiceAxis_83acaf3e-6b03-4976-b637-3e8a4298b1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_83acaf3e-6b03-4976-b637-3e8a4298b1db" xlink:to="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_a8cc7d36-54ec-412b-b4c8-d3ca5b4c4ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:to="loc_us-gaap_RoyaltyMember_a8cc7d36-54ec-412b-b4c8-d3ca5b4c4ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_8bb7ff3d-84db-4207-9c00-be939fcba108" xlink:href="lgnd-20230331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e55a137a-c211-42f6-83c9-2ee07133856b" xlink:to="loc_lgnd_ContractRevenueMember_8bb7ff3d-84db-4207-9c00-be939fcba108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_af9dd8bc-56b1-4e19-a54f-e9e75a021089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_af9dd8bc-56b1-4e19-a54f-e9e75a021089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_89008c81-bdc5-4097-91af-fa4aa1e58477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_af9dd8bc-56b1-4e19-a54f-e9e75a021089" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_89008c81-bdc5-4097-91af-fa4aa1e58477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_f8cb6d3f-4743-4367-9cef-672bcbbf8c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_89008c81-bdc5-4097-91af-fa4aa1e58477" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_f8cb6d3f-4743-4367-9cef-672bcbbf8c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1898bfdd-f5c2-4ae3-9958-9836dc768d62" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_ab1491f9-726d-4188-8cf1-86a58334b80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_ab1491f9-726d-4188-8cf1-86a58334b80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_41db1c2c-7853-4b6c-be9f-52f115ef3af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_ab1491f9-726d-4188-8cf1-86a58334b80b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_41db1c2c-7853-4b6c-be9f-52f115ef3af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_cb531641-219a-41b3-9a95-0d09ecbdb4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_cb531641-219a-41b3-9a95-0d09ecbdb4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_62f9af6b-f83e-4fa1-8c09-93a225842cd3" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_62f9af6b-f83e-4fa1-8c09-93a225842cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_f7443401-2ed4-4690-ae54-8b3b400c2b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_f7443401-2ed4-4690-ae54-8b3b400c2b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_90f28cf1-8218-4386-bc95-5c7fa8a0f9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_df921997-47b0-4039-8945-be4192d17440" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_90f28cf1-8218-4386-bc95-5c7fa8a0f9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_414f685d-5858-46bd-9fd3-1dc2bf235424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_414f685d-5858-46bd-9fd3-1dc2bf235424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_d3861c59-3554-4522-ba96-c0d1574f8fa5" xlink:href="lgnd-20230331.xsd#lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_d3861c59-3554-4522-ba96-c0d1574f8fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_ded3d7a9-1cb4-4384-86fe-2226f8f30792" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_d3861c59-3554-4522-ba96-c0d1574f8fa5" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_ded3d7a9-1cb4-4384-86fe-2226f8f30792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_186acb83-823b-47c7-9d02-debe78f635e9" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_186acb83-823b-47c7-9d02-debe78f635e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_5b131319-507a-4d54-81a3-868a7870c02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_5b131319-507a-4d54-81a3-868a7870c02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d57c5990-dd53-4384-af7b-d8ca629caeba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d57c5990-dd53-4384-af7b-d8ca629caeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3bd8c8c6-adc9-4ab5-afcd-3ac5adea314d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19d229b6-a93a-4a9e-b728-c40755146ca1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3bd8c8c6-adc9-4ab5-afcd-3ac5adea314d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6fe489bb-3cb9-4468-ae5e-116bacc20b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f682bab8-e4a9-4391-9f12-0a3a6939b312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6fe489bb-3cb9-4468-ae5e-116bacc20b29" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f682bab8-e4a9-4391-9f12-0a3a6939b312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f682bab8-e4a9-4391-9f12-0a3a6939b312" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9438238b-6216-4da3-9a58-3d1bd480d48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f0c243b-4a8e-4515-9cb7-a1b6dde5d6b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9438238b-6216-4da3-9a58-3d1bd480d48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_46c06b10-83f3-4b4e-85a1-1716cbfdd1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9438238b-6216-4da3-9a58-3d1bd480d48b" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_46c06b10-83f3-4b4e-85a1-1716cbfdd1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f682bab8-e4a9-4391-9f12-0a3a6939b312" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:href="lgnd-20230331.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_d3d3c327-1529-46db-9a7f-45887f866373" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_d3d3c327-1529-46db-9a7f-45887f866373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_0d7c0768-ca0f-41eb-ab4b-04b129ce4b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:to="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_0d7c0768-ca0f-41eb-ab4b-04b129ce4b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_61c4d108-8f18-4bb0-be98-4fae00186bfc" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_21a9149d-499e-459c-b0ac-c62743b49f55" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_61c4d108-8f18-4bb0-be98-4fae00186bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_ceab4bc6-038b-4a6e-9f0f-fddf6f9598dd" xlink:href="lgnd-20230331.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_ceab4bc6-038b-4a6e-9f0f-fddf6f9598dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_bc2aa060-853a-4a59-a9cf-88da94d26bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract_ceab4bc6-038b-4a6e-9f0f-fddf6f9598dd" xlink:to="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_bc2aa060-853a-4a59-a9cf-88da94d26bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_989c0fe4-17e2-459f-a790-2dbc00cd04b8" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_989c0fe4-17e2-459f-a790-2dbc00cd04b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_96cf589b-605c-49fc-ac33-d880758890ce" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_989c0fe4-17e2-459f-a790-2dbc00cd04b8" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_96cf589b-605c-49fc-ac33-d880758890ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_66bc2877-8797-4025-b1e5-dd825609e857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33620cb2-a447-4e4e-878f-ae439639df8e" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_66bc2877-8797-4025-b1e5-dd825609e857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_b84d3858-256b-4143-ae32-40edb57dd41d" xlink:href="lgnd-20230331.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_66bc2877-8797-4025-b1e5-dd825609e857" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_b84d3858-256b-4143-ae32-40edb57dd41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7dbf5a2e-43ef-4c50-89ee-706b5d06378c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7dbf5a2e-43ef-4c50-89ee-706b5d06378c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5116b757-6029-40f3-b800-2b6e0689ecc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5116b757-6029-40f3-b800-2b6e0689ecc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7d29e08-06f7-4b5c-a9f7-08f6f96faeea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5116b757-6029-40f3-b800-2b6e0689ecc5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7d29e08-06f7-4b5c-a9f7-08f6f96faeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e9e195ce-8360-49d1-9edd-ddaca2e87740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7d29e08-06f7-4b5c-a9f7-08f6f96faeea" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e9e195ce-8360-49d1-9edd-ddaca2e87740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_69e4d66b-8ae8-41d7-a158-93db3ef048b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_69e4d66b-8ae8-41d7-a158-93db3ef048b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_69e4d66b-8ae8-41d7-a158-93db3ef048b1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3bdcc841-3439-4254-88fd-b62b2de0c520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3bdcc841-3439-4254-88fd-b62b2de0c520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b76bc9d6-4663-416b-9793-ca769199b364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b76bc9d6-4663-416b-9793-ca769199b364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_816ff0ee-ae8f-48c8-a34c-c0df9be4c818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_474c7ece-2ada-4b68-b954-a9ffa4d5afff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_816ff0ee-ae8f-48c8-a34c-c0df9be4c818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_FinancialInstrumentAxis_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_da1c7a2e-eab1-4138-b5a7-acaa7272b0b2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_14856b64-1e3a-4959-b819-7dd442848cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_14856b64-1e3a-4959-b819-7dd442848cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesMember_c834ec17-e7f6-45df-88c9-8720bc311749" xlink:href="lgnd-20230331.xsd#lgnd_ContingentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d083438e-9201-4727-bb0b-0b13575bc2c2" xlink:to="loc_lgnd_ContingentLiabilitiesMember_c834ec17-e7f6-45df-88c9-8720bc311749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2062d0fa-f320-4456-b1c2-1358829dc76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2062d0fa-f320-4456-b1c2-1358829dc76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2062d0fa-f320-4456-b1c2-1358829dc76c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CyDexMember_ee71505d-a2c4-40f4-ba8e-b49063855fa0" xlink:href="lgnd-20230331.xsd#lgnd_CyDexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:to="loc_lgnd_CyDexMember_ee71505d-a2c4-40f4-ba8e-b49063855fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_27da52ec-1ba4-44cf-b50b-2a3febbcf697" xlink:href="lgnd-20230331.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6312f493-0b14-4b55-9298-9016677297d0" xlink:to="loc_lgnd_MetabasisMember_27da52ec-1ba4-44cf-b50b-2a3febbcf697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_srt_RangeAxis_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1d8b2dc9-84e9-4d68-9912-db5d2a0ad5f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1ae72ca6-b5d2-4e8e-8bca-ddd736a256c5" xlink:to="loc_srt_RangeMember_1d8b2dc9-84e9-4d68-9912-db5d2a0ad5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6de4e83-2c82-4e19-8d5a-bb47df726a6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1d8b2dc9-84e9-4d68-9912-db5d2a0ad5f3" xlink:to="loc_srt_MaximumMember_a6de4e83-2c82-4e19-8d5a-bb47df726a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_bc8ab290-0cbb-46ae-8c67-d340e47eacfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8ea94cb1-25ae-4327-a5b9-0293a6b5bb4f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_bc8ab290-0cbb-46ae-8c67-d340e47eacfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_5b897338-0313-4fa6-a2fe-678cfa6ce7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_bc8ab290-0cbb-46ae-8c67-d340e47eacfc" xlink:to="loc_us-gaap_TransferredOverTimeMember_5b897338-0313-4fa6-a2fe-678cfa6ce7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_srt_ProductOrServiceAxis_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8bd5d8f4-cb31-49ca-87f5-7b1e5210f8c2" xlink:to="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_dd9cf082-b5ba-47e3-b017-22b394a72fac" xlink:href="lgnd-20230331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_dd9cf082-b5ba-47e3-b017-22b394a72fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_8e3fe225-605c-4524-bc4a-acd06a991d3e" xlink:href="lgnd-20230331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_939637b1-6347-4a5e-a884-0c04c93227c8" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_8e3fe225-605c-4524-bc4a-acd06a991d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb853eb5-593c-444f-ac9e-ff221ec82848" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5fd35c0b-f4d9-454d-bcbe-756eb4ca059a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5fd35c0b-f4d9-454d-bcbe-756eb4ca059a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_08d07568-a9b7-4b9f-8654-1070c1e76f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_08d07568-a9b7-4b9f-8654-1070c1e76f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_fb8612f2-8fb1-4096-b104-6b3c0f62ddb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_fb8612f2-8fb1-4096-b104-6b3c0f62ddb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_459bbe40-f625-4d41-b7c4-ac57ab67dfc5" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_459bbe40-f625-4d41-b7c4-ac57ab67dfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_eca4df3b-a770-463c-80ac-592202f3591b" xlink:href="lgnd-20230331.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_eca4df3b-a770-463c-80ac-592202f3591b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d72cb4bd-06cf-4423-ba3c-c476f461f5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d72cb4bd-06cf-4423-ba3c-c476f461f5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_9fd38474-ceca-4cff-a63d-91dd6e284733" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_9fd38474-ceca-4cff-a63d-91dd6e284733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_d1a57f69-2bbc-4e8e-bc61-d2c357a11bc4" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_d1a57f69-2bbc-4e8e-bc61-d2c357a11bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_869329b7-eef4-4b78-b302-f6c7655b0761" xlink:href="lgnd-20230331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_869329b7-eef4-4b78-b302-f6c7655b0761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_0a541c8a-eebf-4c75-a757-f4207db987fa" xlink:href="lgnd-20230331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_0a541c8a-eebf-4c75-a757-f4207db987fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_c79919cf-0113-481e-9f72-d5cf741d73a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_Investments_c79919cf-0113-481e-9f72-d5cf741d73a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_fe5c4bb4-e57b-4c3a-aece-d9951877031c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_fe5c4bb4-e57b-4c3a-aece-d9951877031c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_433c74fb-abd3-4cc3-b231-2149460224b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_833962e7-f975-43c0-85ec-d7384069838b" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_433c74fb-abd3-4cc3-b231-2149460224b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e94ebee9-4850-4ee0-92bf-d8316fb49a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a5c6ba9-34dd-4665-bf45-52aa4f93f3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e94ebee9-4850-4ee0-92bf-d8316fb49a24" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a5c6ba9-34dd-4665-bf45-52aa4f93f3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ec77072-9726-4cf6-a813-31c0f41584c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a5c6ba9-34dd-4665-bf45-52aa4f93f3b2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ec77072-9726-4cf6-a813-31c0f41584c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9be0ede7-3061-4611-9ffb-f4f4f8005ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ec77072-9726-4cf6-a813-31c0f41584c2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9be0ede7-3061-4611-9ffb-f4f4f8005ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da0db73f-e9eb-494f-9f4e-f016fa0ebec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9be0ede7-3061-4611-9ffb-f4f4f8005ea6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da0db73f-e9eb-494f-9f4e-f016fa0ebec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37eeff7e-0c7c-41e6-9663-a9b16c436d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a5c6ba9-34dd-4665-bf45-52aa4f93f3b2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37eeff7e-0c7c-41e6-9663-a9b16c436d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_37eeff7e-0c7c-41e6-9663-a9b16c436d46" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7890955c-5bfa-450c-8dbb-4572b7d506a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7890955c-5bfa-450c-8dbb-4572b7d506a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_23f29dac-50c4-4b67-acb7-e8e1a2752107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_23f29dac-50c4-4b67-acb7-e8e1a2752107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf511b42-0359-4e5f-b9aa-689b420d5f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_39ecca7c-0730-4a8c-9d0e-41a68ce15c52" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf511b42-0359-4e5f-b9aa-689b420d5f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0593af7b-105f-47e9-b1a0-e1b9cf282509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_2301480f-806b-429d-8522-f9152063281e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0593af7b-105f-47e9-b1a0-e1b9cf282509" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_2301480f-806b-429d-8522-f9152063281e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_d74b7e2c-2d46-4011-b58a-7e869a7a6a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0593af7b-105f-47e9-b1a0-e1b9cf282509" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_d74b7e2c-2d46-4011-b58a-7e869a7a6a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c777ff7f-5063-4570-ae66-9c8fd16a02a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c777ff7f-5063-4570-ae66-9c8fd16a02a9" xlink:to="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_39759f1b-2a3f-470d-a205-3fbd3888aee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_39759f1b-2a3f-470d-a205-3fbd3888aee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46f2c205-c911-4319-8150-b42f545caf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_39759f1b-2a3f-470d-a205-3fbd3888aee9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46f2c205-c911-4319-8150-b42f545caf49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_43b5b3b9-ee9f-441e-bdb6-152ffd3032c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46f2c205-c911-4319-8150-b42f545caf49" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_43b5b3b9-ee9f-441e-bdb6-152ffd3032c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_438470f0-cc12-4850-9ac2-4f5292f3e437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_DebtInstrumentAxis_438470f0-cc12-4850-9ac2-4f5292f3e437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b72534d-65fb-4d36-9a32-be2e3e80cc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_438470f0-cc12-4850-9ac2-4f5292f3e437" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b72534d-65fb-4d36-9a32-be2e3e80cc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_049160f9-0707-454b-b8df-79b195a52eae" xlink:href="lgnd-20230331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b72534d-65fb-4d36-9a32-be2e3e80cc5f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_049160f9-0707-454b-b8df-79b195a52eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd440e26-6037-4d32-b269-c457ab4d083b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_srt_RangeAxis_dd440e26-6037-4d32-b269-c457ab4d083b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd440e26-6037-4d32-b269-c457ab4d083b" xlink:to="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_544afcb9-0e6b-42e1-a630-a01ceee22a09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:to="loc_srt_MinimumMember_544afcb9-0e6b-42e1-a630-a01ceee22a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a049c620-9787-4566-94ea-ac6b5ebe656d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a90d212e-adaf-483b-a4ac-455bea1ba42b" xlink:to="loc_srt_MaximumMember_a049c620-9787-4566-94ea-ac6b5ebe656d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6c7fbc62-f5ca-48a5-be98-d7dd8486c275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6c7fbc62-f5ca-48a5-be98-d7dd8486c275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6c7fbc62-f5ca-48a5-be98-d7dd8486c275" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_26e63832-ae25-4d7a-b96a-f1e54d01c031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_26e63832-ae25-4d7a-b96a-f1e54d01c031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9375b3a3-f3b2-49ce-9814-0179f2df1977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94cf786d-3afc-4cf5-aa2d-186bca191b04" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9375b3a3-f3b2-49ce-9814-0179f2df1977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_4c9ff54d-5737-4264-a5fe-8f874f0e6847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_4c9ff54d-5737-4264-a5fe-8f874f0e6847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_27fd7558-343b-4859-a67e-1687ac6499bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_4c9ff54d-5737-4264-a5fe-8f874f0e6847" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_27fd7558-343b-4859-a67e-1687ac6499bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_df6adb95-f4d9-459d-bfc8-a0d1ef3acf23" xlink:href="lgnd-20230331.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_27fd7558-343b-4859-a67e-1687ac6499bb" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_df6adb95-f4d9-459d-bfc8-a0d1ef3acf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b0825f1-d3a3-44ea-b29d-12c379c6825a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c8ed0596-e78e-437a-85ed-81cc923b8b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c8ed0596-e78e-437a-85ed-81cc923b8b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a41850e1-7489-40dc-abca-f15318a42a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a41850e1-7489-40dc-abca-f15318a42a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_6d375050-f79a-4265-9027-656e79f7d2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_6d375050-f79a-4265-9027-656e79f7d2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_b794f5e2-8fa7-442d-8fb3-f64694871476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_b794f5e2-8fa7-442d-8fb3-f64694871476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b1a1b66b-5382-421b-9bb0-3fd7c723d50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b1a1b66b-5382-421b-9bb0-3fd7c723d50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c577895c-eb92-40dd-a5e1-d5263ed29fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c577895c-eb92-40dd-a5e1-d5263ed29fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_17dfde1f-5c3b-4787-a8a2-95b73816d4c8" xlink:href="lgnd-20230331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_17dfde1f-5c3b-4787-a8a2-95b73816d4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b222e2ce-130b-4aa7-a9a4-87eabef76846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b222e2ce-130b-4aa7-a9a4-87eabef76846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_b59d4fea-c800-4992-b941-4a8b69e9f758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_b59d4fea-c800-4992-b941-4a8b69e9f758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_397f8127-cf49-4057-a11e-bdf6e068ca2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_397f8127-cf49-4057-a11e-bdf6e068ca2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c1114e7d-e2e1-44b2-a08f-d220a9545059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentTerm_c1114e7d-e2e1-44b2-a08f-d220a9545059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_6337d19e-f716-4c16-870b-f89653348c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_6337d19e-f716-4c16-870b-f89653348c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_96a73595-df7c-4983-a6df-136ef55f0e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_InterestExpenseDebt_96a73595-df7c-4983-a6df-136ef55f0e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_0883dea7-ba10-497a-ba5b-3fdacb6c4dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_0883dea7-ba10-497a-ba5b-3fdacb6c4dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_3ac6c649-3302-4460-8b6c-c231965fdd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_3ac6c649-3302-4460-8b6c-c231965fdd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_69c7cbd0-eab9-4bab-826e-ac3f582cb908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_69c7cbd0-eab9-4bab-826e-ac3f582cb908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_26d002e1-2a8c-4e98-a97c-bdc1900321cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_26d002e1-2a8c-4e98-a97c-bdc1900321cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_a7b9efb7-31d1-4da0-b9fb-addcf65531df" xlink:href="lgnd-20230331.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_a7b9efb7-31d1-4da0-b9fb-addcf65531df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2e508ed6-87a7-41a8-b253-39134615142a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2e508ed6-87a7-41a8-b253-39134615142a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_8c3aae14-27f6-4ac8-b2fb-7fd63ce13d5c" xlink:href="lgnd-20230331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_8c3aae14-27f6-4ac8-b2fb-7fd63ce13d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0da74889-eaf9-4a0c-b90d-cd116f0e3195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0da74889-eaf9-4a0c-b90d-cd116f0e3195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_d1d352de-a2bd-4948-9545-1099498ad3a2" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_d1d352de-a2bd-4948-9545-1099498ad3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bb97d7b7-3a40-4682-b3aa-5fcc1d7db45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bb97d7b7-3a40-4682-b3aa-5fcc1d7db45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e17ee029-e28d-462b-b8d7-0287d4963f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e17ee029-e28d-462b-b8d7-0287d4963f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_b20c89a5-08cd-467a-9e8e-632be9754c53" xlink:href="lgnd-20230331.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_b20c89a5-08cd-467a-9e8e-632be9754c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_259b0a62-bd6d-4e27-bf4c-a00a22b24c81" xlink:href="lgnd-20230331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f404be34-6783-4828-bb11-3ace7f1115df" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_259b0a62-bd6d-4e27-bf4c-a00a22b24c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1db6a40b-909c-422a-aebd-48bbeab8e924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1db6a40b-909c-422a-aebd-48bbeab8e924" xlink:to="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7826a314-2e6c-4c36-8535-474cdf5542a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7826a314-2e6c-4c36-8535-474cdf5542a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e919606f-9580-4e76-bed3-1e7aa343059d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7826a314-2e6c-4c36-8535-474cdf5542a5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e919606f-9580-4e76-bed3-1e7aa343059d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_f48eac4f-6347-4d27-99a1-1c8ca7be7afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e919606f-9580-4e76-bed3-1e7aa343059d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_f48eac4f-6347-4d27-99a1-1c8ca7be7afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dca9335d-5ceb-4def-8593-925103c605b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:to="loc_us-gaap_DebtInstrumentAxis_dca9335d-5ceb-4def-8593-925103c605b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f00d1c9a-27f7-4e28-9bcf-ae59510d48af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dca9335d-5ceb-4def-8593-925103c605b3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f00d1c9a-27f7-4e28-9bcf-ae59510d48af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_9b675640-edb1-496a-9519-fce9a323ce1a" xlink:href="lgnd-20230331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f00d1c9a-27f7-4e28-9bcf-ae59510d48af" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_9b675640-edb1-496a-9519-fce9a323ce1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_83814442-c524-4fe2-97e7-1da18688cf17" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d596e52c-8377-43ec-aff8-176b7b33e790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d596e52c-8377-43ec-aff8-176b7b33e790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_10decbea-844b-4156-aaee-5204a064379e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_10decbea-844b-4156-aaee-5204a064379e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_f21f45f4-23cd-4937-84ad-2b55958aa8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_8b57a203-6917-4eb1-ab83-cd63366ed1bd" xlink:to="loc_us-gaap_LongTermNotesPayable_f21f45f4-23cd-4937-84ad-2b55958aa8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_2b9675d7-bf86-403a-84dd-85f1246692b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d60b770a-34f3-4941-b430-a9f39dcabc2e" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_2b9675d7-bf86-403a-84dd-85f1246692b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#IncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7ac51d0c-fc02-4fc2-b81f-7f8a7a9d7be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a1bbb48f-8b31-455d-8b7e-bc8c649a4544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7ac51d0c-fc02-4fc2-b81f-7f8a7a9d7be3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a1bbb48f-8b31-455d-8b7e-bc8c649a4544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4ee9e4eb-c924-48a7-b04d-eec763ed70be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d43e5fd7-ef94-4d89-a8e3-3266a14dc2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4ee9e4eb-c924-48a7-b04d-eec763ed70be" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d43e5fd7-ef94-4d89-a8e3-3266a14dc2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_870dda85-2a16-4bf6-bcc4-3bec270a4242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d43e5fd7-ef94-4d89-a8e3-3266a14dc2e8" xlink:to="loc_us-gaap_AwardTypeAxis_870dda85-2a16-4bf6-bcc4-3bec270a4242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_870dda85-2a16-4bf6-bcc4-3bec270a4242" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_50ee7b2e-93c7-4029-8091-4fc2a829ccc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_50ee7b2e-93c7-4029-8091-4fc2a829ccc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6c0bf108-69f4-457c-aebf-e68cf381268f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51c0026e-0ebd-48bd-8cf6-93f46919d1c1" xlink:to="loc_us-gaap_RestrictedStockMember_6c0bf108-69f4-457c-aebf-e68cf381268f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d43e5fd7-ef94-4d89-a8e3-3266a14dc2e8" xlink:to="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0a49da39-7fac-40e1-89d9-717bd6af571e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0a49da39-7fac-40e1-89d9-717bd6af571e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a15a8f35-d606-40dc-86b7-205ea6260711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a15a8f35-d606-40dc-86b7-205ea6260711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fea54e12-7bb3-4fef-a9c9-cd487b701089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fea54e12-7bb3-4fef-a9c9-cd487b701089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_df039cbd-99ea-4a36-aed9-7b8d2fbf48ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_df039cbd-99ea-4a36-aed9-7b8d2fbf48ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c6e5057f-734e-4a2d-9ddd-ca5d9e17fd38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4793ffba-67e7-44b6-895c-b310afc68c2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c6e5057f-734e-4a2d-9ddd-ca5d9e17fd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a109fc07-8abf-4e0a-b7ac-5c937ff65487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a109fc07-8abf-4e0a-b7ac-5c937ff65487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d2049ed9-0fd4-48b5-bbd0-99d5d2c6e231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d2049ed9-0fd4-48b5-bbd0-99d5d2c6e231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_afc9d63e-3625-426b-bc54-a0968e8b5853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_afc9d63e-3625-426b-bc54-a0968e8b5853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7edb819d-3e6b-49de-8ffa-5aaba8db2bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7edb819d-3e6b-49de-8ffa-5aaba8db2bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6650e6b3-6a59-4663-8102-18730853a1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_811e18f0-732c-421d-aef3-b54c8d9fbc06" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6650e6b3-6a59-4663-8102-18730853a1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee05722f-2034-496c-96ce-308857c3d8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee05722f-2034-496c-96ce-308857c3d8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34d3e541-a293-4e69-9450-a69b972bbf26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34d3e541-a293-4e69-9450-a69b972bbf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_85a867e9-1390-4f05-ace2-6b95581391f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_85a867e9-1390-4f05-ace2-6b95581391f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2b1d1cb2-2546-45f0-bbd5-0eeb1e731ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2b1d1cb2-2546-45f0-bbd5-0eeb1e731ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d620e4a3-a3fa-4896-bd52-6adedef3520b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6535ae9f-3f93-4184-b613-6dd6877aeb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d620e4a3-a3fa-4896-bd52-6adedef3520b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_77ad895f-c920-43f9-b8cb-b8c49732a0cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9aa181de-e4ff-4c6f-9362-a6f8a95b8b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9aa181de-e4ff-4c6f-9362-a6f8a95b8b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c86df621-c189-47d8-aec2-207abce07397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c86df621-c189-47d8-aec2-207abce07397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8f7bb3b-7631-4176-af38-b6ed611c4a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8f7bb3b-7631-4176-af38-b6ed611c4a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a5e260b9-632b-4a2d-b121-a9624d4d34ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a5e260b9-632b-4a2d-b121-a9624d4d34ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f74ef92f-311f-4093-bb65-805d01bf0027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d4da2cb-67de-4173-964a-b92b01dfeb54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f74ef92f-311f-4093-bb65-805d01bf0027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_34bfc3c6-ee1a-4e4d-a8d0-f436f6f4ee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_34bfc3c6-ee1a-4e4d-a8d0-f436f6f4ee4f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_22d75d6e-1aef-436f-8b4b-2485f2aef1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:to="loc_us-gaap_PlanNameAxis_22d75d6e-1aef-436f-8b4b-2485f2aef1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_88f87301-5e15-431e-98c7-c448c8d0a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_22d75d6e-1aef-436f-8b4b-2485f2aef1b6" xlink:to="loc_us-gaap_PlanNameDomain_88f87301-5e15-431e-98c7-c448c8d0a225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_a39e284a-411e-44b9-8a55-37f7325d6f3d" xlink:href="lgnd-20230331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_88f87301-5e15-431e-98c7-c448c8d0a225" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_a39e284a-411e-44b9-8a55-37f7325d6f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_8770008e-1fd1-4ac7-89ae-7bd986aca230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_8770008e-1fd1-4ac7-89ae-7bd986aca230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6cecd8d-ddbb-48a9-8497-4156d29b61ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8770008e-1fd1-4ac7-89ae-7bd986aca230" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6cecd8d-ddbb-48a9-8497-4156d29b61ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember_635a10fa-97e3-4a72-bbdd-f14c4e87c3a2" xlink:href="lgnd-20230331.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6cecd8d-ddbb-48a9-8497-4156d29b61ad" xlink:to="loc_lgnd_AtTheMarketEquityOfferingMember_635a10fa-97e3-4a72-bbdd-f14c4e87c3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_401cc420-e67c-4c70-ae68-3d65a8fabf63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c8fd1c58-0683-4203-8fb2-38645a41a098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c8fd1c58-0683-4203-8fb2-38645a41a098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f936c8-7b7a-4527-9c52-779d588fd8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f936c8-7b7a-4527-9c52-779d588fd8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:href="lgnd-20230331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45d6686b-5440-46c0-9861-1100bc980a63" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_11aee455-613e-456c-ae10-229f2c78cb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_11aee455-613e-456c-ae10-229f2c78cb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_9e0829d2-2dc4-4f4a-beab-594a60e05e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_9e0829d2-2dc4-4f4a-beab-594a60e05e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_55edea73-2401-4f99-a9ca-d56289d744dd" xlink:href="lgnd-20230331.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_3ec4fc3f-64e5-4187-901c-0db0cc750672" xlink:to="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_55edea73-2401-4f99-a9ca-d56289d744dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20230331.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cd6a1656-76e8-4094-b809-21f68320cd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_826f6810-8059-4bd6-89aa-181bf0b90133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cd6a1656-76e8-4094-b809-21f68320cd0a" xlink:to="loc_us-gaap_LossContingenciesTable_826f6810-8059-4bd6-89aa-181bf0b90133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_22ac1fc0-bf33-401a-ba0e-77ddd10a412f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_826f6810-8059-4bd6-89aa-181bf0b90133" xlink:to="loc_srt_LitigationCaseAxis_22ac1fc0-bf33-401a-ba0e-77ddd10a412f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9a18a01e-302c-4086-9f7f-b64c148fbfc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_22ac1fc0-bf33-401a-ba0e-77ddd10a412f" xlink:to="loc_srt_LitigationCaseTypeDomain_9a18a01e-302c-4086-9f7f-b64c148fbfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_1aed8cf6-f4c4-42ba-a73b-90b10ebbd3af" xlink:href="lgnd-20230331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9a18a01e-302c-4086-9f7f-b64c148fbfc9" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_1aed8cf6-f4c4-42ba-a73b-90b10ebbd3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_826f6810-8059-4bd6-89aa-181bf0b90133" xlink:to="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_be417368-aa20-4286-8106-3b91261b6909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_be417368-aa20-4286-8106-3b91261b6909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification_96513d12-edaf-47f9-bd05-3a94a7454bde" xlink:href="lgnd-20230331.xsd#lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:to="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification_96513d12-edaf-47f9-bd05-3a94a7454bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification_b5dd908b-f6c9-4521-846d-5ff653624a61" xlink:href="lgnd-20230331.xsd#lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7d61d7c-d710-4acd-b5eb-f50011f8e7b0" xlink:to="loc_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification_b5dd908b-f6c9-4521-846d-5ff653624a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>lgnd-20230331_g1.jpg
<TEXT>
begin 644 lgnd-20230331_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (+!<8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\IP<88*1\RY%?E!^TU\ /%G_  3Z_:3BM;74;J":PE74O#^M0#RS<Q;CM?N
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MIKEW/?W/A359-+M[B9R\CV_E1RQJS'DE2[*,]%"CM7UM7PQ_P09_Y-T\8_\
M8QG_ -)8:^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><__I7-
M7XAU^WG_  2\_P"3"_AU_P!><_\ Z5S4I >^4445 !1110 5@?%3P!:_%;X9
M^(?#%]@6GB'3KC3I6QDHLL;)N'N-V1[@5OT4 ?@M\(/&FK_L9_M7Z5JE_:NF
MI^!]::#4+9>&=%9H;B-2<?>C,@!Z?,#7[:>-/%NG>/?V>=9UO2+N*^TO5O#]
MQ=VEQ&<K-$]NS*P^H-?'7_!7#_@GA>?$UYOBCX'L&NM;MX0-=TV!,RW\:+A;
MB-1RTBJ &4<LJ@CE<-\X?\$_O^"E]_\ LJ6K>$/%5G/XA^']W(V;< -<:67)
M\PQ*W#QMDEHF(&<D$$L&IZ@4/^"._P#R?IX7_P"O._\ _222OTP_X*%_"0?&
MG]CCQWI"0&>\M].;4K-57+^=;$3J%_VF"%/HY'>C]G7XA? CXFS6VK_#H_#\
M:GM(065E;V>HP;A@@QE5F3()'3!YZU[!JVJ6FBZ?+<WUS;VEI$I:26>18XT'
M<ECP!]:38'XY_P#!'GXH+\.OVVM&M)IO)M?%5E<Z/(2?E+LHEB!]S)"BCW>O
MIC_@N7^TA;:)\/-&^&-A<*^HZW.FJ:HBG)AM8B?*1O=Y?F'_ %Q]QG6_:J_;
MO^ 7[.5M+%X%\*^ _%WC>V8/9OINE6QLM/F!RLKW*+@E2,A8F+9&"4ZCX8^#
MGP;^(7_!1G]HNZ=I[B_U'5+@76MZU.F8-/B) W-C &%&V.-<9V@# !(?F!]7
M_P#!!_X%S";QC\1+R K;R1+H&GLR\3?,LUP1GL"L !'?<.U%?>WP7^$.B_ 7
MX7:+X1\/P&#2M$MQ!%NY>5NKR.>[NQ9F/JQX XHI,#^>^BBBK **** "BBB@
M#]4?^"#/_)NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/_ &,9_P#26&ON>H>X!111
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^<>OZ.
M*_G'JH@%%%%4 4444 %?MY_P2\_Y,+^'7_7G/_Z5S5^(=?MY_P $O/\ DPOX
M=?\ 7G/_ .E<U*0'OE%%%0 4444 %%%% !7R[^UI_P $HOAW^TUJ%SK-AYG@
MOQ3<9:2^T^%6M[IS_%-;Y"LV>2R%&)/)-?45% 'Y$?$+_@B3\8O"EVXT9_#7
MBBVY,;6U_P#9I2/]I9@B@^P9A[US=A_P2/\ V@]<N(XKOPG#:1Q*$22ZUVR=
M(UST 29R /0"OV;HI\P'YL? K_@@]?2WD5U\1_%UM#;J06T_05:1Y!GH9Y5
M7W C;KP1BOO[X/\ P4\+? /P7!X?\(Z+9Z)I<'/EP*2\S="\CG+2.?[S$G@<
M\5U-%%P"BBBD!_./1116@!1110 4444 ?JC_ ,$&?^3=/&/_ &,9_P#26&ON
M>OAC_@@S_P FZ>,?^QC/_I+#7W/4/< HHHI %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6#XW^*/AKX:VPF\0Z_HVAQL-RF^O(X-X_V0Q!/X5\?_P#!0/\ X**Z
MCX*\37G@7P#="UO;%C#JVK( SPR=X(>H#+T9^H;(&"":^#]:UR]\2:I-?:C>
M75_>W#;Y;BYE:664^K,Q))^IK\CXH\5\+EV(E@\#3]K.+LVW:*?9;MVZ[+S9
M^Q<*>$6*S+#QQF/J>RA)722O)KHWLHWZ;OR1^KVN?\%'?@QH3LC^-(;B11D+
M;6%U,&^C+&5_6LK_ (>C?!K_ *&"_P#_  57/_Q%?E917P,_&7.F[QITDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><
M_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%%%0 4444 %%%% !1110
M4444 %%%% !1110!_./1116@!1110 4444 ?JC_P09_Y-T\8_P#8QG_TEAK[
MGKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %<C\>_B./A%\%O%'B7*B71]-FN( W1I@I$2GZN5'XUUU?//\ P5'UI]*_
M8XUZ%,C^T+NSMF(]//23_P!IUY'$&-E@\LQ&*AO"$FO5)V_$]GAW QQF:8;"
M3^&<XI^CDK_@?EG?W\^JWT]U<RR3W-S(TLLKMN:1V.2Q/<DDFH:**_B-MMW9
M_=222L@HHHI#"BBB@"YX>U^[\*Z_9:G83/;7VG3I<V\J'#12(P96'T(!K]L/
MAEXVA^)7PXT'Q# H2+7-/@OU0'.SS(U?;]1G'X5^(=?K;_P3KUB37/V,? \\
MOWDM[BW'/\,5U-&OZ(/_ *]?M7@MC9QQV(P=])04OG%I?^W'X=XX8&$L!AL;
M;6,W'Y2BW_[:>UT445_11_-@4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7\X]?T<5_./51 ****H HHHH *_;S_@EY_P F%_#K
M_KSG_P#2N:OQ#K]O/^"7G_)A?PZ_Z\Y__2N:E(#WRBBBH **** "BBB@ HHH
MH **** "BBB@ HHHH _G'HHHK0 HHHH **** /U1_P""#/\ R;IXQ_[&,_\
MI+#7W/7PQ_P09_Y-T\8_]C&?_26&ON>H>X!1112 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<AXH_:"\!>!Y3'K7C?PAH[J<%;W6;>W(/T=Q0!U]%
M>/:A_P % _@IIJJ9/B9X2;?T\J]$OY[,X_&C3_\ @H'\%-25C'\3/"2[.OFW
MHB_+?C/X4 >PT5P.A?M6?"_Q.R+IWQ&\"WLCA2(X==M6?GH"H?(/L1FNVTS5
MK76K19[.YM[N!NDD,@D0]^HX[T 6**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BL_P 0>+=*\)VXFU74]/TR
M$\A[NX2%?S8@5PVL_MC_  E\/LRW?Q-\!Q2*0&C&NVSR+D9&55R1Q[4 >DT5
MXU>_\%#/@E83^7)\2_"S,!G,=SYJ_FH(JSIO[>WP7U98S%\3O!J>:VT>=J4<
M.#G'.\C ]S@4 >N45R_A7XW^"_';JNA^+_"^LL^-HL=5@N"V>F-C&NHH ***
M* "BBB@ HHHH *_G'K^CBOYQZJ(!1115 %%%% !7[>?\$O/^3"_AU_UYS_\
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MGFM;JV<2PS0N4DB<'(96'((/((K]9?\ @F)_P4I3]H[3X/ _C6XA@\<V,/\
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M $U^\?X=N-S?GW<W,E[<R332/+-*Q=W=BS.Q.223R23WIE%6D 4444 %%%%
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M $KFK\0Z_;S_ ()>?\F%_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH ****
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M110 4444 ?SCT445H 4444 %%%% 'ZH_\$&?^3=/&/\ V,9_])8:^YZ^&/\
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M=^TG)\3/@3J'@74KCS-3\#2+]C+M\TEC,6*#GD^7('7T"M&*_)ZOH+_@E_\
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M]I/_ ).+\??]C'J/_I5)7%5H@"BBB@ HHHH **** "BBNK^"_P $_$W[07Q
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M544 ?@-^T3^S'XR_9:\;MH7C#2GLIGRUM=1YDM+] <;X9, ,.F1PPR,@'BN
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MS_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQS^SSX$UIFWOJOAZPNW.>=SV\;,#R>02<\GFNTK, HHHH **** /Y_/VD_\
MDXOQ]_V,>H_^E4E<57:_M)_\G%^/O^QCU'_TJDKBJT0!1110 4444 %%%=I\
M /@)XD_:4^)^G^%/"]DUU?WK9DD((ALH01OGE;^%%!Y/4D@ %B 0";]G7]G7
MQ/\ M0?$ZS\+>%K,W%Y<?//.^1;V$((#32MCY4&?J20 "2 ?VE_9$_8[\*?L
M=_#M-'T" 7&IW2HVJ:M*@%QJ4HSR>NU!D[4!PH/=BS&3]D7]D7PQ^Q[\,8M!
MT&(7%]<;9=4U25 +C4I@/O-_=09(5 <*">I+,?5:AL HHHI %%%% !1110 4
M444 %%%% !7Y>?\ !;K]E5/!GCS3?BAH]H(K#Q*PL=9$:X6.]5<QRD=O,C4@
M_P"U$2>7K]0Z\[_:P^!MO^T?^SQXJ\'S(AFU6R;[$[8_<W2?/ ^>P$BKGD9&
M1WII@?@714EW:RV-U+!-&\4T+E)$<89&!P01V(-1U8!1110 4444 ?L3_P $
M9?B8?'G[%=CITLF^?PGJ=SI9R?FV$BX3\ )]H_W/:OJ^OS;_ ."!7CCR]6^(
M_AJ1P?.AL]3@3=TV-+'(<=\[XN>V!ZU^DE0]P"BBBD 4444 %,N;F.RMI)II
M$BAB4N[NP544#)))X  [T^OG7_@J?\;6^"/[&/B66WF,.I>)=N@V; D'=.&\
MT@CD$0+,0?4"@#\G/VP?CQ+^TI^T?XJ\7L[FTU"\:/3T;(\JTC_=PKCL=BJ3
M_M,Q[UYI116@!1110 4444 6=%T:[\1ZS::?86\MW?7\R6]O!$NYYI'8*J*.
MY)( 'O7[>_L!_L>6'['GP/M=+:.&7Q1JP2[UV\7!,L^.(E;_ )YQ E5[$[FP
M"QKXD_X(E_LJ+X^^)=_\3=6M]^E^$G^R:6'7*SWSI\S_ /;*-@?]Z5".5K]3
M:F3 ****D HHHH **** "BBB@ HHHH *I^(/#]CXKT.[TS4[2WO].OX6M[FV
MN(Q)%/&PPRLIX((.,&KE% 'Y$?\ !2G_ ()H77[,6I3^,/!MO<7OP_NY/WL6
M6EET%V. CDY+0DG"R'D$A6.=K/\ 'U?T8:OI%IX@TJYL;ZV@O+*\B:"XMYXQ
M)%-&P(9&4\%2"00>N:_(O_@II_P3AG_9=UY_%OA&WN;KP!J4OSIS(VA2L>(G
M/4Q,3A'/3[K'.TO28'R'1115 %%%% !1110 5^WG_!+S_DPOX=?]><__ *5S
M5^(=?MY_P2\_Y,+^'7_7G/\ ^E<U*0'OE%%%0 4444 %%%% !1110 4444 %
M%%% !1110!_./1116@!1110 4444 ?JC_P $&?\ DW3QC_V,9_\ 26&ON>OA
MC_@@S_R;IXQ_[&,_^DL-?<]0]P"BBBD 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?S^?M)_\G%^/O\ L8]1_P#2J2N*KM?VD_\
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M HHHH **** -CX?^ -8^*?C73?#N@6$^IZQJ\XM[6VB&6D8_H !DDG@ $D@
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MU:8!1113 **** "OV\_X)>?\F%_#K_KSG_\ 2N:OQ#K]O/\ @EY_R87\.O\
MKSG_ /2N:E(#WRBBBH **** "BBB@ HHHH **** "BBB@ HHHH _G'HHHK0
MHHHH **** /U1_X(,_\ )NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/\ V,9_])8:
M^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_26&ON>H>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /Y_/VD_P#DXOQ]_P!C'J/_ *525Q5=K^TG_P G%^/O^QCU'_TJ
MDKBJT0!1110 4444 ?M5_P $D_\ E'S\/_\ N(_^G*ZKZ.KYQ_X))_\ */GX
M?_\ <1_].5U7T=4, HHHI %%%% 'R)_P6O\  K>*_P!BU]11-S>&=;M+]V"Y
M*H^^V(SV&Z=?R%?D%7[_ '[3GPH'QQ_9[\8^$PJM-K>E3P6V[HMQM+0L?I(J
M'\*_ 2XMY+2=XI4>*6)BCHX*LA!P00>A%5$!E%%%4 4444 ?7G_!%GXPI\.O
MVNQH=S(4M/&FG2Z>H)PHN(\31$_@DB#WD%?KY7\[G@7QGJ'PY\::3X@TF;[/
MJ>B7D5]:R8R$EC<.I([C(&1W%?OG\ /C/I?[0GP<\/\ C'2'4V>N6BS% <FW
ME'RRQ'_:20,A]U]*F2 ["BBBI **** "BBB@ HHHH **** "H[N[BL+66>:1
M(H84,DCN<*B@9))[ "I*^4O^"N_[3\7P)_9ENO#]E<!?$7CQ7TRW16P\-K@?
M:9?IL(C'O*#SM- 'Y7?M-_%U_CS^T#XO\7DMY6N:G+/;A@04@!VPJ<]Q$J#\
M*X6BBM "BBB@ HHKJ/@E\-+CXR?&#PQX4M@_F^(-3@L=RC)C5Y K/]%4EC["
M@#]K_P#@G_X!/PT_8O\ AQI3+LD.C17TBXP5>Y)N6!]PTI!]Z]AJ&PL(=+L(
M+6WC6&WMHUBBC7@(JC  ]@!4U9@%%%% !1110 4444 %%%% !1110 4444 %
M%8GC/XE>'/AQ9BX\1:_HF@VY&1+J-]%:ICZNP%>*^./^"J'P)\"ETE\=6VIS
MIG$6F6D]WOQZ.B&/\V% 'T+17P_XN_X+N?#32W=-&\+^,=7=>CS1V]K$_P!#
MYCM^:BO./$G_  7YOI=RZ1\,K2#'W9+S6VFSR.JK"N.,_P 1_I3LP/TGHK\H
M]:_X+N_%*Z9Q8>&/ EFC @&6VNIG3/0@^>HR/=2/;M7.7_\ P6O^-EY(K1R^
M%+4 8*Q:5D'W^9V-'*P/U_HK\:9O^"Q?QYEF=E\2Z7&K,2$71K7"^PRA./J3
M3?\ A\1\>O\ H:--_P#!-:?_ !%/E _9BBOQG_X?$?'K_H:--_\ !-:?_$4?
M\/B/CU_T-&F_^":T_P#B*.4#]F**_&?_ (?$?'K_ *&C3?\ P36G_P 11_P^
M(^/7_0T:;_X)K3_XBCE \X_;N_Y/-^)__8R7O_HUJ\FK9^(?CW4_BEXYU;Q'
MK4R7&K:W=27EW*L:QK)*YW,0J@ <GH!6-5 %%%% !1110!^S'_!'?_DPSPQ_
MU^7_ /Z525]05\O_ /!'?_DPSPQ_U^7_ /Z525]05# ****0!1110!_/Y^TG
M_P G%^/O^QCU'_TJDKBJ[7]I/_DXOQ]_V,>H_P#I5)7%5H@"BBB@ HHHH _:
MK_@DG_RCY^'_ /W$?_3E=5]'5\X_\$D_^4?/P_\ ^XC_ .G*ZKZ.J& 4444@
M"BBB@ HHHH **** "BBB@ HHHH **** /FC_ (*]:?\ ;?V O&<F_;]DFT^7
M&,[\WT"8]OOY_"OQ>K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K
M^S9_R<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D H
MHHH ^/O^"W7B@Z#^QC#9AB#K?B"TM" >H5)I_P LPC]*_(BOT]_X+XZVT'PJ
M^'VG#=MNM6N;D\#&8X54<]?^6I_7VK\PJN(!1113 **** "OZ%/@WX0_X5]\
M(/"F@[2O]B:/::?M(QCRH$CQ_P".U^!WP=\.CQ?\7/"NDL 1JFL6EH0>G[R9
M$]#Z^AK^A6ID 4445(!1110 4444 %%%% !1110 4444 %%%% !1110 5_./
M7]'%?SCU40"BBBJ **** "OV\_X)>?\ )A?PZ_Z\Y_\ TKFK\0Z_;S_@EY_R
M87\.O^O.?_TKFI2 ]\HHHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ*
M**T **** "BBB@#]4?\ @@S_ ,FZ>,?^QC/_ *2PU]SU\,?\$&?^3=/&/_8Q
MG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L/%>BVNI:7>VFHZ=>QB:WNK:5989T/1E=20P/J#4- 7****0!1110 4444
M%%%<A\;/COX4_9W\#S^(?%^L6VD:;#\J%SNEN7QQ'$@^9W/HH]2< $T :/Q/
M^)FB_!SP#JGB;Q%?1Z=HVCP&>YG?L.@4#JS,2%51R20!R:_#;]L+]J#5?VM_
MCCJ?BS4?,M[1S]FTNR9MPL+12=D?IN.2S'NS,>F .W_;V_X*"Z]^V?XK2VB2
M?1?!6F2EM/TK?EI6Y N+C'#2D'@#*H"0,DLS?.]6D 4444P"BBB@ K[8_P""
M'WP,/CC]HK5/&EU;E[#P78E;>0@[?MEP#&N.QQ$)L^A93Z5\4PPO<3)'&C22
M2$*JJ,EB>@ [FOW#_P""=G[,O_#+/[,&BZ+=PB+7]4_XFNLY&&6YE5?W1_ZY
MH$C],HQ'6DP/<Z***@ HHHH **** "BBB@ HHKR;]I_]M;X?_LDZ)Y_BK5P=
M2F3?:Z19@37]UZ$1Y 5?]MRJ\8SGB@#UFO-/CM^V#\-_V;;9CXO\5Z;IUV%W
M+81N9[V3TQ"F7P?[Q 7WK\R/VG?^"PGQ+^-LUUI_AB;_ (0/P[+N18[!\W\R
M>KW&-RG_ *Y!,9QEJ^3;R\FU&[DGN)9)YYF+R22,6=V/)))Y)/K5<H'Z/?&S
M_@O+#!--:_#SP8TX&1'J&O2[ 3Z_9XCDCOS*#["OE7XL?\%,/C7\7S-'>>.-
M1TFSEZ6NC :<B+_=W18D8?[SG/3I7@]%.P%C5-5NM;OI+J]N;B\N93EYIY#)
M(Y]V/)JO113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F/\
M@CO_ ,F&>&/^OR__ /2J2OJ"OE__ (([_P#)AGAC_K\O_P#TJDKZ@J& 4444
M@"BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[2?\ R<7X^_[&/4?_ $JDKBJT
M0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G*ZKZ.KYQ_P""2?\ RCY^'_\
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M<=.5-? WQA^./BSX_>+7USQAKM_KNHL"J/</\D"YSLC086-,_P *@"N4HII
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MO_@YM/\ XNC_ (<[_'K_ *%?3?\ P<VG_P 71<#Y?HKZ@_X<[_'K_H5]-_\
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M% 'ZH_\ !!G_ )-T\8_]C&?_ $EAK[GKX8_X(,_\FZ>,?^QC/_I+#7W/4/<
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MA7>Y520BY R?09(&?<4R@ HHHH **** "BBB@ HHHH **** "BBB@ HH +$
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MX[U3XG^-M5\1:W=O>ZMK5T]W=3/U>1R2<#L!T '   ' K(JT@"BBBF 4444
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M"VABMX(AM2.- B(/0 <"I:*0!1110 4444 %%%% !1110!^$'[=W_)YOQ/\
M^QDO?_1K5Y-7K/[=W_)YOQ/_ .QDO?\ T:U>35H@"BBB@ HHHH _9C_@CO\
M\F&>&/\ K\O_ /TJDKZ@KY?_ ."._P#R89X8_P"OR_\ _2J2OJ"H8!1112 *
M*** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^_P"QCU'_ -*I*XJM$ 44
M44 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_X))_\H^?A_\ ]Q'_ -.5
MU7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?./_  5L_P"4?/Q
M_P"X=_Z<K6OQ5K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K^S9_
MR<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D HHHH
M_-7_ (+]Z:8O$OPPO-J!9[;4H0P^\2CVQP?8>8,?4U^>-?IK_P %]=!^T?#W
MX<ZGLR+/4;RUW;,X\V*)L9[9\GIWQ[5^956M@"BBBF 4444 =I^S?K1\-_M$
M> M1!(-AXCT^Y! R1LN8VZ'KTK^@2OYS+"]?3;Z&XB($MO(LB9&1D'(_E7]%
M.AZO%X@T6SOX#F"]@2XC.<Y5U##]#4R M4445(!1110 4444 %%%% !1110
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MHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?\
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M%7P?PUI\N-;OX),KJLZ'(@0CK"C#)/1W QPH+?"-6D 4444P"BBB@ K]O/\
M@EY_R87\.O\ KSG_ /2N:OQ#K]O/^"7G_)A?PZ_Z\Y__ $KFI2 ]\HHHJ "B
MBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?^"#/_)N
MGC'_ +&,_P#I+#7W/7PQ_P $&?\ DW3QC_V,9_\ 26&ON>H>X!1112 ****
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MW!'_ '[_ -[[OY5W-S)>W,DTTCRS2L7=W8LSL3DDD\DD]ZI(!E%%%4 4444
M%%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DPOX=?]><__I7-
M2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT445H 4444 %%%%
M 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8S_Z2PU]SU#W
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M@_;:_IS0VVL6H6#6=,#Y?3[C![=3&^"4;N,C[RL!Z[68!1110 4444 %%%%
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M:K_@DG_RCY^'_P#W$?\ TY75?1U?./\ P23_ .4?/P__ .XC_P"G*ZKZ.J&
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MDDD)9F8Y+$]23W--HHJ@"BBB@ HHHH **** "OV\_P""7G_)A?PZ_P"O.?\
M]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH _G'HHHK0 HHHH **** /:?V9_V^?B%^R9X4O]%\'W.E0V.I
M7?VV875DL[&38J<$G@84<5Z3_P /I/CA_P __AO_ ,%*?XU\FT4K ?67_#Z3
MXX?\_P#X;_\ !2G^-'_#Z3XX?\__ (;_ /!2G^-?)M%%D!]9?\/I/CA_S_\
MAO\ \%*?XT?\/I/CA_S_ /AO_P %*?XU\FT460'UE_P^D^.'_/\ ^&__  4I
M_C1_P^D^.'_/_P"&_P#P4I_C7R;119 ?67_#Z3XX?\__ (;_ /!2G^-'_#Z3
MXX?\_P#X;_\ !2G^-?)M%%D!]9?\/I/CA_S_ /AO_P %*?XT?\/I/CA_S_\
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MA!)%+$X=)5(R&5AP01W%35^+'[#O_!23Q=^R%JT.FW4EQXB\#ROB?2)I<M:
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M?_*/GX?_ /<1_P#3E=5]'5\X_P#!)/\ Y1\_#_\ [B/_ *<KJOHZH8!1112
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M$UXE10!_0]\.?B'H_P 6? VE^)/#]]%J.C:S;K<VMQ'T=3V(/*L#D%3RI!!
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M\_Y,+^'7_7G/_P"E<U?B'7[>?\$O/^3"_AU_UYS_ /I7-2D![Y1114 %%%%
M!1110 4444 %%%% !1110 4444 ?AK_P4.^ =W^SU^UCXKTR6W>+3-5NY-7T
MN0KA);:=V<!3WV,6C/O&:\1K]XOVL_V//"'[8G@1-'\302PWED6DTW4[;"W6
MGR,!DJ2,,C8&Y#PV!T(5A^8WQY_X(_?%[X1:G.^BZ;%XYT9,F.[TIE$^.P>V
M8^8&]DWC_:JTP/E:BO2'_8W^+L;E3\+/B-E3CCPW>$?GY=)_PQU\7?\ HE?Q
M'_\ ":O?_C=,#SBBO1_^&.OB[_T2OXC_ /A-7O\ \;H_X8Z^+O\ T2OXC_\
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M?%FAZ=KVF2\^3=Q!]C8QN1OO(WHRD$>M-,#^>JBOTI_:,_X(56=^]QJ'PO\
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MG>$_"6E^!/#MII&BZ?9Z5I=A&(K>UM85BAA4=E5>!6C114@9OC+_ )%#5?\
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M HHJYH7AW4/%.I)9Z98WFHWDGW(+6%II&^BJ"30!U/[-G_)Q?@'_ +&/3O\
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M#P3_ .".U_\ B*U?#WPG\*^$9$?2?#7A_2WCY5K33H8"O.>-JC'(!^HKH**
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M+_X(<^#FU[]KK4=49#Y.A>'[B4/C@222Q1*/Q5I#_P !-)@?K;1114 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\C'_ "RVX/OZ\]:.8#\)**_8GXP?\$O?@5I&@?;;7P'';W#SHA,>K7ZKC:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218563008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 04, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard, Suite 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,272,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217659232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 88,728<span></span>
</td>
<td class="nump">$ 45,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">193,937<span></span>
</td>
<td class="nump">166,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">29,188<span></span>
</td>
<td class="nump">30,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">14,011<span></span>
</td>
<td class="nump">13,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,331<span></span>
</td>
<td class="nump">3,399<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">328,195<span></span>
</td>
<td class="nump">263,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">8,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">333,916<span></span>
</td>
<td class="nump">342,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">105,673<span></span>
</td>
<td class="nump">105,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license rights, net</a></td>
<td class="nump">10,431<span></span>
</td>
<td class="nump">10,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,743<span></span>
</td>
<td class="nump">12,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">11,666<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">3,943<span></span>
</td>
<td class="nump">4,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,634<span></span>
</td>
<td class="nump">4,736<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">811,076<span></span>
</td>
<td class="nump">762,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,135<span></span>
</td>
<td class="nump">5,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">14,977<span></span>
</td>
<td class="nump">15,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">76,790<span></span>
</td>
<td class="nump">76,695<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">98,929<span></span>
</td>
<td class="nump">98,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">2,776<span></span>
</td>
<td class="nump">3,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">30,010<span></span>
</td>
<td class="nump">30,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">11,183<span></span>
</td>
<td class="nump">10,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">21,861<span></span>
</td>
<td class="nump">21,966<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">164,759<span></span>
</td>
<td class="nump">165,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 17,134 and 16,951 shares issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">154,424<span></span>
</td>
<td class="nump">147,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(935)<span></span>
</td>
<td class="num">(984)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">492,811<span></span>
</td>
<td class="nump">450,862<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">646,317<span></span>
</td>
<td class="nump">597,485<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 811,076<span></span>
</td>
<td class="nump">$ 762,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217518640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">17,134<span></span>
</td>
<td class="nump">16,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">17,134<span></span>
</td>
<td class="nump">16,951<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218604112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 43,979<span></span>
</td>
<td class="nump">$ 36,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">3,717<span></span>
</td>
<td class="nump">4,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">8,539<span></span>
</td>
<td class="nump">8,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">9,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,855<span></span>
</td>
<td class="nump">11,925<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">29,774<span></span>
</td>
<td class="nump">34,383<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income from continuing operations</a></td>
<td class="nump">14,205<span></span>
</td>
<td class="nump">2,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="nump">39,533<span></span>
</td>
<td class="num">(12,877)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1,435<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(240)<span></span>
</td>
<td class="num">(789)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">41,331<span></span>
</td>
<td class="num">(11,277)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes from continuing operations</a></td>
<td class="nump">55,536<span></span>
</td>
<td class="num">(9,144)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(11,922)<span></span>
</td>
<td class="num">(3,785)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income (loss) from continuing operations</a></td>
<td class="nump">43,614<span></span>
</td>
<td class="num">(12,929)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="num">(1,665)<span></span>
</td>
<td class="num">(2,456)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 41,949<span></span>
</td>
<td class="num">$ (15,385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income (loss) from continuing operations per share (in USD per share)</a></td>
<td class="nump">$ 2.56<span></span>
</td>
<td class="num">$ (0.77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic net loss from discontinued operations per share (in USD per share)</a></td>
<td class="num">(0.10)<span></span>
</td>
<td class="num">(0.15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (in USD per share)</a></td>
<td class="nump">$ 2.46<span></span>
</td>
<td class="num">$ (0.91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (in shares)</a></td>
<td class="nump">17,063<span></span>
</td>
<td class="nump">16,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income (loss) from continuing operations per share (in USD per share)</a></td>
<td class="nump">$ 2.43<span></span>
</td>
<td class="num">$ (0.77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Diluted net loss from discontinued operations per share (in USD per share)</a></td>
<td class="num">(0.09)<span></span>
</td>
<td class="num">(0.15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (in USD per share)</a></td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="num">$ (0.91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (in shares)</a></td>
<td class="nump">17,974<span></span>
</td>
<td class="nump">16,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 17,154<span></span>
</td>
<td class="nump">$ 13,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">10,622<span></span>
</td>
<td class="nump">12,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 16,203<span></span>
</td>
<td class="nump">$ 10,962<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052221667072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 41,949<span></span>
</td>
<td class="num">$ (15,385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="nump">49<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 41,998<span></span>
</td>
<td class="num">$ (15,499)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052216663456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th">
<div>Additional paid in capital </div>
<div>Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">$ (15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 372,969<span></span>
</td>
<td class="num">$ (51,130)<span></span>
</td>
<td class="num">$ (917)<span></span>
</td>
<td class="nump">$ 449,090<span></span>
</td>
<td class="nump">$ 35,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2022</a></td>
<td class="nump">$ 793,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">325,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
<td class="nump">468,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="nump">16,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 597,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">147,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(984)<span></span>
</td>
<td class="nump">450,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="num">(762)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(762)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">5,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation', window );">Final distribution of OmniAb</a></td>
<td class="nump">1,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="nump">$ 41,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2023</a></td>
<td class="nump">17,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2023</a></td>
<td class="nump">$ 646,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 154,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (935)<span></span>
</td>
<td class="nump">$ 492,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid in Capital, Increase Due To Separation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217540768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 41,949<span></span>
</td>
<td class="num">$ (15,385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(670)<span></span>
</td>
<td class="num">(1,035)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">9,499<span></span>
</td>
<td class="nump">13,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on investments, net</a></td>
<td class="num">(282)<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights', window );">Amortization of commercial license rights</a></td>
<td class="num">(379)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on debt extinguishment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,532)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">5,931<span></span>
</td>
<td class="nump">9,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="nump">8,754<span></span>
</td>
<td class="num">(16,180)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">(Gain) loss from short-term investments</a></td>
<td class="num">(39,533)<span></span>
</td>
<td class="nump">12,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization', window );">Lease amortization expense</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">240<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">1,099<span></span>
</td>
<td class="nump">43,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">2,035<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(435)<span></span>
</td>
<td class="num">(2,708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="nump">4,614<span></span>
</td>
<td class="nump">11,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(2,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="nump">682<span></span>
</td>
<td class="num">(1,723)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">33,948<span></span>
</td>
<td class="nump">52,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(39,864)<span></span>
</td>
<td class="num">(38,190)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">44,232<span></span>
</td>
<td class="nump">132,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">8,465<span></span>
</td>
<td class="nump">24,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid for equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(2,414)<span></span>
</td>
<td class="num">(4,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProceedsFromCommercialLicenseRights', window );">Proceeds from commercial license rights</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">10,549<span></span>
</td>
<td class="nump">113,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase of 2023 Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(163,356)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under financing lease obligations</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">3,393<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(4,155)<span></span>
</td>
<td class="num">(5,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(775)<span></span>
</td>
<td class="num">(170,421)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">43,722<span></span>
</td>
<td class="num">(4,529)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">45,006<span></span>
</td>
<td class="nump">19,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">88,728<span></span>
</td>
<td class="nump">14,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">2,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain (loss) on AFS investments, net of tax</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">$ (114)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Commercial License And Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromCommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromCommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052220813840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed the separation (the &#8220;Separation&#8221;) of our antibody discovery business and certain related assets and liabilities (the &#8220;OmniAb Business&#8221;) through a spin-off of OmniAb to Ligand&#8217;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#8220;Distribution&#8221;) and merger (the &#8220;Merger&#8221;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#8220;New OmniAb&#8221;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#8220;Merger Agreement&#8221;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#8220;Separation Agreement&#8221;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#8220;Transaction Agreements&#8221;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2022 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 205-20&#8221;). Accordingly, the accompanying condensed consolidated financial statements have been updated to present the results of all discontinued operations reported as a separate component of loss in the condensed consolidated statements of operations and comprehensive loss (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Spin-off of OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). All disclosures have been adjusted to reflect continuing operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2022 Annual Report. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Captisol Sales</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2023 and 2022, the amount recognized as revenue that was previously deferred was $0.1 million, and $0.3 million, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:68.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.833%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2023 and December 31, 2022 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:38.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,691&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bond fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(807)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,051)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bond fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,451)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we sold 3.2&#160;million shares of Viking common stock and recognized realized gain of $20.5 million in total.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended  March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 68 investments which were in an unrealized loss position with a total of $0.1&#160;million unrealized losses as of March&#160;31, 2023. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three months ended  March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three months ended  March&#160;31, 2023, we considered the current and expected future economic and market conditions and concluded an increase of $0.1 million of allowance for credit losses as of March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs recorded against inventory for the three months ended  March&#160;31, 2023 and 2022. As of March&#160;31, 2023 inventory consists of Captisol prepayments of $5.4 million, and as of December 31, 2022 inventory consists of Captisol prepayments of $5.9 million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">439,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License Rights</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,867)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,116)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.4 million and credit loss adjustments of $6.5 million as of March&#160;31, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December&#160;31, 2022.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2022 Annual Report. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended  March&#160;31, 2023, we further considered the current and expected future economic and market conditions and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,681&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares are dilutive. The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,974&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,359&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,001&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052221614224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Spin-off of OmniAb</a></td>
<td class="text">Spin-off of OmniAb<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2022, we entered into the Separation Agreement to separate our OmniAb Business and the Merger Agreement, pursuant to which APAC would combine with OmniAb, and acquire Ligand's OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#8220;Transactions&#8221;). In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following two reportable segments: (1) OmniAb Business and (2) Ligand core business. The OmniAb Business segment was focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb Business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing date of the Transactions on November 1, 2022, the historical financial results of OmniAb have been reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution. Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain specific assets and liabilities constituting the OmniAb Business. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of October 26, 2022 shares of the common stock of OmniAb representing 100% of Ligand&#8217;s interest in OmniAb. Immediately following the Distribution, Merger Sub merged with and into OmniAb, with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of New OmniAb. The entire transaction was completed on November 1, 2022, and following the Merger, New OmniAb is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#8220;OABI.&#8221; After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after November 1, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the Company determined its antibody discovery business qualified for discontinued operations accounting treatment in accordance with ASC 205-20. We recognized a $1.7 million tax provision adjustment related to deferred taxes during the three months ended March&#160;31, 2023 that was attributable to the discontinued operations. The following table summarizes revenue and expenses of the discontinued operations for the three months ended March&#160;31, 2022 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,177&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,439)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,996)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,456)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the three months ended March&#160;31, 2022 (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052220822288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126,592&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,937&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended  March&#160;31, 2023, we adjusted the balance of the Metabasis CVR liability by reducing $0.7 million to mark to market.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of March&#160;31, 2023 is as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2022</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March&#160;31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of our goodwill, indefinite-lived assets, or long-lived assets recorded during the three months ended  March&#160;31, 2023 and March&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052310747584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of 2023 Notes, bearing cash interest at a rate of&#160;0.75%&#160;per year, payable semi-annually. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on a conversion rate as discussed below. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes were entitled to convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day was greater than 130% of the conversion price on such trading day; </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes (the&#8220;Indenture&#8221;). </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on or after November 15, 2022 and prior to the close of business on May 11, 2023 (the second scheduled trading day preceding May 15, 2023, which is the maturity date), holders of the 2023 Notes are entitled to covert the notes without regard to the conditions described above applicable to conversions prior to November 15, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes. No holders exercised their right to convert their 2023 Notes during the applicable period for conversion. After we completed the Separation of the OmniAb Business, on November&#160;15, 2022, the conversion rate was adjusted to 4.8390 shares of common stock per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately&#160;$206.65 per share. The maximum conversion rate of the 2023 Notes was adjusted to 6.2907 per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately $158.97.  The conversion rate for the 2023 Notes was adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dividend date of the spin-off (as determined in the Indenture). The conversion rate and maximum conversion rate are subject to further adjustment under the circumstances and pursuant to the terms set forth in the Indenture.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the current conversion price of $206.65. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, and is being amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of March&#160;31, 2023 is 0.5%.  During the three months ended March&#160;31, 2023 we recognized a total of $0.2 million in interest expense which includes $0.1 million in contractual interest expense and $0.1 million in amortized issuance costs. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we repurchased $165.8 million in principal amount of the 2023 Notes for $163.7 million in cash, including accrued interest of $0.4 million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $1.5 million reflected in other income (expense), net, in our consolidated statement of operations for the three months ended March&#160;31, 2022, and a $0.9 million reduction in debt discount. There was no repurchase of 2023 Notes during the three months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $206.65 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $20.3 million in principal of the 2023 Notes for approximately $19.1 million in cash, including accrued interest of $0.1 million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $152.0 million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, in connection with the repurchases of $227.8&#160;million in principal of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:68.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052223327424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended  March&#160;31, 2023 and 2022 was 21.5% and (41.4)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended  March&#160;31, 2023 was due primarily due to Internal Revenue Code Section 162(m) limitation on deduction for officer compensation, non-deductible incentive stock option (ISO) related stock compensation expense, which were partially offset by foreign derived intangible income tax benefit during the period. The variance from the U.S. federal tax rate of 21% for the three months ended March&#160;31, 2022 was primarily due to the tax deductions related to foreign derived intangible income tax benefit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052220654144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2022 Annual Report.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(153,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,853)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,635)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,237,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, outstanding options to purchase 1.8 million shares were exercisable with a weighted average exercise price per share of $61.91.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2023, 35,881 shares were available for future purchases under the ESPP.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the Market Equity Offering Program</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we filed a registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. </span></div>On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#8220;Sales Agreement&#8221;) with Stifel, Nicolaus &amp; Company, Incorporated (the &#8220;Agent&#8221;), under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100.0&#160;million in &#8220;at the market&#8221; offerings through the Agent (the &#8220;ATM Offering&#8221;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $100.0&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052220293728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies</a></td>
<td class="text">Commitment and Contingencies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the 3 complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div>During the first quarter of 2023, we entered into an amendment to the lease agreement for our headquarters office located in San Diego, California, which resulted in a $1.1 million increase in both operating lease assets and operating lease liabilities as of March&#160;31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218602304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock', window );">Business</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed the separation (the &#8220;Separation&#8221;) of our antibody discovery business and certain related assets and liabilities (the &#8220;OmniAb Business&#8221;) through a spin-off of OmniAb to Ligand&#8217;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#8220;Distribution&#8221;) and merger (the &#8220;Merger&#8221;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#8220;New OmniAb&#8221;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#8220;Merger Agreement&#8221;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#8220;Separation Agreement&#8221;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#8220;Transaction Agreements&#8221;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2022 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 205-20&#8221;). Accordingly, the accompanying condensed consolidated financial statements have been updated to present the results of all discontinued operations reported as a separate component of loss in the condensed consolidated statements of operations and comprehensive loss (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Spin-off of OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). All disclosures have been adjusted to reflect continuing operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Captisol Sales</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div>The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. </span></div>We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs recorded against inventory for the three months ended  March&#160;31, 2023 and 2022. As of March&#160;31, 2023 inventory consists of Captisol prepayments of $5.4 million, and as of December 31, 2022 inventory consists of Captisol prepayments of $5.9 million.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseRightsPolicyTextBlock', window );">Commercial License Rights</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License Rights</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,867)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,116)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.4 million and credit loss adjustments of $6.5 million as of March&#160;31, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December&#160;31, 2022.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2022 Annual Report. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk </span></div>associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended  March&#160;31, 2023, we further considered the current and expected future economic and market conditions and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2023.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income (Loss) Per ShareBasic net income (loss) per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Spin-Off And Migration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessSpinOffAndMigrationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRightsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRightsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052221618288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:68.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.833%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2023 and December 31, 2022 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:38.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,691&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Municipal bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bond fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(807)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,051)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bond fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,451)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">439,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License Rights</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,867)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,116)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.4 million and credit loss adjustments of $6.5 million as of March&#160;31, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,681&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.397%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,974&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,359&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,001&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218450320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Carrying Amounts of Major Classes of Assets and Liabilities Related to Assets Held for Sale</a></td>
<td class="text">The following table summarizes revenue and expenses of the discontinued operations for the three months ended March&#160;31, 2022 (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,177&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,439)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,996)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,456)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the three months ended March&#160;31, 2022 (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052220623712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126,592&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,937&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.</span></div>2.In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended  March&#160;31, 2023, we adjusted the balance of the Metabasis CVR liability by reducing $0.7 million to mark to market.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of March&#160;31, 2023 is as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2022</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March&#160;31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052220744656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:68.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052220696720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(153,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,853)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,635)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,237,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(153,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,853)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,635)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,237,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217545568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>position </div>
<div>segment </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was previously deferred</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EquitySecuritiesFVNIShareSoldInPeriod', window );">Sale of Viking common stock (in shares) | shares</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Gain on sale of Viking common stock</a></td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized losses</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Allowance for credit losses adjustment related to COVID-19</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 14,011,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,294,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for awards</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EquitySecuritiesFVNIShareSoldInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV NI, Share Sold In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EquitySecuritiesFVNIShareSoldInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218636880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 43,979<span></span>
</td>
<td class="nump">$ 36,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">17,154<span></span>
</td>
<td class="nump">13,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">6,228<span></span>
</td>
<td class="nump">4,622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,550<span></span>
</td>
<td class="nump">2,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember', window );">Teriparatide injection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">2,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RylazeMember', window );">Rylaze</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,609<span></span>
</td>
<td class="nump">1,649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,267<span></span>
</td>
<td class="nump">1,549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">10,622<span></span>
</td>
<td class="nump">12,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">10,622<span></span>
</td>
<td class="nump">6,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">16,203<span></span>
</td>
<td class="nump">10,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">2,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">15,300<span></span>
</td>
<td class="nump">5,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 789<span></span>
</td>
<td class="nump">$ 2,888<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RylazeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RylazeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052212761440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 139,424<span></span>
</td>
<td class="nump">$ 108,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(5,051)<span></span>
</td>
<td class="num">(5,451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">134,578<span></span>
</td>
<td class="nump">103,742<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Total short-term investments</a></td>
<td class="nump">193,937<span></span>
</td>
<td class="nump">166,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">19,691<span></span>
</td>
<td class="nump">5,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">19,668<span></span>
</td>
<td class="nump">4,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">9,592<span></span>
</td>
<td class="nump">6,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">9,618<span></span>
</td>
<td class="nump">6,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">13,461<span></span>
</td>
<td class="nump">7,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">13,454<span></span>
</td>
<td class="nump">7,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">5,775<span></span>
</td>
<td class="nump">5,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(4,120)<span></span>
</td>
<td class="num">(4,239)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">1,655<span></span>
</td>
<td class="nump">1,830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Bond fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">82,678<span></span>
</td>
<td class="nump">81,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(807)<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">81,871<span></span>
</td>
<td class="nump">80,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">6,243<span></span>
</td>
<td class="nump">2,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">6,198<span></span>
</td>
<td class="nump">2,162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Viking common stock</a></td>
<td class="nump">$ 59,359<span></span>
</td>
<td class="nump">$ 63,122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217748336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 123,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">10,903<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">134,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">123,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">10,962<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 134,643<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052221544352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 105,673<span></span>
</td>
<td class="nump">$ 105,673<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">439,589<span></span>
</td>
<td class="nump">448,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">55,211<span></span>
</td>
<td class="nump">55,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(23,450)<span></span>
</td>
<td class="num">(22,560)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,610)<span></span>
</td>
<td class="num">(1,577)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">29,600<span></span>
</td>
<td class="nump">29,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(18,043)<span></span>
</td>
<td class="num">(17,670)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">$ (72,434)<span></span>
</td>
<td class="num">$ (65,191)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052216653120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 28,298<span></span>
</td>
<td class="nump">$ 28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(17,867)<span></span>
</td>
<td class="num">(18,116)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,431<span></span>
</td>
<td class="nump">10,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="nump">11,400<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="num">(6,500)<span></span>
</td>
<td class="num">(6,500)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,122)<span></span>
</td>
<td class="num">(9,538)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,574<span></span>
</td>
<td class="nump">8,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(8,745)<span></span>
</td>
<td class="num">(8,578)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 1,857<span></span>
</td>
<td class="nump">$ 2,024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218247680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 1,729<span></span>
</td>
<td class="nump">$ 6,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">834<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">3,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">7,700<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedSupplierExpensesCurrent', window );">Supplier</a></td>
<td class="nump">678<span></span>
</td>
<td class="nump">634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">3,991<span></span>
</td>
<td class="nump">4,183<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 14,977<span></span>
</td>
<td class="nump">$ 15,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSupplierExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Supplier Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSupplierExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217784288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 5,931<span></span>
</td>
<td class="nump">$ 7,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">1,707<span></span>
</td>
<td class="nump">2,196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 4,224<span></span>
</td>
<td class="nump">$ 4,913<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218509120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">53.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052216710608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">17,063<span></span>
</td>
<td class="nump">16,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (in shares)</a></td>
<td class="nump">17,974<span></span>
</td>
<td class="nump">16,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</a></td>
<td class="nump">4,359<span></span>
</td>
<td class="nump">6,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">2023 convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218581040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Oct. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations | $</a></td>
<td class="nump">$ 1,665<span></span>
</td>
<td class="nump">$ 2,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | position</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed', window );">Disposal group, including discontinued operation, percentage of voting interests disposed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052213650864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details) - Discontinued operations<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">$ 9,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">3,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">11,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,255<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total operating costs and expenses</a></td>
<td class="nump">20,616<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(11,439)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense', window );">Other income, net</a></td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Loss before income tax</a></td>
<td class="num">(10,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit</a></td>
<td class="nump">8,540<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net loss</a></td>
<td class="num">(2,456)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">$ 8,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Costs and Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Research and Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052221459120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,416)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpenditureDiscontinuedOperations', window );">Purchase of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,416)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property, plant and equipment included in accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by (Used in) Discontinued Operations, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by (Used in) Discontinued Operations, Operating Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpenditureDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capital expenditure attributable to discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpenditureDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052213595840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingent_value_right</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 clinical trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, regulatory, &amp; commercial milestones and tiered royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingent_value_right</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Mark-to-market adjustment of CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,359<span></span>
</td>
<td class="nump">$ 63,122<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,937<span></span>
</td>
<td class="nump">166,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,887<span></span>
</td>
<td class="nump">3,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,578<span></span>
</td>
<td class="nump">103,742<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,757<span></span>
</td>
<td class="nump">3,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,122<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,212<span></span>
</td>
<td class="nump">67,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,853<span></span>
</td>
<td class="nump">3,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,592<span></span>
</td>
<td class="nump">99,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,757<span></span>
</td>
<td class="nump">3,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,592<span></span>
</td>
<td class="nump">99,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,757<span></span>
</td>
<td class="nump">3,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts Owed To Former Licensor, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmountsOwedToFormerLicensorFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=lgnd_ContingentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=lgnd_ContingentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_CyDexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_CyDexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218443504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of December&#160;31, 2022</a></td>
<td class="nump">$ 84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of March&#160;31, 2023</a></td>
<td class="nump">$ 86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217695600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Tangible asset impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052213273392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 15, 2022 </div>
<div>position </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="nump">76,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortized issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_RepaymentsOfNotesPayableInterestPortion', window );">Accrued interest portion of repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Decrease in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,559,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 convertible senior notes | Notes repurchased in August 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 convertible senior notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 convertible senior notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 convertible senior notes | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="nump">0.004839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 206.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 convertible senior notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="nump">0.0062907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 158.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Repurchased Amount During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentRepurchasedAmountDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_RepaymentsOfNotesPayableInterestPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Notes Payable, Interest Portion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_RepaymentsOfNotesPayableInterestPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052213262208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 convertible senior notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 76,854<span></span>
</td>
<td class="nump">$ 76,854<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total notes payable</a></td>
<td class="nump">76,790<span></span>
</td>
<td class="nump">76,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 76,107<span></span>
</td>
<td class="nump">$ 74,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052218546560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="nump">21.50%<span></span>
</td>
<td class="num">(41.40%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052217853696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (in shares) | shares</a></td>
<td class="nump">2,991,473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">409,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares) | shares</a></td>
<td class="num">(93,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(69,853)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (in shares) | shares</a></td>
<td class="nump">3,237,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 61.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in USD per share) | $ / shares</a></td>
<td class="nump">74.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in USD per share) | $ / shares</a></td>
<td class="nump">38.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in USD per share) | $ / shares</a></td>
<td class="nump">61.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 63.63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">348,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">194,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (in shares) | shares</a></td>
<td class="num">(153,431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(12,635)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">377,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 75.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in USD per share) | $ / shares</a></td>
<td class="nump">84.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (in USD per share) | $ / shares</a></td>
<td class="nump">77.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in USD per share) | $ / shares</a></td>
<td class="nump">59.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 79.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052214345552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (in shares)</a></td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 61.91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember', window );">At-the Market Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_SaleOfStockAuthorizedOfferingAmount', window );">Sale of stock, authorized offering amount | $</a></td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (in shares)</a></td>
<td class="nump">35,881<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_SaleOfStockAuthorizedOfferingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Authorized Offering Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_SaleOfStockAuthorizedOfferingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052221487776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>civil_complaint</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification', window );">Increase in operating lease assets</a></td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification', window );">Increase in operating lease liabilities</a></td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity | civil_complaint</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Increase (Decrease) In Operating Lease Assets Due To Modification</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Increase (Decrease) In Operating Lease Liabilities Due To Modification</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140052219947408">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>lgnd-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20230331"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20230331.xsd" xlink:type="simple"/>
    <context id="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iecbbb8a6bbb64a8dae52bdbe8040eb90_I20230504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2023-05-04</instant>
        </period>
    </context>
    <context id="ie1301938b25745d0b99c779227731ddd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7f8aaddec77946839e2c7db82a635cd5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id674d396b37c4237beed113c89c2675d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3b1846c1e72842cea62ab4d1e84368a3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ac4e08b486c498488e4ec21236f70ac_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iad8c3f3b74a145eba569dc88db6a0243_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic0dbfa3c35724185bcf83cfd276f013a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifeeb7f4be42949899bd810534b9af482_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic34b2229f7744763b8ab956b6b6373a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3bf026842b724db19523809726898537_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f445f5d04b0472a806b41285302bc93_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9ecad473cf1472bad6c4b549c58808b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88f3991b11274a1d83e8d12453c31bde_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia7bf770f68994031a86c11e53838362b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic7216ff5406b44b1ba177f63fab7ca13_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i146393ab4a57499e86ded98459711b21_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i81d3755ad9d54f8ab9d3436775b7948d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5d62bd1799fc4cd490f4762c0c6517d4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i67e09b5d001d427fbb92bfc4d9d410d7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd2fac596ab64c99aae2ed65bc41289e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iabcd11cab6e246f29bd95c8775e1803a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e33362d86644981a7f835e3abb11e2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic69a583af859424c904323cce6fc7c4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dcd4935652a40d29c4ba3d9eee90955_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e695c2f9aa945e39a8aad1f6b165a20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia82d4ad3cea140ef9a6f0c99ee594d64_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d0376708afe4578ba637e295776e58e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia95820899b06425fa25a5ff7bc95fbb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i49152728d14c47108836dbcc6300eb78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic77a2c8cd6b54702aad3fc849424beda_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2195045e053d42548f70094593395273_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0cec76fd474f414982654002b7611f04_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f11779e9d9b4e1f94f4e39f3ebccbe6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d2f609468824c07b03425783adb6d36_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iccf4e3b46ee2408aa97590c16ab24104_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i136be9af2fba4063bbe5c2f2224a8bae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4dbc4a0411f74b34ab89e9e5c50f68a1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ddf6ce6c34e4acfae34f5a67089e27e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i65eeea1681704584af49987ac1e87675_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icc33e31ac6cb43b7a3645f8b84193980_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibcf62d0f95754c7295cc30e21972ebf8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i252ec6f092314ab183cfe571c994ac8b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i507e16f565324f84b591860daa92de64_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2214c64514eb49f2a8842771d28dce64_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i471ece02df084a638a5073e4e480760e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie460943c319f46f089b3dbac6d243d9c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i603a416169e44298a4e5e843b920577a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icab12c145b7a4a9386bead15014c2002_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d1e076699044354a517e91f65469898_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb74890b7510460d8f61f873e0236e2a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib9aa759764214b4c9217f0f8b8b0bf12_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i65ab7c5558dc4b2691364948dff9c3bb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i56e6b2467288481aa925463f0f2dfa48_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaa2a0b5f22124e0299cea65f936d0552_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic358d5ad2b4745ce8983d4eb13528034_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8cf6169f7de846d8b64a2d389e36a41a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0dd089aaa47c4e3f803998025bdb0535_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i77a21caa530e4123b94f8358586e06f0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a5ad898201d43378731028a1922d796_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i59e2033d633a4c469bd9429bc3777327_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1c6bf9aba4794d65841b444357010217_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9af904e6214a46b3913fbe243bd898e5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia1ace55ddf80493b9b3d55cb674104bb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7cc7dff39832419b9fade16b421649d8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i02a49f05176146c7b857da134f78d9be_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id1cc642360a843b4be5f97a5be47caf6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i851627360fcd4241918ea438e1eab5ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1d5edfb22d8410c8c18477fedb0c132_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb5915e8af3848bab85d86525cc3ec55_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i961c8d92f57e44838827ed1e6b8d9094_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib4558a7c600248d4877505fd0fe0dac4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i453dc18f50a14d2f9ad41790b6e0d175_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3aee0771a079448d978ce5fbb46ef39d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icab684ceae90430cbdf56e58b13b7729_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i829bcc778f774caeb60dae78412a98b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2561a5b37f2b48c99b837d7e54c57638_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i00a1d092574043ac8fa8de0d23f735b1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i61c033ee7b9c41bc8ce219eaf434f0fd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i98ff718d557e41b8a4a3be385a2d6d0d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cd14e785e014eb993155735df108dfc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5c4546dd49864a548bead9153260fd3d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia5f7ff0e996a4591a2178b25ce967a99_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id3209d0976344348a32b6d380fe3e5f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i412c3b19a5834235af99c2beb065ad68_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83dfae755f5a424a8225bff059206ef3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idbeaa2397af04381b99149bf21997427_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab4f1100a55e4741878f092afbfc948d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9609e0c75f964fe2ac7c051438151f59_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9fc13b3b0ca47478c28400effc30e73_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6c9c521f34b14454b143d1664a18a4cf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibcdb5f68fd0845c89b3679a08f903458_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i032e4336c3474c48b0ccfb9dc291e4eb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if81e6ed11d5b42fc92035e63ce70dab8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9e9100c0c4a443939a76ff1a531948bf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9dffa8f58aaf4d11b456a8821fe00c3d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3ce88b885fc645c2be76eb7ae40e211f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4fa4dea889b3439d9ac7398cfa1a4773_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i506f1c021fc0401fb3e152136e091307_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if97986f33b4b455eab691feb1d28c9f6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9cbda0e4f007472c8c052957a3e4b0e9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4dd3a95bb7954a1c8b2b9ec9fb784037_I20221026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-26</instant>
        </period>
    </context>
    <context id="i74c3b7100ae2469aa40de930920f80f3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9dfb70c51fa941509f903b3ca26a5da0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i763012af38d44192b91ccced32b2f90c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6f664e124e444754902048088f15d009_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7af671b89641435c982e3ec096f05e13_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie398cfae0ed945faac086dc8267aff48_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2be7139166474f9ab25b9eca300d94ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i915548846dd64cd49f3ecbc68b7eb50a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia17e761190bb48beb5cea13631d8dfa7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1aa89bb486b842e7aff0da151ea9a775_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie872097758d948b3a91b3e4335d836d6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if96faa6fa418473291f9eadf582cb120_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic7841b4be52746df9806cf6af4497ed3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaff7de56710d4853a5026ad4854f9d4b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i40daf9abfb134159be20eab4b760217b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1eb9be9f22f54a458d0741083b4fffc6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i626c103c32154c218e186b029cbda1e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16f7532e1db94ae1a31213e245adfb77_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie74e651db4b74a518b5c4442d96bfb40_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieee5a6d6de4e4ff4a3795c420443d61b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4e4a19aec8e14496aac9d086c4eba78d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0269fb8261c141bab51cf071a61d89b3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iff86df6b5e5a4a6faf716a2960401b63_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i163330301f1d4bcbbb46e375f3c79026_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i018145fcba3c41c1883b1f339bac39e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia57855c3f2b4476a90c99722257f527e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87e940ff49984106a6ac855a4ae9899a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id7356828798748ceb3633210d92c6664_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i81bb98cab8574fe5866d8e7a307f0b74_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i61bedf7508b14e8daf449211c964cd8e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9e3e4858f3084a0590a2499ed0047750_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf45dbfb87d9402794f19a8fa810d6b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i885006a6753a4da88eed97931a8a1096_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2b9d43cacb34c8ea3696baaeee38eb4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="ifcfb68dc76174bf49f8bd077bd649ae1_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="icc2d9f773bb14b7fb48e90c6374538fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i15a6dc40dbc74b84b8d5b169e75d071a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i168fdc9ced384d3482e3122242ace085_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1ad7a5d1cc5a45b3993c229ec308f769_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b9ba0d8fd854d3c980983fb9630d586_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib161369e802141d388e0bea65e72d1d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id4ea1e8485f3460f9907ff44108c41a4_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="id16b6127458b4c908501afd350114da9_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i745a3728e2854def929ed3c0ccc7d673_I20221115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-15</instant>
        </period>
    </context>
    <context id="ic58510ba16f14f209b3c357f93c9d563_I20221115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-15</instant>
        </period>
    </context>
    <context id="i6ba60861c19649ff96ba66c6b831281e_D20221115-20221115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-15</startDate>
            <endDate>2022-11-15</endDate>
        </period>
    </context>
    <context id="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife99d31e979b471fbacc856adb204f2e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i63d75f220eeb405ab2f4a34303ec71f6_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i71225d3c8a82435fa5cd738c3aa181d8_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="iebf2d4e5f2594065932aeccee4503461_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06fe0a09def94247bbb7916c23ae3017_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibfd5947b908543809e005a7628c9487d_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="iff179ee295ea4d7c9424bd57cab84b84_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i54feecd19751474e8d9edd51ce5839ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id5ecd9e788f34ffe8c0888b38e2b02ee_D20221115-20221115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-15</startDate>
            <endDate>2022-11-15</endDate>
        </period>
    </context>
    <context id="iab7dd9fb59ed49818e2ebb4ac883d055_D20221115-20221115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-15</startDate>
            <endDate>2022-11-15</endDate>
        </period>
    </context>
    <context id="i5b031e51a09841e2bba31484e4e6ba22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i233c304b9e6749139554635d622968a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if88ab5f328b647e6a0703df984333731_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i488634fa2ce945148adf1d9adc77ea34_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5ed6d7e4223c47f4aa33849b39b77065_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia698121e1ecb4b6a8dd84ec11d176568_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lgnd:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib199687300914de5bd23ec149948555c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>lgnd:segment</measure>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contingent_value_right">
        <measure>lgnd:contingent_value_right</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="civil_complaint">
        <measure>lgnd:civil_complaint</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM18yLTEtMS0xLTE0MjQ3MQ_44680838-df5f-4c4d-badb-a78239159ec0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM18zLTEtMS0xLTE0MjQ3MQ_c34f36bb-b838-4009-8799-56a30e6769d4">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM180LTEtMS0xLTE0MjQ3MQ_d12094ba-c07b-471c-8c8a-6faabbda4458">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM181LTEtMS0xLTE0MjQ3MQ_2df1a4e7-8931-41ac-ad97-b0be427de96c">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80L2ZyYWc6NWU0ZDJjYjVhNDk0NDk3ZGE4NTJiZGVmNjVlMTVmZGMvdGFibGU6ZDkyZTcyNWI1OTk3NGFlNjk2NTUzY2RkZGY0OTc4MTMvdGFibGVyYW5nZTpkOTJlNzI1YjU5OTc0YWU2OTY1NTNjZGRkZjQ5NzgxM182LTEtMS0xLTE0MjQ3MQ_c13b027a-f2a3-4e6d-8f1a-dfcd124ce86c">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ia82d4ad3cea140ef9a6f0c99ee594d64_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0wLTEtMS0xNTUyNTk_fe1a7d1c-c21f-4655-88cf-d34c7d6e9def">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="id5ecd9e788f34ffe8c0888b38e2b02ee_D20221115-20221115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80Ni9mcmFnOjc4MTYzZWU1ZjA1YzQ3Y2RhMDgxMGI2MjY0MjBkMjgyL3RhYmxlOjNhNDE3OTQxYzg2NTRiMzdiYzQxYmJiODMyOTNlNzVlL3RhYmxlcmFuZ2U6M2E0MTc5NDFjODY1NGIzN2JjNDFiYmI4MzI5M2U3NWVfMi0xLTEtMS0xNDI0NzE_e3fd8a83-b2b6-4469-a953-8ed751e4233b"
      unitRef="number">0.004839</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="iab7dd9fb59ed49818e2ebb4ac883d055_D20221115-20221115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80Ni9mcmFnOjc4MTYzZWU1ZjA1YzQ3Y2RhMDgxMGI2MjY0MjBkMjgyL3RhYmxlOjNhNDE3OTQxYzg2NTRiMzdiYzQxYmJiODMyOTNlNzVlL3RhYmxlcmFuZ2U6M2E0MTc5NDFjODY1NGIzN2JjNDFiYmI4MzI5M2U3NWVfNC0xLTEtMS0xNDI0NzE_3d225a31-e933-4383-a5de-f9be155932f6"
      unitRef="number">0.0062907</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8xNzI_7a6d2203-4183-46eb-90f4-dd911ed7922d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6Y2FhZjY0NDExMGVkNDAwMDk2Yzg1ODQxMmZiMDM4OTIvdGFibGVyYW5nZTpjYWFmNjQ0MTEwZWQ0MDAwOTZjODU4NDEyZmIwMzg5Ml8wLTAtMS0xLTE0MjQ3MQ_c6a4143f-2703-403c-9090-39c909eeab62">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yOTY_a834f892-ca12-40aa-964a-bd27bf294737">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6NjA0NGViOWNhNGM5NGVjY2E2ZjAwMTUxODQ3NDFlMTQvdGFibGVyYW5nZTo2MDQ0ZWI5Y2E0Yzk0ZWNjYTZmMDAxNTE4NDc0MWUxNF8wLTAtMS0xLTE0MjQ3MQ_245e7b41-9db6-4ba4-97a9-cb9097f42dd3">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAy_c936a9ee-62c7-45c4-8761-6fd598f7c4d0">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8zOTg_033a5a84-c5fc-4234-b7e7-9f1ecd8f88b3">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV8wLTAtMS0xLTE0MjQ3MQ_24bdf721-91a1-419f-b792-1f0f34204588">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV8wLTEtMS0xLTE0MjQ3MQ_5c46cc84-7812-4fb1-847c-d5d55c1a373d">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV8zLTAtMS0xLTE0MjQ3MQ_53823bac-bfea-4531-ade7-650b0b0e5127">3911 Sorrento Valley Boulevard, Suite 110</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV80LTAtMS0xLTE0MjQ3MQ_931669da-5688-425c-8658-704bcf88bf01">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV81LTAtMS0xLTE0MjQ3MQ_192ebae9-ca55-4a35-8cb3-3fd1a3f069ec">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6OTcxNzg3ODFmNGI2NDY5Y2I4ZTU5YmY5YzAxOGU2ZTkvdGFibGVyYW5nZTo5NzE3ODc4MWY0YjY0NjljYjhlNTliZjljMDE4ZTZlOV81LTEtMS0xLTE0MjQ3MQ_50623821-f744-4115-8fde-57b8bb87590f">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAz_c14c9f3f-6168-4a5a-802b-942736726cd4">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzA0_d4ca4737-3fd6-41be-9034-c6ce01107666">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6ZmI2MGZiMjVmNzBmNGE2YTlkMzIwMjA2MDM0NThlNTAvdGFibGVyYW5nZTpmYjYwZmIyNWY3MGY0YTZhOWQzMjAyMDYwMzQ1OGU1MF8xLTAtMS0xLTE0MjQ3MQ_561a28c0-760a-4694-b634-36197c28eeee">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6ZmI2MGZiMjVmNzBmNGE2YTlkMzIwMjA2MDM0NThlNTAvdGFibGVyYW5nZTpmYjYwZmIyNWY3MGY0YTZhOWQzMjAyMDYwMzQ1OGU1MF8xLTEtMS0xLTE0MjQ3MQ_321c6a3d-8087-466f-ba4e-b70ed1993d28">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6ZmI2MGZiMjVmNzBmNGE2YTlkMzIwMjA2MDM0NThlNTAvdGFibGVyYW5nZTpmYjYwZmIyNWY3MGY0YTZhOWQzMjAyMDYwMzQ1OGU1MF8xLTItMS0xLTE0MjQ3MQ_42439529-aea4-4642-b26e-0611644afccc">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzA1_ab376826-db37-4708-847e-854709bc84f9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAw_85c54407-c5a3-4e55-a034-d67d0a3bfdfa">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6YjBlOWQzMmQwNjFlNDEyY2JlYzYyYjZlNWE4MDM2ZGQvdGFibGVyYW5nZTpiMGU5ZDMyZDA2MWU0MTJjYmVjNjJiNmU1YTgwMzZkZF8wLTAtMS0xLTE0MjQ3MQ_eef6b635-9668-4aed-805a-5125c32c095e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6YjBlOWQzMmQwNjFlNDEyY2JlYzYyYjZlNWE4MDM2ZGQvdGFibGVyYW5nZTpiMGU5ZDMyZDA2MWU0MTJjYmVjNjJiNmU1YTgwMzZkZF8xLTQtMS0xLTE0MjQ3MQ_9f236061-d018-4f7c-9276-3e18f2b514de">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGFibGU6YjBlOWQzMmQwNjFlNDEyY2JlYzYyYjZlNWE4MDM2ZGQvdGFibGVyYW5nZTpiMGU5ZDMyZDA2MWU0MTJjYmVjNjJiNmU1YTgwMzZkZF8yLTEtMS0xLTE0MjQ3MQ_9289300a-4869-470e-b1f2-556ae6ef93dd">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMzAx_e22a518c-c4a0-4bcf-8b44-cae30c68e653">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iecbbb8a6bbb64a8dae52bdbe8040eb90_I20230504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xL2ZyYWc6ODQzNzA0ZjkxZjkwNDAxNThlYzFlOTQ0NWU0ZmYwYjQvdGV4dHJlZ2lvbjo4NDM3MDRmOTFmOTA0MDE1OGVjMWU5NDQ1ZTRmZjBiNF8yMjYz_ed4bbbea-3781-4dae-a932-b96bf42d2679"
      unitRef="shares">17272547</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMy0xLTEtMS0xNDI0NzE_d872bd37-b343-44a6-8cec-116707812df4"
      unitRef="usd">88728000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMy0zLTEtMS0xNDI0NzE_d583080b-5853-4be3-b52d-683c0f66ab6b"
      unitRef="usd">45006000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNC0xLTEtMS0xNDI0NzE_11b9c6fb-5935-4b8f-88a4-a3ac7dcebeaa"
      unitRef="usd">193937000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNC0zLTEtMS0xNDI0NzE_074321b5-2970-4658-a334-c02ee1b1fcf0"
      unitRef="usd">166864000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNS0xLTEtMS0xNDI0NzE_3d370262-6760-4e31-8808-b5be714a059e"
      unitRef="usd">29188000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNS0zLTEtMS0xNDI0NzE_be735f8d-6004-4740-ac23-eea19bfcb576"
      unitRef="usd">30424000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNi0xLTEtMS0xNDI0NzE_836b7ebb-82be-4750-b3ec-581e789d9d53"
      unitRef="usd">14011000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNi0zLTEtMS0xNDI0NzE_b173eee1-3e88-4754-a1ae-8b1b5b0ac390"
      unitRef="usd">13294000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNy0xLTEtMS0xNDI0NzE_b5065a23-438f-4b31-817f-6ddcb35e541a"
      unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNy0zLTEtMS0xNDI0NzE_53f848e0-f8d8-4ac7-8469-b96957b760dc"
      unitRef="usd">4614000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOC0xLTEtMS0xNDI0NzE_7bebf3cc-923d-459f-8887-2cb125beb1bc"
      unitRef="usd">2331000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOC0zLTEtMS0xNDI0NzE_87b6e2b4-00cf-471d-b5d5-e1c665dc5ec0"
      unitRef="usd">3399000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOS0xLTEtMS0xNDI0NzE_e29f8508-054b-49b6-97f4-c574d2f1daef"
      unitRef="usd">328195000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfOS0zLTEtMS0xNDI0NzE_9cdbd452-9fa4-4a20-bed1-9205449fa39c"
      unitRef="usd">263601000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTAtMS0xLTEtMTQyNDcx_6b3ca74d-f1ec-42ff-bb50-875dce62da4b"
      unitRef="usd">875000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTAtMy0xLTEtMTQyNDcx_085325f3-6eda-448e-9422-d5f5a7b355f4"
      unitRef="usd">8530000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTEtMS0xLTEtMTQyNDcx_35c458f6-7850-48e0-a0ac-2b93b5477b65"
      unitRef="usd">333916000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTEtMy0xLTEtMTQyNDcx_a4d726a6-7f59-4b4f-8d2f-3eb041b07343"
      unitRef="usd">342455000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTItMS0xLTEtMTQyNDcx_9ec3f810-1164-4e81-a17f-f2a383ce9ca3"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTItMy0xLTEtMTQyNDcx_e7a68fb5-62ff-4e2e-a750-0bf57bc4050c"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTMtMS0xLTEtMTQyNDcx_dea9d91a-f377-4b95-b7d9-7d00eb744b2e"
      unitRef="usd">10431000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTMtMy0xLTEtMTQyNDcx_57542daf-3c93-4f18-9e5e-1e2b1b4c5466"
      unitRef="usd">10182000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTQtMS0xLTEtMTQyNDcx_29475e8c-198d-49ed-b7e2-6ababd475ec2"
      unitRef="usd">11743000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTQtMy0xLTEtMTQyNDcx_a83aa778-09d8-4f17-852e-b80bb34e9ab3"
      unitRef="usd">12482000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTUtMS0xLTEtMTQyNDcx_a44cf54a-fbb8-47c5-9432-02a7c2b0f095"
      unitRef="usd">11666000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTUtMy0xLTEtMTQyNDcx_6f0d7c99-2d4b-44d5-97b5-7cae604ffd78"
      unitRef="usd">10914000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTYtMS0xLTEtMTQyNDcx_66daf124-4d37-4608-b473-100cfff4a476"
      unitRef="usd">3943000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTYtMy0xLTEtMTQyNDcx_e07d33e6-0006-4e61-a5f9-e6c47a0deb23"
      unitRef="usd">4095000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTctMS0xLTEtMTQyNDcx_55076947-654a-463b-99d8-e5c64ae585ad"
      unitRef="usd">4634000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTctMy0xLTEtMTQyNDcx_163e7f30-d895-4dc1-9522-fc5b8ce231cc"
      unitRef="usd">4736000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTgtMS0xLTEtMTQyNDcx_cdb42a93-05ae-4721-b2a2-3d943a4db75b"
      unitRef="usd">811076000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMTgtMy0xLTEtMTQyNDcx_953c1211-4e81-469c-abb0-3cdb7cc53933"
      unitRef="usd">762668000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjEtMS0xLTEtMTQyNDcx_5cc2cbf7-4adc-4bff-9f87-fd464650528d"
      unitRef="usd">6135000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjEtMy0xLTEtMTQyNDcx_2715f1c5-5e37-4507-9a79-a1bd7a2c2123"
      unitRef="usd">5307000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjItMS0xLTEtMTQyNDcx_be1db39f-59e0-4e7f-9582-7e7216adb8ce"
      unitRef="usd">14977000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjItMy0xLTEtMTQyNDcx_30d26149-a0e2-4574-ab13-a98690322331"
      unitRef="usd">15681000</us-gaap:AccruedLiabilitiesCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjQtMS0xLTEtMTQyNDcx_b80e8e80-713c-4e32-b90a-ac681815c200"
      unitRef="usd">67000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjQtMy0xLTEtMTQyNDcx_465bf60f-2c83-4dbf-b5ff-b0f39e59af5f"
      unitRef="usd">57000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjUtMS0xLTEtMTQyNDcx_0666daf8-164c-4649-a529-ffb0226fa7c2"
      unitRef="usd">257000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjUtMy0xLTEtMTQyNDcx_1303dd9f-7fea-47aa-80db-f82d8f7c00de"
      unitRef="usd">355000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjYtMS0xLTEtMTQyNDcx_1f36cd14-8759-4154-9db5-58b6eb5634f7"
      unitRef="usd">660000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjYtMy0xLTEtMTQyNDcx_a8abbd4c-5777-47d9-b906-859fef07269b"
      unitRef="usd">670000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjctMS0xLTEtMTQyNDcx_f83eedbd-9c84-40bb-bada-a6b0c70c970e"
      unitRef="usd">43000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjctMy0xLTEtMTQyNDcx_9f508e6e-2fd5-45d3-a4e2-a2553c08f6aa"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjgtMS0xLTEtMTQyNDcx_59eaac34-6b3c-48c0-845f-8742398a35ea"
      unitRef="usd">76790000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjgtMy0xLTEtMTQyNDcx_c6fe1ee3-2a7a-4ac9-8341-2527d5dc102f"
      unitRef="usd">76695000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjktMS0xLTEtMTQyNDcx_131ce4b0-bf02-4f58-99a0-9204481dc074"
      unitRef="usd">98929000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMjktMy0xLTEtMTQyNDcx_f2077dd9-d81b-4e02-8895-5a5ddbfa8e20"
      unitRef="usd">98810000</us-gaap:LiabilitiesCurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzEtMS0xLTEtMTQyNDcx_ed7c24e5-03f7-4081-b802-836bc5b52ea1"
      unitRef="usd">2776000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzEtMy0xLTEtMTQyNDcx_a7c775f4-b834-41dd-83f4-149a4953fb07"
      unitRef="usd">3456000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzItMS0xLTEtMTQyNDcx_b6a28245-db98-4e7a-9d17-4b94719a9a8c"
      unitRef="usd">30010000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzItMy0xLTEtMTQyNDcx_c8c70c1e-26ab-4b52-9b29-b2b29a7e3d5c"
      unitRef="usd">30615000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzMtMS0xLTEtMTQyNDcx_d590a051-f644-4eda-b147-b34bf43b1652"
      unitRef="usd">11183000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzMtMy0xLTEtMTQyNDcx_6393e1d6-fb99-457a-8bed-ad41d644fd37"
      unitRef="usd">10336000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzUtMS0xLTEtMTQyNDcx_80f847c8-122e-46f8-bb4a-d1f607047d7b"
      unitRef="usd">21861000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzUtMy0xLTEtMTQyNDcx_3e48fcf9-ce07-42df-bd02-2dd31264231a"
      unitRef="usd">21966000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzYtMS0xLTEtMTQyNDcx_1f77a480-2245-4b9a-84c9-ff6a5ddf1bf6"
      unitRef="usd">164759000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzYtMy0xLTEtMTQyNDcx_2534c543-6ce6-4a4c-95f7-48a85200093b"
      unitRef="usd">165183000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzctMS0xLTEtMTQyNDcx_50a27a87-30b2-403f-8bed-5f9553d9475d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzctMy0xLTEtMTQyNDcx_ede440d2-e5f4-431a-ac84-6555d537bd8c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMjQ_b14c8aed-5745-411f-996e-36371ee8bcf2"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMjQ_df663241-8926-4417-8ae5-7406e55aa073"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMzg_4ae9d531-b2a5-4409-8ccc-4ddff0f98a49"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfMzg_598d1377-c25d-439c-8fc6-095fcbe295b8"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_251da238-4bad-4cb0-a5d9-44c0beb256bc"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_2652d4f3-2199-49c1-b8f7-17d5697f2a43"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_43de8e9d-2bee-4035-be8f-b4f9186433e4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YzE5YTA3ZjM2M2E4NDJhYzllMjJmMmU2Y2Q0YTU2YzVfNjA_d23bd223-ba1f-43e9-ae7f-1d45e7d4ef05"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMS0xLTEtMTQyNDcx_ec0162fa-5477-4523-bc71-db2b2d53e473"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfMzktMy0xLTEtMTQyNDcx_f181b446-6460-41e6-aa13-a8802709730c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMjE_1527d3f9-8941-4f0c-9822-d5f385543220"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMjE_209ef87e-faff-4a01-891f-c262ed5267fa"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMzU_b809b113-34a7-4123-a8f1-7c5dceb20528"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfMzU_e223dbb3-c1a8-48ac-baa1-b0551580df4d"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNTc_01882027-9cd3-48e4-81e9-65efefb0fa21"
      unitRef="shares">17134000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNTc_894b7259-528d-4995-a4d7-59488bc2fa5e"
      unitRef="shares">17134000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNjQ_11cc6b25-959e-4ff4-ba84-7bd4122a7bb3"
      unitRef="shares">16951000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMC0xLTEtMTQyNDcxL3RleHRyZWdpb246YmZkMjVjOWQ2NGRhNDRkNzk2YmI1MGNiMzA5NTBkYWVfNjQ_ede47baa-1f99-45b6-a66c-2e7892cf671c"
      unitRef="shares">16951000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMS0xLTEtMTQyNDcx_b85818a7-09fe-42a5-a9c1-d6b567e9dbb6"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDAtMy0xLTEtMTQyNDcx_2c3f10df-46fe-411f-ab0b-452837a0597d"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDEtMS0xLTEtMTQyNDcx_c5d935bc-a3ed-48f7-a8b8-8230449e2bb0"
      unitRef="usd">154424000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDEtMy0xLTEtMTQyNDcx_8f98053d-f790-459c-81e4-a607a7755430"
      unitRef="usd">147590000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDItMS0xLTEtMTQyNDcx_713a94b7-8f7f-42a1-bede-22f0cef1cf71"
      unitRef="usd">-935000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDItMy0xLTEtMTQyNDcx_133502ee-a659-4ccd-8bc0-ff1bb6274787"
      unitRef="usd">-984000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDMtMS0xLTEtMTQyNDcx_f43e9903-d624-4b65-a118-30183975ca10"
      unitRef="usd">492811000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDMtMy0xLTEtMTQyNDcx_17330034-243e-41d5-b5b8-9ff05dc23ea9"
      unitRef="usd">450862000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDQtMS0xLTEtMTQyNDcx_6c41ff16-4b37-492c-bfd3-878b2ca51573"
      unitRef="usd">646317000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDQtMy0xLTEtMTQyNDcx_5da636ac-1676-4662-adc3-3e7a15c8024a"
      unitRef="usd">597485000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDUtMS0xLTEtMTQyNDcx_41018261-a35e-4515-8ca9-6b7e283ffaf3"
      unitRef="usd">811076000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xNi9mcmFnOmUwMGRkZWQzZjNhZjQ1YjQ4NzI5ZDgwMmQ4MWUwYzQ3L3RhYmxlOmZlYWFhMGQ1ZDQ2ZjRiNDM4YWU3NGNkY2NiY2ZhYTgyL3RhYmxlcmFuZ2U6ZmVhYWEwZDVkNDZmNGI0MzhhZTc0Y2RjY2JjZmFhODJfNDUtMy0xLTEtMTQyNDcx_5bc53f70-63c5-405a-8c5b-ab26ca89d36a"
      unitRef="usd">762668000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id674d396b37c4237beed113c89c2675d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNC0xLTEtMS0xNDI0NzE_cf2dec23-f574-46c6-89e6-64bcdced0932"
      unitRef="usd">17154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b1846c1e72842cea62ab4d1e84368a3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNC0zLTEtMS0xNDI0NzE_f62fe2bb-1cea-4e7c-8bee-c7947fb39027"
      unitRef="usd">13432000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac4e08b486c498488e4ec21236f70ac_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNS0xLTEtMS0xNDI0NzE_c2a9237d-dba1-4527-8630-baf38b803c46"
      unitRef="usd">10622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad8c3f3b74a145eba569dc88db6a0243_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNS0zLTEtMS0xNDI0NzE_3df7a690-fdbc-4a2b-95a3-74bafe289763"
      unitRef="usd">12122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0dbfa3c35724185bcf83cfd276f013a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNi0xLTEtMS0xNDI0NzE_3a2d1b5a-ae82-48fd-b4ba-9567a5b2c6d2"
      unitRef="usd">16203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifeeb7f4be42949899bd810534b9af482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNi0zLTEtMS0xNDI0NzE_a7c200fb-707a-4d5a-b283-ab0639d9f599"
      unitRef="usd">10962000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNy0xLTEtMS0xNDI0NzE_58e0a30d-683c-406a-b149-30f3803f09d1"
      unitRef="usd">43979000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfNy0zLTEtMS0xNDI0NzE_f29efc4c-1461-412f-8854-97058d877f3d"
      unitRef="usd">36516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfOS0xLTEtMS0xNDI0NzE_e125f651-2860-4b15-a108-622a8202587b"
      unitRef="usd">3717000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfOS0zLTEtMS0xNDI0NzE_eb0a54ec-9b3d-4ff6-9170-7fa573cd2c12"
      unitRef="usd">4699000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTAtMS0xLTEtMTQyNDcx_e3f73a4e-a368-459e-af8f-0504c2737a88"
      unitRef="usd">8539000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTAtMy0xLTEtMTQyNDcx_88b80cc4-90cd-413a-93ef-bcdf3e263669"
      unitRef="usd">8580000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTEtMS0xLTEtMTQyNDcx_80ccdb3c-2491-4244-be36-1abd0f2e3376"
      unitRef="usd">6663000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTEtMy0xLTEtMTQyNDcx_e12e7b4a-1ead-4574-a6ba-0012e4744ded"
      unitRef="usd">9179000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTItMS0xLTEtMTQyNDcx_78922eab-fdaf-4a69-a1f2-7be0aaffc50a"
      unitRef="usd">10855000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTItMy0xLTEtMTQyNDcx_249d567b-4fad-4702-a9dd-0f0630727f99"
      unitRef="usd">11925000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTQtMS0xLTEtMTQyNDcx_c35f2252-30c6-403a-9d7c-f89fd94a314d"
      unitRef="usd">29774000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTQtMy0xLTEtMTQyNDcx_50cd9a5a-0a9e-46a5-a8ac-9382e47c737e"
      unitRef="usd">34383000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTUtMS0xLTEtMTQyNDcx_0dbb2fb3-ea13-4176-8f7c-ffdb86b7b39b"
      unitRef="usd">14205000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTUtMy0xLTEtMTQyNDcx_0f1457e4-f0ba-438f-977c-dfe88b83d621"
      unitRef="usd">2133000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTctMS0xLTEtMTQyNDcx_9302033b-0c13-4e3d-b00b-1bc77e42a53a"
      unitRef="usd">39533000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTctMy0xLTEtMTQyNDcx_1ab2395a-8a86-499e-847f-5e48f463faba"
      unitRef="usd">-12877000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTgtMS0xLTEtMTQyNDcx_7c04aa10-554a-4fed-b1b5-d6fe1c8066e9"
      unitRef="usd">1435000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTgtMy0xLTEtMTQyNDcx_5beaf4d9-bd42-448e-93da-9c914fa530ac"
      unitRef="usd">134000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTktMS0xLTEtMTQyNDcx_f0e215be-3cc3-48f8-b6ee-05b12bc77926"
      unitRef="usd">240000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMTktMy0xLTEtMTQyNDcx_958437bd-c9ee-4f64-be62-d57bf27540a4"
      unitRef="usd">789000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjAtMS0xLTEtMTQyNDcx_17020cfc-3bb3-4b63-a435-f19dd9d7157b"
      unitRef="usd">603000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjAtMy0xLTEtMTQyNDcx_fc03591a-a163-4e2f-b58d-5ae3fd711857"
      unitRef="usd">2255000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjEtMS0xLTEtMTQyNDcx_b4e78f23-cd85-45a6-9648-aded3d87dfeb"
      unitRef="usd">41331000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjEtMy0xLTEtMTQyNDcx_a5dd2280-7384-41fb-9f61-db7aa1c71b2a"
      unitRef="usd">-11277000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjItMS0xLTEtMTQyNDcx_cc08786a-d61c-4a79-b126-bb38c58e21f8"
      unitRef="usd">55536000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjItMy0xLTEtMTQyNDcx_de1206ad-c87a-44d0-895a-b97eca2f4319"
      unitRef="usd">-9144000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjMtMS0xLTEtMTQyNDcx_b9baa159-9531-4d77-bb3d-f4c21431aa1e"
      unitRef="usd">11922000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjMtMy0xLTEtMTQyNDcx_5812b5cb-4125-469b-924b-6e107cb590cf"
      unitRef="usd">3785000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMS0xLTEtMTU1MjQy_81b54c3c-bcf3-49fb-9b8c-26db03caba59"
      unitRef="usd">43614000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMy0xLTEtMTQ0ODIz_e50e705c-2f50-4ee6-937f-7d0ba171a6ed"
      unitRef="usd">-12929000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjUtMS0xLTEtMTU1MjQy_f2ff8d7f-db4d-461b-b8f5-9dbcbebb35d7"
      unitRef="usd">-1665000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjUtMy0xLTEtMTQ0ODM3_18b7a837-731a-44ce-a866-3d34b90f4414"
      unitRef="usd">-2456000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMS0xLTEtMTQyNDcx_3e583849-a62f-45fe-8fd8-02fd19f7930c"
      unitRef="usd">41949000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjQtMy0xLTEtMTQyNDcx_6475f5d5-b47d-4a20-a1ae-a29a6a2dceac"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjYtMS0xLTEtMTQyNDcx_cb322ff0-d039-4e97-a191-1530361ae691"
      unitRef="usdPerShare">2.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjYtMy0xLTEtMTQyNDcx_fc0e108c-f86e-4eed-a559-7c2a16661bba"
      unitRef="usdPerShare">-0.77</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjctMS0xLTEtMTQyNDcx_a749544b-e7f7-45ba-8255-d60895399b5e"
      unitRef="usdPerShare">-0.10</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjctMy0xLTEtMTQyNDcx_e51fcb47-09ae-4a19-a568-e7de75ec5e67"
      unitRef="usdPerShare">-0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMS0xLTEtMTU1MjQ0_7e5f46cc-e419-4f99-9189-ebb21ee98a11"
      unitRef="usdPerShare">2.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMy0xLTEtMTU1MjM4_f7568210-f159-48f9-bbaf-5c4320f2e3bf"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzEtMS0xLTEtMTU1MjQ4_0e307a08-01a2-402b-aae4-6e1d7ea9fd54"
      unitRef="shares">17063000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzEtMy0xLTEtMTQ0OTA5_e08aae95-1e8b-4b20-872c-484b4754cea2"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjktMS0xLTEtMTQyNDcx_ebee0942-852a-4bed-81ac-6234877d852f"
      unitRef="usdPerShare">2.43</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMjktMy0xLTEtMTQyNDcx_ac84b176-2b3f-42c1-92a2-6407927372d3"
      unitRef="usdPerShare">-0.77</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMS0xLTEtMTQyNDcx_82ef2362-ea57-43be-a845-ccce7d4a1740"
      unitRef="usdPerShare">-0.09</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzAtMy0xLTEtMTQyNDcx_7764e38a-0628-44be-86a3-cecccc06c41a"
      unitRef="usdPerShare">-0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzUtMS0xLTEtMTU1MjQ2_23294e7c-6ccd-490e-aa9b-8ed95ba6628c"
      unitRef="usdPerShare">2.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzUtMy0xLTEtMTU1MjQw_74d90240-468f-4c38-97b9-fd6fc20cca44"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzYtMS0xLTEtMTU1MjUw_01baa84e-aad0-4230-a858-bc2cbdb7f4b7"
      unitRef="shares">17974000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8xOS9mcmFnOjIwOTI3Y2NiMTg2YzQxN2FhYjdmZDc4Y2Q2OTk2YTNiL3RhYmxlOmEzOWY0MDQ2ZDlhMTQ5ZTBhZTUyYzZjNGI3ZWY1MDYxL3RhYmxlcmFuZ2U6YTM5ZjQwNDZkOWExNDllMGFlNTJjNmM0YjdlZjUwNjFfMzYtMy0xLTEtMTQ0OTU3_2fc60587-c6ab-4f06-bcee-62381cc5d97b"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfMy0xLTEtMS0xNDI0NzE_96237ef3-5420-4293-8216-881e0f138d53"
      unitRef="usd">41949000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfMy0zLTEtMS0xNDI0NzE_585ae87e-829f-4ee4-b2be-b403c67e575c"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNC0xLTEtMS0xNDI0NzE_a86e5a11-1423-4f38-87be-f94c3b10dae5"
      unitRef="usd">49000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNC0zLTEtMS0xNDI0NzE_1d5b5c9c-90bd-400b-a3f8-d9e3ad419ee3"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNS0xLTEtMS0xNDI0NzE_be0c3bc0-6b71-46c0-b8c6-b10ed273c6af"
      unitRef="usd">41998000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yMi9mcmFnOmM1MWY1YWE1NDgwZDQ5Y2FhMTdhODQ4MzI4ZTMyODM5L3RhYmxlOmYwZmEwNGUxOTVlMzQ3MjNhZmU0M2NkZDY5NTBkMjg3L3RhYmxlcmFuZ2U6ZjBmYTA0ZTE5NWUzNDcyM2FmZTQzY2RkNjk1MGQyODdfNS0zLTEtMS0xNDI0NzE_bda48f12-3df9-4907-af71-82ce28d0ed4e"
      unitRef="usd">-15499000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic34b2229f7744763b8ab956b6b6373a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi0xLTEtMS0xNDI0NzE_538435f8-9071-433c-85e5-e94aaed86593"
      unitRef="shares">16951000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic34b2229f7744763b8ab956b6b6373a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi0yLTEtMS0xNDI0NzE_2cbc3580-baa5-452a-baf8-e1e1b087fb4b"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3bf026842b724db19523809726898537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi0zLTEtMS0xNDI0NzE_a9289047-f977-4a6c-8a77-1ad3c045b635"
      unitRef="usd">147590000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f445f5d04b0472a806b41285302bc93_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi00LTEtMS0xNDI0NzE_bb94eba3-bb5f-41a0-a4e5-247addf573cf"
      unitRef="usd">-984000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if9ecad473cf1472bad6c4b549c58808b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi01LTEtMS0xNDI0NzE_16e0c6b7-6ef3-4eed-b6c3-ce7d55342fb7"
      unitRef="usd">450862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfMi02LTEtMS0xNDI0NzE_014e0bf8-b597-4314-9fe3-8731cc0c0640"
      unitRef="usd">597485000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i88f3991b11274a1d83e8d12453c31bde_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNC0xLTEtMS0xNDI0NzE_45aee39f-e484-4a05-81f4-4816c3bbcf27"
      unitRef="shares">183000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia7bf770f68994031a86c11e53838362b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNC0zLTEtMS0xNDI0NzE_1ebab201-5c1b-4d83-93d3-3f18c08fb9d6"
      unitRef="usd">-762000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNC02LTEtMS0xNDI0NzE_f1296b50-8d3b-4855-8f76-ddc2b462cc80"
      unitRef="usd">-762000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia7bf770f68994031a86c11e53838362b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNS0zLTEtMS0xNDI0NzE_9a0d5a17-f90f-4f9d-8938-f4a92c200b81"
      unitRef="usd">5931000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNS02LTEtMS0xNDI0NzE_4c8d7c2e-0f24-4bdc-b806-a0f87a6ef573"
      unitRef="usd">5931000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic7216ff5406b44b1ba177f63fab7ca13_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNi00LTEtMS0xNDI0NzE_320d337d-58d4-4174-9e8e-1e210d3fb541"
      unitRef="usd">49000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNi02LTEtMS0xNDI0NzE_5b29a7be-1b55-4176-a144-a2a510849970"
      unitRef="usd">49000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation
      contextRef="ia7bf770f68994031a86c11e53838362b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNi0zLTEtMS0xNjA2MTM_34fc2ab1-fe44-49f8-8bf3-96c3504c92ae"
      unitRef="usd">1665000</lgnd:AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfNy02LTEtMS0xNDI0NzE_23cbc02f-cc4d-47dd-939d-6e915be5037f"
      unitRef="usd">1665000</lgnd:AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation>
    <us-gaap:NetIncomeLoss
      contextRef="i146393ab4a57499e86ded98459711b21_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOC01LTEtMS0xNDI0NzE_0c0d8e92-81d3-426a-9ad1-b844f140ca2a"
      unitRef="usd">41949000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOC02LTEtMS0xNDI0NzE_8534d21f-359f-4891-827f-76df2556eff5"
      unitRef="usd">41949000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i81d3755ad9d54f8ab9d3436775b7948d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS0xLTEtMS0xNDI0NzE_baa6028a-a9a8-4665-b3b6-daa21aab678c"
      unitRef="shares">17134000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i81d3755ad9d54f8ab9d3436775b7948d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS0yLTEtMS0xNDI0NzE_1531bb28-1e4f-4828-9a6a-f76ad96fdeb9"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d62bd1799fc4cd490f4762c0c6517d4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS0zLTEtMS0xNDI0NzE_d7066ddf-8ad4-4585-966f-6ea0e6b608a5"
      unitRef="usd">154424000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67e09b5d001d427fbb92bfc4d9d410d7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS00LTEtMS0xNDI0NzE_b6363311-7160-47ac-a507-eef8320153d6"
      unitRef="usd">-935000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd2fac596ab64c99aae2ed65bc41289e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS01LTEtMS0xNDI0NzE_f6bbf927-2772-4d61-bf17-289ca82f7d46"
      unitRef="usd">492811000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOmQwODY3YWYwNDYwNzQ5ZjFhZjExYjQ0YmFiNmEyNjNiL3RhYmxlcmFuZ2U6ZDA4NjdhZjA0NjA3NDlmMWFmMTFiNDRiYWI2YTI2M2JfOS02LTEtMS0xNDI0NzE_35e05e79-e2a0-43f7-84d9-b77f0d660597"
      unitRef="usd">646317000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iabcd11cab6e246f29bd95c8775e1803a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi0xLTEtMS0xNDI0NzE_ddb1e938-5f2e-4755-b702-5591edc8a580"
      unitRef="shares">16767000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iabcd11cab6e246f29bd95c8775e1803a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi0yLTEtMS0xNDI0NzE_db27ea36-ff94-47ee-88de-d83a561f7777"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e33362d86644981a7f835e3abb11e2a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi0zLTEtMS0xNDI0NzE_354a93da-e7d1-4bc0-b830-2f38fde89f26"
      unitRef="usd">372969000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic69a583af859424c904323cce6fc7c4c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi00LTEtMS0xNDI0NzE_a1a5028b-6bc4-4978-8463-50d8f7962aef"
      unitRef="usd">-917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1dcd4935652a40d29c4ba3d9eee90955_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi01LTEtMS0xNDI0NzE_21a7a876-dbba-41a4-9759-4a142d4262c4"
      unitRef="usd">449090000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4e695c2f9aa945e39a8aad1f6b165a20_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMi02LTEtMS0xNDI0NzE_4420df55-5f24-47d9-8e25-60ebb1721f46"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d0376708afe4578ba637e295776e58e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0zLTEtMS0xNDU2Mjc_47f5090d-3576-4793-8c58-e407aee11c39"
      unitRef="usd">-51130000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia95820899b06425fa25a5ff7bc95fbb4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy01LTEtMS0xNDU2Mzg_428a4b4c-21a7-442c-8748-0c159b8b1c22"
      unitRef="usd">35133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i49152728d14c47108836dbcc6300eb78_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy02LTEtMS0xNTUyNTk_6bc5a6dc-f6c2-4801-ba00-d5fbfe1b157a"
      unitRef="usd">-15997000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic77a2c8cd6b54702aad3fc849424beda_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0xLTEtMS0xNDI0NzE_2cd1ce45-9ed6-464d-88c4-da792fb3e4b8"
      unitRef="shares">94000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic77a2c8cd6b54702aad3fc849424beda_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0yLTEtMS0xNDI0NzE_146bce1c-8d82-4309-8592-0ac65b6a3c8a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2195045e053d42548f70094593395273_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy0zLTEtMS0xNDI0NzE_d4ffb068-bf37-44a5-9d08-d7a6cd5564bd"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMy02LTEtMS0xNDI0NzE_85fdd347-832a-4b8b-a767-f29affcb11e5"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2195045e053d42548f70094593395273_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNC0zLTEtMS0xNDI0NzE_ec7aa40d-18a9-4705-b0d9-b345c794ab8d"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNC02LTEtMS0xNDI0NzE_e7d718ce-61eb-47e3-a5d5-f5467ab15b87"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i0cec76fd474f414982654002b7611f04_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNS00LTEtMS0xNDI0NzE_2c5176b3-e01d-4f85-af0a-ec8c60272c27"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfNS02LTEtMS0xNDI0NzE_6f09aefa-e55b-4199-9ee0-54049bc5cfaa"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i0f11779e9d9b4e1f94f4e39f3ebccbe6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfOS01LTEtMS0xNDI0NzE_6440b53f-bbd2-433f-b5cf-f9f0e682dbc0"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfOS02LTEtMS0xNDI0NzE_f77d89d7-8d79-4aa8-8d65-c6aa6ecc7099"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7d2f609468824c07b03425783adb6d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtMS0xLTEtMTQyNDcx_cc5be4b3-c911-49e2-9c62-c2f17f1d1f9b"
      unitRef="shares">16861000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7d2f609468824c07b03425783adb6d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtMi0xLTEtMTQyNDcx_f642ebbc-6dd9-4b98-9cdf-5f876ae633e2"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iccf4e3b46ee2408aa97590c16ab24104_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtMy0xLTEtMTQyNDcx_ffa98808-3d6e-4eb1-97b3-da210a2a27e1"
      unitRef="usd">325368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i136be9af2fba4063bbe5c2f2224a8bae_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtNC0xLTEtMTQyNDcx_6ff13406-4e5b-4f6d-97fa-b3fe1223e9ec"
      unitRef="usd">-1031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4dbc4a0411f74b34ab89e9e5c50f68a1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtNS0xLTEtMTQyNDcx_a8f181a4-6423-4497-b0af-0e9e2ab826dc"
      unitRef="usd">468838000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2ddf6ce6c34e4acfae34f5a67089e27e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yNS9mcmFnOjk1YTcyNGMyZWJjZDRlN2M5OTdjZmEwNWMxNzRjMTlkL3RhYmxlOjUzZTA4ZDc3NjRjMzQzMzNhOTY0ODhlMDA5MzZmM2VlL3RhYmxlcmFuZ2U6NTNlMDhkNzc2NGMzNDMzM2E5NjQ4OGUwMDkzNmYzZWVfMTAtNi0xLTEtMTQyNDcx_2c1ce73b-4290-4210-a769-15ab54603afe"
      unitRef="usd">793192000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i146393ab4a57499e86ded98459711b21_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNC0xLTEtMS0xNDI0NzE_25b564ab-32a1-42a5-a89c-10f3955ba3f1"
      unitRef="usd">41949000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f11779e9d9b4e1f94f4e39f3ebccbe6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNC0zLTEtMS0xNDI0NzE_543030ad-bd69-4057-9cd0-6f707dadc0b1"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNi0xLTEtMS0xNDI0NzE_58d54cce-71d5-4212-98e3-009128a1a2c8"
      unitRef="usd">670000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNi0zLTEtMS0xNDI0NzE_fb073a1b-4d10-4cce-a0b8-1d22698a1933"
      unitRef="usd">1035000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNy0xLTEtMS0xNDI0NzE_6ae9b395-5b41-47a2-9016-2b5fdd58e78d"
      unitRef="usd">9499000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNy0zLTEtMS0xNDI0NzE_e23031e4-6f32-4d38-a572-ac3b7e0b7c27"
      unitRef="usd">13655000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOC0xLTEtMS0xNDI0NzE_1e6fb22a-35e2-4d4c-81cd-6b58642957d5"
      unitRef="usd">282000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOC0zLTEtMS0xNDI0NzE_cdf5a91b-8dfe-473f-8433-0e557e2de9de"
      unitRef="usd">-51000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOS0xLTEtMS0xNDI0NzE_92eea29b-8238-468c-9786-1dfc33762480"
      unitRef="usd">95000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfOS0zLTEtMS0xNDI0NzE_4b8cb8ca-ebd8-4157-9a72-ece35058bd72"
      unitRef="usd">326000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTAtMS0xLTEtMTQyNDcx_c32ba9c5-4f25-43b4-b0e5-aac495847dff"
      unitRef="usd">-379000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTAtMy0xLTEtMTQyNDcx_f4452262-46e2-43cf-8f8f-a514c43a4c7e"
      unitRef="usd">-11000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTEtMS0xLTEtMTQyNDcx_16262bcb-254f-4cec-9f41-e7bb79067969"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTEtMy0xLTEtMTQyNDcx_60861ebe-d26f-4e36-9348-e4f16945952f"
      unitRef="usd">1532000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTItMS0xLTEtMTQyNDcx_81582c47-ea19-4f14-bc04-fa5483c1a439"
      unitRef="usd">5931000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTItMy0xLTEtMTQyNDcx_6d6814cc-64f5-4f4f-8c78-35b889de5251"
      unitRef="usd">9044000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTMtMS0xLTEtMTQyNDcx_1d777f2f-ab00-4228-bcf1-988eb5584979"
      unitRef="usd">-8754000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTMtMy0xLTEtMTQyNDcx_ccfea4d2-a50b-4f9b-a4c3-e0ea1deaa8ee"
      unitRef="usd">16180000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTQtMS0xLTEtMTQyNDcx_f5f88360-c545-4e7b-8b2b-95bd5ee2d400"
      unitRef="usd">39533000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTQtMy0xLTEtMTQyNDcx_1b032fdc-fa31-4c7b-9bfd-51a31190ae51"
      unitRef="usd">-12877000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTUtMS0xLTEtMTQyNDcx_4e1c7aaa-aec5-435a-952a-da845ce92486"
      unitRef="usd">447000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTUtMy0xLTEtMTQyNDcx_d2172d6d-7d6c-48bb-8405-44204d2ea904"
      unitRef="usd">1490000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTYtMS0xLTEtMTQyNDcx_01fb63c3-94da-4ac1-a7fb-6bfd5befc057"
      unitRef="usd">240000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTYtMy0xLTEtMTQyNDcx_e94306ca-2b1e-496b-95eb-0dcaf4c9ba06"
      unitRef="usd">-80000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTgtMS0xLTEtMTQyNDcx_421aa349-7891-4950-89cb-35e419ce7bc6"
      unitRef="usd">-1099000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTgtMy0xLTEtMTQyNDcx_b85e6709-cbba-483a-95b8-69af1b5078a7"
      unitRef="usd">-43638000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTktMS0xLTEtMTQyNDcx_ce8e5e36-9f96-4c17-b5c3-02cbea2abf3b"
      unitRef="usd">-2035000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMTktMy0xLTEtMTQyNDcx_7834a009-a460-4076-9ae7-ab7c587bd8e3"
      unitRef="usd">-44000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjAtMS0xLTEtMTQyNDcx_ba756e7a-71ea-41e1-b5bc-00521d4a0167"
      unitRef="usd">-435000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjAtMy0xLTEtMTQyNDcx_7e9ebde5-32ec-449b-b780-53a4da505233"
      unitRef="usd">-2708000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjEtMS0xLTEtMTQyNDcx_ab36471c-d6aa-47b8-a277-253941860743"
      unitRef="usd">4614000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjEtMy0xLTEtMTQyNDcx_aee669f1-4c5f-4829-891c-b06b1b464624"
      unitRef="usd">11993000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjItMS0xLTEtMTQyNDcx_8dc3dec9-498e-4c5a-a39e-f240cbc092bd"
      unitRef="usd">-98000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjItMy0xLTEtMTQyNDcx_ad255d80-1f87-4878-9b89-31ca3c4365e9"
      unitRef="usd">-2453000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjQtMS0xLTEtMTQyNDcx_000e5444-576c-44c7-a14e-7a94df7b8554"
      unitRef="usd">-682000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjQtMy0xLTEtMTQyNDcx_55ecc3c9-be04-4482-b6a2-562687e4f649"
      unitRef="usd">1723000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjUtMS0xLTEtMTQyNDcx_d9f8c845-e1c4-4ad5-9171-05273038920e"
      unitRef="usd">33948000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjUtMy0xLTEtMTQyNDcx_47823863-7a18-4cd2-8e69-0d85d1a6c6fb"
      unitRef="usd">52011000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjgtMS0xLTEtMTQyNDcx_5f1856da-9fd8-4c11-a394-18d256c38c43"
      unitRef="usd">39864000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjgtMy0xLTEtMTQyNDcx_c341a2b5-52a0-497b-aceb-203b5cea479e"
      unitRef="usd">38190000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjktMS0xLTEtMTQyNDcx_7bd93a2c-3f50-43d7-96e7-32592228ebb3"
      unitRef="usd">44232000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMjktMy0xLTEtMTQyNDcx_dcefffa4-578e-4ca0-af4a-1b13501f6017"
      unitRef="usd">132866000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzAtMS0xLTEtMTQyNDcx_45be8945-ad83-4bd1-ba65-9da5a5ae3810"
      unitRef="usd">8465000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzAtMy0xLTEtMTQyNDcx_409aa1e1-80fb-449c-8cd0-3cc980f62a6d"
      unitRef="usd">24830000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzEtMS0xLTEtMTQyNDcx_1ce75f64-c34b-4c0d-a6f9-f621988079cd"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzEtMy0xLTEtMTQyNDcx_5ec56da6-a059-4250-a86a-ec650cbc6e92"
      unitRef="usd">750000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzItMS0xLTEtMTQyNDcx_bd1e2635-eb41-4c3f-81e1-e30d0f37d83e"
      unitRef="usd">2414000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzItMy0xLTEtMTQyNDcx_ef1f8e12-b79b-4b3f-94cb-131fb72999e4"
      unitRef="usd">4875000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <lgnd:ProceedsFromCommercialLicenseRights
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzQtMS0xLTEtMTYwMjYw_188330bd-e94a-4b6e-8773-38403b11729b"
      unitRef="usd">130000</lgnd:ProceedsFromCommercialLicenseRights>
    <lgnd:ProceedsFromCommercialLicenseRights
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzQtMy0xLTEtMTYwNDEx_d384c1fc-21e8-490a-ac5f-485fd122a3b8"
      unitRef="usd">0</lgnd:ProceedsFromCommercialLicenseRights>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzUtMS0xLTEtMTQyNDcx_808ba859-e886-4f80-aa53-6e94e41e46fe"
      unitRef="usd">10549000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzUtMy0xLTEtMTQyNDcx_f57ec007-fc30-476c-b319-3b5f35ec2c97"
      unitRef="usd">113881000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzgtMS0xLTEtMTQyNDcx_5466acd8-7140-4ea2-97fb-a5adec0be208"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzgtMy0xLTEtMTQyNDcx_5502ec62-63e9-45b7-94ed-471615bfb122"
      unitRef="usd">163356000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzktMS0xLTEtMTQyNDcx_8d7e214a-2372-4a61-94f4-39cf433e3de4"
      unitRef="usd">13000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfMzktMy0xLTEtMTQyNDcx_22d7eb81-2693-41a8-8e33-6d93f2830509"
      unitRef="usd">13000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDItMS0xLTEtMTQyNDcx_c9dedb07-c7e3-4b3f-be62-03b5735040aa"
      unitRef="usd">3393000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDItMy0xLTEtMTQyNDcx_b7741ee3-db59-4faa-ad55-4b2acf6161b5"
      unitRef="usd">347000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDMtMS0xLTEtMTQyNDcx_de2f0905-46a3-4356-948f-16f731d0cba1"
      unitRef="usd">4155000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDMtMy0xLTEtMTQyNDcx_e0b88ee5-3d5f-436f-a2a2-515101381a49"
      unitRef="usd">5862000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDQtMS0xLTEtMTQyNDcx_6b7e5e0e-8332-44e8-8726-8b5dda5a4a3a"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDQtMy0xLTEtMTQyNDcx_478aae58-e474-4e1d-b0fd-1477174ed119"
      unitRef="usd">1416000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMS0xLTEtMTU1MjYz_871a5e41-7959-46ff-abf7-0e9020fb1369"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMy0xLTEtMTQ1Nzgw_a1db3670-6e68-4211-bfa6-58b453a1c303"
      unitRef="usd">-121000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMS0xLTEtMTQyNDcx_17c40dc4-db4c-4c2d-b5a1-7241dbc4920e"
      unitRef="usd">-775000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDYtMy0xLTEtMTQyNDcx_f76f2c57-d860-4755-b5cc-518d9911207d"
      unitRef="usd">-170421000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDctMS0xLTEtMTQyNDcx_60617888-5c1c-4dcb-946c-46b4c33b72fe"
      unitRef="usd">43722000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDctMy0xLTEtMTQyNDcx_1b72b3b3-b0bd-40de-bc5c-ac9290d61c8a"
      unitRef="usd">-4529000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDgtMS0xLTEtMTQyNDcx_b6af7627-7b5e-4b23-98b6-d753b22867a3"
      unitRef="usd">45006000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4e695c2f9aa945e39a8aad1f6b165a20_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDgtMy0xLTEtMTQyNDcx_ed95c95e-e686-4619-9177-cee8647d0043"
      unitRef="usd">19522000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDktMS0xLTEtMTQyNDcx_c6f8cfc9-d27e-493a-8772-815d91efb53d"
      unitRef="usd">88728000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2ddf6ce6c34e4acfae34f5a67089e27e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjdhMmZjMGIxYzZlMzQ0M2ZiZGNhNjQ5ZDhiMTFiYjc4L3RhYmxlcmFuZ2U6N2EyZmMwYjFjNmUzNDQzZmJkY2E2NDlkOGIxMWJiNzhfNDktMy0xLTEtMTQyNDcx_060d306e-e1b0-49eb-8b1a-ee6e7f62a986"
      unitRef="usd">14993000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMS0xLTEtMS0xNDI0NzE_63154f6e-1910-4db7-adc7-455f6a0b6d1a"
      unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMS0zLTEtMS0xNDI0NzE_9d99a8bf-adfa-45bd-bb68-7630e6cac510"
      unitRef="usd">359000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfOS0xLTEtMS0xNDI0NzE_5a0e5326-d40c-4b6e-9387-90dfcea16511"
      unitRef="usd">140000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfOS0zLTEtMS0xNDI0NzE_c36b671b-123d-4b90-8c21-b5c40bc282eb"
      unitRef="usd">2574000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTAtMS0xLTEtMTQyNDcx_9e6102e4-2bd2-443d-af59-c7951db7070d"
      unitRef="usd">2752000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTAtMy0xLTEtMTQyNDcx_f48d2cff-8e76-4d82-9a87-b068fe103137"
      unitRef="usd">306000</lgnd:AccruedInventoryPurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTItMS0xLTEtMTQyNDcx_969520dd-c005-45ba-a0ce-5266c79f3f1d"
      unitRef="usd">49000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8yOC9mcmFnOjg1ZGI4YmYxOWJhZjRmOGQ5MjAwN2VkMGRjZTk2N2FjL3RhYmxlOjcwM2YwMjc3OWE5MzQ2Zjk5ZWJiMjg2NDA5ZTMzMmM3L3RhYmxlcmFuZ2U6NzAzZjAyNzc5YTkzNDZmOTllYmIyODY0MDllMzMyYzdfMTItMy0xLTEtMTQyNDcx_09501e17-fb94-4bc7-a5f1-50f7274ba90b"
      unitRef="usd">-114000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNDM_62971f86-27b9-40dd-bca0-a3243f80e823">Basis of Presentation and Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we completed the separation (the &#x201c;Separation&#x201d;) of our antibody discovery business and certain related assets and liabilities (the &#x201c;OmniAb Business&#x201d;) through a spin-off of OmniAb to Ligand&#x2019;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#x201c;Distribution&#x201d;) and merger (the &#x201c;Merger&#x201d;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#x201c;New OmniAb&#x201d;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#x201c;Merger Agreement&#x201d;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#x201c;Separation Agreement&#x201d;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#x201c;Transaction Agreements&#x201d;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2022 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discontinued Operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 205-20&#x201d;). Accordingly, the accompanying condensed consolidated financial statements have been updated to present the results of all discontinued operations reported as a separate component of loss in the condensed consolidated statements of operations and comprehensive loss (see Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Spin-off of OmniAb&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). All disclosures have been adjusted to reflect continuing operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2022 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2023 and 2022, the amount recognized as revenue that was previously deferred was $0.1 million, and $0.3 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at March&#160;31, 2023 and December 31, 2022 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bond fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bond fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, we sold 3.2&#160;million shares of Viking common stock and recognized realized gain of $20.5 million in total.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended  March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 68 investments which were in an unrealized loss position with a total of $0.1&#160;million unrealized losses as of March&#160;31, 2023. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three months ended  March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three months ended  March&#160;31, 2023, we considered the current and expected future economic and market conditions and concluded an increase of $0.1 million of allowance for credit losses as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs recorded against inventory for the three months ended  March&#160;31, 2023 and 2022. As of March&#160;31, 2023 inventory consists of Captisol prepayments of $5.4 million, and as of December 31, 2022 inventory consists of Captisol prepayments of $5.9 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;439,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;448,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.4 million and credit loss adjustments of $6.5 million as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2022 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended  March&#160;31, 2023, we further considered the current and expected future economic and market conditions and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 260, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares are dilutive. The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023 convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <lgnd:BusinessSpinOffAndMigrationPolicyTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzI5ODUzNDkzMjIxNg_17418758-935a-4444-9be9-8b35420d62ef">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we completed the separation (the &#x201c;Separation&#x201d;) of our antibody discovery business and certain related assets and liabilities (the &#x201c;OmniAb Business&#x201d;) through a spin-off of OmniAb to Ligand&#x2019;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#x201c;Distribution&#x201d;) and merger (the &#x201c;Merger&#x201d;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#x201c;New OmniAb&#x201d;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#x201c;Merger Agreement&#x201d;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#x201c;Separation Agreement&#x201d;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#x201c;Transaction Agreements&#x201d;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.&lt;/span&gt;&lt;/div&gt;</lgnd:BusinessSpinOffAndMigrationPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY3NjY3MQ_47598ced-1cda-483a-830b-79869c4d6e2e"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjA_3855db22-6288-4bab-9e98-06d2943aa43d">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2022 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzg0ODI5MDcyMzIxNw_0f27af25-1ffa-4795-9716-84454cb49c0e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discontinued Operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 205-20&#x201d;). Accordingly, the accompanying condensed consolidated financial statements have been updated to present the results of all discontinued operations reported as a separate component of loss in the condensed consolidated statements of operations and comprehensive loss (see Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Spin-off of OmniAb&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). All disclosures have been adjusted to reflect continuing operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzA_308708ff-f9c5-41b4-895a-20b847d72268">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzk_c850bd97-b4ea-4ec5-a778-d4da98d2a38a">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. &lt;/span&gt;&lt;/div&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTEzNzY_b0af5eec-0328-4c94-a0cc-ae76f6edd1dd"
      unitRef="usd">100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTEzODQ_c011fd26-ea96-4c3e-abf0-02d2511abfdc"
      unitRef="usd">300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzc_be9d3383-a0cd-4810-9593-6d3fb42e6507">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65eeea1681704584af49987ac1e87675_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNC0xLTEtMS0xNDI0NzE_ae350337-0990-4812-a254-21b49b1bdfe0"
      unitRef="usd">6228000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc33e31ac6cb43b7a3645f8b84193980_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNC0zLTEtMS0xNDI0NzE_a18d4a17-be03-44e1-9219-c1d8ea281845"
      unitRef="usd">4622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcf62d0f95754c7295cc30e21972ebf8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNS0xLTEtMS0xNDI0NzE_c1920f7d-3624-4c3c-a858-87cb8cf51657"
      unitRef="usd">2550000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i252ec6f092314ab183cfe571c994ac8b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNS0zLTEtMS0xNDI0NzE_ec134bef-3371-4650-9e31-6d52bc398438"
      unitRef="usd">2701000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i507e16f565324f84b591860daa92de64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNi0xLTEtMS0xNDI0NzE_b56a0410-feba-4d68-be29-31495fabf3ed"
      unitRef="usd">3500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2214c64514eb49f2a8842771d28dce64_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNi0zLTEtMS0xNDI0NzE_11022a19-0239-49fd-8db8-0ea15d50b064"
      unitRef="usd">2911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i471ece02df084a638a5073e4e480760e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNy0xLTEtMS0xNDI0NzE_859b4f1d-b2a4-4154-80e4-1935b7533f6a"
      unitRef="usd">2609000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie460943c319f46f089b3dbac6d243d9c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfNy0zLTEtMS0xNDI0NzE_edcde0fa-5223-40dd-b91f-9208e71a69a5"
      unitRef="usd">1649000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i603a416169e44298a4e5e843b920577a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOC0xLTEtMS0xNDI0NzE_8c1ee6fb-6f65-4c94-98a0-81b0d3bf7d01"
      unitRef="usd">2267000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icab12c145b7a4a9386bead15014c2002_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOC0zLTEtMS0xNDI0NzE_bf91aca7-8c60-4361-9f8e-f3e95964d879"
      unitRef="usd">1549000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id674d396b37c4237beed113c89c2675d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOS0xLTEtMS0xNDI0NzE_0d453d7c-fd56-4341-8113-db607bae69a8"
      unitRef="usd">17154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b1846c1e72842cea62ab4d1e84368a3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfOS0zLTEtMS0xNDI0NzE_9401f54c-4cb5-4835-bb3d-f33252502458"
      unitRef="usd">13432000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d1e076699044354a517e91f65469898_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTItMS0xLTEtMTQyNDcx_9a295de2-6052-4bd3-aa27-ed40f96bc6bb"
      unitRef="usd">10622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb74890b7510460d8f61f873e0236e2a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTItMy0xLTEtMTQyNDcx_c85095a8-0efe-4c18-b9ee-46e2ed4e3776"
      unitRef="usd">6226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9aa759764214b4c9217f0f8b8b0bf12_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTMtMS0xLTEtMTQyNDcx_5a04964e-d6f8-4739-b0df-e5b2e0481bf4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65ab7c5558dc4b2691364948dff9c3bb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTMtMy0xLTEtMTQyNDcx_1eeb3b69-eacc-4f75-91dc-6840e344e4ac"
      unitRef="usd">5896000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac4e08b486c498488e4ec21236f70ac_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTQtMS0xLTEtMTQyNDcx_1721c70a-8188-46c2-adf4-e00686582a92"
      unitRef="usd">10622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad8c3f3b74a145eba569dc88db6a0243_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTQtMy0xLTEtMTQyNDcx_59e85923-f5e4-4b9c-bb0f-4732c9d03e02"
      unitRef="usd">12122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56e6b2467288481aa925463f0f2dfa48_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTgtMS0xLTEtMTQyNDcx_16e43302-e12b-42cb-85b2-9a3213838577"
      unitRef="usd">114000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa2a0b5f22124e0299cea65f936d0552_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTgtMy0xLTEtMTQyNDcx_d8870f92-3734-4f2c-8487-9468e31f8976"
      unitRef="usd">2081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic358d5ad2b4745ce8983d4eb13528034_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTktMS0xLTEtMTQyNDcx_dc4fe534-fdfc-48c9-b262-e378e395fccb"
      unitRef="usd">15300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cf6169f7de846d8b64a2d389e36a41a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMTktMy0xLTEtMTQyNDcx_f70f6364-9e64-4dd2-b271-4d6ba8807646"
      unitRef="usd">5993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0dd089aaa47c4e3f803998025bdb0535_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjAtMS0xLTEtMTQyNDcx_682b2a4d-2bae-4592-abdd-b3642365d4c5"
      unitRef="usd">789000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77a21caa530e4123b94f8358586e06f0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjAtMy0xLTEtMTQyNDcx_f5d5d7dd-bcea-45e0-b1a0-83f6448b92dd"
      unitRef="usd">2888000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0dbfa3c35724185bcf83cfd276f013a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjEtMS0xLTEtMTQyNDcx_5d4f2584-303f-4756-af27-1a488a25f736"
      unitRef="usd">16203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifeeb7f4be42949899bd810534b9af482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjEtMy0xLTEtMTQyNDcx_07ad9890-05a9-4440-90dc-bb9988d92eda"
      unitRef="usd">10962000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjItMS0xLTEtMTQyNDcx_604dd9d2-4c01-48dc-8a5b-ce448c9f7698"
      unitRef="usd">43979000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmQxMTRkODNkMDQzODQ0MTFhMWNkM2U3ODQwZmU3ZjE5L3RhYmxlcmFuZ2U6ZDExNGQ4M2QwNDM4NDQxMWExY2QzZTc4NDBmZTdmMTlfMjItMy0xLTEtMTQyNDcx_354a0806-c949-4929-a47f-bdfa186b029b"
      unitRef="usd">36516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNTE_6e74963a-c5fa-4e59-a24f-cc4b457483aa">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at March&#160;31, 2023 and December 31, 2022 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bond fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bond fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2a5ad898201d43378731028a1922d796_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi0xLTEtMS0xNDI0NzE_d73b9179-ea9a-4931-ab22-eae41c6bb430"
      unitRef="usd">19691000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2a5ad898201d43378731028a1922d796_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi00LTEtMS0xNDI0NzE_4c38d809-bdd4-4c4e-a4c5-0d095de79f05"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2a5ad898201d43378731028a1922d796_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi03LTEtMS0xNDI0NzE_a5f4d011-822b-40ea-8ef7-2461c1e81584"
      unitRef="usd">26000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2a5ad898201d43378731028a1922d796_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMi0xMC0xLTEtMTQyNDcx_0e80101f-1857-4e2d-b0f0-e848d760902e"
      unitRef="usd">19668000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy0xLTEtMS0xNDI0NzE_525d5be2-7e0d-45cc-ba61-a9b9b29beb51"
      unitRef="usd">9592000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy00LTEtMS0xNDI0NzE_22f68359-3751-40b0-8020-1e6af13399a0"
      unitRef="usd">63000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy03LTEtMS0xNDI0NzE_1f6ebb55-e659-4394-b12e-3871438c4e87"
      unitRef="usd">37000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia37ccafda9b24cfc9287aa5f1ecad4a0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMy0xMC0xLTEtMTQyNDcx_eee14821-75f2-4645-b9fc-46754bcc1fc1"
      unitRef="usd">9618000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC0xLTEtMS0xNDI0NzE_bea46e65-390d-4f25-bab5-0eb7d019d979"
      unitRef="usd">979000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC00LTEtMS0xNDI0NzE_86e2cb7c-d2e2-4010-9a89-d4df5c58b555"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC03LTEtMS0xNDI0NzE_2bec7690-deda-49cf-a289-30fd481fb29c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie5a6ac4b7e5149ccb6f8c5657f9aa2a8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNC0xMC0xLTEtMTQyNDcx_d75cc13c-f099-440c-9a70-efd890768f26"
      unitRef="usd">981000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS0xLTEtMS0xNDI0NzE_1c187b06-7685-41d2-99ca-7552d046e2c7"
      unitRef="usd">13461000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS00LTEtMS0xNDI0NzE_9ccdf5e1-0f99-444e-a8df-6127b17319ca"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS03LTEtMS0xNDI0NzE_22186f87-1e17-4195-9931-0347316adf2e"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i59e2033d633a4c469bd9429bc3777327_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNS0xMC0xLTEtMTQyNDcx_65bc41fb-a4b0-4b96-a17f-b032cda3e9aa"
      unitRef="usd">13454000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1c6bf9aba4794d65841b444357010217_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xLTEtMS0xNTY2NTE_6f6cda4a-8b89-4ba3-ab73-ffcf7086e0d4"
      unitRef="usd">1005000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1c6bf9aba4794d65841b444357010217_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi00LTEtMS0xNTY2NjE_c13ec882-a378-40f4-bea1-5fe6e60377c5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1c6bf9aba4794d65841b444357010217_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi03LTEtMS0xNTY2NzE_c778ed4d-1dcb-4e9e-ae8e-79bc2ef414b1"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1c6bf9aba4794d65841b444357010217_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xMC0xLTEtMTU4MTI2_c643cb74-fcd6-4de8-9b67-2ea24761c6b2"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xLTEtMS0xNDI0NzE_b2748502-f80e-47d9-aa1a-5e752a0f4f55"
      unitRef="usd">5775000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi00LTEtMS0xNDI0NzE_a9729e76-dd1d-4edb-b999-cf2393fb3957"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi03LTEtMS0xNDI0NzE_57977e76-1f36-4164-b92f-ee91a96c53e5"
      unitRef="usd">4120000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9af904e6214a46b3913fbe243bd898e5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNi0xMC0xLTEtMTQyNDcx_6a097325-29a1-4ae8-887e-372c3060a81b"
      unitRef="usd">1655000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy0xLTEtMS0xNDI0NzE_0032fe03-f561-42a7-91ef-327ad1b4a32e"
      unitRef="usd">82678000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy00LTEtMS0xNDI0NzE_ef0c22f2-6490-4572-a28a-342dcab82a7c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy03LTEtMS0xNDI0NzE_917287e6-5e27-409b-83c6-88e915260a4d"
      unitRef="usd">807000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia1ace55ddf80493b9b3d55cb674104bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfNy0xMC0xLTEtMTQyNDcx_b9244d9d-48b2-4556-ae2a-ff67529d914d"
      unitRef="usd">81871000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC0xLTEtMS0xNDI0NzE_8d183f78-4428-43ff-b409-90cac9b39f87"
      unitRef="usd">6243000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC00LTEtMS0xNDI0NzE_fb40f4bf-0360-42fb-8b0f-bcf55074bebf"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC03LTEtMS0xNDI0NzE_892b8590-2940-498e-ae43-232535345407"
      unitRef="usd">47000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7cc7dff39832419b9fade16b421649d8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOC0xMC0xLTEtMTQyNDcx_d3e3e163-5e9e-449b-80ec-8277822775fa"
      unitRef="usd">6198000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i02a49f05176146c7b857da134f78d9be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS0xLTEtMS0xNDI0NzE_582b2091-f3f9-43b9-8d7c-86cb703bc553"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i02a49f05176146c7b857da134f78d9be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS00LTEtMS0xNDI0NzE_6169bdf5-d912-46a3-a92b-aa522da034c1"
      unitRef="usd">133000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i02a49f05176146c7b857da134f78d9be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS03LTEtMS0xNDI0NzE_2b329c3b-bb84-453f-b59d-8090c8007369"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02a49f05176146c7b857da134f78d9be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfOS0xMC0xLTEtMTQyNDcx_e15b1f74-799e-432b-ba6c-6ced36df5349"
      unitRef="usd">133000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtMS0xLTEtMTQyNDcx_6405ca81-23ad-4657-9b32-414692dd8a1b"
      unitRef="usd">139424000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtNC0xLTEtMTQyNDcx_6156f8ba-5b66-4efe-9d54-cac088f16e0b"
      unitRef="usd">205000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtNy0xLTEtMTQyNDcx_78cdda33-5fcd-4238-b646-8058e572e29a"
      unitRef="usd">5051000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTAtMTAtMS0xLTE0MjQ3MQ_52a5d529-45f1-48b0-aa90-fa7f6fecfc66"
      unitRef="usd">134578000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id1cc642360a843b4be5f97a5be47caf6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTEtMTAtMS0xLTE0MjQ3MQ_9da5c887-e9b5-45d6-96d0-e8395ce1219e"
      unitRef="usd">59359000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTItMTAtMS0xLTE0MjQ3MQ_496345c8-0ad9-4be4-b2a7-8295c04c4ed7"
      unitRef="usd">193937000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtMS0xLTEtMTQyNDcx_af532a42-7d0f-41ad-be5a-c530f5ab12b4"
      unitRef="usd">5012000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtNC0xLTEtMTQyNDcx_501b2260-ebe8-48aa-9599-712b52e74974"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtNy0xLTEtMTQyNDcx_27131ed8-da66-49cc-aae2-d562be674989"
      unitRef="usd">34000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i851627360fcd4241918ea438e1eab5ed_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTUtMTAtMS0xLTE0MjQ3MQ_79221016-a4c4-4a85-b27b-3311da3ee91e"
      unitRef="usd">4980000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtMS0xLTEtMTQyNDcx_47140f9d-6dc9-48db-a35a-6969942c0872"
      unitRef="usd">6701000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtNC0xLTEtMTQyNDcx_4c222fe3-db2d-46f2-a1c8-fc3d0b81476e"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtNy0xLTEtMTQyNDcx_0c831a73-18b0-41b5-80c0-bcdf4311e0c8"
      unitRef="usd">58000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib1d5edfb22d8410c8c18477fedb0c132_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTYtMTAtMS0xLTE0MjQ3MQ_1a3faeae-57ca-4dfc-9eab-5ccd94294254"
      unitRef="usd">6656000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtMS0xLTEtMTQyNDcx_55066f45-5d79-4216-b6c6-ec4966ae3a15"
      unitRef="usd">7211000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtNC0xLTEtMTQyNDcx_c703a6aa-f2c8-418c-83e8-19434c336543"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtNy0xLTEtMTQyNDcx_157eeb48-1d55-4d90-9d91-8476283ba66d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4cf7ff7836bc45738d6e004a65e3c0ff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTgtMTAtMS0xLTE0MjQ3MQ_14e1a2a0-469e-4b30-852c-790091f0040a"
      unitRef="usd">7214000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktMS0xLTEtMTQyNDcx_071ebfe1-dcdd-4509-b4ea-66d9a04122ab"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktNC0xLTEtMTQyNDcx_6ead52dc-a9c6-4135-8050-b58db3b813ba"
      unitRef="usd">262000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktNy0xLTEtMTQyNDcx_75941e5c-1457-4350-af63-a41c4c661a50"
      unitRef="usd">4239000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icb5915e8af3848bab85d86525cc3ec55_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMTktMTAtMS0xLTE0MjQ3MQ_f751bc3d-b51b-460f-9321-f42cba481408"
      unitRef="usd">1830000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtMS0xLTEtMTQyNDcx_09919565-7922-486f-b326-d4e7e3a25c01"
      unitRef="usd">81815000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtNC0xLTEtMTQyNDcx_01d6f407-4f58-43d4-9256-a090032009c2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtNy0xLTEtMTQyNDcx_a23162e1-71ab-4c7e-8d5a-e5b654583532"
      unitRef="usd">1050000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i961c8d92f57e44838827ed1e6b8d9094_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjAtMTAtMS0xLTE0MjQ3MQ_77a7c3ce-e7ea-4c84-92d8-c483724b0f30"
      unitRef="usd">80765000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtMS0xLTEtMTQyNDcx_bfc791ef-29c7-46ba-b2d2-bd0946bd2be9"
      unitRef="usd">2232000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtNC0xLTEtMTQyNDcx_ece670d5-95c2-409d-9c54-cc5f9eb06971"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtNy0xLTEtMTQyNDcx_17ae0726-ce66-4be5-8409-70ac6ac49df4"
      unitRef="usd">70000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib4558a7c600248d4877505fd0fe0dac4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjEtMTAtMS0xLTE0MjQ3MQ_3ebb1851-1832-43ee-a372-02c911892951"
      unitRef="usd">2162000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItMS0xLTEtMTQyNDcx_38aad831-065b-4a4a-b464-5a939fed238c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItNC0xLTEtMTQyNDcx_6d7852e4-2fc0-4f8e-a42a-6354ca1caef9"
      unitRef="usd">135000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItNy0xLTEtMTQyNDcx_05bda6e3-e96a-45d1-be73-7afb289e4a78"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i453dc18f50a14d2f9ad41790b6e0d175_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjItMTAtMS0xLTE0MjQ3MQ_24d90fa9-1e94-4e50-a1de-f215284c1cc4"
      unitRef="usd">135000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtMS0xLTEtMTQyNDcx_00b86931-d5aa-403c-8fc3-b831e2ae6d5f"
      unitRef="usd">108778000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtNC0xLTEtMTQyNDcx_5905e638-439d-479a-ad82-429401ec3ae8"
      unitRef="usd">415000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtNy0xLTEtMTQyNDcx_fda1f78f-3a2d-415f-a802-09418aa1f0ab"
      unitRef="usd">5451000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjMtMTAtMS0xLTE0MjQ3MQ_b2b6cf02-7996-41a4-a6e0-7c392ef1e58c"
      unitRef="usd">103742000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3aee0771a079448d978ce5fbb46ef39d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjQtMTAtMS0xLTE0MjQ3MQ_272bd51d-0504-4504-bf2d-ed2ed4be0898"
      unitRef="usd">63122000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmYxMzZhNWE1MGE3YTQxMTk4NmVkNGJmYzc2ZWE0NGI0L3RhYmxlcmFuZ2U6ZjEzNmE1YTUwYTdhNDExOTg2ZWQ0YmZjNzZlYTQ0YjRfMjUtMTAtMS0xLTE0MjQ3MQ_be439638-e8a8-41f1-b63d-4c333544b57f"
      unitRef="usd">166864000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <lgnd:EquitySecuritiesFVNIShareSoldInPeriod
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1NDg4MQ_1c4a8a0e-f88e-4651-93d1-6fa1dde85d0f"
      unitRef="shares">3200000</lgnd:EquitySecuritiesFVNIShareSoldInPeriod>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1NDkwMA_143abb3e-c23c-4245-a874-d715c70c97a4"
      unitRef="usd">20500000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjY_54cf48a7-fd46-4431-8761-cfd4f7c0a67c">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMi0xLTEtMS0xNDI0NzE_d6b0142a-3a78-4232-940d-9b14ffc9fd97"
      unitRef="usd">123794000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMi0zLTEtMS0xNDI0NzE_70e11340-7206-4893-a310-6217a302ce46"
      unitRef="usd">123681000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMy0xLTEtMS0xNDI0NzE_650b4070-bc8c-4d84-af0a-a8931d3e1d52"
      unitRef="usd">10903000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfMy0zLTEtMS0xNDI0NzE_e1483567-32a7-4a30-8a33-7158d52dc88f"
      unitRef="usd">10962000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfNC0xLTEtMS0xNDI0NzE_d39521ff-ec36-4146-a80a-8f79399f0dd4"
      unitRef="usd">134697000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmMzNjBiYTk1YWIwMDRkYjA5NTY1MGI5MDU5MzNjM2MwL3RhYmxlcmFuZ2U6YzM2MGJhOTVhYjAwNGRiMDk1NjUwYjkwNTkzM2MzYzBfNC0zLTEtMS0xNDI0NzE_e8296188-44e0-4d30-b1f1-4d75ad47acc1"
      unitRef="usd">134643000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY3NjY1OA_f3b3d99a-d59a-4693-b3f7-1a10d7349c48"
      unitRef="position">68</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDQ0MA_2c640818-275e-4308-85b0-f5ec4f0c6f20"
      unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTM0NTM_6ac043cf-b562-427a-b54f-388d6f0f7961"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMzE_947b28c9-5427-475a-9144-d6b3f1c97092">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDc0NA_a5023f51-1d51-4ca9-b9f4-3b9239735c6c"
      unitRef="usd">100000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNjg_76f4fa06-9e41-4fbf-abe6-95bef2913e88">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. &lt;/span&gt;&lt;/div&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs recorded against inventory for the three months ended  March&#160;31, 2023 and 2022. As of March&#160;31, 2023 inventory consists of Captisol prepayments of $5.4 million, and as of December 31, 2022 inventory consists of Captisol prepayments of $5.9 million.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryWriteDown
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzg0ODI5MDcyMzIyNg_51f33be5-c114-4446-820f-f9e832a6e61b"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMzg0ODI5MDcyMzIyNg_e5b11366-26c8-4764-9f6f-613ebc0562cd"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryNet
      contextRef="icab684ceae90430cbdf56e58b13b7729_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDc3Mg_db9bf30d-a4a9-495b-88b9-d7231f5496bb"
      unitRef="usd">5400000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i829bcc778f774caeb60dae78412a98b2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MDg0Mw_3cf3c629-0369-4ebf-aeb2-befdefa383ce"
      unitRef="usd">5900000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExODI_25f45cc7-5b89-4bdf-906b-4f3aa29071a3">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;439,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;448,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMy0xLTEtMS0xNDI0NzE_9ec3f810-1164-4e81-a17f-f2a383ce9ca3"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMy0zLTEtMS0xNDI0NzE_0ef72439-b33e-4752-8441-26da8704fa79"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2561a5b37f2b48c99b837d7e54c57638_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNS0xLTEtMS0xNDI0NzE_72066a7c-ac76-4238-86fd-540b954789dd"
      unitRef="usd">55211000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i00a1d092574043ac8fa8de0d23f735b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNS0zLTEtMS0xNDI0NzE_91b730cc-78cd-46de-94af-e6086d7e3792"
      unitRef="usd">55211000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2561a5b37f2b48c99b837d7e54c57638_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNi0xLTEtMS0xNDI0NzE_693597ca-365d-462b-aa70-c40b1e1b14ca"
      unitRef="usd">23450000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i00a1d092574043ac8fa8de0d23f735b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNi0zLTEtMS0xNDI0NzE_e2e7f8eb-534e-4037-96a5-029ed68abb0a"
      unitRef="usd">22560000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i61c033ee7b9c41bc8ce219eaf434f0fd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNy0xLTEtMS0xNDI0NzE_d8b4f70c-4860-4e02-83d1-0a6c17d9b6a8"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i98ff718d557e41b8a4a3be385a2d6d0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfNy0zLTEtMS0xNDI0NzE_c3996f9e-1bc6-4119-8a3e-b04d42056156"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i61c033ee7b9c41bc8ce219eaf434f0fd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOC0xLTEtMS0xNDI0NzE_70d99a4f-46ad-421f-b73e-fdd59d802820"
      unitRef="usd">1610000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i98ff718d557e41b8a4a3be385a2d6d0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOC0zLTEtMS0xNDI0NzE_a4539034-4747-4c53-8386-ab90ccbfe22e"
      unitRef="usd">1577000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2cd14e785e014eb993155735df108dfc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOS0xLTEtMS0xNDI0NzE_e50e79ff-d6a0-4302-9c3b-abe1ae33bf61"
      unitRef="usd">29600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5c4546dd49864a548bead9153260fd3d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfOS0zLTEtMS0xNDI0NzE_14b1a874-d615-49c8-a088-b9294ec2dbc2"
      unitRef="usd">29600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2cd14e785e014eb993155735df108dfc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTAtMS0xLTEtMTQyNDcx_21909548-24fd-408b-a19f-524b8a7aaa62"
      unitRef="usd">18043000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5c4546dd49864a548bead9153260fd3d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTAtMy0xLTEtMTQyNDcx_dad988a8-3e40-4d85-8df9-3442b03875d9"
      unitRef="usd">17670000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia5f7ff0e996a4591a2178b25ce967a99_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTEtMS0xLTEtMTQyNDcx_d008fd3e-251e-4319-b83c-4e69b017788d"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id3209d0976344348a32b6d380fe3e5f6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTEtMy0xLTEtMTQyNDcx_7c214f76-602b-4c93-bcfb-b047764da0a5"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia5f7ff0e996a4591a2178b25ce967a99_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTItMS0xLTEtMTQyNDcx_47216518-41ba-425f-8a68-7ea7e70dd74b"
      unitRef="usd">72434000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id3209d0976344348a32b6d380fe3e5f6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTItMy0xLTEtMTQyNDcx_d674969c-31ed-4181-acca-c15825a1031f"
      unitRef="usd">65191000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTMtMS0xLTEtMTQyNDcx_7469135d-4e62-4633-a0dc-6b8abf679493"
      unitRef="usd">439589000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJmZGY4ZTIxNzdhMzQ1NGI5ZjFlZWY2M2JjNDZkNTFiL3RhYmxlcmFuZ2U6YmZkZjhlMjE3N2EzNDU0YjlmMWVlZjYzYmM0NmQ1MWJfMTMtMy0xLTEtMTQyNDcx_f6eb714d-12cb-476b-865c-342ad13295ae"
      unitRef="usd">448128000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <lgnd:CommercialLicenseRightsPolicyTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNTI_03a00336-91c1-4c0c-a088-6fc95dc0564f">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.4 million and credit loss adjustments of $6.5 million as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2022 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk &lt;/span&gt;&lt;/div&gt;associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended  March&#160;31, 2023, we further considered the current and expected future economic and market conditions and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2023.</lgnd:CommercialLicenseRightsPolicyTextBlock>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMTk_e9e1f68d-55a3-4757-9213-618543c88d48">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.4 million and credit loss adjustments of $6.5 million as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi0yLTEtMS0xNDI0NzE_50346d63-7f78-4e80-af0a-639cff5c1980"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi00LTEtMS0xNDI0NzE_76a1a572-afec-43f4-812c-19716fe371c4"
      unitRef="usd">9122000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i52aa8fd0cb9f43e2ace357106a4fbba7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi02LTEtMS0xNDI0NzE_48c2b816-8200-40ed-927e-f144df743c72"
      unitRef="usd">8574000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i412c3b19a5834235af99c2beb065ad68_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi04LTEtMS0xNDI0NzE_c964f41d-2ffd-4af1-a136-3abab39d1d6f"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i412c3b19a5834235af99c2beb065ad68_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi0xMC0xLTEtMTQyNDcx_dc9cb95a-187b-4b13-a527-3209bf1b75c8"
      unitRef="usd">9538000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i412c3b19a5834235af99c2beb065ad68_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMi0xMi0xLTEtMTQyNDcx_401ae691-ce8f-432e-a323-4468f7fdffd0"
      unitRef="usd">8158000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i83dfae755f5a424a8225bff059206ef3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy0yLTEtMS0xNDI0NzE_af2094f2-032b-41f6-b098-0e872fddb792"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i83dfae755f5a424a8225bff059206ef3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy00LTEtMS0xNDI0NzE_430b1040-e1b8-424d-b76d-d99e28898084"
      unitRef="usd">8745000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i83dfae755f5a424a8225bff059206ef3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy02LTEtMS0xNDI0NzE_ebd6b031-152f-490a-b6ba-43af20c79da8"
      unitRef="usd">1857000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idbeaa2397af04381b99149bf21997427_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy04LTEtMS0xNDI0NzE_e30273b5-4bce-475a-bbad-7c18624b4e5a"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="idbeaa2397af04381b99149bf21997427_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy0xMC0xLTEtMTQyNDcx_e8014336-b2a3-482b-8b2b-2311ab48f9d5"
      unitRef="usd">8578000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idbeaa2397af04381b99149bf21997427_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfMy0xMi0xLTEtMTQyNDcx_98349481-a24e-402d-81fb-d4c5eeb29f80"
      unitRef="usd">2024000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC0yLTEtMS0xNDI0NzE_79d8e220-e3a5-46bb-b7f6-6a16bdd9c537"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC00LTEtMS0xNDI0NzE_d7a7af8a-e9f6-4b20-9e9d-d6fc35bd3674"
      unitRef="usd">17867000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC02LTEtMS0xNDI0NzE_8f2d5d61-03d3-41c5-ad73-2d99cabe3acf"
      unitRef="usd">10431000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC04LTEtMS0xNDI0NzE_a5a57c31-a47d-4a47-991d-9a4a82b3354c"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC0xMC0xLTEtMTQyNDcx_0921abe4-3519-4820-ad85-94da3a079ac4"
      unitRef="usd">18116000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOjQwNzAxNzc5ZDhiNDRiMGE4ODEwZTg5NmE1Mjk4NGEzL3RhYmxlcmFuZ2U6NDA3MDE3NzlkOGI0NGIwYTg4MTBlODk2YTUyOTg0YTNfNC0xMi0xLTEtMTQyNDcx_334352f5-3486-45ed-9087-89a1e8f7d939"
      unitRef="usd">10182000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTY0OTI2NzQ2NzcyNg_1760e4ed-ae13-48fa-8c80-855dd0a1f8f9"
      unitRef="usd">11400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="iab4f1100a55e4741878f092afbfc948d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTY0OTI2NzQ2NzczNA_b99b2002-30bd-4829-a74b-fd25e64a4432"
      unitRef="usd">6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MTcwMg_7a7dace0-31e0-4d88-b303-6f4472cb4c90"
      unitRef="usd">11600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i9609e0c75f964fe2ac7c051438151f59_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTA5OTUxMTY1MTcwNg_86ad999c-4455-4494-aab2-98d11bc0e793"
      unitRef="usd">6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNDY_cbe25ef9-b891-4c72-b98f-6fdcc047657b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMi0xLTEtMS0xNDI0NzE_26ecb1eb-96f9-42da-9bc4-764690b530e3"
      unitRef="usd">1729000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMi0zLTEtMS0xNDI0NzE_3f1f8fbc-76b7-49b6-b2b0-925421c81fa0"
      unitRef="usd">6201000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMy0xLTEtMS0xNDI0NzE_1ae17532-3515-4415-8c27-5b1e7e617406"
      unitRef="usd">834000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMy0zLTEtMS0xNDI0NzE_7dcbb7e3-c410-4925-9128-9efbb47e7ac4"
      unitRef="usd">662000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNC0xLTEtMS0xNDI0NzE_341f4c12-8bbd-4848-9fca-50112936e0e5"
      unitRef="usd">45000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNC0zLTEtMS0xNDI0NzE_68c56264-144b-4b91-9063-07b0d4044466"
      unitRef="usd">3989000</lgnd:LicenseeAccrualCurrent>
    <us-gaap:AccruedRoyaltiesCurrentAndNoncurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNS0xLTEtMS0xNDcyMzY_e10d89a3-6308-41af-bb98-a73bba77c6f7"
      unitRef="usd">7700000</us-gaap:AccruedRoyaltiesCurrentAndNoncurrent>
    <us-gaap:AccruedRoyaltiesCurrentAndNoncurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfNS0zLTEtMS0xNDcxODg_02fe9800-447c-4d93-86cc-3620756a3b1f"
      unitRef="usd">12000</us-gaap:AccruedRoyaltiesCurrentAndNoncurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfOS0xLTEtMS0xNDcyNDY_473acd5c-299c-43d1-9fef-033c480752c4"
      unitRef="usd">678000</lgnd:AccruedSupplierExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfOS0zLTEtMS0xNDcxOTg_c9b5cf81-0653-415f-9e13-dbb2f83b10cc"
      unitRef="usd">634000</lgnd:AccruedSupplierExpensesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTEtMS0xLTEtMTQyNDcx_9a3fd616-5d4a-442a-8a9a-4a5057113914"
      unitRef="usd">3991000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTEtMy0xLTEtMTQyNDcx_9f970f6a-e317-4b69-99e3-b3006f2b81be"
      unitRef="usd">4183000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTItMS0xLTEtMTQyNDcx_4083cf22-a743-4373-811d-f74dbb1d44c6"
      unitRef="usd">14977000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7f8aaddec77946839e2c7db82a635cd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFmYWM2YWZmYTk4NTQ3NzliYjJlNGZhYzZjNjk4ZTNhL3RhYmxlcmFuZ2U6YWZhYzZhZmZhOTg1NDc3OWJiMmU0ZmFjNmM2OThlM2FfMTItMy0xLTEtMTQyNDcx_749f71e5-7cfc-428f-98dc-b521aa4e2c01"
      unitRef="usd">15681000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNzc_fa31b73d-9690-4493-b338-51b071a9a784">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjU_595651f8-e53c-4292-b4ef-6a15ac9c6eb3">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if9fc13b3b0ca47478c28400effc30e73_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfMy0xLTEtMS0xNDI0NzE_a82f6bfe-c26a-4d26-ae09-07a8eac7d803"
      unitRef="usd">1707000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i6c9c521f34b14454b143d1664a18a4cf_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfMy0zLTEtMS0xNDI0NzE_0edcde3c-a949-4c28-8819-98c7b6e0d0db"
      unitRef="usd">2196000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ibcdb5f68fd0845c89b3679a08f903458_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNC0xLTEtMS0xNDI0NzE_0ed5bad1-d5b0-45d5-85f8-5a6bc0a6c494"
      unitRef="usd">4224000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i032e4336c3474c48b0ccfb9dc291e4eb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNC0zLTEtMS0xNDI0NzE_74013650-6f37-4728-8e8a-5776f92f1b13"
      unitRef="usd">4913000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNS0xLTEtMS0xNDI0NzE_846c3915-40c9-4df4-b47c-43a36da94e62"
      unitRef="usd">5931000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmFiZTA0ZjlhMDgyMzQ5MjlhNGIxODU1NzBjM2FlMmY1L3RhYmxlcmFuZ2U6YWJlMDRmOWEwODIzNDkyOWE0YjE4NTU3MGMzYWUyZjVfNS0zLTEtMS0xNDI0NzE_3e75c492-a517-4943-9533-132b87db9b84"
      unitRef="usd">7109000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNTc_a26ef8e8-6a4d-40d4-907e-eb1353754303">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfMy0xLTEtMS0xNDI0NzE_13976a70-2b18-4ed6-bf7a-9f0ff6ca2207"
      unitRef="number">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfMy0zLTEtMS0xNDI0NzE_48758972-6d2f-4b2a-8828-1e48041b3962"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNC0xLTEtMS0xNDI0NzE_577af6a8-cd43-4d85-9df3-5a6438b21be1"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNC0zLTEtMS0xNDI0NzE_e18140fe-7aac-4946-8784-1bfcb6e0a890"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNS0xLTEtMS0xNDI0NzE_dd342cb6-b451-43d2-99e8-06f41b6f8617"
      unitRef="number">0.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNS0zLTEtMS0xNDI0NzE_04c9a089-6312-4272-9b7c-0d277022134e"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNi0xLTEtMS0xNDI0NzE_e0d027d6-1268-422e-b0bd-06bf321801ce">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmU5ZDZlNWY2OTUwMDQxMGViNmIzNDdlMzc3NmM4ZThjL3RhYmxlcmFuZ2U6ZTlkNmU1ZjY5NTAwNDEwZWI2YjM0N2UzNzc2YzhlOGNfNi0zLTEtMS0xNDI0NzE_e1f73f5d-49de-4e1d-88cf-bd10db616de6">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExMjk_94765757-143e-4486-a1d3-4b36b14f77da">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="if81e6ed11d5b42fc92035e63ce70dab8_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTg4MjY_2329bed2-f26f-4100-bff0-ea321a004692"
      unitRef="number">0</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i9e9100c0c4a443939a76ff1a531948bf_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMTg4MzI_9cb8e8cf-97dc-4112-b371-818b4bcca661"
      unitRef="number">2</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNDc_ad13ab46-24a4-4009-a3a3-39029779381a">Net Income (Loss) Per ShareBasic net income (loss) per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RleHRyZWdpb246M2E1ZDY1YTRjNzI2NDA3NTg0YTc3OTg4NjQzZjgyYjRfMjExNzg_294b4c1d-1434-46cb-9b15-89bd55ab4901">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023 convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfMy0xLTEtMS0xNDI0NzE_0ff8fa5d-b696-4498-9d7b-f45cba588b74"
      unitRef="shares">17063000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfMy0xLTEtMS0xNDI0NzE_b031d185-8cb2-428f-bec2-27dac06d66f3"
      unitRef="shares">17063000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfMy0zLTEtMS0xNDI0NzE_28a602f4-927e-46ec-b63d-b277b01d17a8"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9dffa8f58aaf4d11b456a8821fe00c3d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNS0xLTEtMS0xNDI0NzE_6297041b-fa99-472b-9f21-dbf7cf7ee11f"
      unitRef="shares">86000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3ce88b885fc645c2be76eb7ae40e211f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNS0zLTEtMS0xNDI0NzE_bb17dfbb-01b4-4d47-bd1d-e78923fc0d86"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4fa4dea889b3439d9ac7398cfa1a4773_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNi0xLTEtMS0xNDI0NzE_d10f5963-553d-4493-ac78-d9196b0e10a4"
      unitRef="shares">341000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i506f1c021fc0401fb3e152136e091307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNi0zLTEtMS0xNDI0NzE_c4bbfb24-391c-4058-8ca5-5fbd61772310"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if97986f33b4b455eab691feb1d28c9f6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNy0xLTEtMS0xNDI0NzE_9909d694-e6eb-4591-aa60-b3307e9ab039"
      unitRef="shares">484000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9cbda0e4f007472c8c052957a3e4b0e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfNy0zLTEtMS0xNjAxNDI_6bccbb16-2ab7-4e55-8d16-58578255811e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOC0xLTEtMS0xNDI0NzE_7a2da2ac-359d-4b49-8655-f692fb2e4a07"
      unitRef="shares">17974000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOC0zLTEtMS0xNDI0NzE_29528725-3f68-4193-87c5-b078e4a8c269"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOS0xLTEtMS0xNDI0NzE_9baf0d7c-53c6-4db3-9a44-5f8dd1b0548b"
      unitRef="shares">4359000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNC9mcmFnOjNhNWQ2NWE0YzcyNjQwNzU4NGE3Nzk4ODY0M2Y4MmI0L3RhYmxlOmJhOWZiNmQzMWIzNzQzNzg4NTkyMjVkMTU1MWI2Y2MzL3RhYmxlcmFuZ2U6YmE5ZmI2ZDMxYjM3NDM3ODg1OTIyNWQxNTUxYjZjYzNfOS0zLTEtMS0xNDI0NzE_fc8f050f-fe68-4a09-a055-dc782271a518"
      unitRef="shares">6001000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMzk0NQ_062a39b7-521b-47c4-a3b0-2a28c3bd9abe">Spin-off of OmniAb&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 23, 2022, we entered into the Separation Agreement to separate our OmniAb Business and the Merger Agreement, pursuant to which APAC would combine with OmniAb, and acquire Ligand's OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#x201c;Transactions&#x201d;). In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following two reportable segments: (1) OmniAb Business and (2) Ligand core business. The OmniAb Business segment was focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb Business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the closing date of the Transactions on November 1, 2022, the historical financial results of OmniAb have been reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution. Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain specific assets and liabilities constituting the OmniAb Business. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of October 26, 2022 shares of the common stock of OmniAb representing 100% of Ligand&#x2019;s interest in OmniAb. Immediately following the Distribution, Merger Sub merged with and into OmniAb, with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of New OmniAb. The entire transaction was completed on November 1, 2022, and following the Merger, New OmniAb is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#x201c;OABI.&#x201d; After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after November 1, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, the Company determined its antibody discovery business qualified for discontinued operations accounting treatment in accordance with ASC 205-20. We recognized a $1.7 million tax provision adjustment related to deferred taxes during the three months ended March&#160;31, 2023 that was attributable to the discontinued operations. The following table summarizes revenue and expenses of the discontinued operations for the three months ended March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss before income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the three months ended March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR Holders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, plant and equipment included in accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMTA5OTUxMTYzOTM5OA_043e5a46-6fbf-4c08-aacd-53719d226a07"
      unitRef="position">2</us-gaap:NumberOfReportableSegments>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed
      contextRef="i4dd3a95bb7954a1c8b2b9ec9fb784037_I20221026"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMTA5OTUxMTYzODYyMw_f13aea37-2c34-49d1-8b58-7d264ec1f4d6"
      unitRef="number">1</lgnd:DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMTE1NDQ4NzIxMDQyMjU_b2649479-c7ec-45d2-9793-8274186b3c02"
      unitRef="usd">-1700000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RleHRyZWdpb246ZjNmZDVlNzQyMDAxNGYxYWE4ZDc1ZTg2OTA2NzViM2ZfMzk0Ng_a67cebb8-37bf-4c38-9c68-a728e9fe16f7">The following table summarizes revenue and expenses of the discontinued operations for the three months ended March&#160;31, 2022 (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss before income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the three months ended March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR Holders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, plant and equipment included in accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i74c3b7100ae2469aa40de930920f80f3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMy0xLTEtMS0xNDg1ODM_b6825e88-73cd-4022-914d-6a337ba9fe59"
      unitRef="usd">263000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i9dfb70c51fa941509f903b3ca26a5da0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfNC0xLTEtMS0xNDg1ODM_dc67856e-78b2-4569-b2da-ddb9574e05d1"
      unitRef="usd">8914000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfNS0xLTEtMS0xNTUzMTA_a29a756f-5967-4d4f-a3dd-4ceb7426321e"
      unitRef="usd">9177000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfNy0xLTEtMS0xNDg1ODM_e35ab43f-c962-4664-9bb9-26a5fb6c6366"
      unitRef="usd">3233000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfOC0xLTEtMS0xNDg1ODM_c221f0fe-e9d9-4a42-888d-0b116486f94d"
      unitRef="usd">11128000</lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfOS0xLTEtMS0xNDg1ODM_a9d02c07-306f-4243-8e3e-c0db1334966c"
      unitRef="usd">6255000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTAtMS0xLTEtMTU1MzE2_9304da69-11ed-42b3-9c5a-a50978515f12"
      unitRef="usd">20616000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTEtMS0xLTEtMTU1MzE2_69bca460-477a-4fca-944c-e0c15b3719e0"
      unitRef="usd">-11439000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTUtMS0xLTEtMTQ4NTgz_c36354f2-d0e2-46a8-8caa-7232dc0fc336"
      unitRef="usd">443000</lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTYtMS0xLTEtMTU1MzE5_5c33e8f4-f4b0-4a61-8bd8-776b9be7028b"
      unitRef="usd">443000</lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTctMS0xLTEtMTU1MzIy_62faa23a-a514-4506-8fd9-aed44bad54c6"
      unitRef="usd">-10996000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTgtMS0xLTEtMTQ4NTgz_85d4c42f-08e4-43c8-bb42-c77d617bf258"
      unitRef="usd">-8540000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmE1MzM3MDA2NzgxMzRkYjJiMmU2YzBkMWYyOWU4NTAyL3RhYmxlcmFuZ2U6YTUzMzcwMDY3ODEzNGRiMmIyZTZjMGQxZjI5ZTg1MDJfMTktMS0xLTEtMTU1MzIy_0731b9e1-11ef-4696-98de-32a52dba7123"
      unitRef="usd">-2456000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfMy0xLTEtMS0xNDg4NDU_33e4ced2-c471-4e57-ad53-41039a17b39b"
      unitRef="usd">-443000</lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration>
    <us-gaap:DepreciationAndAmortizationDiscontinuedOperations
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfNC0xLTEtMS0xNDg4NDU_e489ab7f-53e9-4914-bfd9-0bf0c8027688"
      unitRef="usd">4207000</us-gaap:DepreciationAndAmortizationDiscontinuedOperations>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfNS0xLTEtMS0xNDg4NDU_87da26cb-65eb-4d7f-bfbb-e63514a6eb2d"
      unitRef="usd">1935000</lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense>
    <us-gaap:CapitalExpenditureDiscontinuedOperations
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfOS0xLTEtMS0xNDg4NTI_c634930c-6755-45ae-a9f9-bd678c63cc65"
      unitRef="usd">3143000</us-gaap:CapitalExpenditureDiscontinuedOperations>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfMTMtMS0xLTEtMTQ4ODYy_cd278a80-8324-42c7-8f41-583529921f95"
      unitRef="usd">1416000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid
      contextRef="if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl8zNy9mcmFnOmYzZmQ1ZTc0MjAwMTRmMWFhOGQ3NWU4NjkwNjc1YjNmL3RhYmxlOmY4NTUwMThjMTQ3OTQ5YjI4MTQyODc2NDBlMTlkZWNjL3RhYmxlcmFuZ2U6Zjg1NTAxOGMxNDc5NDliMjgxNDI4NzY0MGUxOWRlY2NfMTYtMS0xLTEtMTQ4ODcy_6c2b9666-8ab8-44da-a68e-d774ba22af64"
      unitRef="usd">140000</lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfNTQzOA_ebcf6033-2410-4de6-9542-32194ff923c5">Fair Value Measurements&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;134,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended  March&#160;31, 2023, we adjusted the balance of the Metabasis CVR liability by reducing $0.7 million to mark to market.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of March&#160;31, 2023 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no impairment of our goodwill, indefinite-lived assets, or long-lived assets recorded during the three months ended  March&#160;31, 2023 and March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfNTQzNg_634b7182-bbab-4f25-abf5-ef8c06ee64b2">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;134,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;2.In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended  March&#160;31, 2023, we adjusted the balance of the Metabasis CVR liability by reducing $0.7 million to mark to market.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i763012af38d44192b91ccced32b2f90c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0yLTEtMS0xNDI0NzE_d0bb0925-e0a1-4b41-94e7-1d18b0f118a5"
      unitRef="usd">7853000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6f664e124e444754902048088f15d009_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy00LTEtMS0xNDI0NzE_153f11ac-0432-45b9-b09b-489aab098ef2"
      unitRef="usd">126592000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7af671b89641435c982e3ec096f05e13_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy02LTEtMS0xNDI0NzE_5a697789-91d9-4032-903c-166fa0202523"
      unitRef="usd">133000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie398cfae0ed945faac086dc8267aff48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy04LTEtMS0xNDI0NzE_ddb92a6d-1c02-421f-a0a2-399d55c7bb17"
      unitRef="usd">134578000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2be7139166474f9ab25b9eca300d94ba_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xMC0xLTEtMTQyNDcx_0c23e762-5f6f-41e0-b1e9-4e05fd0c7bd8"
      unitRef="usd">3992000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i915548846dd64cd49f3ecbc68b7eb50a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xMi0xLTEtMTQyNDcx_e23df4c0-1191-4caa-81c9-72035c7a5411"
      unitRef="usd">99615000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia17e761190bb48beb5cea13631d8dfa7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xNC0xLTEtMTQyNDcx_67c8675c-d34e-477b-bec9-1e5eae5c0c70"
      unitRef="usd">135000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1aa89bb486b842e7aff0da151ea9a775_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMy0xNi0xLTEtMTQyNDcx_464d502f-6eff-4b60-84d3-76ca2979c13d"
      unitRef="usd">103742000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id1cc642360a843b4be5f97a5be47caf6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0yLTEtMS0xNDI0NzE_9da5c887-e9b5-45d6-96d0-e8395ce1219e"
      unitRef="usd">59359000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC00LTEtMS0xNDI0NzE_c496be53-3001-460c-8c4c-c39e32390ad4"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="if96faa6fa418473291f9eadf582cb120_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC02LTEtMS0xNDI0NzE_2a27cd25-b9d5-4cd1-9b8e-210cc8a63cf9"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC04LTEtMS0xNDI0NzE_d8fd738e-bcac-4756-99d9-a39e282d3257"
      unitRef="usd">59359000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xMC0xLTEtMTQyNDcx_9068cb3b-4660-4123-8fff-abd5720af52f"
      unitRef="usd">63122000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i40daf9abfb134159be20eab4b760217b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xMi0xLTEtMTQyNDcx_7b922fc3-7d81-4962-81a7-bb229959c698"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xNC0xLTEtMTQyNDcx_30b8d5ae-61ce-4be6-9e95-17dd5fcf07b7"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i626c103c32154c218e186b029cbda1e6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNC0xNi0xLTEtMTQyNDcx_c50a6717-ebae-4a12-bc10-6d5d5a7ab500"
      unitRef="usd">63122000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i16f7532e1db94ae1a31213e245adfb77_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0yLTEtMS0xNDI0NzE_e4468215-3e55-4a6b-baed-48d0032f7249"
      unitRef="usd">67212000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi00LTEtMS0xNDI0NzE_ada0539d-d54f-4408-909e-754e7210ced0"
      unitRef="usd">126592000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if96faa6fa418473291f9eadf582cb120_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi02LTEtMS0xNDI0NzE_9828a887-5bc7-4e6b-841c-a13996810ada"
      unitRef="usd">133000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi04LTEtMS0xNDI0NzE_7410249c-98f4-4d33-b8c8-de45849f1857"
      unitRef="usd">193937000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xMC0xLTEtMTQyNDcx_9a4cecac-6f47-47ca-b20d-5bf808e6671c"
      unitRef="usd">67114000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i40daf9abfb134159be20eab4b760217b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xMi0xLTEtMTQyNDcx_3c2ac42f-08cb-4df7-a673-88a81a315c90"
      unitRef="usd">99615000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xNC0xLTEtMTQyNDcx_724a4bd2-b40a-46ab-b210-23b7d1dc0716"
      unitRef="usd">135000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i626c103c32154c218e186b029cbda1e6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfNi0xNi0xLTEtMTQyNDcx_f348c4af-a199-44d1-aa55-04941132d7f4"
      unitRef="usd">166864000</us-gaap:AssetsFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ie74e651db4b74a518b5c4442d96bfb40_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0yLTEtMS0xNDI0NzE_7b31b11b-6345-42b4-8ca9-631b2b037840"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ieee5a6d6de4e4ff4a3795c420443d61b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS00LTEtMS0xNDI0NzE_15ba7935-7035-4e8d-85ca-44645d978147"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i4e4a19aec8e14496aac9d086c4eba78d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS02LTEtMS0xNDI0NzE_35fa4ee4-4117-4128-abce-4e55a2891c20"
      unitRef="usd">86000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i0269fb8261c141bab51cf071a61d89b3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS04LTEtMS0xNDI0NzE_42a4d805-885a-4e5a-96cc-9a019e298940"
      unitRef="usd">86000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="iff86df6b5e5a4a6faf716a2960401b63_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xMC0xLTEtMTQyNDcx_336806af-67e9-4a67-bebb-ca87fa3fa29c"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i163330301f1d4bcbbb46e375f3c79026_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xMi0xLTEtMTQyNDcx_39f4ba8b-5523-426d-b235-6b4f7e420787"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i018145fcba3c41c1883b1f339bac39e4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xNC0xLTEtMTQyNDcx_90f0f2ac-5462-4d3c-852f-5520fd55dfc9"
      unitRef="usd">84000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ia57855c3f2b4476a90c99722257f527e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfOS0xNi0xLTEtMTQyNDcx_8a97308f-10ee-43f1-b095-5015f29b47b6"
      unitRef="usd">84000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i87e940ff49984106a6ac855a4ae9899a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMi0xLTEtMTQyNDcx_d201b32d-ebbc-425c-aa24-b944cb4ebdb6"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="id7356828798748ceb3633210d92c6664_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtNC0xLTEtMTQyNDcx_f25485bd-cdd7-48e1-b809-179071ed15d6"
      unitRef="usd">2757000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i81bb98cab8574fe5866d8e7a307f0b74_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtNi0xLTEtMTQyNDcx_8ec760ba-95e0-4d7a-9b48-bd570eb89fc9"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i61bedf7508b14e8daf449211c964cd8e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtOC0xLTEtMTQyNDcx_9a15ed00-06cb-4e4c-b56f-570e2573639b"
      unitRef="usd">2757000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i9e3e4858f3084a0590a2499ed0047750_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTAtMS0xLTE0MjQ3MQ_e24a9a83-10e2-4e2a-96d8-dcea07ada525"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="iaf45dbfb87d9402794f19a8fa810d6b2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTItMS0xLTE0MjQ3MQ_5d485d47-b703-4fed-b01c-fed15110e5b8"
      unitRef="usd">3429000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i885006a6753a4da88eed97931a8a1096_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTQtMS0xLTE0MjQ3MQ_92acf855-8e3a-403a-8408-8eb2aecc1d8c"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="id2b9d43cacb34c8ea3696baaeee38eb4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTAtMTYtMS0xLTE0MjQ3MQ_db50f0c5-cd48-4095-8931-1e2303e23840"
      unitRef="usd">3429000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i16f7532e1db94ae1a31213e245adfb77_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMi0xLTEtMTQyNDcx_5e9a4b22-e433-4cbc-a3fd-d865900cd3a1"
      unitRef="usd">44000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtNC0xLTEtMTQyNDcx_6c6e4192-cc71-449f-82a1-6f636ebcf53d"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="if96faa6fa418473291f9eadf582cb120_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtNi0xLTEtMTQyNDcx_dc396e6e-3eb6-4439-9bbd-252f32f7e076"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtOC0xLTEtMTQyNDcx_5d5e5f02-0ab7-43cc-9de2-bb6772791e7b"
      unitRef="usd">44000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTAtMS0xLTE0MjQ3MQ_10c563a1-684e-4b5e-823a-9379d1cc177f"
      unitRef="usd">44000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i40daf9abfb134159be20eab4b760217b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTItMS0xLTE0MjQ3MQ_f7308289-8587-4df8-be43-4531eb7d4092"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTQtMS0xLTE0MjQ3MQ_1c63a271-4ad2-40e2-8f4b-6597b1e2e46d"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i626c103c32154c218e186b029cbda1e6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTMtMTYtMS0xLTE0MjQ3MQ_f5a3b518-062d-44c3-b8d4-1213516c4d15"
      unitRef="usd">44000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i16f7532e1db94ae1a31213e245adfb77_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMi0xLTEtMTQyNDcx_64c51f87-ec45-4724-9903-32ae54cdf99c"
      unitRef="usd">44000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie872097758d948b3a91b3e4335d836d6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtNC0xLTEtMTQyNDcx_a01b6fc4-4638-49b3-b4b9-60ca829dc9d9"
      unitRef="usd">2757000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if96faa6fa418473291f9eadf582cb120_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtNi0xLTEtMTQyNDcx_7821e480-7c45-447f-a598-469a2d9d5ad8"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic7841b4be52746df9806cf6af4497ed3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtOC0xLTEtMTQyNDcx_d03e90fd-8f16-4628-9968-c5a6580afa8f"
      unitRef="usd">2887000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iaff7de56710d4853a5026ad4854f9d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTAtMS0xLTE0MjQ3MQ_16edf4f7-e076-4da8-a84d-37c97bfd2ed0"
      unitRef="usd">44000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i40daf9abfb134159be20eab4b760217b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTItMS0xLTE0MjQ3MQ_cc3deee5-6999-4584-8864-9a3d67ffee3c"
      unitRef="usd">3429000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1eb9be9f22f54a458d0741083b4fffc6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTQtMS0xLTE0MjQ3MQ_ea2549da-0145-4a50-a8d9-37175deb1265"
      unitRef="usd">84000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i626c103c32154c218e186b029cbda1e6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOjk0N2UxMzAxY2YzMjQ4NTFhOTBmY2M4M2JhNjdjOWQ5L3RhYmxlcmFuZ2U6OTQ3ZTEzMDFjZjMyNDg1MWE5MGZjYzgzYmE2N2M5ZDlfMTQtMTYtMS0xLTE0MjQ3MQ_816818f9-4c8e-4fde-8fed-1a6c723f2351"
      unitRef="usd">3557000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTQ0Mg_98b1b107-af6c-4237-ab41-6093767a2b54"
      unitRef="contingent_value_right">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTQ2MA_a1079393-690c-46e4-84ff-7309e4e64363"
      unitRef="contingent_value_right">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="ifcfb68dc76174bf49f8bd077bd649ae1_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTQ4MA_682f84f8-8e69-4fcf-ac87-6cd8ddf40f22"
      unitRef="contingent_value_right">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="i6d0f16a6c13340ee9da82a7bee6ec4ba_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTYxNQ_6a0ba927-bb30-4fa8-aa8c-d6e97438ea00">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="icc2d9f773bb14b7fb48e90c6374538fe_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMjQxNw_38e0c526-1b36-4484-a385-91eb6f07c1c7"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i15a6dc40dbc74b84b8d5b169e75d071a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMjUzMg_823c1e38-2eae-4222-aa20-f462babbd4b3"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i168fdc9ced384d3482e3122242ace085_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMTA5OTUxMTYzNTg4MA_20fabf36-f11b-42a8-841d-47222a43336b"
      unitRef="usd">-700000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfNTQzNw_eac458b9-a7cc-461e-bf75-87ba75923ec1">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of March&#160;31, 2023 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1ad7a5d1cc5a45b3993c229ec308f769_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOmZlM2MwM2FjYTYzOTRmODhiYzc3MGZlNzUzZDUxZjljL3RhYmxlcmFuZ2U6ZmUzYzAzYWNhNjM5NGY4OGJjNzcwZmU3NTNkNTFmOWNfMC0xLTEtMS0xNDI0NzE_a12fb30e-041c-4572-bad8-1eabeecda3a0"
      unitRef="usd">84000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i8b9ba0d8fd854d3c980983fb9630d586_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOmZlM2MwM2FjYTYzOTRmODhiYzc3MGZlNzUzZDUxZjljL3RhYmxlcmFuZ2U6ZmUzYzAzYWNhNjM5NGY4OGJjNzcwZmU3NTNkNTFmOWNfMi0xLTEtMS0xNDI0NzE_0352094e-4410-4219-a1cd-1664ebd00bc8"
      unitRef="usd">2000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib161369e802141d388e0bea65e72d1d3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RhYmxlOmZlM2MwM2FjYTYzOTRmODhiYzc3MGZlNzUzZDUxZjljL3RhYmxlcmFuZ2U6ZmUzYzAzYWNhNjM5NGY4OGJjNzcwZmU3NTNkNTFmOWNfNC0xLTEtMS0xNDI0NzE_851eba7a-2527-45f1-8227-5b538e746ec1"
      unitRef="usd">86000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_1451b6c9-f270-4a83-8b2a-295548efcabf"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_37abe0d6-403b-40d1-8c14-7cd10932454a"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_74bd868c-986c-4773-9774-7aa9927ce16b"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80MC9mcmFnOjMzMmE0NjEwYTBlZjQ2MDBiZGQwZWIwMjIxODI2MTQxL3RleHRyZWdpb246MzMyYTQ2MTBhMGVmNDYwMGJkZDBlYjAyMjE4MjYxNDFfMzg0ODI5MDcwNTMxMA_d63dedda-91c5-42fa-befb-cf1f0b8d2117"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTE2MA_ecf48e09-4fa2-45b4-b6af-d7f6f03a6bbd">Convertible Senior Notes&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of 2023 Notes, bearing cash interest at a rate of&#160;0.75%&#160;per year, payable semi-annually. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on a conversion rate as discussed below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes were entitled to convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day was greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes (the&#x201c;Indenture&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, on or after November 15, 2022 and prior to the close of business on May 11, 2023 (the second scheduled trading day preceding May 15, 2023, which is the maturity date), holders of the 2023 Notes are entitled to covert the notes without regard to the conditions described above applicable to conversions prior to November 15, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#x2019;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes. No holders exercised their right to convert their 2023 Notes during the applicable period for conversion. After we completed the Separation of the OmniAb Business, on November&#160;15, 2022, the conversion rate was adjusted to 4.8390 shares of common stock per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately&#160;$206.65 per share. The maximum conversion rate of the 2023 Notes was adjusted to 6.2907 per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately $158.97.  The conversion rate for the 2023 Notes was adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dividend date of the spin-off (as determined in the Indenture). The conversion rate and maximum conversion rate are subject to further adjustment under the circumstances and pursuant to the terms set forth in the Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the current conversion price of $206.65. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, and is being amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of March&#160;31, 2023 is 0.5%.  During the three months ended March&#160;31, 2023 we recognized a total of $0.2 million in interest expense which includes $0.1 million in contractual interest expense and $0.1 million in amortized issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022, we repurchased $165.8 million in principal amount of the 2023 Notes for $163.7 million in cash, including accrued interest of $0.4 million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $1.5 million reflected in other income (expense), net, in our consolidated statement of operations for the three months ended March&#160;31, 2022, and a $0.9 million reduction in debt discount. There was no repurchase of 2023 Notes during the three months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $206.65 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, in connection with the repurchases of approximately $20.3 million in principal of the 2023 Notes for approximately $19.1 million in cash, including accrued interest of $0.1 million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, in connection with the repurchases of $152.0 million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, in connection with the repurchases of $227.8&#160;million in principal of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzNzExMw_75a53f03-e31f-47d4-b9ea-7e3e3a5551d2"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTc_5f97b91e-49c3-4176-a17e-cadc38d9bf55"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTMw_75a53f03-e31f-47d4-b9ea-7e3e3a5551d2"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="id16b6127458b4c908501afd350114da9_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMjg2_62e950ee-c4c7-4308-b602-2c0763186aef"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTEwMA_b6ecdf41-2651-4ebf-8481-92b7e3a15924"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTE1Ng_21449247-e863-4086-9fde-2874ec81b5e5"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ie737bdf6f0af4c93843e3dbc62f8fad6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTM1MQ_712d386b-1056-47ea-9013-f1a2dcbb0381"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTQxNg_12c3cd2c-be0e-40b0-992f-789b17a61e7d"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTQ2NQ_6387060c-1178-4af1-9195-81b6880ae240"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="ia8e19d6a4d5c424ab0a18a58d442e2a6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTU3NA_008e5634-9a76-4b9c-94df-bb4cbc042062"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i745a3728e2854def929ed3c0ccc7d673_I20221115"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzOTY4Nw_60e31291-b114-4da6-8a38-f10d50e127b9"
      unitRef="usdPerShare">206.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic58510ba16f14f209b3c357f93c9d563_I20221115"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzOTcxNg_a3557392-cb44-43a0-b418-29fb86dd5325"
      unitRef="usdPerShare">158.97</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i6ba60861c19649ff96ba66c6b831281e_D20221115-20221115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTYzOTcyMA_7e4ea1a4-7c67-46fe-9bfa-f4f1d0a154c3"
      unitRef="position">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i745a3728e2854def929ed3c0ccc7d673_I20221115"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTA0Mg_60e31291-b114-4da6-8a38-f10d50e127b9"
      unitRef="usdPerShare">206.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMjc2NA_6e28aa0c-0072-4eb1-87a9-0bc6786ffe7b"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentTerm
      contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTE1OA_293035ed-7e21-4427-98ef-322acb417793">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTMxNg_0e4719c3-d033-4bbb-bb0c-c2666d2fde6e"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTQ2Ng_de36bde6-2149-4627-a1ed-ebcf5d9b5a6f"
      unitRef="usd">200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTQ3NQ_b77e2a07-1faf-477d-a36b-ba4600cca662"
      unitRef="usd">100000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="idba4167b3c9e4b648dd197ec90391b3c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MTQ4NA_89ba5e9a-6aca-452c-bcdb-c86d8d5ddb4c"
      unitRef="usd">100000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NjI2MA_36c81f29-90e6-475f-8b20-7d0aeb4d2b35"
      unitRef="usd">165800000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="ife99d31e979b471fbacc856adb204f2e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NjI2OA_68469016-2b76-4100-a7cc-b4fd3266755a"
      unitRef="usd">163700000</us-gaap:DebtInstrumentRepurchaseAmount>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MzUwNA_5f8a1a3e-ec66-40a7-82a3-13b8c4a43f8f"
      unitRef="usd">400000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MzUyMg_b9e657ae-7702-4ca0-a175-1e26382d4122"
      unitRef="usd">1500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="idf28025d42e04f1c95f22095cc3e6ae6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0MzU0Mw_2cfeb084-b8a5-46ef-8cc8-a8c90743735a"
      unitRef="usd">-900000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNDc2NQ_ed48a504-01ed-42b6-aa07-f2a388322825"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNTAzOQ_a8c63fb4-e562-459e-abb8-c0f04ff6dfdf"
      unitRef="usdPerShare">206.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="id16b6127458b4c908501afd350114da9_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNTEyMg_c45a0f9e-acdb-4391-af77-3a3d166748af"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNjAyMg_b6f7ff3d-8e46-497f-ac75-37ab066e5e33"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNjA4OA_68485657-0779-4f3c-9622-9b7a42e6cad9"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="id16b6127458b4c908501afd350114da9_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNjE0Ng_3e854418-508d-4422-9bab-2728ae9432f0"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i63d75f220eeb405ab2f4a34303ec71f6_I20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQzOA_ea6c34aa-c20a-4e86-b2ab-a7ba11c750a1"
      unitRef="usd">20300000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i71225d3c8a82435fa5cd738c3aa181d8_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ0NQ_0e39c480-f573-4af8-9410-2ad2bb3b4863"
      unitRef="usd">19100000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="i71225d3c8a82435fa5cd738c3aa181d8_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ1Mg_2e069f75-f2e9-4d50-9d9b-cb6939019dfb"
      unitRef="usd">100000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="iebf2d4e5f2594065932aeccee4503461_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ2Mg_6287ecad-1193-4ed6-a39b-0afb5278a1ef"
      unitRef="usd">152000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i06fe0a09def94247bbb7916c23ae3017_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ2OQ_6dac02f5-2e82-4432-a003-c9f191debaa2"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="i06fe0a09def94247bbb7916c23ae3017_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ3Ng_49a95011-037c-4763-8a88-d063953eab85"
      unitRef="usd">300000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="ia82d4ad3cea140ef9a6f0c99ee594d64_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNzgwNA_dab1843e-98a7-4dfc-9f9d-7b27fe12f3df"
      unitRef="usd">18400000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="id4ea1e8485f3460f9907ff44108c41a4_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNzkxMw_ed48a504-01ed-42b6-aa07-f2a388322825"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="iebf2d4e5f2594065932aeccee4503461_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfNzkxOQ_a8a84b84-8c05-4a66-aeac-65038a242571"
      unitRef="shares">2559254</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="ibfd5947b908543809e005a7628c9487d_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ4Mw_b47cfefd-6998-4892-ac76-2fcbad648538"
      unitRef="usd">227800000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ibfd5947b908543809e005a7628c9487d_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ5MA_55ff3733-edc5-44bf-ae80-193319edaf94"
      unitRef="usd">223700000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="iff179ee295ea4d7c9424bd57cab84b84_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfMTA5OTUxMTY0NDQ5Ng_a1fb4533-93e8-4c25-92bb-7c420409136d"
      unitRef="usd">400000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RleHRyZWdpb246ZDQ4MDYzNTE5ODlhNDY3ODhiODQ3ODE4MWZlNzMzMTBfOTE2Mg_9309692b-3134-47e5-8a98-cff1d6314c03">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMS0xLTEtMS0xNDI0NzE_07383ac9-69ab-41ca-ac5a-bfc45d6a8460"
      unitRef="usd">76854000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMS0zLTEtMS0xNDI0NzE_680669e5-264c-46d9-9587-2f408cf6deac"
      unitRef="usd">76854000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMi0xLTEtMS0xNDI0NzE_d5571347-6dff-4e7e-bf34-235e4ccaf155"
      unitRef="usd">64000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMi0zLTEtMS0xNDI0NzE_9656e79a-9672-4653-b8f8-036847dd296f"
      unitRef="usd">159000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermNotesPayable
      contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMy0xLTEtMS0xNDI0NzE_9833e3fc-7c4d-4a55-a8e7-894af9c1d937"
      unitRef="usd">76790000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfMy0zLTEtMS0xNDI0NzE_b5b56c57-2614-4948-b2bd-d62ed61533bc"
      unitRef="usd">76695000</us-gaap:LongTermNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ie72321e6630d4a0a894dd61ce3b42ecc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfNi0xLTEtMS0xNDI0NzE_02931346-7b10-4ed1-93ec-1315d0ce2fd3"
      unitRef="usd">76107000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i54feecd19751474e8d9edd51ce5839ad_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80My9mcmFnOmQ0ODA2MzUxOTg5YTQ2Nzg4Yjg0NzgxODFmZTczMzEwL3RhYmxlOjI4YjhjYTIyN2UzOTQ4NzJhMzc5MGJkMWMwYTZhZTFkL3RhYmxlcmFuZ2U6MjhiOGNhMjI3ZTM5NDg3MmEzNzkwYmQxYzBhNmFlMWRfNi0zLTEtMS0xNDI0NzE_f524d87d-c499-4ec8-b215-1da736b2307d"
      unitRef="usd">74789000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80OS9mcmFnOjc2MDE5MDk2MTliYzRkY2Q4NmJlZGEwMjZlOTQ1ZDNjL3RleHRyZWdpb246NzYwMTkwOTYxOWJjNGRjZDg2YmVkYTAyNmU5NDVkM2NfMTM2MA_7d271e9d-4384-4d39-a707-8ba78feb7934">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended  March&#160;31, 2023 and 2022 was 21.5% and (41.4)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended  March&#160;31, 2023 was due primarily due to Internal Revenue Code Section 162(m) limitation on deduction for officer compensation, non-deductible incentive stock option (ISO) related stock compensation expense, which were partially offset by foreign derived intangible income tax benefit during the period. The variance from the U.S. federal tax rate of 21% for the three months ended March&#160;31, 2022 was primarily due to the tax deductions related to foreign derived intangible income tax benefit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80OS9mcmFnOjc2MDE5MDk2MTliYzRkY2Q4NmJlZGEwMjZlOTQ1ZDNjL3RleHRyZWdpb246NzYwMTkwOTYxOWJjNGRjZDg2YmVkYTAyNmU5NDVkM2NfNDM4_40a9322a-9316-4657-a5f4-67e18b980b36"
      unitRef="number">0.215</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i363302738c3b4193bfca47cb5cffdd1a_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl80OS9mcmFnOjc2MDE5MDk2MTliYzRkY2Q4NmJlZGEwMjZlOTQ1ZDNjL3RleHRyZWdpb246NzYwMTkwOTYxOWJjNGRjZDg2YmVkYTAyNmU5NDVkM2NfNDQ1_4fa810f4-42f3-4bbc-9de7-0c1c4ba67ea6"
      unitRef="number">-0.414</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjU4Mg_8dc7665e-2d37-48ad-8726-1bebed2a607f">Stockholders&#x2019; Equity&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of the Notes to Consolidated Financial Statements in our 2022 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;409,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(153,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,237,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;377,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, outstanding options to purchase 1.8 million shares were exercisable with a weighted average exercise price per share of $61.91.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2023, 35,881 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-the Market Equity Offering Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2022, we filed a registration statement on Form S-3 (the &#x201c;Shelf Registration Statement&#x201d;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. &lt;/span&gt;&lt;/div&gt;On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with Stifel, Nicolaus &amp;amp; Company, Incorporated (the &#x201c;Agent&#x201d;), under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100.0&#160;million in &#x201c;at the market&#x201d; offerings through the Agent (the &#x201c;ATM Offering&#x201d;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $100.0&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjU4MA_c8d6db34-a66a-4f09-9a28-08ff53bb3c00">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;409,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(153,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,237,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;377,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjU4MQ_702dc7f1-8feb-430b-bf26-4d351dbc86d3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;409,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(153,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,237,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;377,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5b031e51a09841e2bba31484e4e6ba22_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi0xLTEtMS0xNDI0NzE_f589b3ad-7527-4177-b82c-111a6ab70ee7"
      unitRef="shares">2991473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5b031e51a09841e2bba31484e4e6ba22_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi0zLTEtMS0xNDI0NzE_e8e22985-78f5-469f-a33a-0d32fd44dc39"
      unitRef="usdPerShare">61.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i233c304b9e6749139554635d622968a6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi01LTEtMS0xNDI0NzE_03f90597-7fe2-4a85-9824-80dd2f075557"
      unitRef="shares">348453</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i233c304b9e6749139554635d622968a6_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMi03LTEtMS0xNDI0NzE_6fa82cae-635f-41f6-90fb-47db2ca3d7b3"
      unitRef="usdPerShare">75.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy0xLTEtMS0xNDI0NzE_2bc528ce-8b6f-4b75-b152-eebf3d8de24c"
      unitRef="shares">409591</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy0zLTEtMS0xNDI0NzE_f0fa8d16-3fe8-4e0d-80c9-c770ab3af80e"
      unitRef="usdPerShare">74.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy01LTEtMS0xNDI0NzE_97d37511-8f14-4e9d-82e6-5b9155d07b0a"
      unitRef="shares">194615</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfMy03LTEtMS0xNDI0NzE_fd8e6ce1-fc55-4bdc-a9ed-e895e8a650ce"
      unitRef="usdPerShare">84.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC0xLTEtMS0xNDI0NzE_10ad54bb-adf8-4a69-8b06-86adf926fc7c"
      unitRef="shares">93598</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC0zLTEtMS0xNDI0NzE_4412a2b9-de87-4dc5-8ce9-d9da45a17da3"
      unitRef="usdPerShare">38.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC01LTEtMS0xNDI0NzE_7991e9ee-d037-420e-91a6-f8c2aeeece63"
      unitRef="shares">153431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNC03LTEtMS0xNDI0NzE_84f4820d-0172-41ca-94f5-92e0edc1c8c7"
      unitRef="usdPerShare">77.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS0xLTEtMS0xNDI0NzE_d56c8cff-69a4-436f-bc7d-4b71a0f4bbd9"
      unitRef="shares">69853</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="idfd95dd3d1544204a3043be4c609df76_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS0zLTEtMS0xNDI0NzE_1c157a67-2dd8-444d-9160-7e0508dac202"
      unitRef="usdPerShare">61.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS01LTEtMS0xNDI0NzE_caf344d1-3342-450a-938b-2d4c62cd9366"
      unitRef="shares">12635</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i58b406fa98ec4b878ce29976707e61ac_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNS03LTEtMS0xNDI0NzE_eaf309c8-61f4-409b-85f1-aec13364977c"
      unitRef="usdPerShare">59.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if88ab5f328b647e6a0703df984333731_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi0xLTEtMS0xNDI0NzE_dd7a7bec-b755-4332-ac83-f9db4f56358c"
      unitRef="shares">3237613</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if88ab5f328b647e6a0703df984333731_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi0zLTEtMS0xNDI0NzE_3bc570d2-e7fa-4ccb-a607-08f28fa0dcf7"
      unitRef="usdPerShare">63.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i488634fa2ce945148adf1d9adc77ea34_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi01LTEtMS0xNDI0NzE_3a2fa947-958f-4640-83ec-95fd65910d27"
      unitRef="shares">377002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i488634fa2ce945148adf1d9adc77ea34_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RhYmxlOmIxOWZkNjZhMTc2MzQ1MTRhZDc4MDA1ZWNmMTdhYmQyL3RhYmxlcmFuZ2U6YjE5ZmQ2NmExNzYzNDUxNGFkNzgwMDVlY2YxN2FiZDJfNi03LTEtMS0xNDI0NzE_70534698-16f2-4f91-8f3f-a23a19a728ee"
      unitRef="usdPerShare">79.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfNDUw_b612beb9-4d3b-4a10-a1a7-f06f8ee61d62"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfNTI5_8855a7c2-2ca3-415d-bd02-5712f953426e"
      unitRef="usdPerShare">61.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i5ed6d7e4223c47f4aa33849b39b77065_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfNjc4_001c0058-3b78-462e-a495-636d6453e596"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="i5ed6d7e4223c47f4aa33849b39b77065_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfODA1_a88400f2-e55f-4af0-ac51-4f5596bb302a"
      unitRef="shares">35881</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <lgnd:SaleOfStockAuthorizedOfferingAmount
      contextRef="ia698121e1ecb4b6a8dd84ec11d176568_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjE0Mg_74d2d55e-931c-43d9-a110-a4d544513622"
      unitRef="usd">100000000</lgnd:SaleOfStockAuthorizedOfferingAmount>
    <lgnd:SaleOfStockAuthorizedOfferingAmount
      contextRef="ia698121e1ecb4b6a8dd84ec11d176568_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81Mi9mcmFnOmE0MDhjY2Y1ZDJmMjQ1NmY4ZjQxODUyZWZhOTBhMDZiL3RleHRyZWdpb246YTQwOGNjZjVkMmYyNDU2ZjhmNDE4NTJlZmE5MGEwNmJfMjMxOQ_74d2d55e-931c-43d9-a110-a4d544513622"
      unitRef="usd">100000000</lgnd:SaleOfStockAuthorizedOfferingAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfNDc3NQ_38d99a0c-deab-40cc-8c1e-cd0bf650c6e6">Commitment and Contingencies&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the 3 complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;During the first quarter of 2023, we entered into an amendment to the lease agreement for our headquarters office located in San Diego, California, which resulted in a $1.1 million increase in both operating lease assets and operating lease liabilities as of March&#160;31, 2023.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ib199687300914de5bd23ec149948555c_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfMTA5OTUxMTYzODgzOA_0822fd00-b5e3-4b43-9c83-f81c3c6edcb7"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ib199687300914de5bd23ec149948555c_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfMTA5OTUxMTYzODg0Mg_0822fd00-b5e3-4b43-9c83-f81c3c6edcb7"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <lgnd:LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfNTQ5NzU1ODMzNjk4_2fe98717-7a43-4bf4-89f3-9236ea51fa63"
      unitRef="usd">1100000</lgnd:LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification>
    <lgnd:LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification
      contextRef="ie1301938b25745d0b99c779227731ddd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlOGZkZWE0ZGFmNTQzZTM5NDcwZGQyODNiZTU0Njg2L3NlYzpjZThmZGVhNGRhZjU0M2UzOTQ3MGRkMjgzYmU1NDY4Nl81NS9mcmFnOjkxZTgxNzFhN2UxNzRhNDRiM2Q2OWE3MTQzNWM0MDk5L3RleHRyZWdpb246OTFlODE3MWE3ZTE3NGE0NGIzZDY5YTcxNDM1YzQwOTlfNTQ5NzU1ODMzNjk4_6c3af009-a6f0-4886-9591-1dc30480e92a"
      unitRef="usd">1100000</lgnd:LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>57
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%09[QD*-8AG(+;H+0H8>LVC.A,Z86<.R<-.VK6MM]HRA-<U=%^:N3S$W9<M
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M4(B4*$1.0J%9!*R*;K,47J?Z=FO6J5R>F^/J^BL)B)Q$0*.(B:7JF!]!0:X
M$J*$QOK4F@6KC9X#@$@)0,3,+X=$KA@DTF3/+%-M[QP@1$H0(F:&.8RT;V;Y
M6;[[C9XR"5@;JSE4Z_@'(<Z^'G9JG5Q-G;:L![A+NJ33[O9;:YW'$H:(&6&<
MB,5^OE]V%U*]%;- =?+. 3BD!!QBYI-B'_ N2!7/?F. 9W?P4#_2F,4J#QC.
M 3MV"3OVD2V==Q[W6[N5+H_(?=8NLLQ!=3V6N&.?ACM@4X#%<>RS%_0'TXXS
M1Z0L^-?K7>$K;2[-P75]EKACF^'DP'.OFZMIC_Z(7+.)2=/6)_2'\D[KU8&B
MFO#R<]84>6JS<G>V6#PMSG*=_ 2S57Z^.PA^H&J^3%'(%A!J779AP!.[L]7=
MC>1)?CPYYU+R*+]<,>HSH3Z ]PO.Y>%&_8'BA'OP'U!+ P04    " #L@*A6
MV6#^@B('   E(   &    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;*U:VV[;
M.!3\%<);[ 5(8I'4M4T,I'&Z+= V09WN/C,R'0N51"]).TV_?DG)EFSQX@3(
M2RS9PZ/A(7EF2.7\D?$?8DFI!#^KLA87HZ64J[?CL<B7M"+BC*UHK7Y9,%X1
MJ6[YPUBL."7SIE%5CE$0Q..*%/5H<MY\=\LGYVPMRZ*FMQR(=541_O2>ENSQ
M8@1'NR^^%0]+J;\83\Y7Y('.J/R^NN7J;MQ%F1<5K47!:L#IXF)T"=]>A4V#
M!O%/01_%WC707;EG[(>^^32_& 6:$2UI+G4(HCXV](J6I8ZD>/RW#3KJGJD;
M[E_OHG]H.J\Z<T\$O6+EO\5<+B]&Z0C,Z8*L2_F-/7ZDVPY%.E[.2M'\!8];
M;# "^5I(5FT;*P954;>?Y.<V$7L-8.AH@+8-T',;X&T#W'2T9=9T:THDF9QS
M]@BX1JMH^J+)3=-:]::H]3#.)%>_%JJ=G%S=?)U>?YU=3X&ZFMU\_C2]O%,W
M[R\_7WZ]N@:SC]?7=S-P"K[/IN#/-W^!-Z"HP=V2K06IY^)\+!4''6F<;Y_W
MOGT><CSO"^%G ,,3@ *$+<VO_,VG-.^:H\/F8]7SKONHZSYJXF%7]]><TUH"
M(@25XJVM/VV T!Y K[*W8D5R>C%2RTA0OJ&CR>^_P3AX9^O=*P4[Z"ON^HI]
MT2=71"R!&C60ZPOZW[K8D%)UWCJ*;:BX":5+P6:2I@E*S\>;_>Z8J#!2]:-#
M'? ,.YZAE^=LR;@\E917:JYMJ)"5BV0;)]I[/,QPAI,!2PLLCM,XM-.,.IJ1
ME^9EGK.U(J:*64Y5*N]+>@)J*FU$(X,!RF ZS*:)PD&('#3CCF;LI?E)I;"6
MC#_9>,5F9L( P@$O"PJCS,$KZ7@E1WCEK*) DI]T/X4VEHGQ_&# T$2$,700
M3#N"J9?@C5Q2KDKP?H&PL4O-L<5XF$(3A'&6V0EF'<',2_".25(^@V!F/ANE
M,(L&%$T8BG$<0#M)&/0"$WAI3NF"*HISM9C[$7>NE&VP?1II,J1J T4X<##=
MDT)X9$I*4C\4:A9NL^EF"2WCB3,8#XE:<&I%1Y&#:B];T*L4D[\9FS\696DE
MA\SU&D1Q@H?DCN(.R?4Z X\(#:LJRO-"S<ZRR)7EHX!K-^7))[90"8U59(7!
M%#D(]X(#_8ISRY4MYO*I44<MC"LM.6ZV%D&!26CDUP)#H9-MKSO0+SPWBBN1
M1?T 2DIVN3UEB].UH)XR $UY@4H'C2EK@069JYC"7H:@7X<^%#6I\Y>S-L4'
M9V:J35089*Y5UDL4]&M4*P$><C;=P>&0G 658(=)@KT\0;\^M>7?0\[4G!3"
M(#$&W,0E,5(&R4&PER>8/<M;EP6Y+\I"%M1NL*%7YE[JL%\KVN%VHE<[Y%>[
MSA6NR)/+SR!3OF*(AR)G02F-2^RC@GJ10WZ14P3Y6JGQWJA8.9K*!<,L&5IK
M&RR*4X=I0'O;,K^^[>9.SFI=Z0;3R$K85+/88&MB(E=">[5#?K7K_ VGRFFO
M[2-N"A>*#'8F"+N< NJU#?FU;9=)-E"-8^DTQ2N.A[;;!DH<-@SU^H;\^K9C
MO!@HQC'&IG 9.F'#N#+<*QOR*YL^R= 3=:,L1&,>!:T+QD'-I,?H(E.RDCC)
MC!3;8+%+VE O;<@O;8>;AV.I-14L2S.4#;G:8"ET38A>Z9!?Z3ZS^J$]#WA!
M.;!LRQ)#^RPH'$8.:4:]\B'_SNQE6QYDV: % 31F@@T60\=,P+UB8;]B]=E]
M88G ID!!"-/AFK/! NSR/[@7,NP7LM:<E1W[8VQ-I4(PC8=;#"LLBUUL>T'#
M?D%KU]LQCI8=61PFT7"A67'1?NH/6>Z=$![?N17M>5M[4KA;;[F+L3>>W6T!
MFVU[A4"'?>X%$H=>FSJ3+/^Q9.6<<O%'L_N33U:?BKU"^U*?^EK1#GO=BRSV
MB^PMW]4HH?M_ MX$9ZKH*-O*P8:4:_H.1"=!$ "Q).KY@*SEDO'B%YV_ [\H
M9Z 00MM(/4O86@JI+G3E(!)\(3Q?ME1W!_T-;$IS6MU3?O 3LF;:E.EA-?1"
M#G/2"SGV"[F>_:QV)R0.7!F!R0G$8=-+&)]D$=R!7BM+)\I=BA5MWGF5UJ-<
M;#FE'3I,/^8P:[V3P'XG<3F?%_J-G"IO*U+,3XL:Y&15J')GI6EZ!!B%^Z?<
M6ZH6G*Z$KD'NS03VFPFU_UE7ZY)(-2RL/>)EE5IB2_UJ<J-$CPE[I3.MPFEF
M;-JLJ-1Q>()[0X']AN(;E41]-0>4\%I-(#M#TR"$&4J-XWP;+@K2V'$P%?9.
M(O0[B5;CA*6>6E_>6';!88R-26O!15D2I@[C$_8&(O0;"$.2F_7W;/K0?$-F
M.UZQX*S'*^.]=[CZ!;JJ#P]%+9056ZB&P5FB$L#;=]+MC62KYK7N/9.25<WE
MDA)%6P/4[PNF]A_;&_VFN/O/@,G_4$L#!!0    ( .R J%:^V/*I!@,  "$*
M   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&ULK99=;]HP%(;_BI5-4R=U
MQ G?'42B0-5*78N:=KN8=F'"@5A-XLQVH-NOGYV$C+2!P+0;8COG?7G.X1A[
ML&'\6?@ $KV$022&AB]E?&&:PO,A)*+!8HC4FR7C(9%JRE>FB#F012H* ]/&
MN&.&A$:&,TC79MP9L$0&-((91R()0\)_74+ -D/#,K8+#W3E2[U@.H.8K, %
M^13/N)J9A<N"AA )RB+$83DT1M;%V,):D$9\I; 1.V.D4YDS]JPG-XNA@341
M!.!);4'48PUC" +MI#A^YJ9&\9U:N#O>NE^ER:MDYD3 F 7?Z$+Z0Z-GH 4L
M21+(![:YACRAMO;S6"#23[3)8[&!O$1(%N9B11#2*'N2E[P0.P*KM4=@YP+[
M6$$S%S331#.R-*T)D<09<+9!7$<K-SU(:Y.J538TTC^C*[EZ2Y5..N/[N\GT
MSIU.D!JY][<WD]&CFER.;D=WXRERKZ?31Q>=S0B'2/H@J4>"C^@3>H],)'RU
M*K8/&J%'GR6"1 LQ,*5BT]]@>CG'9<9A[^'X0G@#-:US9&.[62$?'Y9/P"OD
M=EENJHH49;&+LMBI7W./GRN)!-6M$K$ENJ(1B3Q* C1C@J;=]WTT%Y*K'OQ1
ME6KFW:KVUAOS0L3$@Z&A=IX O@;#^?#.ZN#/58G_)[-2&9I%&9J'W)V9VE/
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M&UUEP+/[2#:1+$Z/]#F3ZH*0#GUUAP.N ]3[)6-R.]&WA.)6Z/P!4$L#!!0
M   ( .R J%909#IHF 8  (,A   8    >&PO=V]R:W-H965T<R]S:&5E=#0N
M>&ULM5IK4^,V%/TKFG2GP\YLB"7Y$=.0&0CLEIGR&,*VGT4BB*>VE5I*8/OK
M*S]B)=9C20E?2&RNKL_1O;KG2L[HA15_\P6E KQF:<Y/>PLAEB># 9\M:$;X
M,5O27/[GB149$?*R>![P94')O!J4I0/D>>$@(TG>&X^J>W?%>,16(DUR>E<
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MTB3@^E((O0_,!L4MZOT&4$L#!!0    ( .R J%9,M9_67@<  !0\   8
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M$M",-V"_/Z1I\?F O_*X>Q'X_$]02P,$%     @ [("H5G 7<5O9"   JB<
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MHW]IG =G[G@I9D7VMTRKY=D@'J!4+'B=53^*QZ]BXU"HQTN*K&S^HL>-;3!
M25U6Q6IS,2A8R;S]SY\V@=B[ ,:Q7T V%Y#^!<QQ =U<0!M'6V6-6Q>\XM-3
M53PBI:UA-/VBB4US-7@C<SV-\TK!MQ*NJZ:SZZN+SU?SSQ<(7LVOOUU>G-_"
MF_DM_/O^^>IVCJZ_H-GY_"OZ\NWZ[SD:HI_S"_3NM_?H-R1S=+LLZI+G:7DZ
MJD"-'G.4;'[Y4_O+Q/'+%'TO\FI9HL]Y*M+#ZT?@Q<X5LG7E$_$.^)VKCXCB
M#X@$A%KTS%Y_.?'(H;O(TF8\ZHHL+Y=H <ND1 M5K!"L/,4KF=^WJ2LK*<H3
M6]C:89E]6+VL3\HU3\39 -9M*=2#&$Q__P\>!W_8?'ZCP0XBP'818+[1IU=0
MA62>%"N!WF5%6;ZW>=L.,6Z&T#7G8<KPA$U.1P_[;IA60QS2.-R9'0@,=P)#
M[Q2=I_^%%09%J2I154!52HH\D9E .2AO)6\=@*_UAXF>U+4J'B3D++I[?OVL
MAF\YJV\TV$'0QKN@C;VS.EOR_%[HQ2_*2D(AA4 LN%3H@6>U0,4"011U1""L
M*)/\3F9-5&Q!:7\IW)_6<13TYMYBA /JF/IHYT7D]>)"0&@2R5N6Y"GBJT)5
M\M_V W!"YA7X*>\@&WA9BLJJ/S*D0>KV<]<TPG0<.O3'._VQ5_]Y3RYXLY(U
M5)D<E#^(359_T$EK$QZ;,24QZ0DWC4)L5SW9J9X<I3H5=Q5*99D4-22+G@99
MEC7/$X$6PIXR$S/D84^W:4+)V"X<!QTG@Z.D0U58"049E$&2)]#7"*1TRV G
M86#&FT;]1+%984?$\1[@L5?XG]#+Z;1H8BV>],JL9;G4^6&5B@T1_05I,='5
MF#B4DDXI\2J=+[D20]V4I3J\T*F63;BM,HF9G!.*^TI-JTG F$-H1W;LQ284
MCX50"E1NX<"?[,FZ&6?_]^,H9'V5IM40CW$<.'1V_,5^ +_3<_\>:9"U/4BY
MA"0>5D*M]JN$53FS9.PDI+2OW;3#)(XBA_2.S-C+L.DW 6EP6)3%D\X(854;
M&BH8B_I232/,)JX@=SC$?AY>5TNAK*),<!%FK"4+W9P3W\$-1_[>LV%TJ2&]
MUZ T&&NJ[!Z6K<T*]L+SV&[EK48[#$9'2OP"*I,&+Z7N[X1\X(!T)Q>QR3P<
M&$2W6#$ZIK%CVCHZ8C\>+V%-YE6AGJW23*R1_39H(\VT<M4[TK&/O,"^;037
M_)DW'9%NF))$U2)]J<4C%J@Q0[;-BD2!(Z*D@Q_QP^]R5Z#W9K^1OW'%*MGD
M&QOC?M6V6&$\F5"'Y(Z"Q$_!'5R4@&RH[0I-K@TG<5^@Q8BPT"6PHQ_QTZ\I
M>(YJ8A5KXFUL])H6HR&.B$MLAT#R\A[T59LVJW(3;I1.F!%HTRPD@:MS(QT#
MB7][VC]!:)']BKTF>=/-YEN-=AB%CJ_$S]>;6B5+W0Q T_WZ_H58N$HG\=A8
MQ3:[&+O: M(AF/@WF#>J2(1(MXT7SXYUP-PV,D:HL6YLNTL2CQW['=)1D_BI
M>:@?MOFUDM7SD3Z8G(S9V*C]IA5A,77-0$=3XJ=ILWS67*9H42@D_JFU_I6H
MED6Z)]RJVX1HOV^SF RCT*&9=J2E?M+N)SM4+*A3H%G76"U_[=)+;?1D!K%L
M9@SV(P[1'62I'[*'J7+4QIA:($K[L;88N0+=49;Z*6OE@JW 6E6;9,5!:!Q:
MVLPPC6,'&.C>R?)Q1\L+F?,\><W1\MN>+?\_#I=IAW;J1_L/L=Y;+?K0'UT5
ME6/&3$0;66;9\>(QI:&CE-*.X]2_E[WAS^T9<YVGT#EULY4UF]SB+I/WS1;7
M+MW<M@YQ?QO^@M&A\ Z]U(]>O4C6AQRKBN07]$^;#;E>YZ5HN\#/\YL;JWZ3
ML-!$&0Y8K)CC%(%V$*9^"-_J@YF6 4IDS5'UYB"_U&=-"%K8*A-Z<G0*;1#!
M'[FRW]"B)FR'#(=]H-G,PGCL.!^C'9+I"TC>YA'X,/OK!_I:9)!/=J4F4XU\
MMYP!8X9=V=YAE_JQZSP/H2]3U6(RQ,11+UE'5>:GZJ[8UV5S:&<MF-:;4Q9B
M1E%_OFU6. J84WA'5N8GZ^8.FFKJQ+M4M*_T3:G&GP^M5SIO'Z#!S#?[,2BV
ME9*)SG;]O=4QRQ:71J3?75K,ABPD$X=?'7V9G[ZS5XM'O$)WXE[FN9XMW14)
M)8O4ZI.)6Q8&P;CODX7*DY X5B?KH,S\V^+C?!+PL=\;R]%Q')'^WM-BAIGS
M%(+MW;IEWA9C7J_7;66$/D[?H<F*LE;M[;UM]P%IV#Y' C"PMAO,"_!CVXVW
M&NTP(AW%F9_BESEL>6 B&YQ8O349W*]O%A,:NE93AVDV?OU<Z0=]TKK=;>9%
M/FP3KJURS_99\C8!1\_2&XUV&(N.^,Q/_//-J>1"/L'?YI *;=M$>XFW;*"-
M4WJ+$0DCQ[DJZX#.7CR9;L3*[;GO"U(M&^4H-&JV:44#!]591W7FI_K/'-"3
MR7]![;V^H;AY.@*ZP/,O<^.6LTZ^BC]9G6A_Y^"!#^-I#]-FB'$_W*.]IYY@
MQWG?/ Q6HN:HNGUJ:/?I[H&S\^8QJ][GG_#)K'ULK!NF?8KM.U> GA(:]04,
M&7R,(*JJ?3"L?5,5Z^;9JKNBJHI5\W(I.'1EV@"^7Q2P(]F\T3^P>SQO^C]0
M2P,$%     @ [("H5@+G!#[-'P  P5T  !@   !X;"]W;W)K<VAE971S+W-H
M965T."YX;6S-7&F3W#:2_2L(C3W1'<$NU7U(MB-:+=FC7=G2JF7KP\9^0)&H
M*HY89)E'=Y=__;[,!$"P#JEESVQLQ(Q53>)()#)?'DCPN_NB_%1MC*G5PS;+
MJ^^?;.IZ]^SITRK>F*VN>L7.Y'BS*LJMKO%GN7Y:[4JC$^ZTS9X.^_WITZU.
M\R<_?,?/WI4_?%<T=9;FYEVIJF:[U>7^A<F*^^^?#)ZX!^_3]::F!T]_^&ZG
MU^;6U+_NWI7XZZD?)4FW)J_2(E>E67W_Y'KP[,68VG.#WU)S7P6_%:UD612?
MZ(_7R?=/^D20R4Q<TP@:_]R9&Y-E-!#(^-V.^<1/21W#WV[T'WGM6,M25^:F
MR#ZF2;WY_LG\B4K,2C=9_;ZX_X>QZYG0>'&15?Q?=6_;]I^HN*GJ8FL[@X)M
MFLN_^L'RX3$=AK;#D.F6B9C*E[K6/WQ7%O>JI-88C7[P4KDWB$MSVI3;NL3;
M%/WJ'U[H*JU4L5+O2E.9O-;"JSQ1M[)-].XV7>?I*HUU7JOK."Z:O$[SM7I7
M9&F<FNJ[IS4HH?&>QG;6%S+K\,RL(_5SD=>;2KW*$Y-T^S_%"OPRAFX9+X:?
M'?!G7?;4:!"I87\X^LQX(\^6$8\W.C/>VW*M\_0/YD:D;HJ\PEJ3ECD=;H%#
M/Z:YSN-49^H6#PVDMJ[4?U\OJ[J$W/W/*0X) >/3!) N/JMV.C;?/]G17.6=
M>?+#W_\VF/:??V9Y8[^\\>=&_[?M^F=G/;VF?P4IZD538:ZJ4F]S]4MQ9[9+
M4RJ1AF&D[HV*B^TN,[5)5+TQJC([7<I$%_3WW_\V'P[[SV_]8WXP>'Y)<Q=-
M"7+J=%DD>Y6D58SQ0=7234FDQJ:L 8! J4S3)+JJ3"VOLE0OTRRMB<QPLK?;
M/+U>>LK]C/6F+)KU1FE5[=+\JEBMB C;NB[4FQ22F5#SP>QYI:J-+LVFR!)3
M,A=+$Q<E$<"]XKH@3@RGP@I%G%6[LE!8IB8T2[M$O4PAL.FRZ?" 5K$UY1H#
MA6U_YD<AIRR1]VE-Y-^#J@R[=Y^#(56SK-(DM=NIW0X8M6N6V$/>'YWO(SM&
MI%[G<4]=D-$Q)4;YE&,<6M7U'4C4ZIUTNXY_;](JY9V\*<I=3[U^K2XL@;_
M),APCLC+2*7$@?<&6U@9@%!9@@,?2N"L@J;FE19;L6O*JB%A \-IR=?KTK!2
MB_)GFI5>.!"IQ.XY/]-EO%'#D67X,</:L1Q5$0]*#5L!Y$?A;K3='CU?,-K1
MG-+PD")1NQ/=(FQ0QH;TSF W>(=I@ +_*;W4AQQ,BKAA%(Q40-*'H(4?W,M^
M#]O:Y?OI]I%5 A"5"X-H\L+)7ZRK34<KSV@C>E=U6C<,)33;@4J2L,19D]!K
MS*'RHD;_;6IGHQX&XE?OT:XV0*^:=P0CO,Y))-6+E/FC=P9SQ)4(-:Q)N8<(
M9_2Z GKEL7%O7L?P@V!OWKRYB=0'W4 N@U85O^!E/) ;H[OO6&.N5Z!$,"Y
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M!E/2M+H),(T *DDQ/="\++;H5H!B3VZ/G7#H!MM5ZVR0YV']#5"P U@*%O(
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ME,I[$D%J#0Z:JRS]!"9<4=W,%2\RW"^&3%NX<W;0)8?;%N/L)0N7>^EN$M_
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M)"?J_ZY8"1ZTFZ)%38:*W)BD+87[^J ):E72[>LWP5<_W+/#+X'\:QQ+\ON
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MC9Q0=[;2X6/?OT:]SY1H!BO^&$MW?40F?+'L=KOOO1?A,^?N>/A8#&FXOSC
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M<F;$$ MY==G*""P@5&DN_[)"R2U'NO. 6 @EL797?W"JX_F)J*O@%662U,;
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MZ5R9\\^-0KP86H#GJQ+BA LZH/T<\/I_4$L#!!0    ( .R J%8MRWKKR@,
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M6D-1.P6ZWRH:_MW!/7!<;!?_ E!+ P04    " #L@*A6M"SM2#D%  #U"P
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M.1; ^=)B8O<+=C"\].=_ E!+ P04    " #L@*A613XZG?T6  !"1   &0
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MRF%X4[FEEQD283I=_ OX[#V?.@ 6>0^KDJ-)192XI,C7U6QJ@PZ;I05 ,@5
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M [R?.QB#_X4FB'\VY.W_ E!+ P04    " #L@*A6P/R4?1<+  #B'0  &0
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MS3ICZK+H@^?$4P4/X -27^>RFPS:VU7R*$Z'Q[#T)K\_Y/NP()2:1= M]X*
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MB%;T0/5G>#\P\NC.S9TT= J[QXJN/:AL LWOI33G@5U@O$@M_P%02P,$%
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MTG8/PQX8F[:U2J)'TDFS7S_JPZ)H4ZR]4"^Q/NX]NO?R1#J\Y.2)LF]\38@
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M\3Z*C*4Y!7%C3=S83]RZXL:_K7/Y ]3[4&*U*6@;()2VMNTZ*<"G[P3@H*V
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MX@S)6YYCIJ]LN,B0TJ=B:\M<8)0421FU7<<)[0P19BUFQ6\KL9CQG:*$X94
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ML18EJEMB-5!\5UZT'KC2U[;R<:MOUE@8 _U]S;EZ'IB[6W-73[\"4$L#!!0
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M/F:?8$'1HKA6/Q)QEAG*QB.73):<"5C1(M(G90W\-7LV5M-'\7=?@(. 8;\
M5RCN3<-*G$:-.TOO,2I^_BD=)[_V1>=_(CN+U;"+U? 2>_'$S<OGM48$+BT2
MOP5-,8 ;9H!!@[JD:/3>L<";AJ2ZVK8ODD$R3"?Q_M2Y?K-TW)F=R1YULD<7
M93_P/:^0<GGD**HKU :Z-#V5\4[I19,SE>-.Y?BBRB^O#157K&"O!-TVP>WQ
M"JGC'AV#4?Y.;;]5O][;3N_M=7KI)M1P<T2F^^O+99H1>"3D4(<ZD]Y!Q8ZF
M[^Y?9AJV3'<=4];#%'R-3VIVC7KC6YD!7UQ#*>M6NVXY\TWBW?J<NFAH>C]H
M0@NF0K7A5'L%KHDR&=S2E=&AK86)58WO#,_*4I_QPRW]":!V!K2_5LJ^3=P!
MW;]%\1]02P,$%     @ [("H5H*)@V08!   _Q   !D   !X;"]W;W)K<VAE
M971S+W-H965T,S N>&ULM5C;;N,V$/T50@6*+-!$-UNV4]M G*3H KNH$>]V
M'XH^,-+()B*1*DG9V;_O4))ERY:5!JN^6"+%.9HS<TC->+H3\D5M #1Y31.N
M9M9&Z^S6ME6X@92J&Y$!QR>QD"G5.)1K6V42:%08I8GM.4Y@IY1Q:SXMYI9R
M/A6Y3AB'I20J3U,JOR\@$;N9Y5K[B2>VWF@S8<^G&5W#"O37;"EQ9-<H$4N!
M*R8XD1#/K#OW]MX-C$&QXD\&.W5T3PR59R%>S.!C-+,<XQ$D$&H#0?&RA7M(
M$H.$?OQ3@5KU.XWA\?T>_;>"/))YI@KN1?*-17HSL\86B2"F>:*?Q.YWJ @-
M#5XH$E7\DEVUUK%(F"LMTLH8/4@9+Z_TM0K$D0'BM!MXE8%W:C"X8.!7!GY!
MM/2LH/5 -9U/I=@1:58CFKDI8E-8(QO&31I76N)3AG9ZOJ"**2)BLI2@@&M:
M!I='9%4FUCQ;L35G,0LIU^0N#$7.->-KLA0)"QDH<DT>J>0XI<C5)Z'4![($
M258;*H%</8"F+,&Y:Z+,C-I?&"=?-B)7^#(UM362,2[98>7XHG3<N^"X3SX+
MKC>*//((HJ:]C4&H(^'M(['P.@$_4WE#?/<7XCF>W^+/_7\W]SK<\>O$^ 6>
M?P'O#F,<L20W*B<K"'/)M(GUXVN8Y,B8Q%*DY%ZD65XE#1-5I^$0_[\^(3#Y
MJ"%5?[=%N?1BT.Z%.41N549#F%F9$8C<@C7_^2<W<'YM"U%/8(V #>J #;K0
MY]^*'8N!H5N0> +M989GE]*H,:/8*]1<.?VA+1;E"X;%"\SYMYV[(R= ,6R/
M2;:L"L;>H%[5\'Y8>S_L3/?#/M69T+@-&4U(*-)4[/V];?-WV&?N>@)KL ]J
M]D%G[E9EJG*%Z=/",$=5 RGTCU.,XPR&!D6MRD.E.X]!2QXGH\%)'EM67<[C
MJ&8RZF2RW*<O^4[J[5LI$1I;-Z1)F"?EUHUR,+SQ?&77M17$,7[KWN(Z.F,Q
M\(>3$ZKGBP+'<=N9CFNFXTZF3Z"T9*')#WZEPI<VYSH1WBO0GL :9"<UV4G_
MVW/2)_N>P!KL7>=0)3B=R7Z+_ULJK>"/%3@.3D3:LL9IEZA[5-VXW0>+42;Y
M(S.[K+W(Z+1_;Y+Z0FNR]0YLO?Y56F'V%8&>T)H1.!1-;F>)\>,Z]<\TZ _<
M4Z&>+[HDU$/QXG97+Z;H1%<YUBZ:/2?XS0#.A"0<>;0+MQ/OW6GK":W)_E#\
MN/]#]>/V6O[TA=:,P*$ <KLKH!\6[GDU,QB?5CPMBTZ%:Q^UDBG(==%A*U+T
M?&4O5<_67?Q=T;N>S"],=U^TJ >8\J\![)36C"N20(R0SLT(_9%EMUT.M,B*
MAO59:&Q_B]L-T BD68#/8X$QJ@;F!?5_'O-_ 5!+ P04    " #L@*A6IDYF
MX5,#   8#   &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R]5U&/HS80
M_BLCNJKNI+TED(2-M@G29FEU)_7N5KN]]J'J@P,#L0YL:IOD*O7'=PR$)CE"
MNQ7J2["-OV]FOK&'R7(OU6>]133PI<B%7CE;8\H[U]7Q%@NF;V2)@MZD4A7,
MT%1EKBX5LJ0&%;GK3R:!6S NG'!9KSVJ<"DKDW.!CPIT511,_;'&7.Y7CN<<
M%IYXMC5VP0V7)<OP&<VG\E'1S.U8$EZ@T%P*4)BNG'OO+EK8_?6&GSGN]=$8
M;"0;*3_;R;MDY4RL0YAC;"P#H\<.'S#/+1&Y\7O+Z70F+?!X?&#_H8Z=8MDP
MC0\R_X4G9KMR%@XDF+(J-T]R_Q;;>.:6+Y:YKG]AW^Z=.!!7VLBB!9,'!1?-
MDWUI=3@"3+T+ +\%^&< W[\ F+: Z1G FUT S%K K%:F":76(6*&A4LE]Z#L
M;F*S@UK,&DWA<V'3_FP4O>6$,^%SR<4;F:8@4_A8"'Z_@3?P@2G%;#[@582&
M\5R_ABO@ G[:RDHSD>BE:\BXI7#CUM"Z,>1?,#2%]U*8K8;O18+)*=XEISO/
M_8/G:W^0\#U3-S#UKL&?^%/X]!S!JZO74$K-[8'J<?#AW_/Y![X>FFB8YF-L
M;L /&IJ!,*==@J8UW_12@C"C6V;@"4NI#!?9-0UW*"JD9RQ%S F1P3N#!?SZ
M(X'KH?ZM+T.-I5F_)5M@[G3)8EPY5$$TJATZX;??>,'DNSXUQR2+1B([47C6
M*3P;8@\_4''-I=:0*EE PC6I2D)7F !55WL1I-#P)USU2=I0!S6U+;&[T N"
M^=+='4OU]29_-@].-T6#3OY'">:=!/-A":IB@\K6 %4?,[;)$71S\FSH [=J
MW3#/CX,["W_0]DM/RDAD)S(%G4S!H$Q1_]GH4V60Z*57;4RR:"2R$P%O.P%O
M_[=B=CNFPF.212.1G2B\Z!1>_-,1I<O*<LB4K,IK^FC'>9584?L+VS70**:<
M4(]G[_].VK00S" Y1Y<_J0G/O]A-"@9=>6D*QB2+%E\5):\K2HVN[E'/5*#*
MZMY30RPK89HFI%OMVMO[NJL[6U][=P]-E_HW3=,S4T>1<?ITY)@2Y>3FEOQ1
M31_:3(PLZ\YL(PWU>?5P2ZT[*KN!WJ=2FL/$&NC^#(1_ 5!+ P04    " #L
M@*A69.F,=_8#  "I#@  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6RU
M5VUOVS80_BN$5@P)T$0B_9[9!O*R;L76-8C;[3,MG6VB$JF1M)WNU^\HR9([
MTUP7K%]BB>+=/??<\0EONE?ZD]D 6/)<Y-+,HHVUY4T<FW0#!3?7J@2)7U9*
M%]SBJU['IM3 L\JHR&.6),.XX$)&\VFU]JCG4[6UN9#PJ(G9%@77G^\@5_M9
M1*/#PI-8;ZQ;B.?3DJ]A ?9C^:CQ+6Z]9*( :8221,-J%MW2FSO&G$&UXW<!
M>W/T3%PJ2Z4^N9>WV2Q*'"+((;7.!<>?'=Q#GCM/B.//QFG4QG2&Q\\'[V^J
MY#&9)3=PK_(_1&8WLV@<D0Q6?)O;)[7_&9J$!LY?JG)3_27[9F\2D71KK"H:
M8T10"%G_\N>&B",#3-1OP!J#BHBX#E2A?."6SZ=:[8EVN]&;>ZA2K:P1G)"N
M*@NK\:M .SM?E$)>J=6*J!5Y7TAQNR179(&US[8YN$4-.Y!;(%QF!)ZQ&0P8
MMVXW0#)A4B6MP.\9P4;1W#%MR,4#6"YR<XF^'L[L>46$)!\V:FO0LYG&%I-Q
MD.*T 7Y7 V=G@/?(.W2[,>1'F4'VI7V,)+1,L ,3=RSH\!W7UZ1'7Q.6,$8^
M+A[(Q:O+@-]>RW"O\ML[X_>I)M#<^'*L3?M^4W<B;TS)4YA%>.0,Z!U$\^^_
MH\/DAP"P?@NL'_(^_Z LSP_U]5:@MA]6]NYX[^83.AI-XYTGZJ"-.@C2\;YN
M ;DFJ3+6?-%77HH&WX"B80MV&*3HME#:BK^JEG5-+Z3E<BV6N9^OVMG@B*\>
MZ_7\?(U:"*,@A"=,BNMT4Q&58;%R5:(J6E_\T4E\2BD;^P&,6P#C(("?0&+%
M\BH^SU""A+&N@COP01B?0!BRP<"/8-(BF'Q%HZI X_B03$Z0L&1(AWXH-.GT
M,@F"^5490U9:%4=BYE6OY"3^%:7]WN0,@"/!IN$#A,JKL1-350"Y:!BX]!Z=
MQM/_>W8HZY"R(%7'2%\3"=Z>;7P<\]3OGSDSM--<&E3.0\M4 !J*SB/H_0<$
MG;C2L+I6?;($O#?!H5B6/WOC]SV=DDPFYUJU4UH:U,;YVS8L I&P$O[T!R?A
MQX-^<B9XIYPT+)V_X8TR1PZ\(4^%\HKU!^<2[J22AK7RE\^E5KGPQPR:OO0L
M=")*QR^_!="@ K\46R>O]&OT-701H!XQ'9XY(JR34A:6TGN\P&F\EA]"^R*'
M7;R0&M:)+0N+;;!L[%O(*^ODE87E]=_+UC@XOL"-)[3_C[K%1]-# 7I=S4@&
M_\MNI:T'B7:UG<-NZ^FCVUX/<7B'7@N\W.>P0M/D>H0=H^NYJ'ZQJJQFD:6R
M.-E4CQN<)4&[#?A]I90]O+@ [70Z_QM02P,$%     @ [("H5I!Y_\<*!
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MBQN7EQ\G[4V>;6[2W7&3#KDHBWI9D;\7"[8PM#^'VU.@_5@0UK'F/K%VYH*
M_XJ+=X0Z1\2=.!.2"'#AMN#MSSM)QI]<=C;3;<*H%S%_0G4I^>,R(K_\]*L!
M)H)A(I9T,*X91G.:=EV%-KCTV:YR]&SGT+J#M/J]+/A6__C/9W$!\JEF>?5?
M4Y_8W(UGOALY'[ZO5G'"3D=BPJL8OV.C^<]_<X+);R;F,<$B)# M"EX7!0]"
MG_^^SJ\8)^4U.?_^E5PR+GG_:_\^>+:!]QMXN2K<S;V3\5V?*_ &;+E" M.X
M\CNN?)"K;SPNJFO&FQYY)UC[)I8L0=:7I5@I""6):) F<49JGL:9B2P0W[8/
M8H)%2& :KT'':W!0,T& &05,L @)3(M"V$4A!'OW/WA95<W YR)[(K$,A(D]
M$,66O0U8T)L]G(GXI\\@$=(E-5JF'2U3D):+^"'-U[D8YKN&?\3N1+Z[DHG.
MD<A=;]997)?\\8C\'.>KWP2C><YX(F8$D7!E3*1@!=MT<-&S)18O'^-,]G(3
MV^#-V;*-"18A@6E!F75!F1W4C#'#C (F6(0$ID7!F:AL?P(.CD_%G>C038IO
M3,/!UK:\M6C]5(.&_G"VP+JJSDE/ 3GPA"%DRI7L549&P+;6C&"B15AH.F^N
MXLT]J#'=W@Y6*##1(BPT/11*F3F@Y-!%0472JEH+TE?BHSCYL4XY8Z1:QIQ9
M"87VFI!2@&_+FL2WT%6.$E:.A;+J2+SF94Y8G"P;O579ZRUG*+B<;1I1%1<6
MFDZCTEP.++H^<O9CS8KD43*9Q-62K.+'S:92738D+LMLP;AYNH6Q Y(W&SG&
M 8TJK[#0=!*5P') Y2"W@FZ/Z_(X%S^9R.T7_UMOENTGX9^UL^RCD454P=2B
M]3OP<3A<Q-]""CE*"SFP&.I6%R,?J!((%2W"0M-Y4V+)F1[6(HZJCU#1(BPT
M/11*(CE@[M_+S>5V^??T5K(JQ:C@78C0Y-;()ZK2:='Z0]V?47^V/=9G@UV
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M:UY0JYVPT'2>E5#P#JO:R4,5&ZAH$1::'@HE-CSX-&5_H0H#69,X+(C:KH(
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M@_@W;^IRU3R:_JJLZS)O7BY9O&!<&HC?7Y=E_?1&7J#[<PCS_P-02P,$%
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M+POZ4Z!V#G2^4,IN#%>@^_>DOP%02P,$%     @ [("H5JS*S.N" @  ; 8
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M#NE!-0K5?)0F5WT=T^K*Q&MQMTUY'O^'1=<L<:$A+52SH)H-U9Q*FZ@K'AK
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M+(@8+^X@?KY,Q>JF^J88X"GE/\J'L_@?4$L#!!0    ( .R J%8\%$C-"P,
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M"LH&X'DMI3D8]H)A1!>_ 5!+ P04    " #L@*A6[$^-MUT$  ""$P  &0
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ [("H5BZCVG&V P  *!T
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ [("H5LHPNG7K!0  [1X  !@              ("!#@@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .R J%;98/Z"(@<  "4@   8
M              " @2\.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    " #L@*A6OMCRJ08#   A"@  &               @(&'%0  >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ [("H5E!D.FB8!@
M@R$  !@              ("!PQ@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+ 0(4 Q0    ( .R J%8)'D]XZ0(  %$'   8              " @9$?
M  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " #L@*A63+6?
MUEX'   4/   &               @(&P(@  >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&UL4$L! A0#%     @ [("H5G 7<5O9"   JB<  !@
M ("!1"H  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( .R
MJ%8"YP0^S1\  ,%=   8              " @5,S  !X;"]W;W)K<VAE971S
M+W-H965T."YX;6Q02P$"% ,4    " #L@*A6+2?C2IX(  ":%   &
M        @(%64P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%
M  @ [("H5IJS))<V"0  $1<  !D              ("!*EP  'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #L@*A60%3)\T -   :*
M&0              @(&790  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+
M 0(4 Q0    ( .R J%8MRWKKR@,  $ )   9              " @0YS  !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ [("H5N]6<#@4
M!0  Y H  !D              ("!#W<  'AL+W=O<FMS:&5E=',O<VAE970Q
M,RYX;6Q02P$"% ,4    " #L@*A6M"SM2#D%  #U"P  &0
M@(%:?   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( .R
MJ%9%/CJ=_18  $)$   9              " @<J!  !X;"]W;W)K<VAE971S
M+W-H965T,34N>&UL4$L! A0#%     @ [("H5L#\E'T7"P  XAT  !D
M         ("!_I@  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M    " #L@*A6X;52K' $   ?"@  &0              @(%,I   >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( .R J%;Q$*=5QP4  'H.
M   9              " @?.H  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
M4$L! A0#%     @ [("H5E(05\CJ @  3 8  !D              ("!\:X
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " #L@*A6K/@2
M#T4#  !4"0  &0              @($2L@  >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;%!+ 0(4 Q0    ( .R J%9U9&_"I 4  %<@   9
M  " @8ZU  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @
M[("H5K$0 .*H!0  0"<  !D              ("!:;L  'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6Q02P$"% ,4    " #L@*A6[P<?(9P'  #)-   &0
M            @(%(P0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4
M Q0    ( .R J%;7"KD,P0(  'L'   9              " @1O)  !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ [("H5N ]XWP?!
M#A0  !D              ("!$\P  'AL+W=O<FMS:&5E=',O<VAE970R-2YX
M;6Q02P$"% ,4    " #L@*A6M>NP8=\#  "W#P  &0              @(%I
MT   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( .R J%;.
M[DN.#P,   L)   9              " @7_4  !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL4$L! A0#%     @ [("H5N6YDU C P  =0L  !D
M     ("!Q=<  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .R J%:0>?_'"@0  !H0   9              "
M@6CJ  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ [("H
M5F5=/N$N"@  &F$  !D              ("!J>X  'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6Q02P$"% ,4    " #L@*A6?:C^Z[0"  "'!@  &0
M        @($.^0  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0
M   ( .R J%:LRLSK@@(  &P&   9              " @?G[  !X;"]W;W)K
M<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ [("H5O7U"N-?#   .9,
M !D              ("!LOX  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q0
M2P$"% ,4    " #L@*A6/!1(S0L#  !N"0  &0              @(%("P$
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( .R J%:N*^]=
M3 (  *X%   9              " @8H. 0!X;"]W;W)K<VAE971S+W-H965T
M,SDN>&UL4$L! A0#%     @ [("H5NQ/C;==!   @A,  !D
M ("!#1$! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " #L
M@*A6'HT#XY #  "/"@  &0              @(&A%0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( .R J%;OEACMRP(  ($'   9
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M 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #L@*A6[DG=_YX!   (&@
M&@              @ 'B)@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " #L@*A6J,J'V:L!  !!&@  $P              @ &X* $
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     ,P S -P-  "4*@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>180</ContextCount>
  <ElementCount>306</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>64</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Spin-off of OmniAb</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAb</Role>
      <ShortName>Spin-off of OmniAb</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Spin-off of OmniAb (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbTables</Role>
      <ShortName>Spin-off of OmniAb (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SpinoffofOmniAb</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Spin-off of OmniAb - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails</Role>
      <ShortName>Spin-off of OmniAb - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails</Role>
      <ShortName>Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails</Role>
      <ShortName>Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/IncomeTax</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Commitment and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lgnd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - lgnd-20230331.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - lgnd-20230331.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentConvertibleConversionRatio1 -  lgnd-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20230331.htm">lgnd-20230331.htm</File>
    <File>a102-directorcompensationa.htm</File>
    <File>a103-changeinctrlseverance.htm</File>
    <File>lgnd-20230331.xsd</File>
    <File>lgnd-20230331_cal.xml</File>
    <File>lgnd-20230331_def.xml</File>
    <File>lgnd-20230331_lab.xml</File>
    <File>lgnd-20230331_pre.xml</File>
    <File>lgnd_33123exhibit311.htm</File>
    <File>lgnd_33123exhibit312.htm</File>
    <File>lgnd_33123exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="605">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 605,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 180,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 487,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 46,
   "keyStandard": 260,
   "memberCustom": 24,
   "memberStandard": 37,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.ligand.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Convertible Senior Notes",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Income Tax",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Commitment and Contingencies",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.ligand.com/role/CommitmentandContingencies",
     "shortName": "Commitment and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "15",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "16",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Spin-off of OmniAb (Tables)",
     "menuCat": "Tables",
     "order": "17",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbTables",
     "shortName": "Spin-off of OmniAb (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "18",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Convertible Senior Notes (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "21",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "i65eeea1681704584af49987ac1e87675_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "iab4f1100a55e4741878f092afbfc948d_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "iab4f1100a55e4741878f092afbfc948d_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Spin-off of OmniAb - Narrative (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
     "shortName": "Spin-off of OmniAb - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "position",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails",
     "shortName": "Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:PaymentsToContingentValueRightHoldersFinancingActivity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
     "shortName": "Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "if0909306cfaa49b3b8f1bdd23e0a8482_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ifcfb68dc76174bf49f8bd077bd649ae1_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ifcfb68dc76174bf49f8bd077bd649ae1_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "i1ad7a5d1cc5a45b3993c229ec308f769_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "i1ad7a5d1cc5a45b3993c229ec308f769_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TangibleAssetImpairmentCharges",
       "us-gaap:TangibleAssetImpairmentCharges",
       "us-gaap:GoodwillAndIntangibleAssetImpairment",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:TangibleAssetImpairmentCharges",
       "us-gaap:TangibleAssetImpairmentCharges",
       "us-gaap:GoodwillAndIntangibleAssetImpairment",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia82d4ad3cea140ef9a6f0c99ee594d64_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lgnd:PaymentsToUnwindWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie72321e6630d4a0a894dd61ce3b42ecc_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie72321e6630d4a0a894dd61ce3b42ecc_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Income Tax (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.ligand.com/role/IncomeTaxDetails",
     "shortName": "Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "i5b031e51a09841e2bba31484e4e6ba22_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "i5b031e51a09841e2bba31484e4e6ba22_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Commitment and Contingencies - Narrative (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails",
     "shortName": "Commitment and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ie1301938b25745d0b99c779227731ddd_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "iabcd11cab6e246f29bd95c8775e1803a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "iabcd11cab6e246f29bd95c8775e1803a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Spin-off of OmniAb",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.ligand.com/role/SpinoffofOmniAb",
     "shortName": "Spin-off of OmniAb",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20230331.htm",
      "contextRef": "ia3bfadc909be4af7af8cc5b873d1def6_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - lgnd-20230331.htm",
     "menuCat": "Cover",
     "order": "43",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - lgnd-20230331.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 64,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSupplierExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Supplier Expenses, Current",
        "label": "Accrued Supplier Expenses, Current",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "AccruedSupplierExpensesCurrent",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid in Capital, Increase Due To Separation",
        "label": "Adjustments To Additional Paid in Capital, Increase Due To Separation",
        "terseLabel": "Final distribution of OmniAb"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Commercial License And Other Economic Rights",
        "label": "Amortization Of Commercial License And Other Economic Rights",
        "verboseLabel": "Amortization of commercial license rights"
       }
      }
     },
     "localname": "AmortizationOfCommercialLicenseAndOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmountsOwedToFormerLicensorFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Owed To Former Licensor, Fair Value Disclosure",
        "label": "Amounts Owed To Former Licensor, Fair Value Disclosure",
        "terseLabel": "Amounts owed to former licensor"
       }
      }
     },
     "localname": "AmountsOwedToFormerLicensorFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AtTheMarketEquityOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The Market Equity Offering",
        "label": "At-The Market Equity Offering [Member]",
        "terseLabel": "At-the Market Equity Offering"
       }
      }
     },
     "localname": "AtTheMarketEquityOfferingMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AziyoAndCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo and CorMatrix",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoAndCorMatrixMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense)",
        "label": "Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "verboseLabel": "Contingent liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessSpinOffAndMigrationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Spin-Off And Migration",
        "label": "Business Spin-Off And Migration [Policy Text Block]",
        "terseLabel": "Business"
       }
      }
     },
     "localname": "BusinessSpinOffAndMigrationPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Allowance for credit losses adjustment related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial License Rights",
        "terseLabel": "Commercial license rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRightsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License Rights",
        "label": "Commercial License Rights [Policy Text Block]",
        "terseLabel": "Commercial License Rights"
       }
      }
     },
     "localname": "CommercialLicenseRightsPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ContingentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Liabilities",
        "label": "Contingent Liabilities [Member]",
        "terseLabel": "Contingent liabilities"
       }
      }
     },
     "localname": "ContingentLiabilitiesMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CyDexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CyDex",
        "label": "CyDex [Member]",
        "terseLabel": "CyDex"
       }
      }
     },
     "localname": "CyDexMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtInstrumentRepurchasedAmountDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Repurchased Amount During Period",
        "label": "Debt Instrument, Repurchased Amount During Period",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedAmountDuringPeriod",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "label": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "totalLabel": "Total short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, regulatory, &amp; commercial milestones and tiered royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Financing Activities",
        "label": "Disposal Group, Including Discontinued Operation, Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)",
        "label": "Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Costs and Expenses",
        "label": "Disposal Group, Including Discontinued Operation, Operating Costs and Expenses [Abstract]",
        "terseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Income (Expense)",
        "label": "Disposal Group, Including Discontinued Operation, Other Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed",
        "label": "Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed",
        "terseLabel": "Disposal group, including discontinued operation, percentage of voting interests disposed"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Research and Development",
        "label": "Disposal Group, Including Discontinued Operation, Research and Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense",
        "label": "Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid",
        "label": "Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property, plant and equipment included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EquitySecuritiesFVNIShareSoldInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV NI, Share Sold In Period",
        "label": "Equity Securities, FV NI, Share Sold In Period",
        "terseLabel": "Sale of Viking common stock (in shares)"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIShareSoldInPeriod",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "label": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Lease amortization expense"
       }
      }
     },
     "localname": "FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "(Gain) loss from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Decrease in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Increase (Decrease) In Operating Lease Assets Due To Modification",
        "label": "Lessee, Increase (Decrease) In Operating Lease Assets Due To Modification",
        "terseLabel": "Increase in operating lease assets"
       }
      }
     },
     "localname": "LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Increase (Decrease) In Operating Lease Liabilities Due To Modification",
        "label": "Lessee, Increase (Decrease) In Operating Lease Liabilities Due To Modification",
        "terseLabel": "Increase in operating lease liabilities"
       }
      }
     },
     "localname": "LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_MaterialSalesCaptisolCOVIDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, COVID",
        "label": "Material Sales, Captisol, COVID [Member]",
        "terseLabel": "Captisol - COVID"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCOVIDMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCoreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, Core",
        "label": "Material Sales, Captisol, Core [Member]",
        "terseLabel": "Captisol - Core"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCoreMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "terseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Cash Provided by (Used in) Discontinued Operations, Investing Activities",
        "label": "Net Cash Provided by (Used in) Discontinued Operations, Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivitiesAbstract",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Cash Provided by (Used in) Discontinued Operations, Operating Activities",
        "label": "Net Cash Provided by (Used in) Discontinued Operations, Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Repurchased During Current Period, Two",
        "label": "Notes Repurchased During Current Period, Two [Member]",
        "terseLabel": "Notes repurchased in August 2022"
       }
      }
     },
     "localname": "NotesRepurchasedDuringCurrentPeriodTwoMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders",
        "negatedTerseLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 clinical trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromCommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Commercial License Rights",
        "label": "Proceeds from Commercial License Rights",
        "terseLabel": "Proceeds from commercial license rights"
       }
      }
     },
     "localname": "ProceedsFromCommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RepaymentsOfNotesPayableInterestPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments Of Notes Payable, Interest Portion",
        "label": "Repayments Of Notes Payable, Interest Portion",
        "terseLabel": "Accrued interest portion of repurchased amount of debt instrument"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayableInterestPortion",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RylazeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rylaze",
        "label": "Rylaze [Member]",
        "terseLabel": "Rylaze"
       }
      }
     },
     "localname": "RylazeMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_SaleOfStockAuthorizedOfferingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Authorized Offering Amount",
        "label": "Sale Of Stock, Authorized Offering Amount",
        "terseLabel": "Sale of stock, authorized offering amount"
       }
      }
     },
     "localname": "SaleOfStockAuthorizedOfferingAmount",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "label": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "terseLabel": "Payout range (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_TeriparatideInjectionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teriparatide Injection",
        "label": "Teriparatide Injection [Member]",
        "terseLabel": "Teriparatide injection"
       }
      }
     },
     "localname": "TeriparatideInjectionMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20230331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r368",
      "r396",
      "r623",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r201",
      "r254",
      "r260",
      "r266",
      "r322",
      "r468",
      "r469",
      "r470",
      "r480",
      "r481",
      "r504",
      "r507",
      "r509",
      "r510",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r201",
      "r254",
      "r260",
      "r266",
      "r322",
      "r468",
      "r469",
      "r470",
      "r480",
      "r481",
      "r504",
      "r507",
      "r509",
      "r510",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r201",
      "r254",
      "r260",
      "r266",
      "r322",
      "r468",
      "r469",
      "r470",
      "r480",
      "r481",
      "r504",
      "r507",
      "r509",
      "r510",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r434",
      "r585",
      "r601",
      "r618",
      "r619",
      "r640",
      "r653",
      "r657",
      "r707",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r434",
      "r585",
      "r601",
      "r618",
      "r619",
      "r640",
      "r653",
      "r657",
      "r707",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r302",
      "r587",
      "r641",
      "r656",
      "r702",
      "r703",
      "r711",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r302",
      "r587",
      "r641",
      "r656",
      "r702",
      "r703",
      "r711",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r427",
      "r434",
      "r464",
      "r465",
      "r466",
      "r561",
      "r585",
      "r601",
      "r618",
      "r619",
      "r640",
      "r653",
      "r657",
      "r699",
      "r707",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r427",
      "r434",
      "r464",
      "r465",
      "r466",
      "r561",
      "r585",
      "r601",
      "r618",
      "r619",
      "r640",
      "r653",
      "r657",
      "r699",
      "r707",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r248",
      "r249",
      "r368",
      "r396",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r255",
      "r256",
      "r257",
      "r308",
      "r309",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r468",
      "r469",
      "r470",
      "r480",
      "r481",
      "r492",
      "r493",
      "r494",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r537",
      "r538",
      "r542",
      "r543",
      "r544",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r36",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r305",
      "r306"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r172",
      "r190"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.",
        "label": "Accrued Royalties",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r219",
      "r596",
      "r609",
      "r613"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r46",
      "r49",
      "r150",
      "r554",
      "r604",
      "r605",
      "r672",
      "r673",
      "r674",
      "r682",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r31",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r468",
      "r469",
      "r470",
      "r682",
      "r683",
      "r684",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r138",
      "r139",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r110",
      "r119",
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Adjustments to additional paid-in-capital from warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r56",
      "r387",
      "r540",
      "r678"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortized issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r387",
      "r540",
      "r638",
      "r639",
      "r678"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r165",
      "r184",
      "r214",
      "r245",
      "r293",
      "r296",
      "r300",
      "r318",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r495",
      "r497",
      "r522",
      "r655",
      "r705",
      "r706",
      "r742"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r207",
      "r223",
      "r245",
      "r318",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r495",
      "r497",
      "r522",
      "r655",
      "r705",
      "r706",
      "r742"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r311",
      "r330"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r688",
      "r689",
      "r754"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r90",
      "r310",
      "r330",
      "r591"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r491",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r141",
      "r142",
      "r491",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpenditureDiscontinuedOperations": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capital expenditure attributable to discontinued operations.",
        "label": "Capital Expenditure, Discontinued Operations",
        "negatedTerseLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "CapitalExpenditureDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r76",
      "r210",
      "r620"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r71",
      "r76",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r71",
      "r158"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (in USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Warrants issued in public offering (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r44",
      "r173",
      "r188"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r349",
      "r350",
      "r617",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r682",
      "r683",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r30",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r30",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 17,134 and 16,951 shares issued and outstanding at March\u00a031, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r50",
      "r228",
      "r230",
      "r235",
      "r592",
      "r597"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r307",
      "r327",
      "r709",
      "r710"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r412",
      "r413",
      "r424"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was previously deferred"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "2023 convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r26",
      "r166",
      "r181",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r648",
      "r650",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r675"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r675"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r243",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r381",
      "r388",
      "r389",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r166",
      "r167",
      "r181",
      "r250",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r541",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r111",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (in USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r41",
      "r120",
      "r123",
      "r125",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r160",
      "r163",
      "r365",
      "r541",
      "r636",
      "r637"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r40",
      "r160",
      "r392",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r40",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r42",
      "r250",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r541",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r42",
      "r120",
      "r124",
      "r125",
      "r126",
      "r159",
      "r160",
      "r163",
      "r180",
      "r250",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r390",
      "r541",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r708"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r312",
      "r330",
      "r335",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r315",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "terseLabel": "Unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r316",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": {
     "auth_ref": [
      "r204",
      "r678"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.",
        "label": "Depreciation and Amortization, Discontinued Operations",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r74",
      "r291"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r423",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r16",
      "r53",
      "r193"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "totalLabel": "Loss before income tax"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r16",
      "r20",
      "r475",
      "r483",
      "r486"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "negatedTerseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Depreciation and Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r17",
      "r206"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Spin-off of OmniAb"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAb"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r236",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r267",
      "r269",
      "r275",
      "r276",
      "r277",
      "r279",
      "r510",
      "r511",
      "r593",
      "r598",
      "r630"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Basic net income (loss) per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r236",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r269",
      "r275",
      "r276",
      "r277",
      "r279",
      "r510",
      "r511",
      "r593",
      "r598",
      "r630"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Diluted net income (loss) per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-Based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (in shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r119",
      "r201",
      "r231",
      "r232",
      "r233",
      "r251",
      "r252",
      "r253",
      "r256",
      "r263",
      "r265",
      "r281",
      "r322",
      "r411",
      "r468",
      "r469",
      "r470",
      "r480",
      "r481",
      "r509",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r554",
      "r604",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r215",
      "r521",
      "r622"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r215",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r599",
      "r695"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Gain on sale of Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r93",
      "r182",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r513",
      "r514",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r379",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r514",
      "r558",
      "r559",
      "r560",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r513",
      "r514",
      "r515",
      "r516",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r379",
      "r428",
      "r433",
      "r514",
      "r558",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r379",
      "r428",
      "r433",
      "r514",
      "r559",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r379",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r514",
      "r560",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r155",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments as of March\u00a031, 2023",
        "periodStartLabel": "Fair value of level 3 financial instruments as of December\u00a031, 2022"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r379",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r558",
      "r559",
      "r560",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r518",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r545"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r313",
      "r314",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r333",
      "r334",
      "r337",
      "r390",
      "r407",
      "r499",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r633",
      "r692",
      "r693",
      "r694",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r212",
      "r345"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "terseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r99",
      "r589"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r96",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r99",
      "r588"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r60",
      "r89",
      "r668"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r74",
      "r112",
      "r113"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Gain on debt extinguishment",
        "terseLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r211",
      "r342",
      "r590",
      "r634",
      "r655",
      "r697",
      "r698"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and intangible asset impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r690",
      "r753"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r57",
      "r75",
      "r148",
      "r258",
      "r259",
      "r260",
      "r261",
      "r274",
      "r277"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Net income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r52",
      "r164",
      "r175",
      "r196",
      "r293",
      "r295",
      "r299",
      "r301",
      "r594",
      "r632"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r51",
      "r174",
      "r176",
      "r192",
      "r236",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r269",
      "r275",
      "r276",
      "r511",
      "r593"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Basic net income (loss) from continuing operations per share (in USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r51",
      "r192",
      "r195",
      "r236",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r269",
      "r275",
      "r276",
      "r277",
      "r511",
      "r593",
      "r598"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Diluted net income (loss) from continuing operations per share (in USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r20",
      "r193",
      "r206",
      "r487"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r16",
      "r20",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "negatedLabel": "Net loss from discontinued operations",
        "terseLabel": "Net loss from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r53",
      "r193",
      "r195",
      "r236",
      "r273",
      "r275",
      "r276",
      "r751",
      "r755"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic net loss from discontinued operations per share (in USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r151",
      "r273",
      "r275",
      "r276"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Diluted net loss from discontinued operations per share (in USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r19",
      "r21",
      "r22",
      "r23",
      "r102",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r246",
      "r477",
      "r478",
      "r479",
      "r482",
      "r484",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r247",
      "r264",
      "r265",
      "r292",
      "r475",
      "r483",
      "r485",
      "r600"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r171",
      "r191",
      "r670"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r277",
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive potential common shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r95",
      "r97"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r161",
      "r178",
      "r234",
      "r290",
      "r539"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r62",
      "r385",
      "r393",
      "r638",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r64",
      "r386",
      "r638",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r239",
      "r241",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r221",
      "r621",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r209",
      "r220",
      "r280",
      "r338",
      "r340",
      "r341",
      "r586",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r59",
      "r289"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r245",
      "r318",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r496",
      "r497",
      "r498",
      "r522",
      "r631",
      "r705",
      "r742",
      "r743"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r35",
      "r168",
      "r186",
      "r655",
      "r681",
      "r696",
      "r741"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r208",
      "r245",
      "r318",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r496",
      "r497",
      "r498",
      "r522",
      "r655",
      "r705",
      "r742",
      "r743"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Liabilities, Fair Value Adjustment",
        "terseLabel": "Mark-to-market adjustment of CVR liability"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r42",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r106",
      "r107",
      "r351",
      "r352",
      "r353",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal bonds"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Bond fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r71",
      "r72",
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r54",
      "r75",
      "r177",
      "r194",
      "r206",
      "r227",
      "r229",
      "r233",
      "r245",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r274",
      "r293",
      "r295",
      "r299",
      "r301",
      "r318",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r511",
      "r522",
      "r632",
      "r705"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:",
        "verboseLabel": "Supplemental cash flow disclosures:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r293",
      "r295",
      "r299",
      "r301",
      "r632"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income from continuing operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r545"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r222",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r224",
      "r225",
      "r226"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "verboseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Cash paid for equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r29",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r29",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March\u00a031, 2023 and December\u00a031, 2022"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r65",
      "r68"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r676",
      "r677"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r69",
      "r137"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r100",
      "r187",
      "r595",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repurchase of 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r140",
      "r198",
      "r750"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r32",
      "r127",
      "r185",
      "r608",
      "r613",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r201",
      "r251",
      "r252",
      "r253",
      "r256",
      "r263",
      "r265",
      "r322",
      "r468",
      "r469",
      "r470",
      "r480",
      "r481",
      "r509",
      "r604",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r287",
      "r288",
      "r294",
      "r297",
      "r298",
      "r302",
      "r303",
      "r304",
      "r422",
      "r423",
      "r587"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r426",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Kyprolis",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r0",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r19",
      "r21",
      "r22",
      "r23",
      "r102",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Carrying Amounts of Major Classes of Assets and Liabilities Related to Assets Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r96",
      "r98",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r435",
      "r437",
      "r439",
      "r440",
      "r441",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r129",
      "r131",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r216",
      "r217",
      "r218",
      "r282",
      "r394",
      "r395",
      "r396",
      "r398",
      "r402",
      "r407",
      "r409",
      "r640",
      "r669",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "terseLabel": "Performance period for awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (in USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (in USD per share)",
        "periodStartLabel": "Balance at beginning of period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r442",
      "r461",
      "r462",
      "r463",
      "r464",
      "r467",
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r169",
      "r170",
      "r183",
      "r671"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r614",
      "r615",
      "r616",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "verboseLabel": "Short-term investments, excluding Viking"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r45",
      "r119",
      "r201",
      "r231",
      "r232",
      "r233",
      "r251",
      "r252",
      "r253",
      "r256",
      "r263",
      "r265",
      "r281",
      "r322",
      "r411",
      "r468",
      "r469",
      "r470",
      "r480",
      "r481",
      "r509",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r554",
      "r604",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r281",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r119",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r29",
      "r30",
      "r119",
      "r127",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r127",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r30",
      "r33",
      "r34",
      "r88",
      "r655",
      "r681",
      "r696",
      "r741"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r244",
      "r395",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r411",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r9",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Tangible asset impairment charges"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r646",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r646",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r313",
      "r314",
      "r390",
      "r407",
      "r499",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r692",
      "r693",
      "r694",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r629",
      "r648",
      "r650",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US government securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized gain (loss) on AFS investments, net of tax"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r283",
      "r284",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r268",
      "r277"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (in shares)",
        "totalLabel": "Shares used to compute diluted income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r267",
      "r277"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r662": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r663": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r664": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r665": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r666": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r667": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0000886163-23-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-23-000027-xbrl.zip
M4$L#!!0    ( .R J%:VJ=%LW!   *US   >    83$P,BUD:7)E8W1O<F-O
M;7!E;G-A=&EO;F$N:'1M[5UM4QNW%OY^?X6:]K8P8QO;0 (DS0P%;L+<!!AP
MV^FG._*N;*O976TDK8W[Z^\Y1]H7F[5QVJ0L#?F0!+PK'>F<\YQ7R:^^.;T\
M&?QV=<8F-H[8U<\_O3L_8<_:.SN_[I[L[)P.3MG;P?MW;*_3[;&!YHF15JJ$
M1SL[9Q?/V+.)M>G1SLYL-NO,=CM*CW<&USLXU-Y.I)01G="&SUZ_PM_ WX*'
MK__UZIMVFYVJ((M%8EF@!;<B9)F1R9C]&@KS@;7;_JD3E<ZU'$\LZW?[N^Q7
MI3_(*7>?6VDC\3H?Y]6.^_G5#DWR:JC"^>M7H9PR&?[X3.Z]Z!^(Y\^#%X?!
MP=[>_NAP=[2W=_A\=-#G^_O=;N]_/2!R!QYW[Q@[C\2/SV*9M"<"YS]ZT4_M
MRYD,[>2HU^W^^]G"<U;<VC:/Y#@Y(FKATY&"M?F/ Q4I??1ME_Z\Q$_:(Q[+
M:'[TPT#&PK +,6/7*N;)#RT#.]PV0LN1>]#(/\11KP>3TX\S3PV,$\E$Y-0Y
MDLYN)W(H+>MU._U7._A\S9I6T H[IE\OOG1W.[@>PXY8E1X= D&5D0+@@-"?
M?=G=C9;][OS-\<4INWI[?/W^^.3LY\'YR?&[&W9^<7)Y?75Y?3PX.V4KMZ.A
M:SH]OSX[&5Q>LY/+]U=G%S?'@_/+"X;+O!E<GOR77?YZ<79]\_;\BEU=@L+^
M]N@6N'4,6AN"WO,D9-?"6 *!L]%(!%9.!3M.M8Q8[[!%FK_]Z-9WWF'U//RD
MA4C8HL0>]?<Z^^GG1Y7EE>S5KN1")6T1IY&:"\%B$0^%-DR-F)T(-E1<A_A#
M*#4P3L$G6_C[[[\]Z/>[+_.U?B&R:<0C:8'=P08L^0F)_<(DK=U)VI7>RVW<
ML'=RC))_->$ZYH'(K QX9-AY$BB=*DW:T-RM/%%QRI-Y(S;33'@4L:%@ K1>
M#B/!K&(@C0)A).!F0A C/F;2SED A(O$</1AF"C0AI-$+V).@[??XR7Y3R5D
MGL*OFL"1%FZG$9:-E+83)A. "FG8J8<(=E+EP96")<\[;##QS%K@$'+.6!5\
M8'P&RFL8N(>!ED-0CDV&+64CY1)P2N-_8QX*(I&G*3S$06+@Q\S"!I 21G.:
M=B;M1&6PB P6(33C 0WL@8^PI(62)G@P\;"X\"&;310#^A)E83Q6(*A_QFL0
MTH3_I%PC,^$GDPV-#"77\^5'MW"J%@[62*$\!UN5"C)8!5.:(([$B)C/5T&$
MR8"!=T4/65&1O!;+DD@8XQZO6RO(9H!4&&(:C9Y:Y.%F$[#AG,VTM%8D*#,R
M("*)_Q,NP4@LRAYJS&;2KT7,05EDCG>P$ LP!W$"O*_%5!I!JJ%!M22Y9$#)
M&JEWN@J>56Q(40*5A!03>J]@,ZI,EH(?(4+AQ%]+>)KV"/ZMPVJN(?8<$^3!
M5@D[$R)9T XD1<)GA2?2V=C52GD80O#9CL3('NT^7W*^VKV#!_.]>IV'TZ#%
M;8&8<C_?&!!T]%" +4<9[)'&-\$G0.Y5&?Z0RK^&^7>XO3H"7O46)0.:(B.\
M.3+2ZW1?K!>2XR3)> 0!GP5,$@]J'SKLC*^"\K4^)4>_A):A_3(0^+[;[[:
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MS1Z\U1!\L/"_AY/Z$EKGPXE!-P%NJ)(<?J"-FB E&7H'70$,*,V.)J==@/(
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M)L]DU>_9$9W^ZVWH3?M^(ALF1=P9;3J1GTG]KFH+]0A!U3-B@P_6%8%_F$R
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M%7KW819HD6%T,I68GA\SNTUI$BDN(8R!]'8QI??UP=N6L%F,\0(,R8E)!(0
M!@,0 E$#O&61[!8F5HL:^I5\1"I_CF+84!A5&[K_8GMO?3G3\OSL^RF,'DT"
M#5^CVDCG9!D7$/%W*U,]K2J8EG&AP1QD&QP](Y0#+MK<+%-37;HX>G";EC$Z
MRYSEC@% N%43*=>R9OXX194=&*H?\2 SF)ZU(^(E]IPQ"BP]3561:J:(=+FT
MYE91[2.,:9TB3>&3:Q7&A?%3A#:/X5XW6@+X84-H7/:!ZR=M-5#(DB5D=J;D
M2\ @@;>,R]@X@3,U41RG%X%I=G5Q?MYT-H.-51GC+;)!7*6KI-SJ\3@6@,4R
M\=RE9<;L4:>LW+" 7<VY/(.$0>K36]TUU4ZV=WJZ*E2L3%$\DY4=MD;NZ(G#
M>R;L":M&A-1L":[YS"Z6'))/DO;@+4[K.Y:2[;F.Z'R_43F1.^S1W_^V_^HM
ME<10%-BD;IB,,J^NIDSP:QBFYBK'O/%P_-@\5VK*NS GB\Y6Y^9*(H%OH5,@
M(B+"(O):8 H]VODDM/<EK%3MN_0O2_]A"2<:$K04%FR.QT#$!"T5I,D#"7_[
M@<QL@!FA?Y"%K9)_'B?MQDP7TDR_WG[LWB]KX-L4/"XCD]?WY0:[^V_]?SN5
M?/M0)KLBGHI38=F\G(=AG!D-"<F2J0!4!!N>MNJ 3$KXHN9@6ZRNP*:PY;ET
M63:!E18Z)EMY(;T3LVV#C8,6\=GHW$)W!^CFI$O$:7*%B73L&0OM]/.9&NN)
MYL(U*F-U<1Y)3:(D(IL[Q$+4Z'6@P*2WZ&?OR40]=8!Y+TH+;]]@R=-0)TZL
MQ!A8GP/#YMQAH "8?TP"!C.>U9>9EEI]LT9:CS=DM0+D2>\U<^AU;$^$4E:[
M)4BEO3I1"E(.:B2L:F(9/95Z$*1>P*J(* I@&@ !6\W;J1U;1J/Q\J:M_G&%
MNGSB@M8V1%Z[<_Y5L7=N.UAD)J)S559QQ]M0E_+F)B]O?",_W&0L2VHA)0VP
M2<W:6_U6YFQ]2PKC]LIHL8.NE#MJHX41,Q-M/2&#&.:?AV]^.GNI]5 ,%V>/
M!)7@3\*;-"-"+-!!;ZA\J23$:NZ"P# 8W\FK3T+!I9."DRQ@4F3Y+H[&>-,&
ML:1U(J&7>J63!8JK[HVW+]N/=L9W$R^JF\FIG$AWZ12056-@_FEYES8RW010
M8&Z6N$4>E9J)7JF"A!8E8=7FBM.A>?8JLS1+\&;*(V&A(FB=9=Q\M2.X;E1B
MT51>4L$&$7F#YCD7:MEJR113\S+^\0'EC#[*#JT,#B=AU!$WRB:B=*A9T>;6
M:_+LXZ0;\H)L&CQ=_[R:0\I J*F71M+N0296CBS(RSE!5,:YU+RYZBH[38R!
MB:7!*);BZ' IKZRFT!1M+J!,%/^(B7P1EI8SIQ=]/KP)=<Q\LUH<Z"8_UMFX
MG.*4*17O]EIQFF%!B5VL]C#W;*]J^5IIK5UAMNU0%MUDMN**6C&''2 K<<XV
M[WH[T>XJ+PGY*,V++=]/ZY*J/=W%9IAOA)M!.$HQ%;QVT<%^'!,FC%R;3-VD
MOV,([PH&S,BTIAVB%R.,3!SJ*:46D6:QD..*"&YXL4P!:M[A#,<.'+Z#^T^,
M^CHERVB,(+-8+X3B,%^AFKWL]IB>'2M-KFTRZN1DG92(4#!&GG,Z-96_\WK@
MQCE*Y*YY5B7>#DE.9P\0JD=U,\.\/$H5 [>.8/.FOF?< _PBF*ZM"?YUX\4+
MKEM>FG9U_VC-PEWGN50$.UG-*%5SC&M)M"N7MA+,4>Y7DGEO276WUW)WN_]B
M?2)![;7.7;VSH!GF2&_G>"566NB,5Y=U4(S&VUHCN() D#G%E%V) F7+J^VK
M[1Z'A#=%"1?/*P>DK%V+K%-C!40<-]X:40!1+Y7R%JMR]BSI]SB%3?&%J%:1
MX M8%]S0Q"<VN9:%=.Y)(3KB Z .!*:-6 ?5C7)*A!N >8USJU/\SL_-YKMK
MMV#"*NBB$L!HK9X[8:2$]1G2:"@0D^RT*O!YQ<5"X4-_P0O&'YRJOO*RC!N*
M[G;W[VG+V4K?ABVH1NM;B]_L\W?7O/E&D*L*8HI UT@/M_TJ"Z<],5@J=<*N
MHJ<&VB%0-;ZV=$>>0Y/5-)#J&]R2<T60_)'7=^D3S&\SV!@C<"7)GQBHO9,*
MV4(-82<J3MCVS!2*R1K)6\)A$9^W&LT-1.?+6'=IF;@J=[8!C9$B/$#F1K+[
MKS(,JC8D6?FYRXRI>0SH.K5I"3:QK_GZX%0:&(:/#=I4()K7E:<%!G('QZS?
MJH9((P'YDH4_=URA=C;-)Q*I?)SID0GH^?6ZRRJW_VKJ33MR13?5F],T^ CR
MD1U3J]9M&M5O/WESRE/U+ZZU\"7SK"[.:Z7C([R1ZG=* *(+UM#A!(49!A<R
MF4C[R_QJUCO>BPN)RC'K9O4265M*[/E1PUQ*X8W'U)LI#>'/GWV?N8HG6]4%
M44JGK;XUM_4I=/T4NGY0Z#J(TQ !9,+HAMRW#JS>5HG?UNBWY@<6/W$ZF2!"
M?2V4$%Z%.LD+)XL7E6??<>]+EH?)EH[G3VY,UDQ\G*NBS)(V%/1/63I3V6K!
MP1X:D)N(J9%)Y&HQ[F0[U9&"TL, !N%GSL3B2(W(JMP%0FE0?CHU7 4$)7!A
M/+Q3;4FA%;B(A(0AF[Z4ZX3/2M>1I/$D1@JSH6$O?I[)$S6]T<\'][:&&ZW!
M(228:A5^1;_[HK[HZ>LU3< OQ\T)1Y!8097!X(.QSMD+D?YN@E6($I&;?F^,
MHYX(^UAH.N"V"UM4JSSOU<)@,R%H0F!)KB1#OZ)2:Y2R^$&D,2N'$/SIPN0%
M6N_<&@N1N2@[KF6^2\KXOL?,U[V%W7C*?/UCF:^KRG&U;L%(FKGC%9,R)7NY
MJM)DT3"(5 R$OL@  NEC1QX=[C@/X^G)G)/CJJ!0544"!&^UT/]K\+$V4-*N
M:!NM6LC5FFDA[S"!\A,HF)_0ALA7;<G>I9 6Z6Q1&^WOO%Y=&H+^D^I+&P_6
M^'MB-2G>[+[8?DDY^+4PH>0A-1C>ME$C7]Z1:FS=N(!E:1-A:5AR28<>&%O%
M'5U+#UHVB44-XQX= QMC'_BG)6KK9K!AU8AFCQRK(1S8,7#4$Y6)*T7<"YWT
M:U]2PZ5/LJHN^+1=+;$I"-OP$[8Q6WO34);ZPNBEX9<.YW(,>9*7X9=.;*^>
M8B>ENCM__^#@P%R%8]0_L4+C'%E"B6(_4@*J]K(*JM;93<<I=V&[!703]ZEZ
MU9S/WS@K+4U3$U_@:V 5(5Q2GC)33E)3?FD.JC8B5E=6:R@=Z5$E;YJ A:0G
MMOHH487G;27^5AV2#CM/[10WF+G!6PH"^I,$$#?&1$68FM5CQ9"8)#8CB;%&
M&A--X*:RY4PO,\/6UD&&(,>IP]\YZ1RYZ'A,;R']]9KROLJ"PY1J"B<3@7Z(
M7:)MUB>WT LID6PZD[\7!6B096%<7DNFL8G[:3!L*+674\X%)^+=/;?0ADK=
MJ[C;9/-65L=[V'8V;&/U=#QR6$277&"[P'6Q<%Z-W=+*I"-'UC:139>W4;U.
MHM8$84R\C1P^[C#2C*I<: <D"D  -N;X$6(RG>JQ54)\;VG*L'.X^BV41*,P
MUWE/XG<9]VZEC :>Q'U8@4VY,WD&-$'N[[5QN^G/G+4J C-IBG_:C($F/Z]M
M'L[;S;TQK$38.1@X^S!2O6#C2\.;V<;TP52J,*9?=0;(Q"@59$%!K%,)$;XI
M 9?IVG+TS'Y->JXSE4LTN(*L;FHS[[E#\]8=>L3F(&&AJ;X%2PB9K"CTY$#D
MV5L82)LBM+I57@5B_E9[2+?UVVPB84C]IV$CG>[=@<.N%\FB-2+)R!80Z\LF
MDX2L2.([[>OR2>-!:YRX'NC>>CS&,M$9QGQFC.@#PU6?HYUA; \S)GK#\_HB
MI>+#U%@FRZO<I/>/+_7LA$C[!%G!",SA$DK&S;/YJHXYX[M(E=5V*R7]# 6T
MD8NUD)8<)CM8ZB>Z4,B1.>%DYTW]8A=FS-/*S;P,V-S#Q0:NME<37684RB+$
M<[M!X)2BA6PRY2N!=@F"R 9'&1 WX=DO*9M;YD!981G'8[!D!^3(]&Q^C)U<
M8:&^T5\YC;J2?^3\E5>;M>.GE #LQ&R@J(RB@^/!39N*QP%I O_$G9^)F/G]
M=)(8?[A*2 NR%X@S!VV+>4PW1;=JSJH?_:8),4HGIBR9'*Z"*]6^- ?M8M?U
M>N<GG_JMNN@IB9G".NC%TKEFG-9JE?,=CICN6HZT,>_A%+M@/@)/>E]K?VPH
MF5$JI;!+SLXHNWYM\((Y(M!8;99BC\S#.XU-E[(F3-S3]_GEJ"Y:QEWI\2SG
M#MIQ.+[&/PDK,TUUFKN.^Y2[,=I$F$^??CW/X<C$E)N^MK^)Z_.^N<E,EP2X
MW".Y//ZF(-+&?+/2#-)K3%7),)I0?E!V0R%GL.U*N>\H@E"*WF]Y,,]WFU7-
MB$ UT"U@_BP;2>#*;.:9+=RH]JNN#[Y7WX$8[<JJ4=RX..Z2<"=U5.(Z8#\E
MOYD\J4G=[O0B_;<A.79#,9:I$I;*ML3 %9$;,DD5:0M5/9R6*H2TA+)%.3UD
MVQ_D<&D;,"9ILD56D)'UDMP0&4=P@RN;*=;9>VU7S%QYQXDMDVKKSP L.AGK
M6<P\0Y:;\WHC.G]:R?YF30-JE)4,62B<HB)L. H@HFBAC16(43F4Q;"1[9&M
M:IIAA,W;ZLL4W<PMV["Q2 .9R>R I2'V (<*ZUD<$<HR3!K.RQG1;EUNXE(0
MSK:"0.E+/:$D+(M2!*_W0N#UV/&!W28G1HL@TT%I8LZUY/JJ[5O)[S>IOU:S
MJ]3]MG'-?-OLY;*Y8T$E]JLU?4:K5!12ATXVBA!!9*:5C=A0RD3/Y4NP0BXQ
M90]GR'(,+HYA\)+Z0?9<O0K9O>,4(]&H0EC2K=!V/<+#M*UP$^S18D>S,'%=
M39X2.CQ-8O\IH>-K)'08.VA%9D^-)=,E]9D7JM48L'1 %Y7L"+%LE92+H2&1
MB#I9O7&448VBQZ@O+5?PC\W'<N]1FB46I;5J9#RLS6RWC-%6(_5ZS;(]/L-Y
M7Z<Q*M6KQB'  D1?R:[$WWV_BJM^7'"KCSAUL1I5Z4E(Q25,W;I5,VGG&A85
M9N)6\ER?U4Y5U?Y)=Q0GLVCXK<PQ:VII>?*:T':[_Z6;M'W$=??GKO!SQ23.
M^<(/:T#NIT\OXN0(M  B6X<4[Y*L/=).N?R8\Z))I2--.B5/#;9O(^5/PM?7
M*H[NJA1%OY6.=)CI2O>WIA[/G-T\5=.1LC =[](PB_BU]AKUO-H_-,9L!C:;
M)>WJIIDA.KHIO[LTE4S6N]N$S5 I C9[Q&D_,G//**NE9QO=79;3$(M;K+#P
M:RD?UU:]NW47>P_%4/YV>6ZOME^],!O35EO!S9KQ  _3&Y6$*TZ&>F =9T><
M\T#&G3GTO>W7R\_\T_'QBL%A6JUUXM8"?]0,T8D)W,!H"\P/T@G!DSIS.,%$
M3M;+79T'LJO9O +%;L%\C+/&J[GN.J[/NY6VF^!MAOG-4D:8Y]3/:E>/[H8X
M5DWZ5?B"6LU7K<#?E5[=(5+K@!^>WH'^ LR9J(7V]NY,'^\BCQUUB<?V[V*R
M65JP?W9@"^=6RW3KR+Q >(QL*U?8>+EAJ(S =]J1;R69'&^3T"X80<B:F44Y
M,%%4)1%&A0!CQM?8@LYITT-**1PZO?Z,_--E@@%;N!I3G><67^54XL?!23B"
MUY\KXW 1]1F?.1N/RYEY[B*<J(+![SYP#Z1!A,%#T'<\V!:X$67&58W4\/V+
M1&_=ZZVRS^E>>&,9NU>,:1 UP/3F-E.1?N-">3LT:-[H($HS]"E'\PXSR)\(
M7)M.8X K63'55AH,!YCJT$9EF3*Q#;!8N.'1C4X-D0 #1*@J\O*CF45*!!Y7
M?;W<2Q<OP40CP\-<! F^F716#'>,%TK/T; KX8&,\AJDIA44CAS8^2A.;[FP
MLQ &/#/!(!MK,-2$A$.$)'BE0CH4-Y(]T!B,G4[AGHPY8LL&;#PW:4-SP4C'
M9:&W!X=2J"N-127RZ-$@.M1(U+SL9K,-UQH&G90P7^_.4ERR$M60L@4]UC/\
MFVQ+Z%W$&ZK)&RL52<Z:IHX[ A;"H2()LZ#568[%V T7CT[F?+/IL'$XR8LM
MVH:SKL$%.QJB? U>B=UYC(/?M!-@I/-Q"93'W\;?XC1G]NEIJ2.DH#*1S0.+
MWJ9.W:;9[[,X1*@S,KQA;L OPSPW'!>'S+3SD539$FU-+;)V'1IG 8<K8PTZ
M NJ_9@+;P>>&S$!_PK*.I@#GS$HX*0V?"WAQY=R\0'7E4J59FRKO^7-(BR=E
MQSI!O.C\#(X9[IR)8<*O-XR:A,70WF44H#-92IDILU"3I)Q*M#),)'P?JQM<
MJ>/E,EHQW_; \0PA-/E X8Z5Z,:IW&"3&FU X1 (#2=>W]G%< $Y5K .:)HF
MO&$9GN:D"HGL,.!(ECFP[%8$J92ZFU .N]UJRD40?&:76&@3U.LS\&]HGI;
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M/DP4!T:8 W<C94>T5YIJF&FV,;B>D"ZTZ^-;QSAR_8!506J?<$/.A1%D8<Y
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M/_M(>)7:<"/%_/8_YC6:8G:)@$+(=B%%7(>1 "10NLZ3S^')Y_! GT-J,KR
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M.08N@?E!4$<2.CJ#/3\]NPR&_[P<PJ%>G@FRD)P+GNGA^?#H^!*H ?[/WT-
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M[]/QL=B^!N$(KRM!6/CC,<O/R^P&[YQU$S1VI_:0'! =P8;H_F)05>T.\'?
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M>7(]+>,B3%1:YD$5E)=@\/-Q2:4C\(NGG^7.1RX>2P//C4%H,-G(J43%)<M
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M(26W4C/U@ONCL[S&CFOC]AIIN(>UT6.I=73,>:91!!N=..0$Q]*SN2'-)"S
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M\N#7'F".',?1:(8YTFEGRE)GB# <UHR9YJ8RWF<4X[L3O@:@9\52SZZ)(HU
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MSHP'BUIP9.%_@6,B%Y:IQKBVVRWSFW1K'TVK%<YJ?W8'K?#5%'ZQMCO(81G
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MB#4?DT'T,'S,D+?CU0)^;($:%>"?"?"W=!7MO/6,DTQ'PS)F",IL\!A,#Y
M#'ZD.MD:@BX*]&1KXT4 _RI\(VLA!D"'3]7D+C=;?CXD]'784^/21T:3?^FN
M'<JK<ANX$D<//_367"E%42F2FA_.8.RGGX6ESH"ND44<7,9(C)FU'&5*@N$4
M!/&&V85E^#9%EE/E^9A61>*?D%II%6.$\=D-&"/%*>&19B)XDS&F0J89(9GG
MD1MI*>?E ?M%3M$4 ?E5N$ V.WW3.<Q3+K:A;Z,Z2?)2T1FCB;^40NNG%[6
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M[5XD;1^A )3B'A!.!/)>&AOPTUOI(ZOLUPP_>96MY2IS@7."*0)2X:AC4B1
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M\<9[9CO[='V?V<I>!3OY=%V;P4KNN*".*&Z(L!038;QW"!$KE<5<,/=IKSB
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MM,6[G3@D^K-O7)X;WST*@XD\NNSW^KJ=1G2(O-F/L"Q8WG]($>DGZ D4&DH
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M"P_4<\4L#DIK19DG2B>X0($;Q)G&L( 'E.%AE>!AS!W;Q2E6$1D\3VF".5)
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M?+X*&*.8D#]<\]OVO^*/T:OO/,OZY+0V%)WM?YGN']LW[9WV:Z5)G!I)7/'
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MO05WS9JN3%!^^6BQ_^K\FQ6IO$0:,ZF=]J>SHNWSV]9$,F^6>9END/9I]K+
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MQZ,S.RC'M8!-$SN(A;6<C$=AYDM@XC$(01;]D@7ISHJ.!S";0GN37O7" L(
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M35%W-5<OV<,+L"H;/>?6?.J'"U[R5BSX35,LXMRX>RQ\_D%X@IMSLNN1A?4
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M/[&#+ESB2KC*13^2L<YR97B00G/B@-8RH3#!E'1>BO;#UFJ9EX-WM-3X31+
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M/%?-\MXB3X2FPA+,2-K:D:)'3#.[N'.?W(]D'I0KY ]O6OJYEV^;N2FAG->
MG)=G9K H833+;98ZD%^O$/ETZXG=R<RT6@-\AUJ(ZZB_'Z>OR]V',&-=C;*[
MA_R])IU37!K"<I9US->*2\:0Q<$CZ;1U22K##=O:X<STA&Y>]_!M9NM=R%++
M"RQV0-H!Z0,6=.R ],&!=)T[)QF=(CP@0KW+]X YI*4 *LVI#811(VP$(.6Z
M1ZA^ D#Z%>:]N/T#!AFOQMZ'>K)T^!_E&I(KKL.L$6/G?]WX'\U+VR__\'YN
M^JGO7AX=0ZN^;P?_ZOLXG,0_\N),NCMS]P]>O\?,8I@QB0SQ^:ID[.N819F\
M$2%?O\?3^IVYBB>P7P,8L]SSP(3E\'+ 7.:HIM'3EMP$5%J\_E55Y]NDFN^3
MJMXH#[91S^^CNF3+/ON[J/8./KZ/)I(D=4!"6):K BMD*&%($BTX\UH'KENR
M Z^\BVIEOPWF^ZUHC9O?.?5HKI.B?%LI]5CN?8)FC;B'SC+-N\[>2V?E-VZN
M;F:_4V<EOEYG[_X2K4L?):)M-T[IFUW"5MW5U5N/=28:M^S>\WULUZDQ?YDE
MN<&8;/?DEDBHZU3WO\Z([W'FKG3S?>5ZSN\PK;OAPVPR+1<]+R;W3GLAMNDU
M^O'SR6C2S^Z4G^I XD_QYSSQB&[K)C-T=A)S UL[/Y ?+]I(+=X7[9.H_>8I
M8P<V'=AT8',)V- .;.X.;!YU\.KZD#>?)NU^Z9^-2M3'B]%XST['_<_W<3O1
MK2/:VC9OUS^8W#3"[W3 >+VAW233D5JK4\#>F<19I-9')A3!TO+DG%5=KM"U
M#Q?+,[N?][]X\??+H_[^RS_Z>[^]@F=?G?Y]<"CVCU^1O0\?<QM?U@\7LU]X
M[V5N>_#QS6^O\?YOKT_?'1SRO8-?!F]>?J3O#OX\>U/\QOMIKX_/UBLS",RX
M#)(AE93.MUEB9!.V2#+C4Q*>&(WKM$8C;WNTV+[ VPZ:'@\TW2@+^Y;85 Z=
M;AY#_&(<0W_Z+P"M%2+9X=<=XA=NU*F4EEBA**!6](BSQ)$FU"-B%)$I,D4\
MW]HQ/4*;Q7@?<\I AUR/![G:1:K T.D@Z0XAB:Y#$M>>.DTDTA1CQ'$,R% 5
M42*<AZ0X\XIN[>B>4,TLIHY1=;C41ESBH%.9(\8*S3AEPB9C8)='AZ6P0>HN
MD[R%R,0;-Q<8R1,G =&4ZU/91) E3")FG77,!!)DZHR]#IJ^_]!N8NS=%ILZ
M8Z^E^/5Y[\5Z%JDWP(R%140KA[@C#%E!%<I9PRX1IX37V=H3K!D'WUE[+9+O
M)PQ=[6)5G;5WUYC47Z]:@8F-TA#DHTZ(,QJ1990ASJ5.*@6@6CB;>T3<.C>G
MRVZ_B2"^C8/XN3\I!YPO^W8X.NY_T_'F$ZTV=N=HIEE(-BHA4LE[L9I2X5+"
MPE L8V+=@6#K\.RL>2!H$W IGBC"+!<;(TDBAXU&.&I%4PA.F5S#&/<D;M/U
M=ITPW[%5=5MI[JRJEDI\XPB-,^P(YAA%XC2"M0[(*1E0,"92K8W&FF<"H[BX
MA5'5R?IS5MR=&7*W0MPX=(HN2(<90410L$(,MLC)7$6/987NE0GY@FG2TZ)Y
MJUNGM9^*) <7K:7,*)LP9YHX8P@W+E%BC.)4=<<T+93EQC%-9)@JY@3BSL><
MQPVR[&Q RA,M*7<\"MM1\,<IS#<JAGE+:>XH>$LEOGFP$34F/!<;<327;M!@
M>FL'/V!MB75<)Q-$'3-RFX.-3MB?L^;N./A=2_'Z48#1C!N>2]M2#HH;TX T
M20X%[D6,CIJ4@^EI#]-;1WYU9?IO(HB7E> O!7"_1\[3$RCB>$\'O8^YB..=
M:P50_8G MZP0D2M.M-()&VJ32QZ YMK5<#M[[J'TPOZ+YI&*,D%'2C&*S()1
M)YU#3B6)I"72A6"\8 K4@NY1<U='Q(^A#FX'H1V$/H 5?5L,[:SHEN)LXR K
M*)LK2UH4#: K=X"X)IJ @DR>"1>85+R$-VO9=(+?.#RP@]@.8I\PQ+:+I7:^
MB[O%SL;YH4XTB" )PBPPQ(D7R ;%$ W&>.N N?I4SAPX:][/TW'4#D [ /UV
M #42FXB]$BDG:.6L7^6Q(-D/+$@2ICNV;2&$-HYMK;!">4:0Y2IGUW&%C"$!
M&9M#:AQC@OO.S.\@M(/0^S#S;XNAG9G?4IQM'I:#;4& DG+$!#'YL!P#5]4"
M&1XLLU@9FVN^$-TCI)G&W-GY'<9V&-M6FMK9^7<-GNLQ"HQQ)F@2B'$M$1>Y
M.@W6"FEC2=1)!<-,,?2)OG5P80L0=,/57,O;MNY>TDJ#FRY6:L@>R=<[_$!^
MK(!,S( R5.-X,HX38 ^5/6<:E5VA&M5T5)V,^T/?/[&#? 7._]R_CTX\U,7:
M\G'*\[??V73P#K\Y@&>^P+OR>P[?$R5QY""/-I(< Y@LTEYCI(4( 5N2=,J2
M2;:;P4,5[-9!W@$YU]472EH-@)-6]IR4/O2.^1JAO@5S?N:;Y<O^[GMGC*,8
M4\2P"YD#&V05=R@%*J+DEG-&MW;D=C-EZWROE"U1;D>I<7UQ1<KV);<3?G^\
MI ^&E]_(=3J\O#<1V!5O#O[\#*) ]@[\Z=[A>V55L#YBQ C\X$%KY "/D$R<
M*^H=]P87O&P:@?>!E[?=,1U>WMMF >6JI0W&&(\X%P)^&(ZL=109'0AQ'D>5
M+R._!EXN[E"Z )ET#3(WW/ZZ=ET)RJ;Q3^S\DL5+[H5=?*W]=S.N ')U G"6
M@,B/\HREV70VCGD:XV0Z&L8B=./1F1U,SZH3>Y8W\J(1Z_\[Z\-&K])X=%S-
M*WCTJK?;N]O5#_-??ZSZPVH7D'T 4T]8:6[YJ^B=7V90O;#CT!]]LA,/,#ON
M5:^''II9?EX:VK-G^7NR5YT>_?_LO7E36\>V-_Q5=O'<\]RDBN;T/"2WJ,+&
M]B5/!(F-XQ?_0_4(PD+B:###IW]7[RT)(0F;08" 795@D/;0PUJ_-?0:FOZP
M.(5MSIC<O1R+.R^J5@EP.5RJ5B=+BA2[A[%K3^( ;)#>\!5PW1^V/;#=\M%F
MK;A^U<8OL;!$(,FR<,O3[W0SO:5FV[;+VVR) ?G)^:)N@(]C<=KL'Q8;G]X6
M#.RUXD$ZEMR@:>Q\0OD(?-+\GNVNWH,/[8<#R<LXZ/9AEXK0!$J A0QY'9=K
MN;8[_5B0U:=<J"5;D3>VURP1]Z\*5BJ=+G/>I\'Q<>8M^.X36/S-!-8_0,A&
MQ3VY'6S9P;H9'Z:)STV7<]BD-N]L+^NB;SOMTKE1*JKOQYS]"686*XT#J+(S
MZ)8"I=AH X"TBH\Q8^E:L?2"X4LL -Y![<BSR_.>4*O@+;9??MALP]";83!"
MM*(5O\=61MBRM6^ =\/VY2M/8K=4;3+.V0/;;/>J)YQT.P==>PR@4KZD<PQS
M!5* RVVY]5?N:U=#.;:^VXGP!L!KG[$U>MN#1=T">@)IG D+X#\6A_9[+(X&
MX2!OAVVUS@M[<M)JQJLZ8K?9^U8DT XZW7)?RT[$E8R+9R?1YP48BK5>!=&C
MN54D? #:77MT(ZQ8'O605H:WK14?JFO@HT-88X"N9AM^9D$Y'$DYB!\K'?GO
M87OR\L57R&:X=SPW-IYM-S7N9_ROJVVZAE2&+V^Q#FAZT+_^ED?O[#6?/ F;
M6JR)GX?=2^7L("+7C?8;L@G&^IMMG=KSWLJ_K[(<\-OPX09>/CWS'^ISUW\Y
M;J(^N6>5WJYL#-[89(+2'"S_W)%>,ID45]%@'J?;T$>L):6"Q60MMX9KJW5*
M!BM%I'3<KBPE@EPS=YZ((0$SPCT/K*Q0(IVFS%%-HZ=9P/<Z@*29[4IN:W7:
M!\ QL'W'H)1.:"' X2-^MG#5*5PTP<LCCHRV"Y=TBW/XI2H>5T).[/6 ,P 2
MA@PY#P4JO;&\<:W8'(RQK'_8C8!",+?#7A'; 08PS^]2CG"DJXPP8X2F@V[)
M_GD\8Y09H<X(V?*7L)O? %?AHPK8JBG G[XUR"]N=\:ON#1V2ZVW'6.^H%/A
MCLVMU4L4S;KH%)C_P',T SI+(+BNU3QF6L&5A B*1!=8J?BS:5VS!:MXJ4C<
M:!97<'C*J<I<LL#+V+C(;<KAZMX+IQ4+),0D]S=+IRK!!%UZ5Z]ZE#[YPQ@&
MK;B3AN.<&.9NIO1=>-N;5L=_>VU6_]&[,WCWOG>1BI@,<MH0Q+VBR!F=D$S!
M>\R5%,JM@++BP6H#^01+^$2 -Z*SUN4&5FP/JLY0(0 C&M@PX\@OS<R7G0&\
M,/1^_6U$D.7)UJ5X+H_28/PM>]*+OXU^^1T,GY.6/?^MV2Y'4=[T^U72%;.M
M)4O177U]*>36<"7HA@G#PS?_O*>Y-&N4WJW)^@];I;,UIM@#]'47[/J7WFNP
M\HGZNC]Q%TYSNU[MBVW\^ZS68+)+^P,W:'\6ZY$%X2LFA^P->#F=::?G/#\H
MZ2V8];'=*S7(.T:;+'>XVLV6X:[A:DL:D':S2=_BR"T24)4-TXX*Q47 8!I[
MI0RE2C$2PHT3S]X=G[0ZYS%^C.5I[(1"_;8RNUY!3-KQ^^.]+_#IEZ_'>[O?
M.(PMQY@U]X[^:&U_^'JX!VKV]M$W_G5W^W Z)@WNR=\??CW^>@A*.8P'E/,O
M?S0;QY_QU^/W1]O'#;JS>]AJT/=I'(\VD3A!9?2.1(>,!*V=TV"1<9XC);DT
MV($F%EFN7:FH66Q$VHN(VJV![N4#G4K:PKQB1C<N-3.1>A6<IE8RX8.X:>1M
M#72/"707TT#'4@[B<QZ0S2G$C<OU_AQ&A@I.B=<D6;RR+E<I7G".[4,&US[7
M)B(W8]*_NIV47;^=MFT5*4YX I]Y!<.E5<:&7K')A7\?)P"JQJ";8]#YK+)%
M;"1*,)J3IW(@%/S0GBHD0 -341+%L5Q9UVR9*A2^\F*C2ZM.U*RZ2%:=41=4
M\,ZIR)#G!(.Z0 4RA&ID8G*.JZC*/$<IEZD(^"MP3HTBT#NG^6RV4VK,L3L*
M[+NCAG#31H[/&7;NJR&4$=)_#I>YQ![;JK'F]EBS_796+6"<).X)1=J5^20<
M8"9YBP0FA!HF(XYB97U.!Z!GWQ:Z9L\%:04_9,_:K; PWIW1$Z3V0E+)$>$\
M=T4V!!DL&<+*X< QYUR"2L]6C5Z4_[1V'MR(^3Z620XYK&.D*_0/F]T<'=J]
M$E14VR</ZDH8;\,0C3;:8;O3]C4T+1B:/DVJ%?Z\<;&W'PD.VEB&),,:<6(3
M<LYH9!5SSBKE95(KZVI58;Q$1DSM;U@NS>)V_%RS[&U8=D*;\&<[FP?[F*9H
M-,:(<^41#X8A+;U'3%*LA+3,D5P)]!DY'4;1CS#8^&,6?ZPKZP$_\8!?@A_J
MTZ!,9NC6_J:']#<-9<YHL=^=Y<"TVL=]%VFS,Z4@YF!]KI@%#< C6B;GLP"V
M:XH)P:YXKD'@T-+'/:?M7>UX>BE\NA#'4\VGB^33JUKA[L&^-T[XI G"4N3Z
M\"(AD\M4!>=HTJ 38N^!3^]_;/QX'J87H+0\/Y?83LX\K!U?#^SX*E=Y-CVP
M]L8O^M1^B))7NX!:EH(D$HG +5C1U")M#?QF!1:*$&8(+]WQYMY1?K7/:VE9
M>5$^KYJ5'Y&5SZ=9.1F%D[0H,J(0=](@8R++=>:P3-1IXD!X\U6BV1*Q\BOP
M?5S7T'>BK6\NE#6=7KW0RL7X1\6+7U4:QB+6YZ7@_H+/+FO(?TC(WYK5WCC6
MS"=*<SE=,'298D@3$E!2'&Q=$CCW<F6=\%6C9IM(/D!]]%MQT?/(6*OAM(;3
M)SHZKN'T@>%T6H-6W"1%HD#*)X\XU2F7W/7("4JLY;";F "<BE6I'Z6OY*/
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MJ#2?GM9&_$.#V&T#"T<[!>BU>;E/-7@M"KQVYACTGE*2<(HHFF 0MYPBK75
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M6?95$HZXP!+I% RR,7#N;!#<ER5P5HV9=5W6=OQCL_;6&.^&=6KJ8)DE03:
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MU7!V&SB;B6,QFFJ; TV%\PKQ")J;YL0C2Y@Q4A,,>+?(RC UE-50MCSS?H)
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MRGD!HZ+N>%[589WM]3J@V>1#O3)N(=^9OYV(HS@^@4>6AXPML#5B#NAIE3>
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MM*YHI/3\9\(*.$<\5Y&0 \<_>S/+, .-(GLRI-'';0-"5L%W--F17,\X2^2
M2)(IWF;V\Y@L B"W$X:F.._E'>T='!7\:I@Q=4,O*%D\R-:Z.?K5)&JZ.?H
M7,;Y_C N<&V[7/RY/ZQHA4AE!QX:E[L3?IH?Y$D&"Z3=WXX[I7L//I]^<@]_
M?C:/=@]^'G[[[GRU4AX&ONGK/G-0:::.'H0I:$[+]CASS90A<O5FGOP'&=;!
M:X7V^&]T_%YLLQ0L5IUYJ:%CK9,>NJ&IFPFV?@\,'F+&E]F=3_=:GDF?R6-#
MJ0%"^4QI00SK"2%%'$O&T^Q7_?I(ET.MK'21]V0]?7.YI[_Z%:;G/-O(\,!5
M:E\52^E84/G*=525)=A\<!ZO=/SD@>Y<]\=\H%E=3=#Q_'\/V)")[.O_4V)D
M#'SB4L6^=\#5OBPS8H;WE<7YKK(X\9GCVN0\JDS.U:W J7VR_ <Q"Q=1LYA7
M@E<\M*17E&N 3SU[\XY-Z*/-NJC1M-,S.*ID^@B9.D+TI%!N@8NB+'D\J4[C
MXH*D(GE5H, P[U[OY_EWE)!5]F4I_*%L>)[WS_%*3EZ.P>F#L_5=Y3;&O, 7
MB;Q'D3XD[,P<!*V<H;#M/H)YJ.WO=S2B4W.GJQW#.-I[D.QY08%;)+_)&&<"
M1B',O*1I4#:)<-:T;Y.DIU)#R905.;])5G!A,\QY>J?DLS16)5.<Y QG;H;D
M> N=*UIP[8TIF8TF[6B<@=S6U6 %^%/#B=SF?U^"R]K/FGL.'R03<*^*_)+U
MZ7JJ\3Q0$)P3>*$J@1EH@@^;5G?9J49(X)?]?(2?=NC7U="\-X')Y. #B^Q6
M,3@;P0/G8 QUU%TJ.N#2,2AXGG:U'1'7PBF-RZ:GB60%ID_*B^;5%J7VT*W8
M#\P64W[H^QP_88,17M")*UOP+3%1!R]FRW)2T'4HD9BX%I-;D(N1AA1F!%VO
M#3@?4^"L^0)\+*6,>_IJ#,21/"]?=,2 %US\%-Y&U\9PN 4G=L!7?><PEDS^
MIX&6_8;TJ_*%+C7*&^*]+-9&0,E#\'3.LA$-( .'L*12!@I$A$$XT[1:KEWF
MD^DWR:LSN2Y>4TI-48MH1FT4S*J<C$9Y(38P'_9R/$=%^=7"\$N,'A483(4/
MY>3Q#CX;<10N:FRYX2-,*\<11-@B*Z:I#",?,BF1(B&2HD24Y(P"*>4DCNL!
MY,-=C.RJ2]U.-=\Z<9\54293LSK-JUEX N3(:#(FBAACSEA6)+0.-."0+"GP
M>F5,90)'<C)!;W.9[*JVNNS("]R834H*%R,_*"Z ;5_"!$@CJ@:!%^08((F7
MDUZ/*N>))HBEQ^P[\4$>]=4B8=@!?HJ#%-6%L_"Z2WZEE$;B3ONXSIIGXZR(
M)P.L5XYY'1TC>XJ.))&9&F.4N=)Q[^.;D9ZD*(Z%[J.4"9;P1@I>R5),DRNB
MG.A2S1;&.Y%BV#+W5!#MI,J+U_9^Q&>4A;$C;N3 @W,Z=&,@*MTZFKP!;#ZX
M1IQI4RT,2I5!6D)>!!)/.+($T!G]G5Q209*EJ$4JB64D_\#VBV/!C;K )'/X
M<X5!Y!@D QC=Z!"C VF.Z1)"B)6\Z+%A]E.)[9.\CY%,#.O$B/@PS#A04*?Q
M/J$W&J^LBB'&^=R$1R/."F):T.N:2$\V?><U#?*/_PJ<P'JME9>#*$>-%-$S
M0BNG&*H4M"N3,2D KEZ3H -.D5;BF O,R9\2KE+PPF([*G:53OJH64'>8L:&
M)&>8(IP@2?P^N^@(780'5PM0"MW6C^470RP'F'Z)EL$/Q.\Z-=>*;5JX;9M)
MU5?2\'%]*+!">8_W 008K.PC2(,!B_F$*FS*J=J*CLI=G_I)]6DC:5V59LS\
MX()7V>^%^@S.27VH#+H5IB*$_ 2K.<!XN-3Q+!.\:2BS) ,I>=6Y-#SO;Q,P
MI-/+9U>G\4[CW];^XC4_6]%U]C<Y^_?H'&40O]@^(C]J. ^H^>CF&&@$?:SX
M/Y.LJ&P6<1$T$C5XDK]Y?#:$B?90V9'LZ&>@*<N8I"A=Z8&P1<.^Y,*0**FT
M@GXLC2RP=S$798BI+%.3&>0)[PMUFZ!<A%^CD9.E&9IR(&[!'L84F52+LAQG
M(OR!*6Z8M2+1IN4X^TI+2),2AHPN*:T38_F9RNU%>[OB)O@;2%-$#(K1Z!'3
M[>68KT<2@@I%T']$=Z; '0)G"@?'N"[=EI$)%V<C'$S:BC#!0596-W!J*4 8
MP'/%I;@C@(?2;%QEA#8W @@ Q/,62M<%9SU-?HKB!AGI0/0TP0I!D)"DF/2:
M-CIN$O@[DV)(BIR#)H=-C95>$S)P+-Q*(F>T2A3I7FHC&!JM5SK$,]X?5?[.
MM00+9HY\5ECJTG69IL&:#7 97"*=7$A5"SXF7@$#93UO+K'I@31\VT$5TA)9
M)/E@@/@AF*-!)LT+#3-1T%(7][,]/N1$NPV?4Q!NY7*IY3>WA+*-XS,^D/6C
M [H#@'.)+^,^G-6/,<@%!>)2<81,BY'1A1$ZVC^%'89!7GDK2Q9;=4>+"2EP
MFI+W/W(T.H9@#F,PA (]IS.3 L\K2TC+$COJ=64K#0S3)3:I%I620P_[%&$@
M V]Z@<$H3D2"@5P1"ON4&L?R+^'?H-FIEQ-L#")M0W3L?X";!NP$9X3W'(N&
MNB#''\T>E<I;7H(K-*C,.B(9\MXX;@(XOV?(Q'AHHS[E]63DPG14%*091JG8
M103:P8 EAUSZB$!2>=%/T$HP_=<EAOZ%Q%Y&C77P:F< =-+1#H"4OG>TCRD<
M6]'1_L5^_NQH?V0XD'8B9+J8SEOV QVK?>%EBY5NJ0A2BH%2]4L1 J,$3RQ1
M'6!*!>\+Q_.5#%_AUI'_VV0^7D6BX.A*JMB"@2H>4ZYS1W+M<(SW.]7+:3AY
MX)TZ(-8X>N7CC 1TB! ])>\+V@>*I?(O+G2VB-.)HYJ3E4JLUJJI4MY@N%$<
MY SV"-R% 1]K,>P:D<V0\T04J!4R[V0(AR#NG#I59$6%V:;L@EQC&05$I3 B
MS[Q.=J\3RG'$&46]$4D75YM^@V&V$V']-ROJU/J3$<SM*$VWD"F&XG)0PQ2)
MJHY]*E&"(!HX",*B+DOL"/LIP2(4J6)C57B^\W'GG?9<)#^@CBL42 %.6>S?
MBX[\"XTA!S^91)VIND8Q1/TK3<AUF!?)0/&A\&EACD,=(4RB/+FL]/AE(\^(
M+*MC+@)G!WE1@ HX+<#J:@8VNX@^-%U761]T8_$77/Q*A0;@03G%MXT7*GDK
MXW J>*_"Z$V_C+SJ>DMHNB WAESI+#@.7'0'UX:IX).JJG]7?4#V  PC'44J
MX00_,$'+!F\.%\/@I/*U76U_@*:.L"52!?>BS;X";;5#V%RZ+#$5S2RH J(Y
MU$EN%(OGA70EJERO4LUJGL)JL@ ;#/Z:U.,27<KM>E[_&E$Q:LI0^<PD@$1>
M?#D!N4HX!9):E5TNWT44C7;'8@>:#)B:'KO:3A5Q;&X1T0>8>1@_B4 (IIFT
M,V"X:\IM&UPQ!.L1>(M3J(J >]&PDP_0!M"-3G5AHR*X:, (S"*P<60Z'TUS
MNL#%LD09DOR=8LC_@_H '1I2 _.C,[H^HGBLN/82K%]-L'F%U(CB,FE<RP3S
ME6J#GES2@;4EY077Z[5%<:3[UM1*$FN?1PE="F^?<CXM$"B3XR5OP49DTI?:
M\T-6)NP_K[33/T__]T5=H?9^=P=E,!B),A:H;JY0(+S?_W#R<>=X7P6EG\-R
M"KQ_9J S5&$2VF"BT!DDTWYO!RRTT5F1C]CX[%)[#A\<OB#,(AX5$Q2&IJ_
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M1-7S%:>H?08C0:>'60R;IW!TP(2(4:EJS\4KB#'@:3:#MY/P",BD+"<$@(-
M42\4(1#['>9C(8%@,\]J?@>Y4G'OZ<S!S4T:">,*1"-0^@5H'S&5?#(NQS \
MSE?!\BP7--4<0/-S[4YB5"M@;RP^:]PYS>EH[_(A&?3H)9SP(;(+;6KWKN=[
MY>PT^M_V<= 5U\>=)J', G?5($*+2:@S3Z&@&(@D8>% C9.L/"/I(Y1A(=3:
M$D@JAJ^LU8WXR7!V),5^4QH/B!EH>;-(6;N6EF](2&:P06 Y$B;GE/W0WO(A
M3[/Q+T/FR/7=,V".U34-%RWRM0%SK*YEKXR_LO*PIM%U@INAQ5S]G1NVDPU6
MQ^'9BCA'^V2;.=8"YK2 .2U@3@N8LT%BM'VRS<A:N\1(.*DB!ASQ-"^X\ES'
M[,>-^QMMW?UT"Y4S=?WL=ES;V]9\JL>2!;)U3-2BC4SY F''=)S;P\MIB;@E
MXOMO)^9TO*"%S&F?W*0G'T^\:+\RM<'XIGC^HRPP?$[-W!^@;.IQUZ+9'3]P
MVTV]W4T-.J:]-$.]U5KMDVTX:<5P$J44R@YO^; -)3UR!V)):9[=\<RM;73=
M>N$;)5\>/Q,MQUX.K?4!EUHJ;JEX<];M>AW7^;6FX6TLJ7VRC24M9J\]JC/#
M1I<83L(JAE4 (VN^6E INLGN^V)STS*[&PO/O/I>WT"(/<!>_WX;"6"/@127
M&&V.V5U^_;>UM+!XL;=""_::M+#"0)NG<-HG[T"!MT7GOUYTOK'U5']Q*ER:
MC#G5_-7I:=BM_3PKL7PI@JW =N:JAI"7XVS 1)GP<(+=M>>L(]PR.=9,I%(V
M#Z\*$AN;B0WJL6X1SJ&9**=E8SXHZS;RLGA0'*,H/UPP =5%?'Q6<*X-8"/.
M2HW#?B>:=H!MYX4Y89N=NJ01,XNI6A$MG=_I(Z%H?N\  =24(5YZSHJ,ZA-I
MA?BNS]V3KI;RA)JDEV,VGHSSXK*>$_:@-W]?>VH+ZR>IE'0([SGFYWP(G[W+
M$Z1%T=C<]*SG@Q=:/QL CXA:SZ$&+YB(KW$&>0J;R0MMNK4]5I/*YU KP"D
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M*.+-49\1 M8$2 )T 4EY(720I1@YP-*'QM_CMXU!<V%*2"8%5Q[V$'P>C';
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M<-U@W3;Z\-4RAF)00^3#P]FUU%3:)+38!@08-"I,>A[ \&9QY#/NPE$"T2>
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M?9H6'(0( 'O_O@Q!CUEO)^+AV&:\B.)O-L</*:I.75?X"AZ?A,_F<^Z.A7X
MCU!@%Y'4[MDX,EX)$YPR-=1_%U1:4CB&>70\EV+.I,^9%S??"L%4LO'G(S3B
MC<A*_<>AH[? 2=0D06!=]?#U,8 PI[?J202+TO]\Y($ '*;'ILX=GTM6MN,
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M; PRWKUB!PX38ZE3W" 1]H3>F<%TA?#1AO%4]5X07^)I9EK>SU1+TJ@%B3V
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MIW,I)-NF<S&P.O2M9?\WT(<L8%*U;%MY=^K<40Z6IZTW8F#Q*!DXT:N #<6
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M\'H5=N^8-?7DM*(RNGR__ A^ O_\V_\'4$L#!!0    ( .R J%9LL3M/H%4
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M^*[\YZC*ZTTMO"7_8C+_%,P]3C(1T@LHG$P1A3J#DSZ#E"K(4FQA/-]W%'>
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M$ZY.J>Z%CVYK#AXG/J?!1\-JMA';MHW+UQ^7'QX=TQ^__0]02P,$%     @
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MF0*_HK0VS]'7HN!O9;F1+O#H'/DIO &[MX&A.]A/;*,VI89NW8ZHMABR-@W
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MT>%T&%V7.B^FV#/].8YIQ$&<-?#Z'-7VK+1*7F1*Z^WK49KO]^BSKD@IP]W
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MA-CSEF^:,Y&E%"4# *4'$]%C ].VD>"#\$F4@'N/>W59Y.XC<G=GW&K'H8
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MI\R'+T\A,9/F[#_4^BE+MTQ8) [)ZA^:>XR+X1<SOV0,'!3G9L6YPG\,-M*
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M2@3'Y'.L>'VM^(LS\NS0>)UWYPP/J60\!KWVY=(<WR\^!:C2'7D3YM1 !N5
MI2_],ZUDC@@J8QV2P\R,")FT;V[N"#W4I'BS5#W!2LJ;B;-Q35F4:&8?'Q#X
M=G#'*]4[L+'91^IU9N;HD+.BQ_(-%]]\)Q,SAPM=3WL>U^T$7>[D^5?[_%IH
M2T<TE1/@AA#8(P2\P-*)_Q;L!(]29B7"75!;U>'>?$;/"Y >R)%L0$Q*)POB
M#N9.NK'!M;(=AY3W^R:-%<US'BSXJ&ULV"9&TX9I=!MF(J3VHEQ0T8KH"#FH
M[&A7QV!I]5'7AH8NG4%HUE3<1]\2F05_)=3P,)61"8,<I$KH.L;Y\=1;V&66
M4B20%B;33!&1@ [QICWA_UA6]S1B[=>ZAG]D0=4. /L(13"KGJ.DEQGP6UDF
M%N&LPBP?,"@A!^\PNT2WLATHF3<WR$08,4N[RVKQGXG3/I^7TW;#!Z243 %
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M)=/GDJ7PGPLG/CES5O26ZN9*KDZ:<VM$7U4RVW]%?=IC?W'._ZT^.H RF70
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M+[YAO<L@FL:UA *VRBTF$LM\.%I%=%(ZS(2W>*;Y@3MA_O%!?[&)'LBM&]D
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M=QJS:!-2^GB81_Y R+S.HM34]/EW;P[<BV-BJ]L:@6J6X B)]-%H)U=;>^?
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M4EYN("L5(W[M_^]_%N*-_ U02P,$%     @ [("H5M2V<0;KY   8H<) !4
M  !L9VYD+3(P,C,P,S,Q7VQA8BYX;6S<O7ESY#B2+_C_^Q38GK69*C.ABP=(
M@CW',U4>/6DO*S,WI>IZ;\O6PG!*G Y%J$F&,C6??@$><2@N@ %0[#:;J4Y)
M).#^ _&#P^%P_[?_^?UA#IY$617+Q;__(?QC\ <@%FS)B\7=O__AU]OW$/_A
M?_['__@?__9_0?B_?_[Z$;Q=LM6#6-3@32E(+3CX5M3WX#<NJK\"62X?P&_+
M\J_%$X'P/YJ7WBP?G\OB[KX&41#%+_]:_BF/<<I(SB$-< X1$3FDN?H/9W'
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M3\TN="D!6RMB'^UYV:"=ID7_ S'2 <I %1P%"5V*X,G8H,&-CQ<2=*G^.Y%
M%S<VL)Z\&@-1JEWFEKOT0U6M!)_%*<Y1FN:0LBR&"(48XB@@D(=A$F9Y%I'
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MJKH)R>J^TCA@(HY$"I.8YQ#%B8"4(0EC@@C%RF3!MED0CW<V02^+EA4J?GD
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M@73NS30D$2<ZO"%)*$12F>)YH(Q$92ZFG/,P#E!FYITVZW!ZSN>/R\5=&^;
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M36= ("4AA8203'(D8A99YH7:[6!J4ULGX %2B6>;#>H%;F;+^R5H>)[!K6A
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M>0H@%CR%29K&,<<\95+:A179"6 SA<>),^KDWYZ:=EX&RQ$P<SKX0]7S8G8
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M1*(P2)(4!EF20!0G N9I&,,TP%1F-$FSV*@XA&.YIL: 76A:]:<+? D7C-(
MG\,XV(_JFVBB9>:KYF[8X;KR5SV);K)Y[Z2T\'">[!AT'XZ/"Z1Z/0?)Y5">
M=*0X:'X8<?]:B<_R7547#ZJ+:A;A+(KC((,2Y1@B(A7_AC2&DLA$$)XD ;)R
MW^XV/S4:_;4]+UK+9\>F+Z S(\7A@'CFMI=8* -O.2_8,_B]^U\O^7<.P^&(
M=5XT/BIY'%;L)0<<>6K85&XVJI^6BW4 =$L>W<'T>O'.9,XB1G4&'2G5%(]R
M2 .&]68R8BC,&4TL0^?,.IZ>W[)U3W5[R!]$*^Z/EC:5(>IF[. >2<^LT4*X
M+7%O\OS0"?VC%S/'#BA'?&+8Z:@\8P?$2_ZQ?/O"!(%;^>]^*^K[7Q=+6HGR
MB="YVI\^KNIJU\6@?UR5I9+J9U(551_#]]RT-<LXYS0*)-2Y>R"*4@(QS24D
M:9)DH:19ALGLL?'1*?.IK,VHS(NL-O/UI<3^IFZ39Z_-&Z[6_;F.9 (QD.M2
M0\66(Y]4;=(LUMR%^N=_"M/@7^/P"N@I,C"3H=./05"6LC1 D AEK"(2"$@S
M&4),6)1)@B0-\NYC>+?@?U>?0B_OE#Z$7W3XV\Y7$$_A*S!;8U]]7#TOR9O\
MF5?;&4?!-Z4CV%82M%KN.7;7>H)&T:MU#/QSVZR'[)L^AL)UUDZG,KY.MD\?
M,!_-$NJELZ&I_%_>:[IF;+E2A/:%/&N!KA=\_Z; +,XX#4B<0RXCJL-L,TB"
ML+ES%*4Y8P*'N5VZ_R%B3,UITLL,'ENAF^!TTEV7L;YL>^$0F5&^?^ ]<_JA
M:YG% JR'XLO64-A<!!M0F> 2))U5+Q@DQ,@5#BX!:K\*PD6M#6;-]LQPXW7>
MY!R/$X90H(QMQHD^J-/&MD@P9(CB5,@\Y-(H"YM)9U-CP,W)N#7''0?4F,F<
MP.2?K_K8@>TJ$EY<R":0N".>XUV-32]GE3Y (N??N80J/BZKZKT2]6#,C) D
MR5,<08QTP&W ,<1!PB%E-)(X(D3$P:Q>UF1N0QBGNK2BC77'_B;%)U&OG<T*
M_NI'H,<5L+7H?>H2)?L08CD)OPV]N )U')+YX>,&RXW$FT-XM8'5R"^EIJ,K
M<%W794%7=6,OU4M=[<UI%),YA$Y)Z62'KT!-)@ <)BBC-P<FF7@BQ5P/_/ME
M>4/F8I.Y3N>Q^X74W4\WJM.YZ'Y^?DMJ,4NP"%@J,AA$.='NY@2JG2&%^DYW
M%,4B#0FWH:_AHDR-UFYU'Y:I)H:/@QF/C8.N9WY[D?I245>O%93+$FJ]KD O
MN_KKO"$GM?/3N\!6L_6?@=;M"FQ\@PXS6%R,M:ML%L,%&3>SQ<6 [66YN+S%
M@3F ]?VOS_(WHN/JZ\_EU^+NOG[W792LJ,27LF!B_<>J^VL5SJ)<9ADE&0QE
M$D%$,(,T5T9A2!G/8QK3T/;NU2 YIA>0T(D(1"<Y>-2B7U[6=] HF3&M=^0]
MDVPCOS8.>^R7)6BDO *]%J!18^N9:OV00\_:14"Z2DX\2(9Q4Q9? M->(N.+
M&AN0"?3G<OFMTEOPY6+Y\+P3 ;J.)3X8!]H$:AR.+ I$R!.:<Q@G@6)3(3-(
M$0T@B5 NTYSF*#8O;.1!P*EY[RZ*^O(VBJ?9=@ICXYF(6^U KQZPC[5O!W9(
M^-DX0VR18_25AWJDI*.^AMQ1^E&/@W R'ZF/?L=+4.H1M9V,I3[[&>H$5\N7
MJ.HOI."?1#T+&=.UP"0,F0X?B,,<YFDD881X%)(4I13%=D=D.^U/;5WMQ0./
M2CY;__4N<J;.ZL%X>/=,=U!HT?1&HN>Q-^2QJ,F\^&]%8_U#5UO9E:_U94WG
M1_8'87+F?=YM?617\T'5]OW*AQ\;>,VB'ZTWRZHIK]ZQ2#4C2(29$!0&F4PA
MHB2$E"848A:&.0\%SK/(QD=\M*=)NH"W$N\S+6_CANS,:\OSK.,0FS&#$^ \
M<\1FTK]9H_7N'%KV]R3.(>'J:L31?L:]#7%.W;T+$&=?&+#+OWYH0G,^?Q/\
M=OE^63Z(\F/!5+/+\D -]1D/8T32.(8TBA%$J4P@1@2K?Z4L"&B6"I(:;^#M
M^IZ:#=%)#Y9*?'TX*QL%P+S3P&(#9SD&!MMO?\AZ9IH>5"VYKM30R@YZX;=/
MA;:B=?QA;;$/]H?Y2%M<Q]C;;6"'H7=R;VK9Y'C;SF&Z[NPH!S8Q,/$3*1=J
MV:F^B++/0U4P?:D-(YIQF&(J(&*40I(D.0P$Y32.@RBU"Y(ZV,O4K,=&*+#8
MBXY:'W==? !V&&PS6_)B"#VS>R^?SL?4IN>[:N[M,(>)F4Y!X"H'T\$^QDVW
M=$K-O<Q*)Q]V4E&WJU0QXVD:9UG 8)X%BA0$$I"@G, @P#3-$XYR;%1H_G0W
M4S,%3];/O=)T<5$1W1Y<PU/NBR'S?8S]HF3N%>AD]%8G]P4&?LKC]IV\9E7<
M%XJ>*8;[\NF1TR W__DJ_K8JJJ(6-Z)\4A9,FZDRG(4!8P*Q4&\O,XCB-(,4
M!\K,BRF6.!$IPT8;3:]23HV'E%AZ%TK4IP/:&]EZ5PJ(5L'2K>5G5,T8[-7'
MRC,!.DA@W/P/6*L*.EVGDZ?89"A>.RGQ21G_/C(0F\#L+-VP46<#?) 6!Z+[
M@FW$[NMJH3A/<QHQR&(2012&"<0Q$3 +$Q%G>8@D-[KNYT&VJ2T8-_62_172
MAF'8-A.),T6[O ^B@9/S]8;&\_I@'UMR<*78J'AUM@B;]_&T<*2^WKB.Y&A]
MA?&U<\;Z&8&3SEK'78[GS/6#U8ZSUU,70R.'GE1;R_*Y3;6YN10>449B&H>0
M\%Q"))$N<YSI)&>8!H3D3*I6K$*(#G<TM35T+:=M'-$1',WV2"[0\;R,K44<
M)SWK.42<!1$=Z6;D:*+3RNZ'%9UYWHX,JK*>?16/71W+Z[M2- SS1A]*B?*1
ME/7S)_5EO%T^D&(Q"Z.4Y2%+821%"%%&8I@CD<,,98%(& GR5)HP@U6O4Z.)
M;2F!%A/\W@IJ&.IM!_EI$O$&I'?/L36&QC0R")-3G*(:W.(3]=.&2^SZ&H58
M!JG?L\RPEP>ZF_66]7XY5V]4;?VC69IAFL09A92E'"*E-B1)0& 4QY%,DCQF
MB-J<1.]W,;5CZ#:(L=J2\U^ :"2U]/+N@TD10:'@$J8QTJ7? P1QI@RZ*,EE
M0F*2YQ&RSU5[&:3C)9K]F<P;[SFI 15WQ6+1I#J1G3?]8G!#DN9IG#(8LS2#
M*,PYS%D60T91'*0!"644V^9^=0&M_\2M6\"*!7<(J>&1PD4@^3X/V)G'76U"
MW[E?CB/BRBV_W\&X/O6C"NXYQ(\_.;7*L.^7I11%K8NJ_";T'5_!KY_4WO].
M-*7^=)J$=?S73&1<B(Q&4$I&(4J"'&*) YA%@>0LH#G)K*KP34.MJ1GVG>Q=
M3=E+0K^F@>^K%Y[U]3%,_U37L"SM%D!7H(<(=!BU16N;'#I>4NA,:]Q?^PC9
MK5)_'V?.7@9RO)JX@Z0;<*K=QF.+]T)4OQ1SH39K"Z%O[7PIEWS%ZD:L[7__
MTM2KF*6$J"U"&$&J"^8V8=6ZSKOZ#XD0"9C./VE\>CU,AJFML(UH%D>7 Y$W
M.'+VCZ?G1:I3 &@-KL!&AZOF3E\G>I>KX.K%S^#W5AV;W!0#A\+BM-C_D(QT
M*GS)T#@Z][T,RY/GNP.;'N\<]S+==\YK+VQJ8%5C0>M-+KV76?9TPL5OV@&C
M?GY3"E[4.G7I#*4YCX*0PQ3IDYF ZN/:/(49SR4*DA!%9OF8+A%B:JM-*QG0
M]WI$!4HQ;_)4UDM =E):5DHAP'7:RVJML&6%XR$C9K8Y\ST.GE<IHVRB:RV:
M&.=NU+0B#@L47P"CJVK$0T08M_3P!2#MU1F^I"T[WN2BF+U;U,U>0=$*:4K/
M*^.?]+=M*"<Y2@(,$YH2B,(H@R24"$I,TA"C0 AL5%[X7$=3X[]65K EK'8F
MD+.7=.S0/<UC+C'SS%5#X3(F(U,L#A".6IG^>+=\^DDUT7*-^L>&8LXV/ J-
MF*K74X7Q\P,+@!:+HA8?59M<M:\&6E^6NE:F0%U=,[4/6#7FP/7#LJR+_VZW
M)PDG-$<<PRA/,HAPDL \CP/U8\I0S&+">#A;B#O]HID992^$T83(VPFQ+8K'
M[8RHJC_I6EN]N(!LR6M9@M%^4)05FRCH,V79ZI-6C@DDB$B(>21S%J8!9Z&-
M9>MI2,:MA79P*(#Z/]EH!^=:/5"L]0.D4=#[8)D9M7Z'P/,RT0H/&^G!1GS0
MRG\%MD?GVF2BV!>P' R?J^J4]@*,6WIR,$![=26'MS3 T7PKRN*1Z/AO+CXL
M_DLPW6#G2",DBW >,Y@P76Q81AA2FF+(1)*P)$I$BHSNXY_K:&IDMRVJ(K1.
M5@O'Y2E0#1S%CJ#R3$H[**W%'.+G/067A3/7$6PC>6P/P^?(%VL Q4F'ZZGW
MQ_.J&FBQXSHU>7X 1=ZP>\%7<_%9OED^/.B<^63>>6G;3/FWVLVPN8-! Q;@
MG$MEPX<"HBA4M(DE@5$69XG(L$A#(^MQ2.=3H])>?!VSMU$ ],<59VI+7#X6
M!FSK$6'/#&P$+OB]D=_HVLSE>%O0M4?<1Z+PRSYN.T8?B-9)EK=M<SSF'ZCM
MSFHPM(V!49OKWKZ4.C]P_?Q%?2NU3K3ZMU7QJ+_&IK]9$I(@#["$DK <(I0P
M2%+)8!"R/*0DPFD46<55&G8\Y96AE_P*-+*W*8)[Z3L",V0MZ_$P<Q_X0-GS
MZG 9J/:A?98(N0J^,^UVW/ X2S#V MALWQ]<S?A%M?5-FN@V@?^ZIDN2\RP7
M,8-IF"&(1!A"&BH6(Z&^X*-&A:6172D[\\YM)M4X]>O>W.M(P@H4BZUD\*V_
MLYEG\TUM>L-Z2P.&Q(RY_,#LF;MZH<$/O=@_:JRW4LFWHIO4/!I2V-@2,7<%
MCDT['KO0L24@!PH>V[9P8=!LY\%$(:4!I9!FB$&4X@3F*!,P%%F4!7& HV18
M/.PD_9;;08 #PRP'!;-.S3.YC<.E<:<7A91.U?=H]*$,C_X<%MCYFC&;9N&8
M+B(MU[<#/FY,A%\4):Y*P3\OONKPI5*QHLZR7/VZ6-)*E$_:TONP>%S5ZL]*
M,?56\WULO"X!R446TPS&$8XABG &L=IEPC3/19!G-(\SHZ1U/H6<&EEN[S]W
M1=:_^2B>U.#%X'VQ((O&J[-U*<3R2-O'B!L>>K_R./H^%E_?4+L"6QJ"7D4=
MG+!6LLD57UV!;3U!H^C+X;=PF-J?HWL<$5<G[3Y$'/<LWB/(>Z?U/OL:ML1\
M%34I%H+WF?L[&R:D62*I"&"4I,H61BF"E$2Q^@#B#(5(8LFL'(^'NYD:S?=2
M M&):4?>1[ TH]_+$?),H&MPUK4USEK+UHQW&@1'G'6DDU%9Y[2B+WGCS-/#
M9OZ7<LF$X-5[)9R.>?\L;^Z797TKR@>=PZVJ&_-E%C$FDS")8$!XH';%A$(2
MH@Q&DN64D#Q/,FGGRS/K>'I^O%YNH(<3-+=RE/%7:=FA8J<'4&RDMR,.PZ$P
M(Q+W\/H_>]C"]:;#M1$::JG!!P-<K:G&#B9'U&/8Z:A49 ?$2VJR?'MH":"'
MA^6B29[3K:D89:I7(6$F20Y1QC)("$J@8J-,<,IRA*V"KO=ZF)IIT@H(&@EM
M2_R\!,^,1RZ"Q#-E;*/AP0PYJKJS>CXOVQ^YE,\1]?:K^!Q[<(##_>=5I6R8
MJE*-TF+1;&(^K72C.N9"9Y>^4TS1[([:B(L/5;427//*.\+N#SUR(TJU@9I)
M(N- H!PF22[T!8P,XC!*(,54I F7:BMC'GGL2\JI\4FK5!.,])>O%2@:-=H5
M6"A%]&]!U4ANX0OW-L0&9PQ3&#C/K->K"+9TO );([E6HJN=V@7U?=@:W'?-
MX!Y\$-Q,9KPMCE"F,.XCG<2\\OC;G?'X'I>31T7>.A_OQ,DW?CL'5]X[&YAI
MY%#AB>IE&8.$QI@2%D&)=+11KD_PTS2&(15!*D049\+*5VG4Z]36\\/U7&SS
MA!CA;;9]<(ZBY\7U"(#C5)2P LM5O@^C/L=-\&$#PUY&#ZN7+T@)WY+?VY4^
MJFEKTC6T=SB/X$RQ3RICCB$-B=J=T A#C+':K""19300 4UCJQ!N:Q&F1E5:
M^":;CC)96+N1;_++@]5"C000#X_SY;,0W2]WBL4]JH;:,L>MZU6I6X%O17U_
M+^9M!=)'\JP4F8.:?+?-DC1@<,VHT.^0>>;%FQ;D5ORK_@3];)DP(M6GM)4_
MUG$Z\4%HNDPW;B? ^.G(!P%T,%WYL):&\6MO='X5C\NR24A_(^[:PX\T(7F2
MYQ$436F?)$D@R3"%498$*$YD'IAY><YW-36^W&SPRK6LH.J$M:.X$_B:49D;
MU#Q3U@:PC9C@YAQ@UD1T'@M'A'.BHU&)Y;S"+PG$X(T!GN3] '&=S:VQ_U:+
M>I;FDJ0X32!C5#$%9C'$@3+ >(HQR1@+*"5F69(,>C/Z[$=-A]3+J>] -%DC
M>2>JA6/O#,(&[E@'J+WJ[9$F,>1;Y\A9.#;=(3B2>_(B).V<BV;8G'01GFEB
M/$>?F2X[[CK#5RZ]G/QIV9S@"_Y5_;<LF/I78Q'^NBAT>J&Z>"KJYQ=W^F,A
M$BZB&,J(16J[FPB8,Z2CAP)=+HW%*.5VX4(7R3.]**+=4/)>C^XHNU=BZ/7E
M(2-FN(<=:Q1\;V>WX%]KLC\0C3+KX? :Y>T$6><7I(?(\DJWIB^ [?A5ZDL:
MO2 XXN:Q6'R6\GK!?RGN6A?F2_=[B((PC#&&89()9=Y* G&2!1#C0)FZ^@8/
M-\\89-[OU';%O>0#CJL-0+8(.' +W5@A!%IJJ,0&2FZP%MSJE.,B@ ><\+L%
M>NPS^\. .SYL-X?(Z/C<H+GQ#\3-=3QXQ&WQ^M S(K7)WZ2,89+())$<)B1)
M($(Y@U02 2G.,$H3A.+8Z%;YX>:GQLIKZ08FXMG%SO1X92@BOFU-8S &'((<
MTMG9 <=.XR,?7AQ2;/]@XN!3EVYXU0[Z<5F1^9_+Y>JQ4KOL^8H7B[O#)\OJ
MS\L'L9:D*SM\<R^$3KUSS7FA'R-S_?9\J>_X55MI'S.>$)(2R&4:0Z2O8^,T
M"B%EC BJ]L@QMRN8.KX.DZ.>[01[I"R?]3W>ZP?M$:GT[WXA_Z6KM\Q)4VU'
M_>)ZDX)G^T+PUTT=GNZ)_^P/E_4%AZ%;\_&^+=L-_22_&,_4W.L,6J6OP%IM
M<"00:"0?P.B#X=QS,)X&K^1O&'V(CGLIQA=E:F7*_](X:3XLVLB$\R6G=?I,
MD; ,4B0E1")/($;:4YT'&*<T2U**+/W34]%M>K[NKS>_5J!SL4ZW9+GM)V2X
MODY%W@FMNN,5+F\QTL>/+4K_2-7+!X[_Y N8V^KU#U+#?.!PCE?&?*B PZO+
M;H1I*J^I_K^J'MY)*9H:;$H0ICVW=V(6J24[QB2!+*4Y1"1B, ^3'(9ISK*0
M1PF.K*("K7J?V@YX+:(NK-4(#DI-;S\0M<O5"Z^6VW+9M1L.LZ71&\B^-XTZ
MDF4C^!7H10=:=K4VK?'?B.^V1*PU:@YKPYKW/7I16&M8#E6#M6_$O@SLV^[0
MZ?]9D5+U,7]N R-G-$2*KT0,!:--U R&)$H)#)&(:1XE,F?4M +LD3ZF1E:]
MF& M9Q>M:U[V]1B:IUG($4:^N<8:'JLRKV< &%3A]5B;HQ5W/:/4=EW7<X\.
MLUU:?W%7'G:=>CV(\C3B&8)Y(M3DUM<7<,JD3JC%PI )E*'<SN5PL)_I;?\[
M ;M<]Y:Y[0]C:69@7(R/Y\G=E^+L ?*1F/XD!H[,@L-]C+K\GU3SY3)_^N%A
M<WZ=F_ZCCL3M#Y*>/RGQNP+D6<YQCE,. Y3I(CXHASB6 42!R+C,(Q3;W4\_
MV^/4EOJ/R\5=FR%O4_]BWD2*;Y6^L&.'\ZB;,853+#VSQJ:@12/L)HWQ\Q78
M".R.08RQ<<0FY_L;E5F,U7_),N8OVC%.I4S;K]J;<_V]J&8Y1C0+)(*IH!E$
MRL2 -.81S*,<)V&""8]3$U;9:75JS*$/JXJJ+AB9]XFZVW@:+:QA;-$N;*=I
M83 8(T02#<#!>,H?U/O4M%8O;$UI]=-F.N^V-<J4/2A^/RT/_W% C';G-*UN
ME[\NOA4+_AO1SM7_G[QW6VX<Q]:$7X41,S%3'6'L(4B0!*:OG*?:&9.=F9/I
MZHX==:' T<EI67*+DBO=3_\#/.A@210 @30K_HON<MHDU[<^D L+P#J8U&28
MY5!1O7I/,P80C+6K3U,$6)+!6*HBSG*K";Y7RM0^S0ZGB9/9U$BC/UJH#A'#
M9SGM_TZ#,37P=[M/4@,R^D= DAR"J$.0-5+(M ]I;N'2E\CH#8X^>_-XH="7
M\!\$/E^\V&_=TQP;?3<]"VK__</3Y_*;I//RWU+\2LO%IV55S1B'(F59!A(B
MC67,4T!R40"8PX2)(DTRMS8"-D*G9B@-+M-<I"L8_O?RG\:'WZ]\X[;VL6+>
M;OD3FL^!S6E[^+_#>Q-]^#OX_/$FZD!'-=N_&-SG#[J<5T(N- 5:#%F)''4]
MY$+"RR61T[T>KEF[I?-UN3)3TQ>U771]6*Y.%C"<<4P$3$QV<II0@ 3EID4I
M!"*%@D"88U5(NTU9/P#3W:WEN^*@SMLSGH-AX>P-2O# 9LL9>R WQYNS7O_'
M_:GC.4;>&A]X3/Y/"=.#Z99K/WM39R&\DZKDY7H&"R*+#$EMI 31YBI. !98
M $Q(SE),>9(Z=E2^+'1Z)BIP?Z83/-NY36&Y&]CZ'/=M^F4/;]0"#N@MV;,S
M4$.G$P)?M;G3>0(N-7KJN=/SM,K$]FTWJ-LZ!GIZ?TNK'Q_FRS^VV0$SSHG(
MLAP"JI($H"PG@$B: U4D(B,YS ES.[6RE3RU]5L-W/%TRIIERU.J(;@;^K2J
MCLK>G5GM4-]$!G=D@$=;Y &/K5S)"G5\92UWW&,L5SJ.CK.<'^ 9/,/KZE75
M-\EE6;>]_"S7K2LVDRBG1<X8P$6> 00)!@S%.2@X2B%/8"I)YF*-^H1-S0!U
M6*/5%FQ= MDQGJ:/7CLS%(JT@2W/EJ]O>WPU]8AOY_J%K6M/FW3>MRLIRG5D
M-A^VL3@! W LV H5A],G:MQP' NECZ)R;.ZY-K7_0[DHU_)3^60R&=;Z=2FU
MG"8>J*DU(0DJ<,8$R N6 B23 C *<T Y(@41I$!4^F7D7Q(]-7NSGTC?8 <U
M^&B'OLN,]ROR83\H=G9I&*H'ME(!6;XBW=R6L.!9XA<%OU)RMRTAYW.RK9_@
MVPMS\217:_-0D[6P3;O:R]J>$;UFPP55(,ND]I94!@')"P*@S G&+(DI=>S9
M:R%U>MM%=5KG4]W@2G]DVHV-S&YF]'FY-@5 -NM*CTY=\N&73_))4YTXYD;9
M#(6=!0M,[]#[V3NT=77?F[T$VF@/<LB&G-;\!&O1>5GBR$T[K2DX;N-I?^N5
M-<^:@SZ3@;I<F*"#.N8NDX54:8Y!D9H :*GT,BZ!$O"4YAGE!<DQ\BJ!=DK:
MU+RI]LQZ!](I>-&.8$LW*11MXYSRVS/F7SVMCXG0Q=1.RGJ=VFI]:I\MM=9[
MDY_9V%JBO9A6LPS4:S\]+;?=JB%)8ZDP!Q Q[<P06 !2" H$S+3IB#&)I>/1
MEXW8Z7DS6X!NEL.*8SL#$IJW@>W(SBDQ\4$MR@&ZA;O0$LBH6(D<U;:XD/#2
MQ#C=ZYXS\:E<E_=US.I;6LD[_8!WRP=:+F:97B*)!&% &8\!8G%B4C2%MC&D
MP"3%*LN);0K%.2%3<T=V.,TIC(Q^;V ZY%*<I;/?B(0B:6"CX<R/4X[%)0*N
M2+DX^^C1,C N*;>?D''QVI'KS+6E;M[_E"M>5F:;YD6=F_8O\NNJY'(&%2)9
MP86V%S %J* $8)Q00.)4PCA6B?95G%8TX^">FC'ZLK<'LVPT,76\UI%6-9([
MG6ZB/[KJ7;2MWM7^54:/1K'7JR[G^.)8KM2F]SH,O1M^?66X;>VW]_LOSE'9
MMXZ!J*9@ O7>_,;LM:NY.:+^<]1J\QN*8)78/,7[395WY8,VNU_4G895*=.D
M\=?E4GQ9?9>K)_WT>E])0 094SE@:6K.1"76/^5Z_8UBRN*84.)6N<!"YM2F
MJ :R.3_H0)N?#>S(% 1O@'MMZ=D,@-UT$9C6@4U]$$:=S;,#1X%,JXW$4<VB
M P4O39K+K?Y5T3Z4%:?S_Y)T]4'_IIK)/,M8GIHR:";H/5,IP"I'("FT46((
M$YDKUZIH+V1,S=QLRWXU.",#-*J1NI=%>TEGOS$)1-+ QL.#'Z^Z:&<8N*HN
MVLMGCEX7[8Q2I^JBG;O4LZV[7)MHT:^KY5,II'CS_%ME@B-.!)5N"WVA5"J,
MJ 1"+Z8!BED."!49T,]7*8]3)"1WV_5W!S&],X Z<%K-EW]4D1GBO7I*=(O>
ML<Z:Q]C8>27#\CVPG='@FRCU#KY9?/YB-(C*Q5].AK4/4L7-G\10O>?= 8S;
MD]Z;H*->]?Y/NC)HXE.YD!_UC]6,Y4([-I0!$@MS#L$AP$@E((U90F6<9ZGB
M7I$26Q%3<WCV>J09C%$-TC<X8D>D8T2$%SU#;XFY,>,?!'&D?.C(AYV UPEW
M.%+P;(S#\96>@0WEPF09U 7@OJ[*!2\?Z;PKQ#+C"@M*LP(DN:( *5( 0E *
M&$$<<@&E(FRVD/<F[>_._F/O%6KU8I/FQ3X2/=Q+OJWULUEH=B-5J["K#[ED
M\_:8R#'5MW\ +,,=KN9SI#B'!F=7%7(+M=L@#QB':45)J!B'7EGC!C?8J'T4
MU6!UT]3Z:6W[GG_>U)%!N> <(<@ C64!$,P$( E3II9MG.!4NR7:5CW6G4&T
M%5VM!S[O=,7O\IF^U&+ U44',J+KB,G[<K%HMT0;#/5Q9GV,V5/%Z)5?#(*U
M/YJ(%"!ABAXFYEA B1BD/)%20*1P!ML7X_U"_.E?BTZ'D5X*N1!_KM=AX(/M
M(0=X^D?;EDW/MASH'VL6)G"Z[3MPKWV^[8S[SW'"[3L<XW4;.P? <^=YN=CN
MD3;]3]__-'#E#%,J4)%CD$BS"$,D!3A3!,1%CF)6%#'C<+9>KNG<<GOYG"2G
M'9>MO '/7XV,:%G;C[(&&OTB&ZA_\:@K<)YARVWB$+P-O1N\AS'ZV'+6P@Q8
M..DB%:'V=,_*&7?K]I*Z1SNT%V_P*!WY?YX?->BR:C,A>"HPE!R##&N/%L4Q
M YAR M(\4WH9I-=",K:NY7WX[*EMO7;H'$H[OB"K_PN_DH*!O^D.V.6$D(LT
M.)3A]J=CI.+;%U\*MQ*4I_7MK2_YXI;QBD>>QGI0&?+,)5=FO[UYWO[XGZ6V
M;RO^X[G.2*]CP I*DC1+,R 5Q@ 5L0"$\ Q BAC)F+96@KJ<"=F)G9JQVLLP
MWX*-J%XE?[[]NU?XG27[EEO%P3D=>L_X"CK]$^2LV F=(M<O]'62Y*R(.)LF
M9W>W]\G5N>HEOZY,8?F4Q EG>LED(H#UN@DK0+A(@1 JEHB(G ODF(Y[0>3T
MPG!,+4Z#.9K7%7O*7<6>IM6A\UG5!<HABQ'1GFA."3%YB@6@":$@3@H9)R+A
M!1,SO7 ;D>[M2>'06^4UI,!\6A__!7LMAS\![*D?=1/UD^AS"FC%3+B#P'YQ
M8Y\%6BE_XCC0[CZ/-6Q=T>B;?-3OTP^SX?9N8Q*GNS+F]1G"W1_+=K62X!B*
M#!> JTR9@QL,<$IS !,L8((2HNRBJITE3\VE;.I K7;@M2&/;C?WFVIM"D4E
M#@M"IP&P6#4/1>O@^V2&T3W<40-\V^BV@7X3:? ^ZVXGFAU6Y4/1/=*:W87V
M0.MZ'\9Z5_U.#QQO3\!'SX,= Z\'>$P![\KJ<5G1N9Y+-H\?%WR^,5G5IL)7
MW;!B(T4;R+I<?.B"K$Z$=BLHM4^I.) HU9-#3@6@1*6 0)P()HM4$JL U("8
MIC9M;*&ZQ]R''"F+661\_@>>7SJ%HEJCFVBK4[2O5+35ZB;:#99;H/Y@P^8P
M*XT_?"/-5V&&,=!,%I;EWCDND*CQ9K^PW!S,BX$?[;?992J_;QLZ<?W<INIT
M$A=YQO,"Q#DC .GU$J ()4"D0L4JS[',A<N.^VDQ4YO7#,KH *9?>>\SI-IM
MNEQ/U<!3D =+SOLK_20$VE4Y(V34O91^15_NH%RXVK/KR!,MY^8Y'Y:K[[0I
MD+OK4[G7?ZG>I/EML6J[5AHP;Z1:KN0=_3E+,<FXTAXS3<T.;<PH8!FB ,<Q
MQDSF)EJZR^BPLQE!<+EMY>[0#;R=&VVV<*.Y_K=M=\FP8V9GD,8;AY%<:(W_
MH('N5D&@P0*CHO[=7G^X9L1VBK7M4EBM6Z25"]@Q)237H5JK!,$T;@^6D#0>
M-6L)^G#/)G9=$%B=6U.WX/RB?JN:W?294D1!1!' ).< )8@ G!0(P$(RKE0F
M4P7M3\MZ94WKJ&R7E-XDSZT,6+!48%/Y'4SV\VQG/Z_G;Z1V=5ORVC2Z;QU[
M&FQSD!:P19T-*:':TO7*&K<5G8W:1^WGK&[R;CG7F:LZ#-W$LJ_D#[FHRB?9
M1)BVAPE%1I14* ,YQXEV\!)M7B!- >,9R2A+:,ZM#LV<)4]ME;CO&C0QY'P?
M^C:BW/AUCLE*]J-AZ;H-P?' 9NCVR]N/T>UZO2K99FVFV6B]C+[2^A0G?.5R
M9X;"]:NSE#MV\SHW.DYTLG-\@&?ZK[PWV[0G=\NZH&2I8BQC@0$N4J'=(/U_
M3% &,KT@I1G%J6+0J93(99E3LU4'N\G++5C'%$H+KNWL46 &AS]K.;$5;Q$N
M[YY;:,]+J*Q "XGCYO/94W"4B>=PJW]IQKKP8VF>^4T^+E?K&2$Q@@0E@,4L
M!H@D": $<J#75ZQ($\SCS,J\] F9G#WIB@_N@$8-4O?BC$>$]MN04#0-;33<
M&?(JSWB.@JOJ,QX]=/0"C>?4.E6A\>RU[A_Y)\WY_.N/Y4*VR?Q<<<E-U\@D
MER;E!#) !$Z!Q!2R-%,93PO;C_OEPZ?V4=?XHAK@I:SYR\1=_HBOH6/PHRUK
M)IP^VG,J>WVL1P\;[2,]I\;^QWGV&C\__ZM>22SJ2ES\QV(Y7]X_MPXG*I(D
MC^,$X$1_I4A(!1C"#'!!"%6<%%P2MR2,<Z)<WL^1:J#J1=5<KO7*> O5S:,_
MRZJ=&Q^"J8&_Y YBM,,X@-]^B8A SOI9,:-ZZ)>4?>F67[S^VH;VIRMP?%\O
M^3_;2AIMN,QS?4Q^)W^NWVB%_CE3F# !20H$YPH@&7/ LEP"D4+,D[Q(,,[=
M;,?UH*9G9?;;L]?XVS([T5=]61>%YFAX @R>Y4[#J ,RL#$[61=I5VBF:_QS
MLQV4-B G,LI$M38A-RN"41MJ+^-Z0.-N=00C\&@G)-R3KSR7;K9ZS9'W#!<\
M)5(*D!$B 6(X!HPD!.!49"A7F4H%=RDS=$*&TXIJA )#NZ/4]C"H+E7?[DXU
MK=[\MF)/\>MX"NW'VFAGSUUMH4^]IV?^Y\W'ZH<^9=Z3\#IGR\<JGCU1/G&I
MWX>O'[0RI]/O9//?CXN/BR<]-RU7I:QF"6,$BIR#N$#:X8)" 9(E&<"Y:6(#
M84Y3[!8<V"O/+2AEC*"_#IRCN]3/JMV'?SU3XYB #F?T2X?T+R8;=0]L.&M@
MQ4D@N] O:U0+8:7V2UMA=Y.?U3"A<[M"B+_IUV.Y6IM8N?HL9[-8?UW)AW+S
M\%FN9S2%*<]0##C$!4 DEH!BTW469;&(<Y0EM/ H&>\ P<.LC%% ?@]S)%K0
MIEYNEU&TV?^[B7TMJVI3ETOGRVKM&*'B,F)V]BGT (P81+R#?1/MC\*[[2BT
MV/]R$WT.&3WGP5D@:^8B>53;YD')2TOG\PB//.4SA6/YCU(^U>OY+^JK7*GE
MZL%\I&]7Y5JN2JK7_<O-^IM9\^N_<GW9C*F<YAA3 #,* <IQ"C!E#&!.N5YE
M%8IS:9VI' K5U ZW&H11O5D2_4*KB)J2X@:II>4+.V;]-O'51F+$#:Q]I<R.
MU58ML\^XIUC4:783M6-8*W<3M>J]QN@YI"Z_QBB.E+P\ZFBZI3*'9KTWF3F8
ML/'2F4/S<Y#0'/SA?HL*+?RAW>JL$55?-NMJ31?&&9Y1IG!1Q K0F$J $BX!
M)E@"B55&DD301&0N,:%]PJ8V%398HZH^RUGN</HWU^BE.F>)8+ H ,0Y!4C2
M A"N*,!YHA27,>29<N^;$XKP\5K=O*'SV@*&;G332SZ&5&&&(* )S<V.&P,T
MU:XB54FJ$I1(R+%K;YJPU _?3F:/^$#-9'HIMUONAB)Q8(^MM14USINF,4MU
M$^UA#;>8M6$DT.JU5]2HRU4;I5^N3ZWN\9LS32_[/\KY?)8E69SFE ,H!-9V
M@V% BP2!.,L*(AE63,1NH1'=HZ<7X- A<[,!6ZH2A!-*5 ST?_3R.S5'FH(J
M@"C7OD1,2<*1BROA0]08;L.5--F911_E!S:!%_5VMG0OE0QDU;:/'=6"O53F
MI;4Z^OMUENEV\;)H[,>'1UJNS+IBQB6'*4X8,-8+(,)20#",@40$)PE/];>8
M^'R*?4*G^IG6->Q?UN..RBUNO\^XEWZW3SP4J2-]_C6?+RM*1Q\O\^EM'FP(
M"FPZ>D6^BEFQ(>&<R;&ZU_/$\E22V1W]^5XIR==?U,F_S["V0XR+'"0PEGHI
MG&K[E&<$9*K@4JE")AGU.;OT 3/14\PV[F=-?^I5\D*JTM%0^0V,Y1'E8#R_
M9B+KC2E=%#4ZF,7QZ:L"'EI>PV*HXTLO#.,>9%Y#T]&1YE4/\RPI65)6SNMB
M2-LF+4;.?%EM5G*6DCR!*!5 $9@!5"02L Q*D\=32&'Z)FM;Z! .VB_.R4L;
MK?7D?(?9L;)D/[=VYBP<8P/;K3V@-]%>OZ8=V( 5)ZU("55YLE_8N!4HK10_
MJD1I=Y=G42+Q_S;5NNZ->[?\)HTBY5Q^UF[<-ESU;OF65C^^KI9/I;89;YY_
MJTQ3D6U<ZXFRTXAG:5I0!(J$YP#QF "L>*('IXC3+-- E&/"X! PI[=+MJ>E
MJ<2SZO0T?7+;(D==E+O^L_DEURI'CZW.IJ_WKG.L<[WX05\).W/YVL,\L)%]
M,;Y;!4W$VF$TOOFST3/ZNC>VO_S6M(WY2[2+X7<K-.]>LVG  0E5WFD(B.-6
M@AJ0Y*.B44/*\LYGT)*-I]ST5W[3K$EG,J,$,L4 3!,]BZ0( 4+C&.0R11S3
M%%*IG#,93DGR6*:/MT)OFZ4[)S.<I-3."E]#TV@)#(:?>E'=8(Q^:5$&3&2Z
MP$.XI(634L9.5^A3]42B0N_EOBD*2JY6QMBT3]_S?)NTA%BD<2P 3V@*D$@3
M@&/M9<:8Y#G$G/'"Z13P@KRIG3IT<+<N(/UI%FN+GFAW+YHM-^K"D3?TEES'
MVY[5.%CN!LX7L.(E6(Y O[21\P*L5#_.!;"[S;.JS:I]?!W,\96NOJR^K\T4
M7J^CO\I5'=\QR[,4,J;-2B$)U4O63 )*A ("RP+J%2Q/N54K,C>Q4S,Q6]1-
MY.)-]$A7T5.]$60"N7[[_L[$=34!78[Q7);C8&=\PK,[L W:$=N&>6G,^C6.
M&M3M7IO&W81_!:R:XT14J!HZ=D+'K:CC1,11?1VWNZ]9!]7/->LSQZV3,W=/
MZ!MHI]\MQ$$V+"[0$-1G/Y;R"C[[655/^^SG+_<L$74Z$6%7,>?-\^Z2MJ#.
M[1]T)=K2*+_J"]?5QT73G+3IF!Y#GF:)7N[' A9Z+D888$4P@"3'4N:T@(0[
MUHP*CW)ZN\<U2'E%R/408VEGO%YY? 8V?.>2N/8+2YG]W9.UIXR67=4IO59I
M-#75&KHVR[6V 4M.#3<4H6I0#8!PW*)4PU%\5*5J0%&^!XZBKB-,YU]IJ==\
M;^ECN:;SMB@F3@1D& G M,4'2.0IH(E,@(PEQSP3++;+L[:2-K75UPZL7G>5
M9I\GX@U>UP.\/HIM3^("$3?XD=J6,P,4:,Y:J$-T,+$A)=BQ5I^LD<^G+-0^
M/FBRN<DW[(F;+B>+^]O[E:S-6-<;(T&,I$5M,-(4H"13@'&J0)S#%,,\1KQ@
M3LUTSTF:FNTP"4MRQ<LZXHG7)R)U1S;GH*=SS-J9C2!\#6PRMABC'<@!C,5%
M*H(%.)V3,W)LTP5UC\.:+MW@WT#D0UF9TNBUT_)!_ZZ:T1Q"JG@.$H(@0*3(
M %-ZB9D0Q3D6&<LX=>T@<B1E:D9AVR"C0=HN&:(:JWL3D6-2^VU",*J&/A_R
M8<FKD<A9%J[J)'+\U-%;B9Q5[%0OD?,7^WD#[Q\>Y\MG*;_+U9.V*:>7/.^K
M=?E@=FS_[T:O:,KU<UNWM[I;OI'?Y*-^F7[0.M#EPW(^7_ZA[5*#L"[]E/&X
M (FB&4 2ZB4)3 F (BTX9E(J*-QVHX8%/+V-J09W1+MFOI%:KB*U66]6,NKT
MJ/RWK08>?SO'9SIC.N)FULD"Z>UHF\@0;K8CU\N(R6A/.W/@_O.%M0WG=HTS
M$(%\MX'!CNH CD/\2R]R)*E^,],_I%F"27&K[2R];[OTF$R@^4;_]KBL"2P$
MXZE@(),YUJO7/ <8,P:*E.9IHA1&;JM71_E3<U];2[)IHIXCT<#>12!$VGYP
MTP"U;A7I/7^XCI(9(8F3'*3<A(I  @'!&0:0XX2D6<JI*ERRJH8<I1'2K/9'
M2=MZTZ!9X]Z.5ANLMANTT<;);N(>D/V!9^(.>=1";]NHU3UDFC'9PWT3M1J%
MFVD]F0LT=;I*'W4N]*3FY>3F^Y@KCO+9Y;,B]O*L:)N5=EM5FX?FX*AS_^[D
MZ@'.<IX6<4(9P-0DA!4D!Q1) E"NN%Y592J%3D5#AH,ZM3EPYT9K=-$OSY*N
MO([UAQE7A]/]5Q^MZ1_R[Z7=[BE\LUM*&9T#G_0/.BPA#_R' 3K^N?^@A)\\
M_A]6HD]5]K9UUH?EZLQZK<DJT7^OP>AE6K?,JVX7XEVYTCB6J^JPG=:+WG5Y
M4@@!4P1R)C. N*" (,4!E2E7G#*4I9G=MMUHF">X<[?7E_"6UX7YS;F9V;\[
M9^]<:H6/\1[T3U&3'-NA9ZI!U!VD#^+HP]-?A'P,(",6*!^1U\/BY6,*]HPP
M65;5V[I:S[U<\%)6G\J%_+B6#]4L5R*6#$G E3)IR:H E&8<""8II_IW6&"G
M$).SHJ:V%C%(HP.HT>\&;%2C/?^YNS)L&6H2A+>A8TT\*7./-KG(1JAPD_."
MQHTWN:CP4<#)Y3L\G-E=X%43T"*_U6%7,T8XE()B$*M8 21X"E@F4T#2),EP
MF@M$K0).^H1,S4"<#4)SR%+N)=7"F0M U< V88^E%F+TK3]4S\U?NL! KXMS
M[M[QO)(+Z \<B4O7>GS.[Y^6#W).VZ#'K*"80I6!.)%4S_5, B:9 %F!4BDR
MA1&T_X@/'CVU3[<%Y_"-'C)E\65ZZS_P]]CBNAP">HD#AY95WER,U'?JTNO@
M9I%.:MMKAP[O&,_ZG$1Z8'-.7^$9N?:O3;E^_B[Y9M64]WOZ7+[=K%9F%VXA
M/FN\S3]F-)$9Y)B (J,<H)S% .=,F6Z$"B80:6?"J3J!K>"I62G3#K>I7F4"
M OY>_M/L1O&]7DN.D6.V_-NM2(9@=6C;5T..=IAOH@]_!Y\_!HS'<B0E5&25
MK=AQ8Z0<R3B*=G*]W_,DN-V@^:)NNYA-LU=#YW(G>K=<%SF6G"/M'U%*3=02
M 8QE,8 DA93$1,14.!WNNDB?FH6JFQ7O?TY;'8!:KD"EM;ABT\1M8"Q/9X>B
M>V#3=8'I[]9,NQ^<^C 6ZBS42?:XQYL^M!R=6'H]Y+IZ<Q_*1=TE<UFMJZ9J
M@1(()2PO )09 DA@!7":*2"R7.52%7'&H$^EN2-)DS1?!TWK'1,(SW-J9XV"
M,#6&Y?G8D51##%Z&X2(/@0O('<MYE=)Q9]4]5S3N_ V^19BZ%8:V C(GYG]
MQM#$JB4(X"S7TPN)I4A%"D4>NUB!O6=/[;O?@^9::7;'E]T7[LG"P-^T#0$>
MQ:B.5 U6@&KWY)&+3AVI=%QHZO@2CYW8SW)]J@[UR38J55_I^5SBG")8 "YY
MK!<I^EO&J8 @@T5.<P5EFEGUH0Z*:FH&8%=1WKEO0-C1LMA(?HTQ&-C\F 8
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MK_'S$3XM%_?Z:W@P<7R57EF:+[Y-#K]=B,\:<_./NC+!-J0,,<F*W"SDF"H
M(E@ AC(,6)K0@C-!M.O@<OCAA6)J'WP-/FK1;ZL6U'5.=AK8Q+ %'"@[5V-P
M^@>V+<&8=_9 KF(ND$OBAV%4'^4JFEXZ+=<]S",XZ>MJR:44];+MZ"BZ#;70
MRZ6<$ZI74$4A ,*9 @1R"&(N$**0B(Q:E<:R%3@UX]=!;C9'0H0<V;#>;]Z&
MX')@2W9(XXG@%>?((1L:'>*$ M,Y4E30M;2Z!0 Y<-0;[F/SG/&">QRT.@CE
M<;DO3'_O1_W:_-"KV=L'LY2=45(4*>04),I$ZA!BNN"B!.!$9HH7!8Z3JSI[
M'XJ;FF'>X1,1K1&:19@P 2;E5HGKFGF_X-OR\" 8BT.?"1PW\.ZP1@W8X=IV
MGR9EH(;=+X2]:JONTXI?:M)]YB[?Z)GE:GVG_<R/BR?9]*JJ9BSG&.,T!4I1
M9,XR(< I)" 6&,4Q2HN<6G6#Z1,R-0M28P3&X]868XO2-8KE!)EVAN):B@8V
M#PT[!E_TT8(=CXB/\^H'B]<X(6+D:(OS2A['2O1<&\*!^%0NY,>U?-"+.H'T
MDBY/02(Y TB)%&#&$L#3F.HO/6%%EOA[#ELY4_O@7\QXT>\&:51#==RT.D>L
MCXO@1=>XOH$=4U=Z!4<\#.(.[*2\HA]PI&J_ W!\N6=9TSFMJB^J3G;?O;,B
MY3*72(("0ZZ7$0H!%K,,%"REA8@%E#QSJEYZ2LK43$$-TBP8:IA76(+3G-K9
M@:N9&M@*^)#D7D2TCX10M4)/RABW)&B?FD>5/WLOOJ)4SL>JVDCQ;K,J%_=?
MY:I<BB9T^W2<YJR@<4X%4:#("Z57!8@#FE ,*%=Q@F%!4JZ<5@7N&*9F. QZ
MJD>\2T#=-J#=+/181/+A<;Y\EK+])=\/O7[4#]HU!F\ZU-:5>W_(N8C4<A4]
MTN>5B:]>TY_Z3]Y];'V&VG+-,NP #KZDJ2EO\'>-;V].Q\#O0I2[SN ?EBLE
MR_5F%3#0YPH^0U;T<40P?FT?/XI.5OGQ?%3(3*4FN/UV(3YJ!A;K\DE^-:;A
MZW)>\N>9R@J>$\E-#7G3C*8@@*B" @&)_@N/1<R3$&E(O2A<OMH1<XQ.9+2$
MR#KJ'Q#;[9Q!21[#-)ZW@='O#>)HF&IF_M0-FMG3CV ":3M6%-GEY-@]RKOQ
MX$K6CS_(?J\CQ4U,II;Z=24?RLU#M;^-FI$$"1HKP)#* 2I$!@A/,5 X5JI@
ME+-,N$5P^P&Q^DS'C>E^40GEL0$=Z7_M[61[A'E[CI2=A1R0_?$ZH]<*1+_L
MJ_ 7,P1;+>KHK$Z/FV'VSJ]C,ERS0A\08_<LO(*H$ZT+KWF:IPO)?TBQF4O3
MF/FP-)46]^MR*?XHY_,[$RNVJ[F:9B@KXI@!04S%;9D@0$5.].(]+1!F:<*D
M9?VH*U!,T(5LE3#?:X>Y_ER;JCD?A9GX5&FT.*[0YNAG>HR:I9\Y[$@,[6?N
M#<$1Q?58; ?F]UJ)@3Q.?Q)#>9P>",;U./TI.O(XKWB49_1_VR:IE$;$<77?
M7?U=$@N5H S('&. TE0 DE!H?,PT(1PK);F;I;05/3WS^.GC[9N/GS[>?7S_
M/;K]_"[Z?O?E[?_YSR^?WKW_]OU_1N__[V\?[_[+,;;?=ACL3-\0U YL[_8@
MU]:MK1(^2,B^(SNAHO1MQ8X;F.](QE$LONO]?G;JM^]WJ[HWPG.;_J3EM6UY
MM$$27'$.TIA*@'+]$Q$Q!)#$*HX187ELU8#MLJBI';'\]CVZ7VJ3MZAWGJHM
M6C?;TT.MG;4)0]C ]D5SU:&,=C OMX5RMBZ7V0AD3WH$C6I!+BO\TF98W#%0
MO;/J0AF=7_65:[TF;<X[_B%-<+H4M_H;H_?R_4\3N5[)KZN2RQG*\BQ-8P)R
M4@>"HEB;':2 9%F>4*G]I5@&+H(6#OWT?*H:NQ3U6>YOW]]%CWJ=69_INA[I
MCO@*7'/>\>K#.N(YR;FZ:I5M8;6& 5--HN'@)NI8B%H:HHZ'J"9BQ'IKX4=O
MK")L 9%/X(AGT"%Q+M<V (0K^PYN]Q'V//:VW9CXLOAF)F)STM\DT*ZZ?[XQ
M#1#K'8<9TXO\6$H"$$8"( @S0.,T!E!1F>5Q(@KAE/D0#-G4W/)=#\/]%H:5
MR1MJL7>)Z5MEVCT\WZ:&5X^MW4SV*B,V\#RUWW#RBO'Q;Y@8BLO0;16OQO4Z
MS1=#T7FV16,P 9Y+''G?IKJ9D[7%_5Y[^P77<!;W)@;VTS; &D&<%S!-0*%H
M!I I\<90(4".\X0EE*:8.&6P.,J?FFUNX4=;_.:KKS6(]E2H8[>OB'5W'23+
MA<1PU ^]& C-NKL;[\==*%?<4?JX[K0?-4<NL>=C/".EGF@Y-^;TPW+UG<ZE
MR0/:;2:U80?&.Z_6M>F=Q0CR0HD89 J;8%$( 47:CR4BS07-N+:3PJ4&L2L
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M52&SECPYT[]Y?)S7"W?M E9['\]BN0!&I4B#+I_*]?/_=MLDM!\+CI&,62)
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M5/UG>+86H#OS9FUD#HC^W68&W'_/UZ5N:K&;LY($'/N(4,AI'"L?EODPI8)
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MS#QN7-=U\=#LM1NAV^$M/ZZX^/G_Q*]%PK G0\0@HWZ@_-W8A\03"8R2@++
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M+E*_[WJVLZ[B/& PS-C!,;9390<<E6[0A4!JF#>JMP?<&O"]+49EC,LD EL
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MW$CTJDFFZL:RNR&B_RSF <(<NZ9AFTZ[M'3GSX]2ED(61FY.=H+./[]Y<F+
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M\JP9\9T\]AX"I,=2:0<9%&+JRK6'9^ARTA)L-#7]XQTX6RU\42+)9&TVO'6
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MCF6.X0U^C[OVCN #LX,C"\E[Y\A<25>'4ALR5S(!ZF032Q&Q^92!G0AK/'-
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M"]._A]DIWL-A1"THZ*+#P->$ME"U(%($L)Z";EG(?[XY9GLHE#Y Y;A/?#L
M:2L-=H#1RP3/ZL/BGNO;#:?Q)J?OD$2]FJ[Q;$C>5C3O,"T^SC>?LI'21*,C
M&1L&/@=9^P,7\)&\'9]3%ESR4F+K+O)#\S3N(^*C^@\]H:.#W=+L!41P11"?
M";A"4T\R3^IQAOPO-%XZIH1LW1?IJ.]=!GOB?$STCZ+M4=^[U <".VWZ"S6<
MXH?%>R3=;4^_P%%+YSP(C8D""=K/40L&(21I$M>(\48IY^TW"8<2,>Z[Z&,
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ME@FMI0'+:S2@@H!(F *TSOL4*>0MK:W>?;0</)EUNOJ\6(797Y>+T\^KBVO
MS1BY"FER<\]: -'>J]^=+584(5T"G!MM)%,)DK04%!D3(68EZ]O8PD@6UH36
MQNQ0FD?.U[5 U:VIK,=48Y]VZF)J\J\8*F_;<&$/:W7W!S6P63M0V,AR7:QT
MJ>K+LU 5+YS3&ERQ'E1!"YZ6!,:,=4*:@K+UCGV(GH,?H=SQV9>X-E(%P^G\
ME:K.OO2%<,V3IDTEM1+:^G3S(?$@S'9B>YKAXM9SDV9*Z#5@)=^35EA/XPS?
MXWRZ6+Y>K/<+1>_YI 8&9A<:&UF8^F#M4M<7&$+C.?=1D&-M&+F[Q0$YP $T
M.;["%!9X;MW/\6Y*#I]8?_53+Z&<].8ZHX 1G@[I.JXT8*% 0N>2"S-&Y-;/
M.NXA95Q+TD#_MR?+'R[R7JW'13OK?0S&Y3]N8"/NH:216;CX]#NP83U&IKTA
MQQ)5;6:+$.H=BHC9\"R0HVF]=1X@IT'+Y9L??0E9[U&BTPI$SAH49@D^D5-?
M"] P"*5R\_ZA#]$S^G"7)IBXHX]R&PWT&<]LGD]^VCX$VO:DVBOU<OM36F1?
MOD-;(VNR_>C+*@/-HS?D/.KZ:E0QP\$+X\ ::^M]B[2R]6W4=0H.+I:[);;J
MH-T%7Y>%+))X\X8CG7DZ0_""0[!%!.]H7\C6KTUV)FY<:W( )FZ5R VBCEY=
MD-KP:;JY0:1O7SPZW/<^[8%/:Q+([$9K(SMSN=RF&^75]>XXLT21&BTOH(*/
M=+1$!TXX R:BBID)Z]J7ZSR&P(/KEG99[')O" *_3ZDF#84YZXN(O&8.&0_,
M.\9Y:U/U. K'M5?#8>M6'=-P>NO30SKD3GVL6H)>:@K^ +4%.2NNE/8@&7/U
MK;L&'TJMHQ&(PH@*WQ^IMF!36O;+Z6HZQ]6JWF^^*876_77Z<7MOLU'9MRL;
M6&<NK55@"GIR2J($5WR (+1DSI3$<+<>F;NO^2.4 CP&5M>J_@9230=E@&<5
M#C>LQ+>;7-4.\ES*#,@=U@%L)+EZ=EC'@M3<<5\&JEOY#F7C%IR.!\L!]=?%
M4Y^[KZ]OLI6X8SY)"=QFVFRJUO;4F5DANU"'40<,K:_X=B)LW%+5\5'97GL=
MF,K?5OBF/%^MIR<DJ]5$%9&#YQFRJ2W-(E/D/^L(+C&#6$+PK'4ET'4*QFUQ
M,#[(#M!'!V@Z&S>Y[<<]WTBC]B)[>KI:+TYP>7.O!$_[(Y !3TK6!J&*/ I7
M"B#3V:F$6:O6'34?1^&XW0C&1^. ^NP"K0FG7^HLWM6'9<AU8/2F$=3Y'.G+
MGS^9S1:_U_ZC+Q;+9XO3N"ZGLXMITQLA3&QV@LM(6[.$"$HJ,OD.$8HJ3LLL
MF#&M*P5:TC]N_X(>D#X2%CK8!Y?OOF[L9QTB$YX;*))O6D3Z^D0GTY=T'&&.
MBH?6%U3WT3)N5X/Q\=E$1V,_XKQG1L=-EE!P8ZP+M=V-KR,[!'B9$R2/F*)+
M,N@;A17W)()V6V_<=^@C)X$&4$D'%NWNEK?;WLTDUY=DO2F0^X)U_M"YT9:8
MC53D6X=D:2/%XB$F'D$8[;0IR6!HW7=C#S)W JO_\<!Z+,UVD2=Z'I;SZ?QC
M[6VWX??F;N0.8S0L ]/6U6(@!E'0Y@S>Q61Y4M:W;@O_'9)V2Z2S'Q>7+576
M:\7%(?=S'S:N];%O)\]6'?EN\B[>N[J9U 9SEA2HBX04MZ-D$%1*X#%DSE/Q
MV;3..'?QZOG9=!4^?ES6]N";I<[2'1M]76Y=YJ+0@2G0D?QJ)40 9Z6K-9V9
M:68<JM8#K78B[$>XO'P,\N[(QS?6WMCQT?OT"?/I?:.P;S"F(D/,Q0%S]1%2
M5@)BY!F2SJ4>5S*FO%.4])A5?X2;R7TP-ZQZ.HB8ZF.5]YC.QED_^1*FL\I/
M'1\29C?W5,@^JV(+V* 4J%++1W5$0,.X0.N8TZTGK3V&OA_AHO(@PSB4+CO
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M0BXRU[_B2<3E1->IY(9)0,-9W3J1MHX3$$3*%E6PB.%[SMOW%AD=#(?J;S&
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MP;.7;R:61(X=@N";[DX\@[=*@Y!9AY0,1=CI>&B\B\31^Q . Y7=(7FPWCJ
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MC8'$B2.%'"%FIT!;ER07Y$9BZQ9;CZ&O6T=_3W0LCJ2J+@[4<PXF,D8E93:
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M51>=+C?C(77> :0W*JAW)VJVX6XA7G3V^#G#>RF1U_0/5C\F@9? T'BH5X9
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M(PH 9(0IO+FY\M$<S4*0%2@M\!A@X 1")= /!8>$L!F;6 J'N7!:D6, K<N
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MFI6(;'DS/QN:]?OC%5'<PC1C8PAC"VR)>:N S(+WZJOQG6[*M8^_TK1_Y2+
M3M3Q.?-(]Y$Y"3Y((#=9UH]MQ[?I(T+8"M<,3M:OX-IF.%O<\L>6L4@_-6VE
M+W*,V;.?7V;;66G1A0XA](E>[_+"UV?9;_KQJ/F,]>(O4$L#!!0    ( .R
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M&.N\#=E\C%6_AL_:V:>IYB/9_?\ 4$L! A0#%     @ [("H5K:IT6S<$
MK7,  !X              ( !     &$Q,#(M9&ER96-T;W)C;VUP96YS871I
M;VYA+FAT;5!+ 0(4 Q0    ( .R J%8;-/%NUDD  "/C 0 >
M  "  1@1  !A,3 S+6-H86YG96EN8W1R;'-E=F5R86YC92YH=&U02P$"% ,4
M    " #L@*A6ANKO"S"> 0 ![A( $0              @ $J6P  ;&=N9"TR
M,#(S,#,S,2YH=&U02P$"% ,4    " #L@*A61C!"WM$0  "7JP  $0
M        @ &)^0$ ;&=N9"TR,#(S,#,S,2YX<V102P$"% ,4    " #L@*A6
M0XQP3"LD  ![6P$ %0              @ &)"@( ;&=N9"TR,#(S,#,S,5]C
M86PN>&UL4$L! A0#%     @ [("H5FRQ.T^@50  N[<# !4
M ( !YRX" &QG;F0M,C R,S S,S%?9&5F+GAM;%!+ 0(4 Q0    ( .R J%8_
MCMR#@Y(  "K*   4              "  ;J$ @!L9VYD+3(P,C,P,S,Q7V<Q
M+FIP9U!+ 0(4 Q0    ( .R J%;4MG$&Z^0  &*'"0 5              "
M 6\7 P!L9VYD+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4    " #L@*A6/9"%
MV;R!  "2W 4 %0              @ &-_ , ;&=N9"TR,#(S,#,S,5]P<F4N
M>&UL4$L! A0#%     @ [("H5AZ@QGOC"   (3L  !@              ( !
M?'X$ &QG;F1?,S,Q,C-E>&AI8FET,S$Q+FAT;5!+ 0(4 Q0    ( .R J%:^
M;I>OO@@  "\\   8              "  96'! !L9VYD7S,S,3(S97AH:6)I
M=#,Q,BYH=&U02P$"% ,4    " #L@*A6V]%4TYP&  !_*P  &
M    @ &)D 0 ;&=N9%\S,S$R,V5X:&EB:70S,C$N:'1M4$L%!@     ,  P
*-@,  %N7!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
